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Abstract
Genetic Algorithms (GAs) are a search heuristic modeled on the processes of evolution.
They have been used to solve optimisation problems in a wide variety of fields. When
applied to the optimisation of intervention schedules for optimal control problems, such
as cancer chemotherapy treatment scheduling, GAs have been shown to require more
fitness function evaluations than other search heuristics to find fit solutions. This thesis
presents extensions to the GA crossover process, termed directed intervention crossover
techniques, that greatly reduce the number of fitness function evaluations required to
find fit solutions, thus increasing the effectiveness of GAs for problems of this type.
The directed intervention crossover techniques use intervention scheduling information
from parent solutions to direct the offspring produced in the GA crossover process
towards more promising areas of a search space. By counting the number of inter-
ventions present in parents and adjusting the number of interventions for offspring
schedules around it, this allows for highly fit solutions to be found in less fitness func-
tion evaluations.
The validity of these novel approaches are illustrated through comparison with conven-
tional GA crossover approaches for optimisation of intervention schedules of bio-control
i
application in mushroom farming and cancer chemotherapy treatment. These involve
optimally scheduling the application of a bio-control agent to combat pests in mush-
room farming and optimising the timing and dosage strength of cancer chemotherapy
treatments to maximise their effectiveness.
This work demonstrates that significant advantages are gained in terms of both fitness
function evaluations required and fitness scores found using the proposed approaches
when compared with traditional GA crossover approaches for the production of optimal
control schedules.
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Chapter 1
Introduction
Genetic algorithms (GAs) are search procedures inspired by the mechanisms of natural
adaptation. They were defined by Holland [1] in 1975, and have been extensively
studied and used in real-world applications.
GAs have been used to find good solutions from large search spaces across a wide range
of application areas. One such area where they have proven successful is for deriving
solutions to optimal control problems. Optimal control theory is concerned with finding
the best control schedule for a dynamic system which optimise a performance criterion
in some way.
Optimal control problems arise in a wide range of fields of engineering and sciences
[2], however, the task of designing and implementing algorithms for solving optimal
control problems can be a difficult one [3]. GAs have been readily applied to this type
of problem as they require little knowledge of the problem domain itself to search for
solutions.
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GAs work on a set of solutions, termed a population. Each member of the population
is referred to as a chromosome and encodes a solution to the problem in hand. For
many optimal control problems each chromosome encodes a set of interventions across
a time period. Each chromosome has an associated fitness score describing how well
the encoded solution solves the problem in hand. Following a survival of the fittest
metaphor, fit solutions are assigned a higher probability of producing offspring than
less fit solutions. Offspring are created through the evolutionary inspired processes of
crossover and mutation, where crossover splices genetic material from parents into off-
spring, and mutation introduces diversity into the solutions. The crossover process is
commonly regarded as more innovative than the mutation operator [4]. Conventional
GA crossover approaches exchange the scheduling information contained in parent so-
lutions at random to produce offspring.
Although GAs have been applied successfully to a range of optimal control problems,
they have been found to be slower when compared to other search heuristics [5; 6; 7].
This leads to the question of how GAs could be made more effective for this type of
problem.
The hypothesis put forward in this work is that the performance of GAs can be im-
proved with respect to intervention based optimal control problems through using the
number of interventions present in parent schedules to direct the offspring to promising
areas of the search space. As crossover is key to the GA process and is considered more
innovative than mutation an extension to enhance crossover could therefore provide
a more effective search for problems of this type and improve the GA performance.
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In order to prove this position, novel techniques have been created, termed directed
intervention crossover approaches. Through comparison with traditional GA crossover
approaches for optimisation of bio-control and cancer chemotherapy schedules, the va-
lidity of the novel crossover techniques will be demonstrated.
The remainder of this thesis is structured as follows:
Chapter 2 contains a review of genetic algorithms, including details of their opera-
tion and theory. The main components of GAs are discussed, such as the encoding of
solutions, how fitness is assigned to solutions, how parents are selected to produce off-
spring and how offspring are subsequently constructed. Other aspects of GA operation
are considered, such as how the population is initialised and when the GA operation
terminates.
Optimal control problems are the application domain for the techniques discussed in
this work. Chapter 3 provides an introduction to these types of problems and describes
some heuristic techniques for solving them. The limitations of using GAs for optimal
control problems are discussed and an extension for their improvement is outlined.
Chapter 4 discusses techniques developed to test the validity of these extensions. This
chapter introduces the directed intervention crossover techniques of Targeted Inter-
vention with Stochastic Selection (TInSSel), Calculated Expanding Bin (CalEB) and
Directed Uniform Crossover (DUC). The rationale and algorithmic processes for each
of these techniques are described.
In order to assess the novel crossover approaches detailed in Chapter 4, suitable test
problems are required. Chapter 5 details the test functions used for analysis in this
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work, namely bio-control scheduling for mushroom farming and cancer chemotherapy
drug scheduling. This chapter describes the background for the problems as well as
their mathematical formulation.
Chapter 6 details the experimental method that will be used for the analysis of the
crossover approaches. This chapter details the rationale behind the selection of GA
parameters used for experimentation as well as the statistical tests and methods used
to ensure accurate analysis of data.
Chapter 7 reviews the strengths of traditional crossover approaches for optimisation of
the problems detailed in Chapter 5. This chapter reviews single point crossover (SPC),
two point crossover (2PC) and uniform crossover (UC) for both bio-control and cancer
chemotherapy treatment scheduling.
Chapter 8 details the results of applying the novel crossover techniques discussed in
Chapter 4, to the problems described in Chapter 5. These techniques are compared
to the best performing traditional crossover approach found in Chapter 7 in order to
determine the benefits of the novel techniques.
From analysis of the findings in Chapter 8, an extension to the novel crossover tech-
niques is proposed. Chapter 9 details an implementation of this extension called Fitness
Directed Crossover (FDC). This chapter compares the FDC technique with the best
performing novel and traditional crossover techniques for optimisation of the test prob-
lems.
The final chapter summarises the contributions made by the novel crossover techniques
introduced in this work and reflects on the associated strengths and limitations. Further
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extensions to the directed intervention crossover approaches are described as well as
potential areas for further analysis of the work.
Finally, Appendices A through to J contain the detailed experimental analysis from
Chapters 7, 8 and 9. This shows the empirical results of applying the techniques to the
test problems over a range of experimental parameters, as well as the associated tables
of statistical analysis.
5
Chapter 2
Genetic algorithms as a method
of evolutionary search and
optimisation
2.1 Introduction
Genetic algorithms (GAs) are search procedures inspired by the mechanisms of natural
adaptation. They simulate the evolutionary process, and have a simple operation.
They were defined by Holland [1] in 1975, and have been extensively studied and used
in real-world applications. GAs are considered attractive in many fields due to their
robustness, simplicity and the variety of solutions they find [8].
GAs start with a population of random individuals, where each individual encodes a
solution to the problem in hand. Through procedures that model survival of the fittest
concepts, solutions with higher utility will have preference in producing offspring. Over
time this tends to lead to better individuals typically being found.
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initialisation
selection
breed children
update population
completion
Figure 2.1: The GA process
This chapter is a review of these search procedures and starts with an overview of their
basic operation and methodology. It discusses the concepts relating to how a popu-
lation of solutions is encoded, initialised, scored for fitness and selected for producing
offspring. Other areas reviewed are how offspring are produced and reintroduced into
the population and how and when stopping criteria are determined. Following this,
the rationale and underlying theory of the GA will be examined. Current GA practice
is then described, outlining the common methods for determining parameter settings,
including both population size and crossover and mutation rates.
2.2 Genetic algorithm operation
The GA process is shown in Figure 2.1.
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In general, GAs are initialised with a random population of solutions, where each
solution represents an encoding for the problem in hand. Following this, solutions are
typically selected to produce offspring based on their fitness, with greater opportunity
offered to fitter solutions, thus facilitating good solutions to pass their material on to the
subsequent generations. Children are then bred from the parents using the evolutionary
inspired methods of crossover and mutation. The population is subsequently updated
to include these children. If the stopping criteria has not been reached, the selection,
breeding and replacement process repeats, otherwise the GA process is complete. Each
of these components will be described in more detail in the following sections.
In order to apply GAs to a problem, an internal representation of the search space and
an evaluation function are required, and both of these components are critical to the
successful application of the GAs to the problem of interest [9]. The following sections
will explore these concepts in greater depth.
2.2.1 Encoding
When applying a GA to a problem domain, the first step is to determine an appropriate
encoding. This is seen as one of the primary decisions concerning a GA [10].
The encoding allows each possible solution to encapsulate the relevant variables for the
problem. The set of all possible solutions is termed the search space for the problem.
Many different encodings have been used, with a string representation of a binary struc-
ture being the traditional approach, and other encodings including real, permutation
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and tree encodings. In a binary encoding, with a bit string of length n, each individual
represents one point in a space of size 2n.
As GAs are inspired by the theory of evolution, various terms are used from this domain.
Each solution is referred to as a chromosome, which is made up of decision variables,
termed genes. Each gene has a value and this is termed the allele, such as a 0 or a 1 in
a binary representation. The position of the gene within the chromosome is known as
the locus. For example, given the following binary encoded chromosome:
1 0 0 0
The gene at locus one has an allele of 1, with the remaining three genes at loci two,
three and four respectively, having alleles of 0.
Deciding an appropriate encoding for the GA is a key decision and is considered a
central factor in the success of a genetic algorithm [11]. Once an encoding for solutions
is found, an evaluation function, more commonly referred to as a fitness function, is
required to provide a score of a solution’s utility.
2.2.2 Fitness function
In GA terminology, fitness is defined as the means of profit, utility or goodness that
is to be optimised [12]. The fitness function is the only information the GA requires
of the problem [13]. By evaluating a chromosome with regard to the fitness function,
a score will be returned pertaining to how well the chromosome solves the problem
in hand. Continuing the biological metaphor, the fitness score reflects how well the
individual is adapted to the environment [14].
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A simple fitness function known as the Onemax problem, is shown in Equation 2.1.
This problem takes a binary string x of length l and seeks to maximise the number of
1’s present. The greater the number of 1’s in a solution, the higher the score the fitness
function returns.
l∑
t=1
xt, xt ∈ {0, 1}l (2.1)
If the chromosome described in Section 2.2.1 was passed through this fitness function,
it would return a score of 1. The optimal solution to this fitness function would be for
each gene of a chromosome to contain a 1.
Once an appropriate fitness function has been decided upon, the initialisation method
and stopping criteria have to be defined. Each of these concepts will now be discussed.
2.2.3 Initialisation method
Genetic Algorithms work on a population of chromosomes. This has a significant
advantage in that a high number of portions of the solution space are explored with
great efficiency, concentrating samples in the most promising regions [15].
Traditional GA methodology uses a random population initialisation, where each chro-
mosome is created by picking random values for each gene. This is of benefit since no
knowledge is required of the structure of solutions.
As with most aspects of GA methodology, alternative initialisation methods exist. In
a domain where the GA user has a knowledge of what represents good structures, the
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population can be initialised including some ‘seeded’ good values. This benefits the
GA as salient characteristics from these solutions can spread through the population
allowing for highly fit solutions to be ascertained in less time than with purely random
initialisation. Other techniques include using the best solution found from previous
runs of the GA as a partial solution from which to generate the population for the next
run [16], and for some problems, case-based initialisation of populations [17].
2.2.4 Stopping criteria
There are various options open to the GA practitioner for deciding when the search
process should stop. Common approaches involve the GA stopping after a fixed number
of fitness function evaluations, when the population has converged or when a solution
of a particular fitness has been found. If the optimal fitness score is known, the search
process could be stopped on discovery of a solution with this fitness, however as many
optimisation problems have complicated objective functions or contain difficult con-
straint structures, in practice, any near-optimal solution would be desirable if obtained
with a reasonable effort [18].
Theoretical guidelines for the number of fitness function evaluations required to stop
the search process have been reviewed and include bounds for an optimal solution, for
certain classes of problems [19] and bounds for convergence [20].
The following sections review how solutions are selected for breeding, how the breed-
ing process produces children through the methods of crossover and mutation, and
subsequently, how these child solutions are introduced back into the population.
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2.2.5 Selection
The selection mechanism chooses the chromosomes in the population for reproduction
and its main function is to emphasise better solutions in the population [21]. Generally,
selection is based on the fitness of the chromosome, thus the fitter the solution the more
times it is likely to be chosen to reproduce. Selection is seen to provide the driving
force in evolutionary algorithms, and selection pressure is seen as a critical parameter
[22]. If the selection pressure is too high, there is a high probability of the population
prematurely converging to a sub-optimal solution. When the selection pressure is too
low, there is not enough drive in the system, thus optimal solutions may still be found,
but the process may be much slower than necessary. To combat this, techniques such
as Boltzmann selection are used which varies the selection pressure in a similar manner
to the temperature control of simulated annealing, according to a preset schedule. This
provides a low pressure at the start of the run which facilitates reproduction from less
fit individuals and thus increases diversity. As the run continues, the selection pressure
grows thus giving more reproductive opportunity to higher fitness solutions.
In Holland’s original work [1], fitness-proportionate selection was used. Fitness-proportionate
selection uses the fitness of a solution relative to the average fitness of the population
to determine the likelihood of selection to produce offspring. This is commonly imple-
mented as roulette wheel sampling whereby each solution gets space on the ‘roulette
wheel’ proportional to the fitness of the solution compared to the population. The
higher the fitness of the solution compared to the average fitness of the population,
the greater the space on the wheel allocated to that solution. When the wheel is spun
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(i.e. when selection occurs), there exists a higher probability of the selection marker
landing on a fitter solution.
Although widely used, fitness-proportionate selection of this form has various draw-
backs related to scaling. If the population is created randomly, there will probably be
a wide spread of fitness values. As this form of selection greatly increase the likelihood
of selection relative to the population average, numerous copies of these fitter solutions
will be chosen for reproduction. This can introduce the problem of super individuals.
This is caused through fitter than average solutions dominating the selection process.
This may lead the GA to prematurely converge on sub-optimal solutions due to a lack
of genetic diversity [23]. Techniques such as winnowing and rank based selection [24]
have been designed to allow fitness-proportionate selection to overcome these problems.
Winnowing subtracts the worst fitness score from the previous w generations from each
of the current fitness scores to produce a more constant selection pressure.
Rank based selection was introduced by Baker [24]. In this approach, the members of a
population are ranked according to their fitness and the number of expected offspring
for each member is calculated based on this rank, rather than on the direct fitness value
of the solution. There are varying forms of rank based selection commonly in use, such
as linear and exponential.
Both rank based selection and fitness-proportionate selection can be quite expensive
processes. Rank based has to sort the entire population and fitness-proportionate
has to undertake two passes of the population, one to calculate the mean population
fitness and another to determine the relative fitness value of each solution. A popular
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alternative to these approaches is tournament selection. Tournament selection has been
shown to provide better or equivalent convergence and computational properties when
compared to alternative approaches [25].
Tournament selection has been used in a number of works and follows a simple premise.
First, n individuals are chosen at random to compete, then the fitter of these individuals
is chosen for breeding. Binary selection, where n = 2, is commonly used [26]. Larger
tourneys can also be used, and the larger the tournament size, the higher the selection
pressure. As described in [27], a key strength of tournament selection is the ease of
parallel implementation.
Comparative analysis of selection schemes have been undertaken, such as [28]. When
compared to truncation or rank based alternatives, tournament selection has higher
selection variance and smaller loss of diversity for the same selection intensity [29].
However, as with all approaches, tournament selection has drawbacks. As each tour-
nament is carried out separately, tournament selection can suffer from sampling errors
[22].
Truncation selection was first used in genetic algorithms in [30] and incorporates some
threshold T , where only a fraction of T best individuals can be selected. Each of the
individuals in this threshold have similar probabilities of selection.
Once individuals have been chosen to produce offspring, the next step is to create
offspring. This is achieved through the processes of crossover and mutation.
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2.2.6 Crossover
Crossover and mutation are termed the genetic operators and provide the main search
functionality of a GA. Mutation creates random diversity in the population while
crossover promotes emergent behaviour from existing genetic components [31]. Crossover
is commonly regarded as more innovative than the mutation operator [4] and the search
power of a crossover operator is commonly considered as a measure of how flexible the
operator is in creating an arbitrary point in the search space [32].
Once parent solutions have been selected for breeding, the next step is to apply crossover
and mutation. As with its biological equivalent, the GA crossover process creates
offspring representations from parts of the parent representations. This allows salient
characteristics from the parent solutions to be combined to produce children that are
potentially fitter than either parent alone. Indeed, without the crossover process, GAs
would amount to little more than random search [33]. Crossover is applied subject to
a predetermined probability pc. Typically a value n is generated between 0 and 1 and
if n ≤ pc crossover will occur. If n is not less than pc, one of the parent chromosomes
are copied at random, into the next generation. Commonly used crossover techniques
include single point crossover, two point crossover and uniform crossover [34]. Each of
these will be reviewed in turn.
2.2.6.1 Single point crossover
Single point crossover (SPC) is the simplest form of crossover. A crossover point in the
chromosome is randomly determined and the parts of two parents after this point are
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exchanged, thus producing new offspring. Consider the following two parents selected
to produce offspring:
1 1 1 1
0 0 0 0
If crossover was determined to occur after the second gene, this would produce the
following two children:
1 1 0 0
0 0 1 1
2.2.6.2 Two point crossover
Two point crossover (2PC) is an extension to SPC which selects two crossover points at
random and swaps contents of the parent chromosomes between those points to form
offspring. Using the two parents described before, if crossover points 2 and 4 were
chosen, this would make the first child comprise of gene 1 from the first parent, genes 2
and 3 from the second parent and gene 4 from the first parent. Conversely, the second
child will have gene 1 from the second parent, genes 2 and 3 from the first parent and
gene 4 from the second parent. This produces the following two children:
1 0 0 1
0 1 1 0
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2.2.6.3 Uniform crossover
Uniform crossover was studied by Ackley [35] and subsequently popularized by Syswerda
[36] and is a popular alternative to the one and two point crossover approaches. Uni-
form crossover (UC) can perform more genetic exchange per crossover process than
both single and two point crossover and works on a probability of taking a particular
gene value from one of the parents. Typically, this involves generating a random num-
ber, n, between 0 and 1 for each child gene position, and if n ≤ 0.5 then the gene value
becomes the same as the first parent at that locus. If n > 0.5 then the offsprings value
for the gene in question is copied from parent two. Usually the swapping probability sp
is taken to be 0.5 [37], however, parameterized versions of UC, where different values
of sp are applied, have been used and found to be useful in certain cases [38].
Using the two parents selected for breeding detailed previously, if the random values
0.1, 0.6, 0.2 and 0.9 were generated for n for the first child, this would translate to
taking gene one from parent one, gene two from parent two, gene three from parent
one and gene four from parent two. This would create the following child:
1 0 1 0
If for the second child the values 0.8, 0.8, 0.9, 0.1 were generated, this would create the
following child:
0 0 0 1
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Using UC, if both parents contain the same gene value at a particular locus, this value
will always be copied to the child.
UC is probably the most commonly used crossover operators due to its ability to re-
combine non-common genes and find and protect common genes [39]. However, some
research indicates that UC outperforms two point crossover for smaller populations,
while for larger populations, two point crossover is the superior approach [40]. There is
no consensus on the ‘correct’ crossover approach to use on a particular type of problem.
The crossover stage is key to the GA process. Once this crossover process is complete,
the next step is to apply mutation to the offspring.
2.2.7 Mutation
After crossover has produced offspring, mutation is then applied. Mutation diversifies
the search directions and avoids convergence to a local optimum [41]. Mutation intro-
duces new gene values into the population and through this, allows exploration of other
areas of the search space. For example, if a population consisted of binary solutions
which all had a ‘1’ as the last gene of the chromosome, no amount of crossover could
ever change this as regardless of crossover strategy or crossing point, each solution will
continue to have a ‘1’ in the last gene position. Mutation, could change this value (or
indeed any other gene in the chromosome) and thus provide evaluation of a different
area of the search space. The simplest form of mutation is ‘bit flipping’. Here, for a
binary string, if the current gene value is a ‘0’, mutation produces a ‘1’ and conversely,
for a gene value of ‘1’, mutation produces the value ‘0’.
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Mutation has a probability associated with it, pm, which is generally quite low, usually
in the region of 0.01 to 0.005. For each gene, a random value is generated and if this
is ≤ pm, then the value of that gene is subject to change. For example, given the
following binary chromosome:
1 0 1 0
If the random values generated to test for mutation were 0.800, 0.900, 0.200 and 0.001,
where pm is 0.005, this would mean leaving genes one, two and three as they are but
flipping the value of gene four, thus producing:
1 0 1 1
Once the processes of crossover and mutation are complete, the offspring are evaluated
using the fitness function as described in Section 2.2.2. They are then ready to become
part of the next generation of solutions. There are various approaches to replacing the
old solutions with the new and these will now be discussed.
2.2.8 Replacement
Alternatives exist regarding when to add the offspring to the current population and
which members of the current population should be removed to make space for these
new members.
A common technique for incorporating offspring into a new population is the genera-
tional method. This means that for a population of size N , parents will be selected
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from the current population to produce offspring until some predetermined fraction of
N offspring have been produced. This fraction of new individuals for each generation
is called the generation gap [42]. A generation gap of 0 would mean that none of the
previous population is replaced, with a value of 1 specifying that the entire popula-
tion is replaced at each generation. Once produced, the current population and the
offspring are merged to form the next generation, of size N . This process continues till
the stopping criteria is met.
To ensure that good solutions are not lost from generation to generation, elitism is
commonly employed. With elitism, the best chromosome in the current population is
guaranteed to be added to the next generation, i.e. it will not be overwritten by new
offspring from one generation to the next. This ensures that the gene values which
currently provide the best fitness will not be lost to the subsequent generation.
The generational replacement technique is not without some potential drawbacks [21].
One is that even with an elitist strategy, many good solutions may not reproduce and
thus their genes are lost. One solution to this problem is that of the steady state
replacement strategy.
Steady state is an alternative replacement approach which places a small number of
offspring into the population at each generation. Various studies have compared this
and the generational approach [43] and while the generational approach may be more
commonly used, techniques such as GENITOR [44] use a steady state replacement
strategy as a key part of their algorithmic operation. Although there is no ‘correct’
choice for the replacement strategy, for some non-stationary environments, steady state
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has been shown to outperform generational replacement. This was attributed to it
allowing offspring to be immediately used as part of the mating pool, making a shift
towards the optimal solution possible in a relatively early part of the optimization
process [45].
The generational approach tends towards a high generation gap value, thus replacing
most of the current population, while the steady state replaces only a few individuals
and thus has a smaller value. As mentioned previously, techniques such as elitism can
be used to protect good solutions with a common representation of this ensuring that
the best solution in the population is copied forward to the subsequent generation.
The Chapter thus far has reviewed the representation and operation of a genetic algo-
rithm. The following section reviews the theory which underlies this process.
2.3 Genetic algorithm theory
Conventional understanding of GA operation centers around the theories developed by
Holland [1]. This is based on the notion that useful parts of different solutions can be
combined to form good solutions. Holland introduces a schema as a similarity template
to represent a set of solutions from the search space. Holland’s work focussed on bit
strings, and each schema is represented by the alphabet {0, 1, ∗}, where * represents a
wildcard at a particular position.
Using this ternary alphabet, 1*01 represents a schema which requires the first bit to
be a 1, the second bit can be either a 0 or a 1, the third bit as a 0 and the fourth
bit a 1. If a bit string obeys a schema s pattern, it is said to be an instance of s.
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Both 1101 and 1001 are instances of the previous schema. Each 1 or 0 in a schema
are known as defined bits and the order of the schema is the number of defined bits.
The distance between the two outermost defined bits is known as the defining length.
The previous schema therefore has order 3 and a defining length of 4. The operation of
GAs can thus be regarded as “a search for schemas of high average fitness, carried out
by sampling individuals in a population and biasing future samples towards schemas
that are estimated to have above-average fitness” [46].
Holland used these concepts to perform analysis on the effects of the GA operators on a
schema H. This showed the dynamics of the increase and decrease of schema instances
and was formalized as the Schema Theorem, as shown in Equation 2.2.
m(H, t+ 1)) ≥ m(H, t)f(H)
f¯
[
1− pc δ(H)
l − 1 − o(H)pm
]
(2.2)
where:
m(H, t) is the number of instances of schema H at time t,
f(H) is the average fitness of strings representing schema H at time t,
f¯ is the average fitness of the entire population,
pc is the probability of crossover,
δ(H) is the defining length of schema H,
l is the length of binary string,
o(H) is the order of schema H,
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pm is the probability of mutation.
The schema theorem assumes fitness-proportionate selection, one point crossover for a
population of binary strings, using non-overlapping generational replacement but has
been extended to consider various other selection schemes and operators [47; 48].
This theorem says that while selection emphasizes fit schemata (a template that iden-
tifies a subset of strings with similarities at certain string positions), the variation
operators destroy some and “advocates the idea that GAs achieve success through the
juxtaposition of short, low-order, high performance schemas”[49]. These short, low-
order, high performance schemas are known as building blocks and are sampled, re-
combined and resampled to form chromosomes of potentially higher fitness, also known
as the building block hypothesis [12].
Holland’s analysis of the schema theorem also showed that when a GA is evaluating
an individual, it is actually evaluating partial solutions as well. Consider the following
chromosome:
1 0 1 1
when this is evaluated by the GA, it is also evaluating sub solutions of 1011, such
as 1***, 1**1, *0** and many more. This evaluation of partial solutions is called
implicit parallelism and is considered one of the reasons why GAs are so powerful [14].
This means that when a population of N solutions are evaluated, a number of partial
solutions are also evaluated, at a cost of only N fitness function evaluations.
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Mitchell believes that with regards to GA theory, there is more open questions than
answered ones [11]. This has not stopped GAs being widely applied and the following
section outlines some of the current practice in the use of these techniques.
2.4 Current genetic algorithm practice
The previous sections reviewed both the components that make up a GA and their
underlying theory. This section builds on this by considering how parameter values for
these techniques are derived.
2.4.1 Parameter settings
As discussed previously, when applying a GA to a problem, there are various choices
to be made including the selection type and crossover type. These may in turn have
associated parameters, such as tournament size for tournament selection or probabilities
for crossover and mutation. Other parameter settings required for a GA run include
determining the population size.
In his 1975 thesis, De Jong [42] carried out a systematic study on the effects of para-
meters on the optimisation of a set of test functions. There were five test functions,
namely the sphere model, generalised Rosenbrock’s function, step function, quartic
function with noise and Shekel’s foxhole. Experiments on these functions found that
population sizes of 50 - 100, crossover rates of between 0.6 and 0.9 and mutation rates
of 0.01 and 0.001 were effective.
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Although the parameter settings were effective for the five test functions, these settings
have been used as a template to a wide variety of solutions but theoretical results have
proven this to be a mistake [14]. It is therefore essential for the GA practitioner to test
problems over a range of parameter settings, rather than opting for standard parameters
which proved effective for a different type of problem.
There is strong empirical evidence showing that population size is one of the most im-
portant parameters, playing a significant role in the performance of genetic algorithms
[50]. In principle, small populations are at risk of under representing the search space
and thus converging to a poor solution and large populations allow exploration of fewer
generations per unit of computational effort and thus may preclude convergence [51].
Parameters such as population size have added complexity in that they are not inde-
pendent, and have interacting roles with other aspects of the GA. The interacting role
between population size and crossover are of great interest to the genetic algorithm
community [33]. Despite the operational simplicity of GAs, they are complex systems
to analyse [52].
As deciding upon a relevant crossover or mutation level is a factor in the successful
application of a GA, various techniques have been used to try and automate these
decisions. Grefenstette [53] used a GA to self-adapt the optimal parameter settings
and this has led to a variety of approaches to take the onus of parameter setting
away from the GA user. As crossover is traditionally regarded as the main search
mechanism in genetic algorithms, most efforts to self-adapt the characteristics of this
operator stem from this area [54]. Many different techniques exist in this field including
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the Self Adaptive Genetic Algorithm (SAGA) [55] and more recently the parameterless
GA [14; 56]. These aim to give the users more time to focus on other aspects of
experimentation and will allow non-expert users to harness the power of GAs [57].
There are a variety of choices in methods and parameters for configuring a GA. Values
for parameters can greatly affect the ability of the GA to efficiently find a near-optimum
solution [58]. It is therefore of key importance that fundamental components of the
GA, such as crossover methods, be robust to changes in these parameters, such as
population size and mutation rate or the replacement strategy used.
2.5 Summary
This chapter has introduced genetic algorithms as a method of evolutionary search and
optimisation. The components of a GA were described and the theory underpinning
their operation has been outlined. Through this chapter, the crossover process has been
described as the main search proponent of GAs and some common crossover techniques
have been outlined. The importance of parameter settings has also been described. Due
to the difficulty in determining parameter values, it is important that GA techniques
are robust to variability in these parameters. The next chapter will review a particular
type of problem to which GAs can be applied: optimal control problems.
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Optimal control problems
The previous chapter introduced Genetic Algorithms as an evolutionary inspired search
technique. GAs have been used to find good solutions from large search spaces across
a wide array of application areas. One such area where GAs have proven successful is
for deriving solutions to optimal control problems. Although optimal control problems
arise in a wide range of fields of engineering and sciences [2], the task of designing and
implementing algorithms for solving optimal control problems can be a difficult one [3].
However, as GAs require little knowledge of the problem itself to search for solutions,
they can be applied readily to problems of this type.
This chapter discusses optimal control problems within the context of evolutionary
computation and is organised as follows. Section 3.1 will discuss optimal control prob-
lems and Section 3.2 will review how GAs and indeed other Evolutionary inspired
approaches have been applied to solving optimal control problems. Finally, Section
3.3 concludes this chapter, describing a novel extension for the GA crossover process
in order to improve GA performance when applied to optimal control problems. The
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experimentation and analysis of these novel crossover techniques form the main thesis
of this work.
3.1 Introduction to Optimal Control
Optimal control theory is concerned with finding the controls for a dynamic system
which optimise a performance criterion in some best way. These controls are usually
not a single input but may be multiple inputs of different values over time. An example
of this may be to find the times to press the accelerator on a car to drive it around a
track in the minimum amount of time, or alternatively, to minimise the fuel usage of
the car for a lap of the track.
The essential elements of the control problem are defined in [59] as:
1. A mathematical model (system) to be ‘controlled’
2. A desired output of the system
3. A set of admissible inputs or ‘controls’
4. A performance or cost functional which measures the effectiveness of a given
‘control action’
In the above car examples, the mathematical model would represent the car, the desired
output would be to complete the lap of the track, and the controls would be timings of
when to press the accelerator and for how long to keep it depressed and by how much.
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The cost functional for the first example would be the time taken to complete a lap,
with the fuel usage during a lap forming the cost for the second example.
A vector of variables represents the state of the system and a control set of variables
transforms the system to another state. The problem in optimal control is to find the
control vector which transfers the system to a state which maximises or minimises some
performance criterion, whilst adhering to the set of equality and inequality constraints
that may exist. In the car example, constraints may be in place for how far the
accelerator can be depressed or for the cumulative fuel usage throughout the lap which
must be less than the fuel limit for the car. It should be noted that both the control
vector and the state vectors can be discrete or continuous.
Mathematical techniques such as dynamic programming can be used to solve problems
of this type, however, this technique has been shown to break down on problems of
moderate size and complexity [60]. In the field of chemotherapy scheduling for example
it was observed that traditional algorithms for optimal control can become intractable
as constraints are added, thus for more detailed analysis, alternative approaches are
required [61]. A range of these alternative approaches will now be discussed.
3.2 Heuristic Approaches to Optimal Control
Optimal control is one of the areas which has received the most attention in the field
of evolutionary computation techniques such as genetic algorithms [62]. Although
genetic algorithms were first developed in the seventies, it was not until 1990 that
they were first applied to optimal control problems [3]. This initial work successfully
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applied GAs to two discrete-time optimal control problems. This work was further
extended in [63] and used a modified version of the standard GA, which included
a form of arithmetical crossover to tackle three optimal control problems. Arithmetic
crossover forms children through linear combinations of their parents gene values, using
a parameter a, which is either a constant (uniform arithmetical crossover) or depends
on the age of the population (non-uniform arithmetical crossover). In [63] the GA was
successfully applied to a linear-quadratic problem, the harvest problem and the push-
cart problem. For all three of these problems, the solutions found by the GA were close
to those found by a search-based computational package. The conclusion from these
initial works was that GAs could be successfully applied to optimal control problems.
Since then, evolutionary approaches such as GAs have been successfully applied to a
variety of optimal control problems [64].
One such problem where GAs have successfully derived optimal control schedules is that
of the optimisation of cancer chemotherapy treatment schedules [61; 65; 49; 66; 67].
This work shows the effectiveness of GAs in finding solutions in a highly complex search
space: the composition of an optimal schedule for anti-cancer chemotherapy treatments
is a non-linear optimal control problem which is subject to contradictory constraints
[68]. These constraints include the maximum instantaneous dose for each application
of the drug, the maximum cumulative dose for the drug and the maximum permissible
size of the tumour.
Variations of GAs, such as the Co-operative Co-evolutionary Genetic Algorithm (CCGA),
have also been used to solve optimal control problems [69]. The CCGA approach was
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introduced by Potter and De Jong [70] and involves a population with a number of
sub-populations or species, where each species represents a part of the problem to be
optimised. The fitness of members of the species are evaluated and individuals from
each species are combined to form a complete solution to the problem in hand, and
the evolutionary process proceeds in the usual GA fashion. In [69], both the standard
GA and the CCGA use a binary encoding, standard uniform crossover and bit-flip
mutation to find solutions which outperform the dynamic programming technique for
the optimal control problems under review.
An alternative GA technique, Adaptive Elitist population based Genetic Algorithm
(AEGA) was found efficient at deriving drug scheduling policies for optimal control
of cancer chemotherapy [71]. This approach uses an elitist crossover operator which
actively tries to reduce the population’s redundancy.
GAs fall under the banner of Evolutionary Algorithms (EA). GAs are one of the 3 main
streams of EAs, along with Evolutionary Programming (EP) and Evolution Strategies
(ES) [72]. Both EP and ES have a number of similarities and were developed at the
same time, with EP being developed in America and ES in Germany. Both of these
other approaches have also been applied to problems of this type.
Evolutionary programming was first presented by Fogel in the 1960s [73] to evolve finite
state machines, and this technique has been successfully applied to optimal control
problems [74; 75]. Unlike GAs, EP has no selection for breeding as each member
of the population generates one offspring and EP does not use crossover and instead
relies purely on mutation to manipulate genetic material. Each subsequent generation
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includes a percentage of the fittest individuals in the current generation and the EP
replacement scheme is always elitist [76].
Evolution Strategies were first developed in [77] and as with EP, use mutation to
create and modify genetic material. Originally the population was represented by a
single individual being represented as a real valued vector [76], however, more recent
ES algorithms, such as those described in [78], are population based.
Although both EP and ES have many common features, such as real value representa-
tion of individuals and the use of mutation as the main search operator, they are not
the same. Variations in the recombination operators and selection mechanism lead to
differences between approaches [72].
Villasana and Ochoa [5] compared the performance of GAs, Evolution Strategies and
Simulated Annealing (SA) for deriving bang bang optimal controls for cancer chemother-
apy. A bang bang controller is one which switches abruptly between two states. Sim-
ulated annealing was first introduced in [79] and as the name suggests, builds an anal-
ogy with the way metals cool and anneal in thermodynamics, where the optimisation
process is represented as the process of cooling. A solution to the problem is perturbed
and will be accepted, even if the solution fitness score is less than that of the current
state as long as the temperature is high. As the temperature decreases, only smaller
more efficient changes will be accepted, and this allows for a more local search of the
space. This work showed the effectiveness of ES over both Simulated Annealing and
GAs for problems of this type, with GAs showing slower convergence than the other
approaches. This has led to further work by these authors using ES as opposed to
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GAs for problems of this type [80]. Simulated annealing has also been successfully
used by others, such as Agur et al [81] for deriving optimal controls for chemotherapy
scheduling.
Although GAs have been used effectively, as stated above they have been shown as
slower to converge to good solutions than both ES and SA. This is also the case when
GAs were compared to Particle Swarm Optimisation (PSO).
PSO is a search heuristic developed by Kennedy and Eberhart in 1995 and was inspired
by the social behaviour displayed by bird flocking or fish schooling [82]. Each solution
is encoded as a particle. Particles traverse the search space, based on the best solution
that particle has found so far, as well as direction from the best solution found globally
by the swarm. In this comparison, GAs were once again outpaced in finding optimal
controls for complex models [6].
GAs have been compared with estimation of distribution algorithms (EDAs) for the task
of producing cancer chemotherapy schedules [7]. EDAs are a byproduct of GA work,
first detailed in [83]. They use a probabilistic sampling of the population rather than
mutation or crossover and use the information gained from this sampling to produce
the next set of population members. GAs were again outperformed for deriving optimal
control schedules . EDAs proved more effective than GAs with regard to both the speed
at which a feasible treatment could be found and the fitness of solution found.
The efficiency of the GA for problems of this type can be improved through various
means. Tuning of those factors which affect the optimisation process [68] can increase
the speed of the GA as can changing the encoding for chromosomes to an integer
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representation as opposed to the traditional binary approach [84]. The GA search
process for optimal control problems can also be improved through incorporation of
problem specific heuristic arguments into the GA process [85].
As stated previously, GAs have been successfully applied to optimal control problems.
This section has described that when compared to more sophisticated approaches,
GAs are typically slower to find solutions. GAs are however a computationally cheap
approach to problems of this type.
This raises the question as to whether there is there another way of enhancing the GA
to quickly find good solutions to optimal control problems? Is there any information
contained in good solutions that can be harnessed to direct offspring to promising
areas of the search space in a quick and efficient manner? If the search process could
be directed through observing the information contained in highly fit solutions, this
could speed the discovery of good solutions. As stated in Section 2.2.6, crossover is key
to the GA process and is considered more innovative than mutation. An extension to
enhance crossover could therefore provide a more effective search for problems of this
type and improve the GA performance.
One such technique, which reviews the structure of parent chromosomes to better create
offspring is introduced in the following section.
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3.3 Possible extensions to conventional crossover tech-
niques
The previous section discussed optimisation problems which require scheduling of in-
terventions of some form across a time period to provide maximum utility. Most
evolutionary approaches to optimal control problems use a coding system which would
set the control value to be used at a definite time in the interval [ti:tf], for instance [2;6]
[64]. Representations of these interventions could take many forms, from simple alter-
natives such as a binary string encoding of a bang bang problem, where a ‘1’ represents
an intervention at that point and a ‘0’ represents no intervention, to more complex rep-
resentations, such as an integer encoding defining the strength of intervention dosage
or action to perform.
As detailed in Section 2.2.6, crossover is key to the successful operation of a GA. For this
reason, it appears logical to first review modification of this part of the GA process to
suit problems of this type, as this will directly affect the key element in the GA process.
Conventional GA crossover approaches, such as those discussed in Section 2.2.6 have
been used to produce solutions to these types of problems. However, traditional tech-
niques such as UC and SPC do not consider the number of interventions contained in
parent solutions and instead just blindly crossover genetic material.
A simple example of this issue can be represented by a situation where an optimisation
function requires interventions to be scheduled over a ten day period, with one potential
intervention per day. This could be easily represented as a 10 bit binary string, where
a ‘0’ represented a non intervention and a ‘1’ an intervention.
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If two solutions are selected for crossover, one which is averagely fit, with three inter-
ventions:
0 0 1 1 0 0 0 1 0 0
and a much fitter chromosome with seven interventions:
1 0 1 1 0 1 1 0 1 1
Standard crossover approaches could be used to produce new solutions. However, as
the solution with more interventions is considerably fitter than the solution containing
less interventions, and both have been selected to produce offspring, is there some
useful information as to the beneficial number of interventions for offspring contained
in this? SPC would randomly pick a crossover point at which to recombine material and
UC would work probabilistically along the solutions, picking genes from each parent
and would, assuming a conventional value for the swapping probability n = 0.5, take
roughly half the genes from parent 1 and half the genes from parent 2. Could there be
any advantage in ensuring that offspring have a number of interventions which is close
to that of the fitter parent?
Although a simple example which ignores the non-linear landscape of many complex
problems, it does however introduce the question as to whether it may be beneficial
for conventional techniques such as UC to consider the number of interventions which
appear to offer more utility? However, even if considering the number of interventions
for simple binary bang bang style representations proved effective, how would these
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considerations work for gene representations which include a range of allowable values
for an intervention? For example, in a situation where different dosage strengths can
be represented for each intervention. In order to answer these questions various novel
crossover approaches have been constructed and these are detailed in the next chapter.
3.4 Summary
This chapter has described optimal control problems. This began with an introduction
to this type of problem followed by a description of GA applications to optimal control
problems. This showed that although GAs can be used to solve problems of this type,
they have been outperformed by other search heuristics.
In order to improve the effectiveness of GAs for problems of this type, an extension
to the GA crossover approach was proposed. This extension reviewed the number
of interventions contained in chromosomes selected for offspring production, and uses
this information to calculate offspring intervention levels. Chapter 4 details various
implementations of this extension.
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Directed intervention crossover
approaches
The previous chapter discussed problems which require interventions to be made at
points across some time period. Chapter 3 concluded by asking whether GA crossover
techniques could be made more effective for these types of problems through reviewing
the number of interventions present in fit parents and using this to determine the
optimal number of interventions for offspring.
To answer this question, techniques need to be constructed both for deciding upon
intervention levels for offspring and also how to select the appropriate interventions
from parents. The creation and investigation of such techniques form the main focus
of this work and due to the processes involved, these approaches are termed directed
intervention crossover techniques.
To increase clarity in the following descriptions, some definitions are necessary. In this
work, each gene represents a possible intervention of some action at a specified time
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and if a gene is set to 0, this represents no intervention at that point in time and any
other value represents an intervention. Thus all genes with a non-zero value will be
considered interventions. The intervention level of a solution is simply a count of all
these non-zero genes contained in a chromosome.
The next section reviews how intervention levels for offspring are calculated and the
following sections outline techniques for selecting appropriate numbers of interventions
from parents.
4.1 Calculating target interventions for offspring
Various alternatives could be used for calculating the number of interventions for off-
spring based on intervention levels in parents. One could simply use the intervention
levels of the fitter parent as the number of interventions which children should contain;
however, as variance in the population is vital to successful interrogation of the search
space, this may preclude a thorough analysis of the search space and prompt prema-
ture convergence. Another alternative could be to vary the offspring intervention levels
around that of the fitter parent, while allowing some variance in the sizing. This would
allow offspring to further explore the search space around that of the fitter parent.
The latter of these alternatives formed the starting point for this work, although the
hypothesis of premature convergence for techniques using just the fitter parent inter-
vention level is tested in the Directed Uniform Crossover approach as described in
Section 4.2.3.
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This work focusses on the traditional GA approach where two parents are utilised to
produce two offspring, although Section 10.3.2.3 identifies possible extensions to this.
This approach raises the question as to how to vary the intervention levels for offspring
around that of the fitter parent? As this is a new area of research, there are currently
no techniques for performing these calculations. Many alternative approaches could be
constructed, but the one chosen for initial investigation, which also takes into account
the fitness level of the less fit parent, was to use the difference in intervention levels
between parents as bounds for exploration around the fitter parents intervention level.
This presented a logical starting point for experimentation and works as follows:
The first step of the sizing process is to select the number of intervention points to be
present in each offspring. The fittest parent in the recombination pool is found and the
number of intervention points utilised by this parent is noted as (IF ). Although the
size of the fitter parent is known, exploration is encouraged in this process by adjusting
the number of interventions in the offspring such that they vary around that of IF . In
order to calculate the limits of this variance, we first calculate the absolute difference
in the number of interventions, (Di), between parents as:
Di = |I1 − I2| (4.1)
where I1 and I2 are the number of interventions for parents one and two respectively.
For a given offspring, a stochastic element is introduced such that the actual number
of target interventions to use IT , is calculated as:
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IT = IF − Di2 + rand(Di) (4.2)
IT is a natural number constrained by the minimum number of interventions Imin,
which must be applied (usually 1) and a maximum number of interventions Imax. Imax
is limited to the size of the set of interventions present in both parents. The function
rand(x) returns a random real value between 0 and x. If Di is even, the window of
variance is simply calculated asDi/2. However in order to always have an even window,
if Di is odd, one is added to Di before IT is calculated. In order to enforce variety in
the population to avoid stagnation, if Di < 2, for example when both parents are of
the same size, Di is set to 2 before IT is calculated, thus always giving a window of
variability of at least one either side of the fitter parent size.
This approach results in IF acting as the centre point for the mean target intervention
level with bounds determined by the difference between the two parent intervention
levels. The rationale behind this method is that the fitter parent should act as the
guide for a new set of interventions but that exploration around this point should be
encouraged.
To clarify this process, consider the following two parent chromosomes representing
intervention schedules across time. They use a binary representation where a 1 rep-
resents an intervention and a 0 represents no intervention at the given point in time.
Let us assume that the first parent chromosome has a weaker fitness than the second
parent chromosome.
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0 0 1 1 0 0 0 1 0 0
1 0 1 1 0 1 1 0 1 1
Thus IF = 7 and Di = 4, since I1 = 3, and I2 = 7. Given the stochastic nature of
Equation 4.2, the target intervention level IT , will therefore be a value in the range 5
to 9.
A new value of IT is calculated for each child separately, thus producing more variety
in the offspring and consequently, the population.
It is interesting to note that if either UC or SPC were presented with these parents for
producing offspring, the children must contain interventions at locus 3 and 4, and with
the exception of mutation, have no other way to remove these from offspring. Using
the sizing technique described above, this allows for the crossover process to potentially
shed some of these interventions which could facilitate a broader search of the solution
space.
This section has described sizing calculations for determining the number of interven-
tions to be present in offspring. These calculations include variance producing a range
of possible intervention sizes which centre around that of the number of interventions
contained in the fitter parent. This variance is scaled according to the difference in
intervention levels between parents, thus when two parents are close in intervention
size, the window of potential variance around the fitter parent intervention size will be
smaller and conversely, when there is a large difference in intervention sizes between
parents, a larger window of potential interventions will be used. Constraints are in
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place to ensure that the window is always able to be sized around IF , and also that
the number of interventions for offspring will never reduce below 0 or be greater than
the interventions present in the parents. The ability of directed intervention crossover
techniques to shed interventions even when they are present in both parents has been
noted.
Now that calculations are in place for determining the size of offspring, the next step
is to decide which of the interventions should be selected for inclusion in the offspring.
4.2 Intervention selection
When deciding upon which interventions to pass onto offspring, one concern is whether
to pick genetic material via a uniform distribution over time, such as conventional
treatment protocol for application of cancer treatments [86], or whether to pick the
genetic information stochastically, irrespective of the distribution over time. In order
to investigate this issue, crossover techniques to demonstrate each of these options were
created. Targeted Intervention with Stochastic Selection (TInSSel) and Calculated Ex-
panding Bin (CalEB) provided techniques for initial inspection of directed intervention
crossover concepts. Each of these techniques will be reviewed in turn.
4.2.1 TInSSel
Targeted Intervention with Stochastic Selection (TInSSel) is a directed intervention
crossover technique which, as the name describes, picks the genetic information in a
stochastic manner.
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Consider the two parent chromosomes described earlier. They use a binary represen-
tation where a 1 represents an intervention and a 0 represents no intervention at the
given point in time.
0 0 1 1 0 0 0 1 0 0
1 0 1 1 0 1 1 0 1 1
Having determined the number of interventions a child will have using the sizing cal-
culation from the previous section, the next step is to calculate when the interventions
will occur. TInSSel ensures that intervention points present in all the parents selected
for crossover are passed on to the offspring before interventions present in only some
of the parents. The locus of interventions present in all parents selected for breeding
are placed in the set of duplicates Sdup, and these intervention points will have priority
in being passed to the offspring. It would appear prudent to ensure that priority is
given to these genes when passing information onto offspring over genes present in only
one of the parents. This is similar to the operation of UC, as if a ‘0’ or ‘1’ exists at
a particular locus for both parents, regardless of the parent chosen to select the gene
from, the duplicate value will be chosen.
The locus of interventions present in one parent but not the other are placed in the
set of interventions Ssingle. From the parents described above, Sdup = {3, 4} and
Ssingle = {1, 6, 7, 8, 9, 10}.
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Interventions from Sdup will be added the child, at random, until IT is reached or no
common intervention points remain. Note that if IT is less than the size of Sdup then
not all elements of Sdup will be included.
Having selected interventions common to both parents, the number of additional inter-
ventions required is therefore IT minus the size of Sdup. This will be a value between
0 and IT since it is possible that there are no duplicate interventions across all par-
ents. To determine the remaining points that will be used, interventions are randomly
selected from the set Ssingle until a total of IT points have been picked from both Sdup
and Ssingle.
From the earlier example, all offspring for that situation would require between 5
and 9 interventions. As this is more interventions that those present in Sdup, other
interventions will be required. In other circumstances however, two alternatives exist.
If the target number of interventions IT was less than the number of elements contained
in Sdup, the required number of interventions would be picked once only, at random,
from Sdup until IT was reached. The other possibility would be that IT was equal to
the size of Sdup, in this instance offspring would simply contain all the interventions
contained in Sdup.
From the above example, both offspring will contain interventions at locus 3 and 4.
This means that dependant on the result of the rand() function, between 3 and 7
other interventions will be required for offspring. For clarity, the number of remaining
interventions will be termed IR.
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As TInSSel does not enforce a uniform distribution for selection of the remaining genes
over time, it can simply pick from the set Ssingle until IR is reached. Each gene can
only be picked once from Ssingle. If the rand() function had returned a 1, this means
that IT would be 6. As discussed, interventions from Sdup will be added first, thus the
child will contain interventions at locus 3 and 4, and IR will be IT - 2 = 4. Thus 4
interventions will be picked at random from the set Ssingle = {1, 6, 7, 8, 9, 10}. When
these are added to the material from Sdup = {3, 4}, this allows possible offspring to
include the following combinations {1,3,4,6,7,8}, {3,4,7,8,9,10}, {1,3,4,8,9,10}, among
others.
4.2.2 CalEB
The Calculated Expanding Bin (CalEB) approach was created to ascertain the effec-
tiveness of picking genetic material distributed over time. Many problems, especially
of a medical nature, require interventions distributed throughout a time period. One
such example is that of cancer chemotherapy treatments, where conventional treat-
ment protocol administers cancer drugs according to such a distribution as it is easier
to organise patients to be present for treatment at fixed times [86].
CalEB uses the same initial process as TInSSel for selecting interventions from Sdup
and is identical to TInSSel when the number of interventions required for offspring,
IT , is less than or equal to the number of interventions present in Sdup. When IT is
greater than Sdup, CalEB produces a list of possible interventions, which contains IR
copies of each gene in Ssingle ordered according to their ascending locus position. This
list is broken into IR bins, and one intervention is picked from each bin at random for
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addition to the offspring. If an intervention has already been added to the offspring,
an alternative intervention is picked, and this process is continued until an offspring of
size IT have been created.
Thus, continuing the above example, the offspring will contain interventions at locus 3
and 4 and IR = 4. There would therefore be 4 copies of each intervention from Ssingle,
taking the form:
[1, 1, 1, 1, 6, 6, 6, 6, 7, 7, 7, 7, 8, 8, 8, 8, 9, 9, 9, 9, 10, 10, 10, 10]
This is partitioned into IR bins, each containing 6 interventions, producing the follow-
ing:
[1, 1, 1, 1, 6, 6]
[6, 6, 7, 7, 7, 7]
[8, 8, 8, 8, 9, 9]
[9, 9, 10, 10, 10, 10]
Each bin is visited in order. If an intervention with the value ‘1’ was picked from the first
bin, then either ‘6’ or ‘7’ would be valid choices from the second bin. Alternatively, if an
intervention with the value ‘6’ was picked from the first bin, only an intervention with
the value ‘7’ would be able to be picked from the second bin. Once a valid intervention
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has been picked from each bin, these values twinned with the interventions already
added from Sdup will then be used to set the appropriate intervention values for the
offspring. Thus if {1,6,8,9} were picked from the four bins, these would be added to the
{3,4} from Sdup, producing {1,3,4,6,8,9}. In a binary environment, this would therefore
produce the following bit string:
1 0 1 1 0 1 0 1 1 0
The above chromosome shows that the genes at the locus contained in the list of genes
to set are all set to the value of ‘1’, while all other gene values are left with a ‘no-
intervention’ value of ‘0’.
4.2.3 Directed Uniform Crossover
In Section 4.1 an alternative for calculating the target number of interventions for
children was introduced whereby the target is set to the number of interventions con-
tained in the fitter of the parents selected for crossover. This in effect would set IT to be
equivalent to IF . This was dismissed as the basis for the directed intervention crossover
techniques as it was felt that this greedy style of intervention calculation, where the
target is the current best, may preclude a thorough analysis of the search space and
prompt premature convergence. In order to ascertain if these assumptions are correct,
a technique based on the concept of using the number of interventions contained in the
fitter parent as an absolute intervention limit for offspring was created. This approach
is termed Directed Uniform Crossover (DUC).
Using two of the parents defined earlier, whereby:
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Parent 1 is of average fitness and contains three interventions:
0 0 1 1 0 0 0 1 0 0
Parent 2 is considerably fitter and contains seven interventions:
1 0 1 1 0 1 1 0 1 1
as IF = 7, IT = 7.
The required number of interventions, IT are then selected from the parents in the
same stochastic method as described for the TInSSel technique.
4.3 Summary
This chapter has introduced three novel GA crossover techniques, TInSSel, CalEB and
DUC for the optimisation of optimal control problems. Each of these approaches are
in the category of directed intervention crossover, whereby the number of interventions
for offspring are calculated in some way from the parent intervention numbers.
Both TInSSel and CalEB use a window of search around the number of interventions
in the fitter parent, facilitating search around promising areas of the solution space.
The intervention target calculation for DUC simply uses the number of interventions
contained in the fitter parent for the offspring intervention level. Once the interven-
tion target is calculated, each of the approaches select interventions present in both
parents before those interventions only present in one. If more interventions are still
49
CHAPTER 4. DIRECTED INTERVENTION CROSSOVER
APPROACHES
required, both TInSSel and DUC pick in a stochastic manner from the remaining set of
interventions, whereas CalEB picks interventions in a uniform distribution over time.
In order to evaluate the directed intervention crossover techniques, suitable optimal con-
trol test problems were required. A bio-control scheduling problem and a chemotherapy
scheduling problem were chosen for test environments, and the following chapter will
review each of these problems.
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Test Problems
In order to ascertain the effectiveness of the directed intervention techniques introduced
in Chapter 4, suitable test problems are required. These problems need to be optimal
control problems which require discovery of highly fit intervention schedules. This
chapter introduces the test problems under review, that of bio-control optimisation
and cancer chemotherapy treatment scheduling.
In the following section (Section 5.1), an introduction to the biological aspects of the
bio-control problem will be outlined, followed by the mathematical representation of the
model dynamics. This will be followed by Section 5.4, which details similar information
for the cancer chemotherapy treatment scheduling problem.
5.1 Bio-control problem
In the field of mushroom farming, one of the principal constraints to the quantity
of mushrooms produced is the presence of sciarid flies. Sciarid larvae are known to
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feed on the mycelium in the casing layer of mushrooms causing crop production to
significantly decline. Both chemical and biological controls have been used against this
pest. Biological controls are beneficial as it avoids the build up of chemical controls
which can be detrimental to the environment and can lead to pesticide resistance [87].
As constraints about the use of chemical insecticides have increased, entomopathogenic
nematodes of the genera Steinernema and Heterorhabditis have been shown as an envi-
ronmentally safe alternative [88]. These nematodes are isolated from a wide variety of
ecosystems ranging from sub-Arctic to arid and tropical climates [89]. Entomopatho-
genic nematodes of the genera Heterorhabditis and Steinernema are commercially used
to control pest insects [90] with Steinernema feltiae proving the most effective nema-
tode for controlling sciarid species [91]. Scientific evidence supports the conclusion that
using nematode worm Steinernema feltiae control is safe to the environment, applica-
tion personnel, the general public and the consumers of agricultural products treated
with them [92].
Application of the nematodes to mushroom crops acts as an excellent defence mech-
anism. The principal aim of the farmer is to maximize the profit of crop production.
This would appear to be achieved through maximizing the use of the bio-control agent.
There is however a financial constraint to the use of the nematodes, therefore, the
number of actual intervention treatments needs to be kept to a minimum. It is the
optimization of this intervention schedule that forms the fitness function for the ex-
periments undertaken in this work. In order to successfully resolve this optimization
problem, treatment schedules need to be derived that minimize the sciarid larvae pop-
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Adults
Eggs
Larvae
Pupae
Live for TA days
Die at rate δA per day
Develop over TE days
Die at rate δE per day
Pupate after TL days
Die at rate δL per day
Reach adulthood after TP days
Die at rate δP per day
Figure 5.1: The Sciarid Fly Lifecycle
ulation, whilst also maintaining an acceptably low level of intervention points and
nematodes used. These potential schedules can then be reviewed by the farmer to
make an informed decision, based on their priorities and preferences, regarding which
approach to implement. The mathematical formulation of this problem follows.
5.2 Problem formulation
In [93], a generalized model for the lifecycle of sciarid flies is specified which includes
potential infection from Steinernema feltiae. The lifecycle for sciarid flies is shown in
Figure 5.1. This shows that the adults lay eggs which turn into larvae. These larvae
pupate and become adults which subsequently lay more eggs.
In this model, there is a set of discrete intervention points (t1, t2, ..., tn) where nema-
todes can be applied to the system. The key optimization question is at which points in
the model should the nematodes be applied to maximise their effect on the sciarid fly
population. As the nematode control agent is only effective against sciarid flies when
they are in their larval stage, the nematode intervention schedule needs to maximize
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Parameter Description Constant Value
E,L,P,A Egg/larval/pupal/adult host density Variable
N Free living infective nematode density Variable
TE , TL, TP , TA Duration of egg/larval/pupal/adult stage 5, 10, 5, 8 (days)
δE , δL, δP , δA Daily mortality rate of egg/larvae/pupae/adult 0.35, 0.125, 0.1, 0.275
ρ Viable eggs laid per adult pest 75
β Infection rate of nematodes 0.000095
λ Nematodes produced per infected host 4000
µ Mortality rate of nematodes 0.7
TI Delay between infection and lysis of cadavers 12 days
A0 Initial density of adult pests 4.5
Ta Time of adult invasion 7 days
Table 5.1: List and Definition of Model Parameters
the impact on this particular stage of the fly’s development. The equations specified
in [93] are used to model the effects of intervention schedules. Table 5.1 defines the
parameters and constants used in the equations of this model.
The implemented model assumes that the infection process is about to start and the
adults are ready to lay eggs. Eggs die at a rate of δE with those eggs that survive
developing into larvae after TE days. Larvae die at a rate of δL and those remaining
after TL days pupate. The pupae die at rate δP and after TP days the remaining pupae
subsequently turn into adults and lay more eggs for the duration of their TA lifespan.
Thus the full life cycle of the sciarid flies takes place over TE + TL + TP + TA days.
Equations 5.1 - 5.12 are used to model the dynamics of the nematode / sciarid pop-
ulations. Equations 5.1 - 5.5 model the change in eggs, larvae, pupae, adults and
nematodes respectively from one time step to the next. Equation 5.6 defines the prob-
ability of surviving the egg stage, 5.7 the probability of surviving the pupae stage and
5.8, the probability of surviving the adult stage. Equation 5.9 defines the transfer rate
into the egg stage. Equation 5.10 calculates the duration of the adult host stage, 5.11
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the maturation rate from the larval stage and 5.12 the probability of surviving the
larval stage.
dE(t)
dt
= R(t)−R(t− TE)σE − δE(t)E (5.1)
dL(t)
dt
= R(t− TE)σE −M(t)− δLL(t)− βN(t)L(t) (5.2)
dP (t)
dt
=M(t)− δPP (t)−M(t− TP )σP (5.3)
dA(t)
dt
=M(t− TP )σP −M(t− TP − TA)σPσA − δAA(t) (5.4)
dN(t)
dt
= λβN(t− TI)L(t− TI)− µN(t)− βN(t)L(t) (5.5)
σE = e−δETE (5.6)
σP = e−δPTP (5.7)
σA = e−δATA (5.8)
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R(t) =
ρ
TAV E
A(t) (5.9)
TAV E = [1− σA]/δA (5.10)
M(t) = R(t− TE − TL)σL(t)σE (5.11)
σL(t) = e
∫ t
t−TL
βN(x) + δLdx
(5.12)
The fitness calculation for the model is detailed in 5.13. As detailed in Section 5.1, it is
the sciarid larvae which cause damage to the crop. Thus the fitness score is a count of
all the larvae present in the system throughout the duration of the modelling process
plus the penalty of intervening multiplied by the number of interventions. Since the
aim of the intervention schedule is to reduce the total number of sciarid fly larvae in the
crop, the optimal treatment schedule will be that which returns a fitness score closest
to zero.
F =
T∑
t=0
L(t) +NP (5.13)
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T=Number of time steps
L(t) = Larvae in existence at time t
N = Number of interventions used
P = Penalty per intervention
The model is over a 50 day period, where the farmer can either spray a crop on a day or
not. Due to the nature of the control, in that it can either be on or off, this means that
this problem admits a bang bang control strategy [94]. In order to encode schedules for
optimisation by the GA, a 50 bit binary chromosome was used. This means that each
day is represented by the bit at that particular locus in the chromosome, i.e. day 1 is
represented by locus 1 and day 50 by locus 50. As the bio-control agent is either applied
on a day or not, a binary representation is sufficient as a 0 represents no intervention
on that day and a 1 represents application of the bio-control agent on that day. If the
following chromosome represented days 1 - 4 of a schedule, this represents application
of the bio-control agent on days 1, 3 and 4.
1 0 1 1
The dynamics of the sciarid larvae population in the absence of bio-control agent are
shown in Figure 5.2. This shows the number of sciarid larvae present on each day of
the 50 day period. The number of sciarid larvae increase, decrease and subsequently
increase in a cyclical manner, as was shown in the work of Fenton et al [93]. Over a
50 day period, there are two distinct peaks in the number of sciarid larvae. At day 10,
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there are approximately 38 larvae before the population decreases and at day 34 there
are 80 larvae present.
Figure 5.2: Sciarid Larvae Population
5.3 Experiment parameters
The experiment parameters for the bio-control scheduling problem will now be re-
viewed. Section 5.3.1 describes the limit for the number of fitness function evaluations
undertaken per experiment. This is followed by Section 5.3.2, which describes the
penalty values associated with each application of the bio-control treatment.
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5.3.1 Fitness function evaluations
Through analysis of preliminary runs of the model for each crossover approach, it was
found that 5,000 fitness function evaluations (FFEs) was sufficient to ensure conver-
gence for all crossover approaches under review. The statistical output of the runs are
therefore analysed in 100 FFEs increments for each approach, and therefore are from
100 - 5,000 FFEs.
5.3.2 Intervention penalties
Each intervention in the schedule represents the mushroom farmer having to spend time
and resources in spraying the crops. This information is incorporated in the model as a
penalty value associated with each intervention, P . This encourages the system to use
as few interventions as possible while also deriving as effective a treatment as possible.
A major difficulty in handling constraints using penalty function methods in GAs has
been to set appropriate values for penalty parameters and this often requires users to
experiment with different values of penalty parameters [95]. With too large a penalty
value per intervention, the omission of interventions may become as important as the
placing of key interventions. In order to fairly compare crossover techniques for the
scheduling of interventions, a range of penalty values were used. Through empirical
analysis, P values of 0, 5, 20, 35 and 50 per intervention were shown to represent many
aspects of the search space. When P is 0 per intervention, this means that the best
solution is to apply the bio-control agent at nearly every opportunity as there is no
cost associated with intervening. When P is increased to 50 per intervention, the best
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solution appears to be application of two well placed interventions. By increasing P
above 50, initial tests found that the best solution became one or zero interventions,
as the penalty per intervention became higher than the benefit received from the in-
tervention. For this reason, P was capped at 50. As the increased value of P makes
placement of interventions more important, this should allow for a fair comparison of
crossover techniques, without any bias introduced by any one intervention penalty.
As well as the bio-control scheduling problem, the novel crossover approaches will
also be applied to the task of cancer chemotherapy treatment scheduling. Section 5.4
outlines the cancer chemotherapy scheduling problem followed by Section 5.4.1 which
describes the problem formulation. Section 5.5 describes the parameter settings for the
experiments.
5.4 Chemotherapy scheduling problem
Cancer is a class of diseases whereby cells display uncontrolled growth. According to the
World Health Organization, it is the leading cause of death worldwide and accounted for
7.9 million deaths (around 13% of all deaths) in 2007 [96]. Chemotherapy is commonly
used to combat cancer and treats the disease through using chemicals which kill cells.
Composing an effective chemotherapy treatment schedule is a non-trivial task; indeed
chemotherapy is often considered one of the most complex cancer treatments [97].
Through the use of deterministic mathematical models, valuable efforts in the analysis
of cancer chemotherapy have been made [98]. However, the problem can be regarded
as analytically intractable due to both its multi-constraint nature and the non-linearity
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of the optimisation functions [49]. This complexity makes this problem an ideal test
to assess the abilities of the directed intervention crossover approaches in searching a
multi-constraint, extensive search space where GAs have been previously successful for
calculating treatment schedules [99].
As mentioned in Section 3.2, a variety of mathematical models for the optimal control
of cancer treatments exist. Over recent years, a body of work by Petrovski and McCall
has applied GAs to models for single objective optimisation of cancer chemotherapy
[66; 67; 99; 49] as well as for multi-objective optimisation [100]. GAs and other search
approaches have been analysed using these models, with alternative techniques applied
including particle swarm optimisation [6], and estimation of distribution algorithms [7].
It is the single objective form of chemotherapy that is used as the fitness function
for this Chapter. The multi-objective function forms part of future work for these
techniques, as detailed in Section 10.3. Although the single objective model can allow
for a number of different drugs to be scheduled, for transparency and initial testing, the
focus will be on single drug schedule optimisation. The single objective chemotherapy
model provides a well-used test function for ascertaining the effectiveness of the directed
intervention crossover approaches for chemotherapy scheduling.
When encoding solutions to this problem, a binary representation is commonly used to
encode dosages [66; 99; 49]. A binary representation uses 4 bits per dosage to represent
dosage strengths between 0 and 15. Analytical work by Petrovski et al found a clear
advantage in using an integer encoding for dosages compared to binary encoding. For
this reason, integer encoding of dosage schedules will be used in these tests.
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An integer encoding of solutions is more appropriate for the idea behind the directed
intervention crossover approaches. As the directed intervention techniques use the
number of interventions contained in parent schedules to define offspring schedules,
a binary encoding where 4 bits are used to represent a single intervention would not
elegantly fit with this model. For instance, with 4 bits per dosage, a dosage of strength
15 would be represented by the binary string 1111, and a dosage of strength 1 would
be represented as 0001. Both of these dosages represent one dosage in the schedule,
however, the directed intervention technique would count the dosage strength of 15 as
4 interventions for offspring calculation and the dosage of strength 1 as 1 intervention.
In a integer encoding, whether the gene has a value of 1 or 15, as long as the dosage
strength is greater than 0, it will be counted as one intervention for offspring inter-
vention level calculation. Each non-zero gene will be counted as an intervention, and
this will provide a more logical representation of interventions for directed intervention
crossover.
An integer representation of the single objective chemotherapy scheduling problem
provides a well tested, non-binary optimal control problem with which to test the
directed intervention crossover approaches. Section 5.4.1 will now discuss the formula
used for this function.
5.4.1 Problem Formulation
As mentioned in Section 5.4, an integer encoding is used to define the concentration
level of the anti-cancer drugs. In this encoding, each concentration has an integer value
in the range 0 to 15. A 0 represents no intervention of the drugs at that time, and
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15 defines application of the maximum dose. This concentration range of 0 - 15 was
considered sensible by the clinical oncologists with whomMcCall et al have collaborated
[86].
If the following chromosome represented days 1 - 4 of a schedule, this represents no
application of the cancer drugs on day 1 or 2, with the maximum allowable dose on
day 3 and the smallest allowable dose on day 4.
0 0 15 1
The aim for the chemotherapy equations is to minimise the final tumour size N(Tfinal)
after a fixed treatment period [T0, Tfinal]. Thus the objective of the search is to find a
treatment schedule that minimises N(Tfinal). In the model by Petrovski and McCall,
the tumour growth is defined by the Gompertz model as shown in Equation 5.14. Work
by Petrovski and McCall compared a range of tumour growth models and found that
the underlying tumour model does not affect the ability of the GA in the objectives of
treatment [99].
Equation 5.14 shows how the population of tumour cells of size N at time t will grow
at a rate λ and the proximity of the current size N to an absolute limiting size θ.
dN
dt
= N(t)λln
θ
N(t)
(5.14)
A relationship exists between the concentration of anti-cancer drug and its ability to
kill cells. This relation is shown in Equation 5.15 where N is the number of tumour
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cells at time t, C(t) is the drug concentration at time t and κ is the toxicity of the
drug.
dN
dt
= −κC(t)N(t) (5.15)
Equations 5.14 and 5.15 are combined to form the differential equation shown in Equa-
tion 5.16, which represents the tumour response to chemotherapy.
dN
dt
= N(t)λln
 θ
N(t)
− κC(t)N(t) (5.16)
Each treatment is evaluated through passing its encoded dose schedule, where Ci rep-
resents the dosage strength for day i and permitted dosages are in the range 0−Cmax,
to a simulation of the response based on Equation 5.16. The score returned by the
fitness function is calculated using ln
 θ
N(Tfinal)
, where N is minimised when this
score is maximised. A description of the complete mathematical model can be found
in [65]
The parameters used in these expressions for the experiments carried out in this work
are shown in Table 5.2. These parameter settings were obtained from McCall to match
those of the work of Petrovski and McCall. This allows for analysis of the directed
intervention crossover techniques on a robust, well tested model. The tumour growth
rate is defined by λ and the maximum cumulative dose of drug by Ccum. The toxicity
of the drug is defined by κ and θ represents the absolute limiting size of the tumour.
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Parameter Value
λ 0.7
Ccum 120
κ 0.045
θ 100
Table 5.2: Chemotherapy Model Parameters
As with many complex models, this model is subject to a number of constraints. These
constraints are detailed in equations 5.17 - 5.19.
g1(c) = Cmax − Ci ≥ 0 (5.17)
g2(c) = Ccum −
n∑
i=1
Ci ≥ 0 (5.18)
g3(c) = Nmax −N(ti) ≥ 0 (5.19)
Equation 5.17 details the maximum instantaneous dose, Cmax, for the drug, Equation
5.18 the maximum cumulative dose of the drug, Ccum, and Equation 5.19 the maximum
permissible size of the tumour, Nmax. The goal of cancer chemotherapy is to achieve
the beneficial effects of treatment without violating the above constraints [6].
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5.5 Experiment parameters
As with the bio-control problem discussed previously, each experiment reviewing cancer
chemotherapy optimisation will run for a fixed number of FFEs. Section 5.5.1 details
the rationale behind the chosen limit.
5.5.1 Fitness function evaluations
Although 5,000 FFEs was sufficient for analysis of the crossover approaches for bio-
control scheduling, preliminary analysis of the chemotherapy problem showed a re-
quirement for a larger number of FFEs. Through analysis of preliminary runs of the
model for each crossover approach, it was found that 40,000 fitness function evaluations
(FFEs) was enough to ascertain the trends and abilities of each crossover approach for
this problem. The statistical output of the runs are therefore analysed in 1,000 FFEs
increments for each approach, and are from 1,000 - 40,000 FFEs.
5.6 Summary
This chapter has introduced two optimal control problems with which to test the di-
rected intervention crossover approaches described previously. Chapter 6 details the
experimental method which will be used for analysis of the crossover approaches at
optimising both of these problems.
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Experimental method
6.1 Methodology
Chapter 4 outlined novel GA crossover approaches for application to optimal control
problems. In order to evaluate the effectiveness of these techniques, empirical analysis
is necessary. This will allow investigation into the hypothesis detailed in Chapter 1 that
the performance of GAs can be improved through using the number of interventions
present in parent schedules to direct the offspring to promising areas of the search
space.
Correct parameter settings for GAs are crucial to their effective traversal of the search
space and it is clear that a good choice of GA parameters can lead to improved per-
formance in most practical problems [101]. However, choosing parameter settings for a
GA usually requires experimentation and there is no easy way to set them well for an
arbitrary problem [14]. It is therefore important to evaluate approaches over a range of
parameter values in order to gauge their performance in a fair and balanced manner.
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In order to address this aspect, a structured approach was taken to study algorithm
performance. This chapter described this approach and the rationale behind it.
6.2 Parameter Selection
Chapter 2 outlined the various considerations present when using a GA. Mitchell has
indicated that although individual optimisation of parameters such as population size
and crossover or mutation rate appears logical, these parameters tend to have nonlinear
relationships, and cannot be optimised individually [11]. It is therefore important that
a spread of parameter combinations are evaluated for determining the robustness and
effectiveness of the crossover approaches under review. Typically a range of population
sizes, crossover and mutation rates are empirically evaluated to decide on settings [14].
In addition to settings for the population size, crossover rate and mutation rate, other
concerns for the GA practitioner include deciding upon an appropriate selection mech-
anism, crossover approaches and replacement strategies. The rationale for settings for
each of these parameters will now be reviewed.
6.3 Population Size
When using a GA, the decision maker has to decide on the number of solutions to
be present in the population. As described in Section 2.4.1, the effective performance
of the GA method depends upon this parameter and it has a major influence on the
successful convergence of the GA to the optimum solution [102]. Goldberg observed
that if the population size is too small the genetic algorithm will converge too quickly
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whereas if the population size is too large it will take a relatively longer time for
significant improvement [103]. As the population size can have such an large effect
on the performance of the algorithms, it appears prudent to experiment with a range
of values. Each of the experiments are therefore reviewed for population sizes of 50,
100 and 150. Although smaller population sizes have been successfully used elsewhere,
they may require the selection of an initial population in a systematic way rather than
a more conventional random initialisation approach [51].
Alander conducted experimental work which suggests that for some problems classes,
a population size of between n and 2n should be considered, where n is the bitstring
length [104]. This finding, however, cannot be generalized to cover all problems for GA
applications. As described in Section 5.2, the bio-control problem is encoded as a 50
gene bitstring and using Alander’s analysis, this would point towards populations of
between 50 and 100 for this problem being sufficient. Petrovski et al found that the
optimal population size for the chemotherapy optimisation problem is approximately
75 [84]. This means that the population sizes, N , of 50 - 150 should be an appropriate
range for both of these problems.
6.4 Crossover Rate
Although crossover probabilities of 1.0 are common in the literature[105], it is prudent
to evaluate the approaches over a range of pc values. For this reason, the experiments
will review the novel techniques over crossover rates of 1.0, 0.9 and 0.8.
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When pc = 0.9, this means that, on average, 1 in 10 of children inserted into the next
generation are purely replicas of one or the other of the parents selected for crossover.
Similarly, when pc = 0.8, on average, 2 in 10 of the children being added to the next
generation of solutions are simply replicas of the parent genes. Although lower crossover
rates, such as pc = 0.3, could have been undertaken, as values in this range are quite
uncommon in literature, pc values in the range 0.8, 0.9 and 1.0 offered a more standard
parameter range for experimentation.
6.5 Mutation Rate
In the absence of mutation the evolutionary process stagnates after several generations
and cannot proceed [106]. This stagnation is because without mutation, the only
variation in the population is that introduced when the population is first initialised.
Although crossover can recombine genes, it cannot introduce any new genetic material
into the population, hence stagnation occurs.
Conversely, if the mutation rate is set too high, the problem becomes almost random
due to the abundance of new material for the algorithms to sort through.
In order to evaluate the approaches over a range of situations, experiments will consider
three levels of mutation, 0, 0.005 and 0.05. This will show the ability of the algorithms
to cope with no mutation, a median level of mutation and a high level of mutation one
order of magnitude greater than the median level. Through reviewing these experi-
ments, this will show how the techniques deal with instances where no new material
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is being added to the population compared with the case where large quantities are
introduced, as well as a balance between these ranges.
6.6 Selection Mechanism
Various alternative selection mechanisms can be used and there is currently no theory
as to which selection approach should be used over others for all problems. Indeed,
it has been shown that all selection algorithms suffer from loss of diversity for some
reason or another [107].
In this work, binary tournament selection has been used for all experimentation. This
form of tournament selection has a low selection pressure and allows for less fit solutions
to contribute to offspring. Furthermore, this form of selection offers no advantage to
any particular crossover approach under review and thus allows for a fair and unbiased
analysis of each of the crossover approaches. As described in Section 2.2.5, tournament
selection has been shown to provide better or equivalent convergence and computational
properties when compared to alternative approaches [25].
6.7 Crossover Approaches
Chapter 4 introduced novel directed intervention crossover operators for application to
optimal control problems. In order to determine the effectiveness of these approaches
it is necessary for them to be compared to standard GA crossover techniques.
Rather than comparing all standard approaches with the directed techniques for all
experiments, it would appear prudent for evaluative purposes to first compare the
71
CHAPTER 6. EXPERIMENTAL METHOD
standard techniques only. If one of the standard techniques is consistently as good as
the other techniques or better, this would allow the directed techniques to be compared
with this, facilitating reduced computational overhead and statistical comparisons. For
this reason, for both optimal control models under consideration, the first set of exper-
iments will compare uniform crossover, single point crossover and two point crossover
to determine if a single approach is better than others for these optimal control prob-
lems. This approach will then be compared with CalEB, TInSSel and DUC to allow
for clearer comparisons as to the efficiency of the directed techniques.
6.8 Replacement Strategy
Section 2.2.8 described two common approaches to replacing offspring in a population,
namely the generational and the steady state approach. When configuring a GA, there
is no defining rationale with regards to which of these approaches should be used for a
particular problem. In order to ensure that the crossover techniques under evaluation
are not receiving any unfair advantage through the replacement strategy used, both
generational and steady state replacement experiments are examined.
Rather than duplicating all graphs and statistical analysis by reviewing each experiment
setting for both generational and steady-state, a reduced approach was undertaken. As
generational is the more common approach to replacing offspring into the population,
each experiment will be reviewed in full for this replacement strategy. Steady-state
replacement will be considered for the median case for each experiment, thus from the
population size described in Section 6.3, this will be for a population of 100 and from
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the crossover rate described in Section 6.4, pc of 0.9 will be used, for pm of 0, 0.005 and
0.05.
To ensure that the best member of the population is not lost due to replacement, an
elitist strategy is used for both generational and steady state replacement strategies.
This ensures that the single best member of the population will not be replaced from
one generation to the succeeding generation.
6.9 Statistical Analysis
In order to determine the effect of the novel crossover approaches to optimal control
problems, statistical analysis of the results is necessary. By conducting the appropriate
statistical tests, information can be derived as to the efficiency, robustness and differ-
ences between approaches. If the data points are normally distributed, then techniques
such as t-tests and the plotting of mean values with standard deviations and standard
error would be appropriate. However, if the data points are not normally distributed,
then non-parametric techniques such as the Kruskal-Wallis one-way analysis of vari-
ance, and plotting of median and inter-quartile range values would more accurately
represent the data and its divergences.
In order to check the distribution of the data points, twenty samples were selected at
random from the underlying data set across all runs. Each sample represents the best
fitness score found for each of the 100 runs of the parameter configuration. By analysing
these samples through the use of the Shapiro-Wilk test and a histogram, information
concerning the normality of the data can be obtained. The Shapiro-Wilk test is one of
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a number of techniques that check for the normality of the underlying population. It
evaluates the null hypothesis that a sample came from a normally distributed sample.
The larger the test statistic, the more probable the sample came from a normally
distributed sample and thus the null hypothesis can be rejected if the test statistic
becomes too small (< 0.05).
Chapter 5 introduced both of the problems under review. There were two classes of
problem from which data could be analysed, the bio-control scheduling problem and
the cancer chemotherapy scheduling problem. As described in Section 5.3.1, the bio-
control scheduling data is sampled over 5,000 FFEs, in increments of 100, from 100 -
5,000. The bio-control problem is also sub-divided into penalty values (P ) of 0, 5, 20,
35 and 50, as described in Section 5.3.2.
The chemotherapy scheduling data spans 40,000 fitness function evaluations (FFEs)
and is sampled in increments of 1,000 from 1,000 - 40,000 FFEs as outlined in Section
5.5.1.
Both the problems are then divided into experiments by population sizes, N , of 50, 100
and 150, crossover rate, pc, of 0.8, 0.9 and 1.0 and mutation rates, pm, of 0, 0.005 and
0.05. In each of these experiments there are 6 crossover techniques used, SPC, 2PC,
UC, CalEB, TInSSel and DUC. The following 20 data points were chosen at random
to ascertain whether data points are normally distributed.
1. Bio-control, 1,300 FFEs, P = 50, N = 100, pc = 0.8, pm = 0, SPC
2. Bio-control, 700 FFEs, P = 20, N = 100, pc = 1.0, pm = 0, 2PC
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3. Bio-control, 4,000 FFEs, P = 20, N = 50, pc = 0.8, pm = 0,UC
4. Bio-control, 3,200 FFEs, P = 0, N = 50, pc = 1.0, pm = 0.05, 2PC
5. Bio-control, 200 FFEs, P = 35, N = 150, pc = 0.9, pm = 0.005, 2PC
6. Bio-control, 4,500 FFEs, P = 50, N = 100, pc = 0.8, pm = 0.005, UC
7. Bio-control, 4,000 FFEs, P = 20, N = 150, pc = 0.9, pm = 0, UC
8. Bio-control, 2,300 FFEs, P = 35, N = 100, pc = 0.8, pm = 0.05,TInSSel
9. Bio-control, 1,200 FFEs, P = 50, N = 150, pc = 0.8, pm = 0.05,DUC
10. Bio-control, 700 FFEs, P = 20, N = 100, pc = 0.9, pm = 0, 2PC
11. Bio-control, 3,400 FFEs, P = 50, N = 150, pc = 1.0, pm = 0.005, UC
12. Chemotherapy, 29,000 FFEs, N = 50, pc = 1.0, pm = 0.005,TInSSel
13. Chemotherapy, 11,000 FFEs, N = 50, pc = 1.0, pm = 0, SPC
14. Chemotherapy, 4,000 FFEs, N = 50, pc = 0.8, pm = 0.005, SPC
15. Chemotherapy, 24,000 FFEs, N = 150, pc = 0.8, pm = 0, 2PC
16. Chemotherapy, 36,000 FFEs, N = 100, pc = 0.9, pm = 0,TInSSel
17. Chemotherapy, 11,000 FFEs, N = 150, pc = 1.0, pm = 0.05, UC
18. Chemotherapy, 32,000 FFEs, N = 50, pc = 0.8, pm = 0, UC
19. Chemotherapy, 23,000 FFEs, N = 50, pc = 1.0, pm = 0,CalEB
20. Chemotherapy, 36,000 FFEs, N = 100, pc = 0.8, pm = 0.05,TInSSel
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Figure 6.1: Top row shows samples 1 and 2, middle row samples 3 and 4, and bottom
row samples 5 and 6 with Shapiro-Wilk p-values of 0.4741, 0.6480, 0.0060, 2.9500E-07,
0.0002 and uncomputable respectively
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Figure 6.2: Top row shows samples 7 and 8, middle row samples 9 and 10, and bottom
row sample 11 with Shapiro-Wilk p-values of 3.0434E-19, 0.0050, 0.7690, 0.9436 and
1.0429E-21 respectively
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Figure 6.3: Top row shows samples 12 and 13, middle row samples 14 and 15, and
bottom row samples 16 and 17 with Shapiro-Wilk p-values of 0.0523, 0.4190, 4.2309E-
05, 0.0004, 0.0002 and 0.1453 respectively
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Figure 6.4: Top row shows samples 18 and 19 with sample 20 beneath with Shapiro-
Wilk p-values of 0.1136, 1.0273E-06 and 0.6723 respectively
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Figures 6.1 - 6.4 show the histogram plot for each of the 20 test cases. The label for
each figure shows the associated Shapiro-Wilk test statistic.
Through analysing these tests, it is clear that normality cannot be assumed in this
data. Test cases 3, 4, 5, 7, 8, 11, 14, 15, 16 and 19 all have a test statistic of less than
0.05 and thus these data points are not from a normally distributed sample. The test
statistic could not be computed for test case 6 as the data had all converged to one
value. As 11 of the 20 data points are not normally distributed, it is prudent to use
non-parametric statistical techniques for the analysis of results. These non-parametric
techniques will now be described.
6.9.1 Non-parametric Statistics
As shown in Section 6.9, normality cannot be assumed for the data in this work. As
there are more than 2 samples for comparison the Kolmogorov-Smirnov cannot be
used, thus all statistical analysis will use a Kruskal-Wallis one-way analysis of variance.
The Kruskal-Wallis is an extension of the Mann-Whitney U test for 3 or more groups.
This test will return a p-value which will show the probability that samples are from
different populations. Due to the number of statistical tests per experiment, results
will be evaluated at the 99% confidence level. Therefore when a significant p-value
(< 0.01) indicates that at least one of the groups is different from at least one of the
others. This test does not however identify which groups are different, thus in order to
distinguish this information, the formula detailed in Equation 6.1 is used [108]. This
allows us to test the hypothesis H0 : θu = θv against H1 : θu 6= θv for the two groups u
and v.
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|R¯u − R¯v| ≥ Zα/k(k−1)
√
N(N + 1)
12
(
1
nu
+
1
nv
) (6.1)
k = number of samples or groups
nj = number of cases in the jth sample
N = number of cases in the combined sample
Rj = sum of the ranks of the jth sample
R¯j = average of the ranks of the jth sample
R¯ = average of the ranks in the combined sample
The formula in Equation 6.1 will allow for analysis as to which groups statistically differ
from which other groups. The analysis of groups will review 4 samples, with 100 cases
per sample and an α value of 0.01. This means than when the mean ranks of groups
differs by 47.99, there is a statistically significant difference between these groups.
If normality of data was assumed, numerical summaries would display the mean and
standard deviation / standard error. Since normality is not assumed, all numerical
summaries will plot the median and the inter-quartile range. As we are concentrating
on finding large differences, any loss of statistical power of data where the data is in
fact normally distributed is not important. Also if differences can be obtained under
non-parametric tests then standard tests would tend to be more positive.
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6.10 Summary
This chapter has outlined the GA parameter settings and the rationale behind their
values. This has included the population size, crossover and mutation rates, selection
mechanisms and the replacement strategy used for experimentation.
The data set was analysed for normality and it was found that normality could not be
assumed for the experiment results. To this end, appropriate non-parametric tests were
described for analysing statistical differences between samples, allowing for accurate
analysis of differences between crossover approaches. As normality cannot be assumed,
it was considered prudent to plot all result output showing the median and interquartile
range values.
This chapter has described the experiment method that will be adhered to by the
experiments undertaken in this work. All parameter values and statistical tests have
been chosen in such a way as to facilitate an unbiased and accurate comparison of the
crossover approaches under review.
Section 6.7 recommended that the traditional crossover approaches should first be
reviewed for optimising the optimal control problems detailed in Chapter 5. In line with
this, the following chapter reviews the abilities of SPC, 2PC and UC for constructing
schedules for bio-control application and chemotherapy treatment.
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Evaluation of traditional
crossover approaches
In order to determine the performance of the directed crossover approaches described in
this work, it is prudent to first examine the performance of existing crossover approaches
for deriving schedules for the two problems described in Chapter 5. As described in
Section 2.2.6, Single Point Crossover (SPC), two point crossover (2PC) and uniform
crossover (UC) are all commonly used GA crossover techniques and each represents
a viable approach to test against. Rather than comparing all of the proposed novel
techniques against SPC, 2PC and UC, it seems prudent to first review the traditional
techniques for the optimal control test problems described in Chapter 5. If one of
these techniques is consistently at least as good as the other approaches, it is logical
to compare the directed techniques with this best performing traditional crossover
approach. This would greatly reduce the required number of statistical tests needed
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to check for performance difference between the novel approaches and the existing
crossover techniques.
With this in mind, the following sections review the abilities of SPC, 2PC and UC
for deriving bio-control schedules for mushroom farming. The subsequent section then
reviews the performance of these same algorithms for the construction of single drug
treatment schedules for chemotherapy.
7.1 Evaluation of traditional crossover techniques for bio-
control scheduling
For this evaluation, the bio-control problem is sampled over 5,000 fitness function
evaluations (FFEs), at intervals of 100, resulting in 50 data points for review. For
each sample point, 100 runs of each crossover approach were recorded for each of
the parameter combinations. The best scoring values for each run for each FFE are
recorded. This is consistent with the parameters used in Section 6.9. As Section 6.9.1
showed that a normal distribution cannot be assumed in these experiments, the median
and interquartile range of these values will be displayed.
Each of the following sections review the effectiveness of SPC, 2PC and UC for bio-
control scheduling over a range of penalty values per intervention. As detailed pre-
viously, it is important to review the crossover techniques with a range of parameter
settings. A complete set of results has therefore been collected and these can be seen
in Appendix B. This Appendix contains the complete set of results showing the fitness
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scores against FFEs associated with these experiments across a range of population
sizes, intervention penalties and crossover and mutation rates.
Rather than reviewing each parameter combination in turn, it appears prudent to
consider the intermediate parameter settings for each approach, instead of explicitly
detailing each possible parameter combination. To this end, each of the following sec-
tions of this chapter will review SPC, 2PC and UC for the varying levels of intervention
penalty P , as described in Section 5.3.2, with a population of N = 100, crossover rate
of pc = 0.9 and mutation rates, pm, of 0, 0.005 and 0.05. One can then compare these
against the complete set of results in Appendix B to check for consistency.
Initial analysis for each intervention penalty will review these intermediate parameter
settings with a generational replacement strategy. A review of the placement of inter-
ventions will follow. As this review is after 5,000 FFEs, this represents the case when
each of the crossover approaches have converged. This details the average placement
of the interventions by each of the crossover approaches over 100 runs and will pro-
vide insight into the dynamics of the problem. This will be followed by analysis of
the intermediate parameter settings under a steady state replacement strategy. The
replacement mechanism, R, for each experiment will be defined as either generational,
R = g, or steady state, R = ss.
The results for each of the runs could be displayed in a number of ways. Techniques
such as Run Length Distributions (RLD) [109] could be used to show the performance
of each of the crossover techniques, however, the approach chosen was to use graphs
displaying the results for both the fitness scores and intervention usage for the in-
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termediate parameter settings. By plotting the intervention usage and fitness scores
versus FFEs over the range of FFE samples, this shows the number of interventions
contained in schedules, the associated fitness of the schedules and the fitness trends
and convergence characteristics of the approaches.
As the task of bio-control optimisation is a minimisation problem, lower scores are
fitter than higher valued scores. On the graphs, SP, 2P and U represent SPC, 2PC and
UC respectively.
The intervention graphs show the number of interventions associated with the corre-
sponding fitness graph for the same FFE sample point. Intervention usage represents
the number of times that the mushroom farmer requires to spray the crops, with an
intervention of 0 representing no doses from the farmer and 50 interventions showing
a dosage on every day of the schedule.
7.1.1 0 penalty points per intervention
This section reviews SPC, 2PC and UC for bio-control scheduling with a penalty of 0
points per intervention. As described in Section 7.1, this will focus on the intermediate
parameter settings. Figures 7.1 to 7.3 show both the fitness scores and associated inter-
vention usage for the intermediate parameter settings under varying levels of mutation,
pm. Figure 7.1 shows the fitness scores and associated intervention usage when pm is
0, with Figure 7.2 and Figure 7.3 detailing pm levels of 0.005 and 0.05 respectively.
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Figure 7.1: Results for N = 100, pc = 0.9, pm = 0, P = 0 and R = g
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Figure 7.2: Results for N = 100, pc = 0.9, pm = 0.005, P = 0 and R = g
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Figure 7.3: Results for N = 100, pc = 0.9, pm = 0.05, P = 0 and R = g
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Reviewing Figure 7.1, an interesting correlation appears between UC’s rapid increase
in fitness with the accumulation of interventions. This shows that when there is no
penalty, the optimal solution is to use a high number of interventions, a trend which
UC is quicker than the other approaches to exploit. Both SPC and 2PC converge using
fewer interventions than UC, with 2PC being able to accumulate more interventions
than SPC in the latter stages of the experiment.
Figure 7.2 details the fitness scores and intervention usage when pm is increased to
0.005. Scores of a similar fitness to those found when pm was 0 are returned, but less
FFEs are required to find them when pm is 0.005. Through reviewing the interventions,
UC appears quicker to accumulate interventions and this is reflected in the fitter scores
for the first 1,500 FFEs.
Figure 7.3 shows the effects of increasing pm to 0.05. All of the crossover approaches
tend to use a similar number of interventions, and this similarity is displayed in the
almost identical fitness scores for this level of mutation.
The high levels of intervention usage displayed by each crossover approach for each
pm level could be attributed to the 0 penalty points associated with each intervention.
There is no cost associated with intervening and as the effect of each intervention is to
reduce the number of sciarid larvae present, this in turn produces fitter scores. This
would account for the high levels of interventions in schedules produced by each of the
crossover approaches.
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7.1.1.1 Intervention placement
The previous section outlined the fitness scores and associated intervention usage for
the traditional crossover approaches, under a generational replacement strategy for a
penalty of 0 points per intervention. In the case of no mutation (Figure 7.1), UC was
shown to use more interventions than both SPC and 2PC, with 2PC in turn using more
interventions than SPC. The average placements of these interventions at the end of
the experiment, after 5,000 FFEs, are shown in Figure 7.4.
UC returned fitter scores after 5,000 FFEs than both of the other approaches and uses
more interventions to do so. Figure 7.4 shows that on average, UC focuses more inter-
ventions than the other approaches on the first 20 days and also has more interventions
on average between days 25 and 39 than the other crossover techniques. As shown
previously in Figure 5.2, the first cycle of sciarid production is in the first 20 days,
followed by a period of rest, followed by the second cycle of sciarid larvae in days 25 -
40. As UC has on average more applications on these days than the other approaches,
this results in fitter scores than the other approaches.
As shown in Figure 7.1, in the absence of mutation, although 2PC is outperformed by
UC, it returns fitter scores than SPC. 2PC uses more interventions than SPC and as
shown in Figure 7.4, 2PC on average focuses more on the second cycle of larvae growth
(days 25-40), than SPC. This more focussed application during the second cycle of
larvae growth returns fitter scores for 2PC than the single point alternative.
The average intervention dosage will now be reviewed. This shows the average applica-
tion doses from the best solutions found over each of the 100 runs. As this is bang bang
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problem, each intervention is either fully applied or not applied at all. If the average
dosage for an intervention is 1, this represents application of the bio-control agent on
that day by each of the 100 best solutions. Conversely, if the average dosage is 0, this
shows that the intervention is not used by any of the 100 best solutions.
Figure 7.4: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 0
and R = g
Figure 7.5 shows the average intervention placements for the traditional crossover ap-
proaches when pm is increased to 0.005. As shown in the corresponding fitness results
and intervention usage graphs (Figure 7.2), each of the crossover approaches return
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similar fitness scores for this setting, using a similar number of interventions in sched-
ules. Figure 7.5 shows that each of the crossover approaches do not focus interventions
on days 22 - 24 or 40 - 41, but focus largely on the other days. This collective focus in
intervention placement explains the similar fitness scores produced for this experiment.
Figure 7.5: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 0 and R = g
The intervention placement when the mutation rate, pm, is further increased to 0.05 is
shown in Figure 7.6. As with a mutation rate of 0.005, each of the crossover approaches
return similar fitness scores for this experiment, using the same number of interventions
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to do so, as shown in Figure 7.3. The intervention placement, as detailed in Figure 7.6,
shows that all approaches focus interventions predominantly on days 4 - 18 and 27 -
37. This similar placement of interventions, focussed around the two cycles of larvae
development, explains the similar fitness scores returned
Figure 7.6: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 0 and R = g
7.1.1.2 Steady state replacement
Section 2.2.8 noted that there are two common methods of updating a population,
namely generational and steady state replacement. Section 6.8 described how in order
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to determine the effectiveness of approaches, both of these replacement strategies would
need to be considered. As with the generational equivalent described in Section 7.1.1,
this experiment details the performance of approaches under steady-state replacement
with intermediate parameter settings.
Figures 7.7 to 7.9 show the fitness and intervention usage associated with performing
the previous set of tests with a steady state replacement strategy. Figure 7.7 shows that
when pm is 0, each of the crossover approaches are slower to accumulate interventions
under steady state replacement when compared to generational replacement. Although
each of the crossover approaches utilise marginally fewer interventions than under gen-
erational replacement, UC alone returns similar fitness scores under both replacement
strategies. Both SPC and 2PC return weaker solutions under steady state replacement
than generational, when pm = 0.
Figure 7.8 shows the fitness score and intervention usage for steady state replacement
when pm = 0.005. When compared with Figure 7.2, where the only difference is the
replacement strategy, each crossover approach has a similar performance regardless of
replacement strategy.
It can be seen that whether under steady state replacement (Figure 7.9) or generational
replacement (Figure 7.3), all crossover approaches behave in a similar manner when
pm = 0.05.
Through comparing intermediate parameter settings for both steady state and gener-
ational replacement for pm of 0, 0.005 and 0.05, similar behavior is displayed between
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approaches. When pm is 0.005 or 0.05, each of the approaches seem unaffected by the
choice of replacement strategy.
Under a steady state approach, when pm = 0, both SPC and 2PC converge to less
optimal solutions, requiring fewer interventions, than with generational replacement.
As no new material is being added into the population through mutation, it would
appear that replacing the population as a whole, as with generational replacement
provides the variety required by SPC and 2PC, which does not exist when 2 children
are introduced to the population each generation. As UC can recombine more genes
per crossover process than both SPC and 2PC this would explain its ability to cope
with pm of 0 for steady state or generational replacement in a similar manner.
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Figure 7.7: Results for N = 100, pc = 0.9, pm = 0, P = 0 and R = ss
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Figure 7.8: Results for N = 100, pc = 0.9, pm = 0.005, P = 0 and R = ss
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Figure 7.9: Results for N = 100, pc = 0.9, pm = 0.05, P = 0 and R = ss
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7.1.2 5 penalty points per intervention
As described in Section 5.3.2, intervention penalties are applied for each bio-control
application. This section details the effects of increasing the penalty to 5 points per
intervention on each of the crossover approaches. As with the experiment described in
Section 7.1.1, intermediate parameters of N = 100, and pc = 0.9 will be used.
Figure 7.10 shows the fitness scores and associated intervention usage for a mutation
rate, pm, of 0. Figures 7.11 and 7.12 details the fitness and intervention usage for pm
levels of 0.005 and 0.05 respectively.
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Figure 7.10: Results for N = 100, pc = 0.9, pm = 0, P = 5 and R = g
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Figure 7.11: Results for N = 100, pc = 0.9, pm = 0.005, P = 5 and R = g
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Figure 7.12: Results for N = 100, pc = 0.9, pm = 0.05, P = 5 and R = g
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Figure 7.10 shows the fitness scores and intervention usage for the intermediate para-
meter settings with a penalty of 5 per intervention and pm of 0. With no intervention
penalty, the best solution appears to be to accumulate many interventions in the sched-
ule. With a penalty of 5 per intervention, the best solution when pm is 0 appears to
be to reduce interventions to a schedule containing around 16 - 20 interventions.
UC is quicker to reduce interventions than either SPC or 2PC. After 2,500 FFEs, each
of the approaches has settled on a number of interventions,with UC using around 17 in-
terventions and SPC and 2PC requiring about 19. This rapid reduction in intervention
levels displayed by UC accounts for the efficiency of its fitness scores for the first 1,500
FFEs. Through using fewer interventions throughout the test, UC settles to solutions
with better fitness than either SPC or 2PC.
Figure 7.11 shows the fitness scores and intervention usage when the mutation rate,
pm, is increased to 0.005. As with a pm of 0, UC is quicker at reducing intervention
levels than SPC and 2PC, resulting in fitter scores till around 3,000 FFEs. At this
point, all approaches use approximately 17 interventions and return equivalent scores.
Figure 7.12 shows the effect of increasing pm to 0.05. In this situation, each of the
approaches utilise approximately the same numbers of interventions, which accounts
for the similar fitness scores displayed.
7.1.2.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the traditional crossover approaches, under a generational replacement strategy for
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a penalty of 5 points per intervention. With no penalty per intervention, the best
scoring schedules used a large number of interventions. With a penalty of 5 points
per intervention, the crossover approaches use less interventions. Figure 7.10 detailed
the fitness and intervention usage in the absence of mutation. Figure 7.13 shows the
average placement of these interventions.
When pm was 0, for a penalty of 5 points per intervention, UC was shown to return
fitter scores than both SPC and 2PC, with 2PC in turn, returning fitter scores than
SPC. Figure 7.13 shows the average intervention placement for each of the approaches
after 5,000 FFEs. This shows that while all approaches focus interventions on the two
main cycles of sciarid larvae growth, UC does not apply interventions as regularly at
other points. As there is a cost associated with interventions, this accounts for the
fitter scores returned by UC for this parameter setting. 2PC was fitter than SPC for
this experiment and, as shown in Figure 7.13, although intervention placement is not
as focussed as UC, 2PC uses less interventions than SPC to return fitter scores.
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Figure 7.13: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 5
and R = g
Figure 7.14 shows the average intervention placement when pm is increased to 0.005.
For this parameter setting, each of the crossover approaches returned scores of a similar
fitness, using the same number of interventions to do so, as shown in Figure 7.11. As
each of the crossover approaches are focussing their interventions in days 4 - 13 and 28
- 36, with limited application on days 13 - 16, this explains the similar fitness scores
returned.
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Figure 7.14: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 5 and R = g
Figure 7.14 shows the average intervention placement when pm is further increased to
0.05. Each of the crossover approaches use similar numbers of interventions to produce
comparable fitness scores, as shown in Figure 7.11. Each of the crossover approaches
use similar intervention timings to produce these highly similar fitness scores. As the
mutation rate increases from 0.005 to 0.05, more randomness is being added to the
population. This randomness is clearly shown through comparing Figures 7.14 and
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7.15, in that the placement of interventions is not as focussed for the higher mutation
rate as for a pm of 0.005.
Figure 7.15: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 5 and R = g
7.1.2.2 Steady state replacement
We now consider the alternative steady state replacement strategy. Figures 7.16 to
7.18 show the fitness scores for SPC, 2PC and UC when R = ss with pm values of 0,
0.005 and 0.05. There is a penalty of 5 points associated with each intervention.
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Figure 7.16 shows that when pm = 0, SPC and 2PC perform worse under steady state
than with generational replacement. This was also the case for an intervention penalty
of 0. UC is also affected by the change in replacement strategy and returns solutions
of less fitness for steady state than for generational replacement. Inspecting the inter-
vention usage, each of the approaches struggle to reduce the level of interventions for
steady state replacement compared with generational replacement. This would account
for the difference in fitness scores between replacement strategies.
Although each of the approaches are not as efficient under steady state replacement
as opposed to generational, UC again returns fitter scores compared with the other
approaches for this pm level.
The next cross comparison required is to check for an increase in the level of mutation.
Figure 7.17 details the approaches under steady state replacement when pm is increased
to 0.005. As with the generational case, SPC and 2PC improve dramatically when pm is
increased from 0 to 0.005. There is more overlap between intervention usage for steady
state replacement across crossover approaches than was present under a generational
replacement strategy. For this reason, the solutions returned are closer together than
observed under generational replacement, especially between 1,500 and 2,200 FFEs.
When pm is further increased to 0.05, as shown in Figure 7.18, each of the approaches
utilise approximately the same number of interventions throughout the experiment.
This accounts for the very similar scores returned by each of the crossover approaches.
These scores are similar to those displayed under generational replacement.
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It is interesting to note that when the mutation rate, pm, is increased from 0.005 to
0.05, regardless of replacement strategy, there is a decline in the fitness scores returned
by each of the crossover approaches. This indicates an upper bound for the mutation
rate for this problem.
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Figure 7.16: Results for N = 100, pc = 0.9, pm = 0, P = 5 and R = ss
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Figure 7.17: Results for N = 100, pc = 0.9, pm = 0.005, P = 5 and R = ss
112
CHAPTER 7. EVALUATION OF TRADITIONAL CROSSOVER
APPROACHES
Figure 7.18: Results for N = 100, pc = 0.9, pm = 0.05, P = 5 and R = ss
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7.1.3 20 penalty points per intervention
The next experiment considers the effect of increasing the number of penalty points per
intervention from 5 to 20. Figures 7.19 to 7.21 show the fitness scores and associated
intervention usage for a penalty of 20 per intervention and pm values of 0, 0.005 and
0.05 respectively.
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Figure 7.19: Results for N = 100, pc = 0.9, pm = 0, P = 20 and R = g
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Figure 7.20: Results for N = 100, pc = 0.9, pm = 0.005, P = 20 and R = g
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Figure 7.21: Results for N = 100, pc = 0.9, pm = 0.05, P = 20 and R = g
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Figure 7.19 shows the fitness scores and intervention usage when pm is 0 and the penalty
per intervention is 20. As with lesser intervention penalty values, UC is quicker at
reducing the number of interventions, and returns fitter scores. Both SPC and 2PC
reduce interventions over the duration of the experiment, but at a slower pace than UC.
As both SPC and 2PC settle on more interventions than UC this results in convergence
to less optimal scores.
Figure 7.20 details the experiment when the probability of mutation, pm, is increased
to 0.005. As with a pm of 0, UC is quicker to reduce the number of interventions than
both SPC and 2PC, resulting in fitter scores for the first 3,000 FFEs. At this point,
all crossover approaches tend to the same number of intervention placements and all
approaches return similar scores for the rest of the experiment. It would appear that
for this level of penalty, placement of 4 interventions during the schedule returns the
optimal score.
As pm is increased to 0.05, as shown in Figure 7.21, each of the approaches use ap-
proximately the same number of interventions throughout the experiment. Due to the
similarity between the number of interventions in schedules, each of the crossover ap-
proaches return similar scores. The scores returned by each of the crossover approaches
are less fit with this mutation level compared to those returned when pm = 0.005. As
stated in Section 7.1.2.2, this shows an upper bound for the mutation level in this
experiment.
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7.1.3.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the traditional crossover approaches, under a generational replacement strategy for
a penalty of 20 points per intervention. Figure 7.19 detailed the fitness and intervention
usage in the absence of mutation. Figure 7.22 shows the average placement of these
interventions.
As with the lesser intervention penalties, in the absence of mutation UC returns fitter
scores than the other approaches, with 2PC returning fitter scores than SPC. Figure
7.22 shows the placement of interventions for each of the approaches. UC uses fewer
interventions than the other approaches, mainly focussing interventions on days 6 -
9. 2PC is not as focussed as UC in the timing of interventions for this experiment
and as there is now a cost of 20 points per intervention, this results in less fit scores
being returned. SPC focusses applications mainly at the first sciarid larvae cycle,
but also shows occasional application to the second cycle. It would appear that the
benefit associated with this latter interventions are not enough to outweigh the cost of
interventions, hence the lesser fitness scores for this experiment.
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Figure 7.22: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 20 and R = g
Figure 7.23 shows the intervention placement for the fitness scores and intervention
usage shown in Figure 7.20. This shows that for a mutation rate of 0.005, each of the
crossover approaches focus on placing interventions on days 6 - 9. This accounts for
the similar fitness scores returned by each of the approaches.
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Figure 7.23: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 20 and R = g
Figure 7.21 showed that each of the crossover approaches use a similar number of inter-
ventions to produce fitness scores in the same range. Figure 7.24 shows the placement
of these interventions. All approaches focus mainly on the first sciarid larvae cycle,
with a limited number of applications across approaches to target the second larvae
cycle. This similarity in intervention placement explains the close relation in the fit-
ness scores returned by the crossover approaches. This focus on intervening early in
the sciarid larvae cycle, targeting the first larvae cycle, was shown to be the most ef-
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fective approach in the work of Fenton et al [93]. Related studies by Brownlee et at
[110], also found this to be the case. In that work, Brownlee et al concluded that the
destruction of the larvae population early in the schedule means few larvae remaining
to breed and repopulate. As with the intervention penalty of 5 points per intervention,
the higher mutation rate is shown to produce less focussed schedules than when pm is
0.005, resulting in scores of a lesser fitness.
Figure 7.24: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 20 and R = g
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7.1.3.2 Steady state replacement
We now need to check if the previous observations concerning generational replacement
still hold for a steady state replacement strategy. Figures 7.25 to 7.27 show the fitness
scores and intervention usage for the same previous intermediate parameter settings
and a penalty of 20 per intervention when R = ss.
Fitness scores and intervention usage for steady state replacement when pm = 0 are
shown in 7.25. In the absence of mutation, as with lower intervention penalties, each
of the crossover approaches struggle to find solutions of a similar fitness when R = ss
as for the case when R = g.
Under generational replacement, when pm = 0, SPC and 2PC settled to schedules
requiring placement of 6 interventions, and UC required 4. With steady state replace-
ment and no mutation, SPC settles on 9 interventions, 2PC uses 8 and UC requires
6. This shows that each of the approaches experience difficulties in the production of
schedules requiring less interventions under a steady state replacement strategy. One
explanation for this is that in the absence of mutation, each of the approaches uses the
diversity in the population to help drive the intervention reduction process. As less
diversity is introduced with 2 children per generation as opposed to complete replace-
ment of the population, this would account for the difficulties in intervention reduction
when pm = 0.
Figure 7.26 shows the fitness scores and intervention usage when pm is increased to
0.005. As with generational replacement, UC is quicker to reduce the number of inter-
ventions in the schedule, resulting in fitter scores for the first 3,000 FFEs. At this point,
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again in line with generational replacement, each of the approaches produce schedules
requiring placement of 4 interventions and return solutions of similar fitness.
The fitness score and intervention usage for the case when pm is increased to 0.05 is
shown in Figure 7.27. In line with experiments using a similar pm level and a lesser
intervention penalty, when the penalty is 20 per intervention, each of the crossover
approaches produce similar scores. This is accounted for by the reduction in interven-
tion levels at a similar pace by each of the crossover approaches. At this mutation
level, similar scores are produced by each of the crossover approaches, regardless of
replacement strategy used.
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Figure 7.25: Results for N = 100, pc = 0.9, pm = 0, P = 20 and R = ss
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Figure 7.26: Results for N = 100, pc = 0.9, pm = 0.005, P = 20 and R = ss
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Figure 7.27: Results for N = 100, pc = 0.9, pm = 0.05, P = 20 and R = ss
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7.1.4 35 penalty points per intervention
With an increasing penalty associated per intervention a varying number of intervention
levels have offered fitter scores. For an intervention penalty of 0, each crossover tech-
nique settled to approximately 47 interventions. With a penalty of 5 per intervention,
approaches tended to around 17 interventions and for a penalty of 20 per interven-
tion, each approach converged to schedules requiring placement of 4 interventions. The
next two experiments review the fitness and intervention usage for the crossover ap-
proaches when the intervention penalty is increased to 35 and then 50 penalty points
per intervention.
Figure 7.28 shows the fitness scores and associated intervention usage when pm = 0.
Figures 7.29 and 7.30 detail pm levels of 0.005 and 0.05 respectively.
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Figure 7.28: Results for N = 100, pc = 0.9, pm = 0, P = 35 and R = g
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Figure 7.29: Results for N = 100, pc = 0.9, pm = 0.005, P = 35 and R = g
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Figure 7.30: Results for N = 100, pc = 0.9, pm = 0.05, P = 35 and R = g
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Figure 7.28 shows the intermediate parameter settings with generational replacement
and a penalty of 35 points per intervention when pm = 0. In this instance, as with
previous penalty levels, UC is quicker to reduce intervention levels than both SPC
and 2PC. UC converges to solutions using around 3 interventions as opposed to the
5 interventions used by SPC and 4 by 2PC. This reduced intervention usage returns
fitter scores for UC as opposed to SPC and 2PC.
Figure 7.29 shows the effect of increasing pm to 0.005. As with a mutation rate of 0,
UC converges to schedules using 3 interventions. By around 3,000 FFEs, both SPC
and 2PC have also reduced to schedules of 3 interventions. With this similar usage of
interventions in schedules, similar fitness scores are returned from each of the crossover
approaches from this point.
Figure 7.30 details the effect of increasing the mutation rate, such that pm = 0.05.
As with the lesser penalty values, when the mutation rate is at this level, all crossover
approaches return solutions with lower fitness scores when compared with a pm of 0.005.
Each of the crossover approaches utilise a similar number of interventions throughout
the duration of this experiment and this in turn leads to similar fitness scores being
returned by each of the crossover approaches.
7.1.4.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the traditional crossover approaches, under a generational replacement strategy for
a penalty of 35 points per intervention. Figure 7.28 detailed the fitness and intervention
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usage in the absence of mutation. Figure 7.31 shows the average placement of these
interventions.
As with the lesser intervention penalties, Figure 7.28 shows that in the absence of mu-
tation, UC uses fewer interventions than both SPC and 2PC to produce fitter scores.
Also inline with previous experiments for this mutation level, 2PC uses fewer inter-
ventions than SPC to produce scores of a higher fitness. Figure 7.31 shows that UC
focusses mainly on interventions 6 - 8, and rarely intervenes on any other day. 2PC
focuses mainly on these days, but also has interventions on other days on the sched-
ule. SPC, as with 2PC mainly intervenes early in the schedule, but also occasionally
intervenes at other points in the schedule. 2PC has more interventions outwith days
6 - 8 than UC, and returns less fit scores. SPC has more interventions outwith days
6 - 8 than 2PC, and is poorer than 2PC. This would imply that the benefit gained by
intervening at these points does not outweigh the associated penalties incurred.
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Figure 7.31: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 35 and R = g
Figure 7.32 shows the intervention placement for the fitness scores and intervention us-
age detailed in Figure 7.29, when pm = 0.005. Each of the crossover approaches return
similar fitness scores for this mutation rate, using the same number of interventions in
schedules. Figure 7.32 shows that each of the approaches focus interventions mainly
on days 6 - 8, thus explaining the similarity in fitness scores returned.
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Figure 7.32: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 35 and R = g
Figure 7.33 shows the intervention placement for the fitness scores and intervention
usage detailed in Figure 7.30, when pm is further increased to 0.05. For this mutation
level, less fit scores are returned by each of the crossover approaches compared to a
pm level of 0.005. Figure 7.33 shows that while each of the crossover approaches focus
interventions between days 6 and 8 of the schedule, applications on other days of the
schedules do appear. This similarity in intervention placement explains the similar
fitness scores returned by each of the crossover approaches for this mutation level.
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Figure 7.33: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 35 and R = g
7.1.4.2 Steady state replacement
We now repeat the previous evaluation for a steady state replacement strategy. Figures
7.34 to 7.36 shows the fitness scores and intervention usage for each approach with
intermediate parameter settings, a penalty of 35 points per intervention and a steady
state replacement strategy.
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Figure 7.34 shows pm = 0. As with the previous intervention penalties, the steady
state scores returned by each of the crossover approaches for this mutation level are
less fit than those returned under a generational replacement strategy. This difference
in fitness scores between approaches can be explained by the greater number of inter-
ventions required by schedules produced under steady state as opposed to generational
replacement.
When pm is increased to 0.005, as shown in Figure 7.35, similar trends hold for both
generational and steady state replacement. Regardless of replacement strategy, UC
is quicker at reducing interventions, and thus returns better scores for the first 3,000
FFEs. At this point, both SPC and 2PC are consistently producing schedules with a
similar number of interventions as UC, and therefore return scores of a similar fitness.
Figure 7.36 shows the effect of further increasing the mutation rate, pm, to 0.05. As
when pm = 0.005, there is little difference between scores returned or interventions
used under either a steady state or a generational replacement strategy. As with this
mutation level for lesser intervention penalties, each of the approaches create schedules
using approximately similar numbers of interventions, resulting in similar fitness scores.
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Figure 7.34: Results for N = 100, pc = 0.9, pm = 0, P = 35 and R = ss
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Figure 7.35: Results for N = 100, pc = 0.9, pm = 0.005, P = 35 and R = ss
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Figure 7.36: Results for N = 100, pc = 0.9, pm = 0.05, P = 35 and R = ss
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7.1.5 50 penalty points per intervention
The final experiment describes how SPC, 2PC and UC compare when the intervention
penalty is further increased to 50 points per intervention. As described in Section 5.3.2,
a penalty of 50 points per intervention represents the upper bound for the intervention
penalty level.
Figures 7.37 to 7.39 show the fitness scores for each of the crossover approaches for
intermediate parameter settings with a penalty of 50 points per intervention.
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Figure 7.37: Results for N = 100, pc = 0.9, pm = 0, P = 50 and R = g
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Figure 7.38: Results for N = 100, pc = 0.9, pm = 0.005, P = 50 and R = g
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Figure 7.39: Results for N = 100, pc = 0.9, pm = 0.05, P = 50 and R = g
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Figure 7.37 shows that when the probability of mutation is 0, as was the case with a
smaller intervention penalty, UC is quicker at reducing interventions than the other
approaches. UC settles on schedules requiring fewer interventions than those returned
by SPC and 2PC. By UC using 2 interventions as opposed to 3 by 2PC or 4 by SPC,
fitter scores are returned by UC for this parameter setting.
Figure 7.38 shows the effect of increasing the mutation rate, such that pm = 0.005.
After 2,700 FFEs, all approaches use around 2 interventions, resulting in similar fitness
scores from this point. As with lesser intervention penalties, UC is quicker at reducing
intervention levels and because of this produces fitter scores for the first half of the
experiment.
The effect of further increasing the mutation rate to pm = 0.05 is shown in Figure
7.39. The previous experiments have displayed that all approaches struggle to find
the optimal scores for this higher mutation level. This remains the case when the
intervention penalty is increased to 50. Although all approaches are reducing in the
number of interventions, this is not as direct as with the lower mutation rates, resulting
in the similar fitness scores returned by each of the crossover approaches.
7.1.5.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the traditional crossover approaches, under a generational replacement strategy for
a penalty of 50 points per intervention. Figure 7.37 detailed the fitness and intervention
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usage in the absence of mutation. Figure 7.40 shows the average placement of these
interventions.
As with each of the lesser intervention penalties, in the absence of mutation, UC pro-
duces fitter scores than both 2PC and SPC, with 2PC scores in turn being fitter than
those returned by SPC. Figure 7.40 shows that UC focusses 2 interventions, on days 6
and 7 of the schedule. 2PC and SPC both focus mainly on these points, but both dis-
play interventions on other days of the schedule as well, SPC more than 2PC. As there
is a high penalty associated with interventing, these extra interventions in the schedules
would explain the difference in fitness scores returned by each of the approaches.
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Figure 7.40: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 50 and R = g
Figure 7.38 detailed the fitness and intervention usage when pm was increased to 0.005
and Figure 7.41 shows the average placement of these interventions. For this mutation
level, each of the approaches focus application on days 6 and 7 of the schedule, and
this explains the similarity in fitness scores returned.
147
CHAPTER 7. EVALUATION OF TRADITIONAL CROSSOVER
APPROACHES
Figure 7.41: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 50 and R = g
The effect of further increasing pm to 0.05 was shown in Figure 7.39. For this mutation
level each of the approaches used a similar number of interventions to produce fitness
scores in the same range. Figure 7.42 shows the placement of interventions by each of
the crossover approaches. Each of the approaches focus application on days 6 and 7
and display similar trends in terms of lesser applications used. This similar placement
of interventions by each approach accounts for the fitness scores in the same range
returned by each of the crossover approaches.
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Figure 7.42: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 50 and R = g
7.1.5.2 Steady state replacement
The same experiment will now be reviewed for a steady state replacement strategy.
Figures 7.43 to 7.45 show the fitness scores and associated intervention usage for each
crossover approach with intermediate parameter settings, a penalty of 50 points per
intervention and a steady state replacement strategy.
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Figure 7.43 shows that as with lesser intervention penalties, each of the approaches
perform worse under steady state replacement as opposed to the generational approach
when pm = 0. UC outperforms both SPC and 2PC in that it finds fitter scores in fewer
FFEs. UC also converges to solutions of a better fitness than those returned by SPC
and 2PC.
The effect of increasing the mutation rate, such that pm = 0.005 is shown in Figure 7.44.
As with smaller intervention penalties, the performance of the crossover approaches
does not differ between replacement strategies. UC is again quicker at reducing in
intervention levels and as a result of this returns fitter scores for the first 2,700 FFEs.
At this point, both SPC and 2PC are producing schedules with a similar number of
interventions and return solutions of a similar fitness from this point onwards.
Figure 7.45 shows the effect of further increasing pm from 0.005 to 0.05. As with earlier
experiments featuring smaller intervention penalties, each of the crossover approaches
perform in a similar way, irrespective of the replacement strategy used. SPC, 2PC and
UC produce schedules using a similar number of interventions during the course of this
experiment and, as was the case for generational replacement, similar fitness scores are
returned by each of the crossover approaches.
150
CHAPTER 7. EVALUATION OF TRADITIONAL CROSSOVER
APPROACHES
Figure 7.43: Results for N = 100, pc = 0.9, pm = 0, P = 50 and R = ss
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Figure 7.44: Results for N = 100, pc = 0.9, pm = 0.005, P = 50 and R = ss
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Figure 7.45: Results for N = 100, pc = 0.9, pm = 0.05, P = 50 and R = ss
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7.1.6 Summary of bio-control scheduling experiment
This section has reviewed the traditional crossover techniques, SPC, 2PC and UC for
deriving optimal control schedules of bio control applications over a range of interven-
tion penalties, mutation rates and replacement strategies. The intervention penalties
have ranged from 0, as described in Section 7.1.1 through to a penalty of 50 per inter-
vention, as detailed in Section 7.1.5.
Through reviewing SPC, 2PC and UC over this range of penalties, three trends have
appeared, namely:
1. Trend 1: When no mutation is present, UC is better than both SPC and 2PC at
deriving fit solutions.
2. Trend 2: With a mutation rate of 0.005, UC is quicker at finding fitter solutions
than both SPC and 2PC.
3. Trend 3: When the mutation rate is increased to 0.05, all approaches exhibit
similar performance, and each return weaker scores than those found for a pm
level of 0.005.
Each of these trends hold regardless of whether a generational or a steady state re-
placement strategy is used. It can be further noted that with mutation levels of 0.005
or 0.05, the choice between generational or steady state replacement has little effect on
each of the crossover operators. When pm = 0, under a steady state replacement strat-
egy, each of the crossover approaches display weaker performance compared with the
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generational equivalent. Although each crossover approach is affected by this change
in replacement strategy, SPC and 2PC were affected by this change more than UC.
Indeed, when pm = 0, SPC and 2PC appear to struggle to converge to good solutions.
An explanation of this difference in fitness scores between replacement strategies when
pm = 0 is given in Section 7.1.1.2. It can be observed that as no new material is being
added into the population through mutation, using generational replacement provides
more combinations of material into the population than the steady state alternative.
As UC can recombine more genes per crossover process than both SPC and 2PC this
would explain its ability to be less affected by the choice of replacement strategy when
pm = 0.
The placement of interventions during the 50 day schedule has also been reviewed
for each of the intervention penalties. This showed that while each of the crossover
approaches target both cycles of larvae growth for lesser intervention penalties, as
the penalty increases, intervention focuses mainly on the earlier larvae cycle. Section
7.1.3.1 details that this is in line with previous empirical evaluation of this bio-control
problem.
This set of experiments were conducted to find out if one of the traditional crossover
approaches was consistently at least as good as the other approaches for the task of op-
timising bio-control schedules. It was proposed that if one of the traditional crossover
approaches was at least as good as the others, it would serve as an appropriate base-
line comparison method for the directed intervention techniques. From reviewing SPC,
2PC and UC across varying mutation rates, crossover rates, intervention penalties and
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replacement strategies, UC is shown to consistently perform at least as effectively as
both SPC and 2PC. For this reason, the comparisons of directed intervention crossover
techniques for bio-control scheduling as described in Section 8.1 will use UC as a base-
line crossover approach for the purposes of comparing performance for the bio-control
problem.
7.1.7 Further analysis
The previous sections reviewed SPC, 2PC and UC across a range of intervention penal-
ties using the intermediate parameter settings. From these experiments a number of
trends were observed that held for each of the parameter settings, regardless of the
penalty value per intervention.
In order to further analyse the abilities of each of the crossover approaches, it appears
necessary to review them across a range of parameters outwith the intermediate set
discussed previously. As with previous experiments, this review will consider the range
of intervention penalty values. Appendix A.1 details the abilities of SPC, 2PC and
UC across the range of population sizes, crossover rates, mutation rates and interven-
tion penalties. This describes how in the absence of mutation, UC finds fitter scores
than both SPC and 2PC and that when the mutation rate is increased to 0.005, all
approaches find comparable solutions, with UC quicker at deriving these. This also
describes how each of the crossover approaches return comparable scores when the mu-
tation rate is increased further to 0.05, with these scores being less fit than those found
under a mutation rate of 0.005.
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Several trends have been demonstrated regardless of the population size or crossover
rate for these experiments. For experiments with no mutation, UC appears as the more
flexible crossover operator, returning fitter solutions than both SPC and 2PC. When the
mutation rate is increased to 0.005, both SPC and 2PC increase in performance relative
to UC. Even with this increase in performance, which sees SPC and 2PC converge to
similar solutions as UC over time, UC is quicker at finding these fitter solutions. When
the mutation rate is further increased to 0.05, it appears that this mutation level is
sufficiently high that too much randomness is introduced into the population. This
makes it hard for all crossover approaches to find good solutions. For this mutation
rate, all crossover approaches appear comparable. Each of these trends are in line with
those described previously in Section 7.1.6.
7.2 Evaluation of traditional crossover techniques for chemother-
apy treatment scheduling
Each of the traditional crossover approaches will now be reviewed for the task of
chemotherapy treatment scheduling. Section 7.1 reviewed SPC, 2PC and UC for the
optimisation of bio-control schedules. This section extends on these experiments by
reviewing the effectiveness of each of the traditional crossover approaches at deriving
chemotherapy treatment schedules. The formulation of this chemotherapy problem was
described in Section 5.4.1.
For this evaluation, the chemotherapy treatment scheduling problem is sampled over
40,000 fitness function evaluations (FFEs), at intervals of 1,000, resulting in 40 data
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points for review. For each sample point, 100 runs of each crossover approach were
recorded for each of the parameter combinations. The best scoring values for each run
for each FFE are recorded. This is consistent with the parameters used in Section 6.9.
As described in Section 6.9.1, as a normal distribution cannot be assumed in these
experiments, the median and interquartile range of these values are displayed.
The following sections review the effectiveness of SPC, 2PC and UC for chemotherapy
treatment scheduling for both generational and steady state replacement strategies. As
detailed previously, it is important to review the crossover techniques with a range of
parameter settings. A complete set of results has therefore been collected and these
can be seen in Appendix F. This appendix contains the complete set of results showing
the fitness scores against FFEs associated with these experiments across a range of
population sizes, crossover rates and mutation rates.
As with the bio-control experiments, rather than reviewing each parameter combination
in turn, it appears prudent to consider the intermediate parameter settings for each
approach, instead of explicitly detailing each possible parameter combination. To this
end, each of the following sections will review SPC, 2PC and UC with a population
of N = 100, crossover rate of pc = 0.9 and mutation rates, pm, of 0, 0.005 and 0.05.
One can then compare these against the complete set of results in Appendix F to check
for consistency. Unlike the bio-control scheduling problem, there is no explicit penalty
associated with each intervention.
Initial analysis for each intervention penalty will review these intermediate parameter
settings with a generational replacement strategy. This will be followed by a cor-
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responding analysis of the intermediate parameter settings under a steady state re-
placement strategy. As described previously, the replacement mechanism, R, for each
experiment will be defined as either generational, R = g, or steady state, R = ss.
Graphs displaying the results for both the fitness scores and intervention usage for the
intermediate parameter settings under both generational and steady state replacement
will now be reviewed. Both fitness versus FFEs and intervention usage versus FFEs are
plotted over the range of FFE samples. As the task of cancer chemotherapy treatment
optimisation is a maximisation problem, higher scores are fitter than lower valued
scores.
The intervention graphs show the number of interventions associated with the corre-
sponding fitness graph for the same FFE sample point. Intervention usage represents
the number of times that the patient receives chemotherapy drugs, with an interven-
tion of 0 representing no application of chemotherapy drug doses and 100 interventions
showing application of the chemotherapy drug on every day of the schedule.
Figures 7.46 to 7.48 show the fitness score and intervention usage for intermediate
parameters and a pm of 0, 0.005 and 0.05 respectively.
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Figure 7.46: Results for N = 100, pc = 0.9, pm = 0 and R = g
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Figure 7.47: Results for N = 100, pc = 0.9, pm = 0.005 and R = g
161
CHAPTER 7. EVALUATION OF TRADITIONAL CROSSOVER
APPROACHES
Figure 7.48: Results for N = 100, pc = 0.9, pm = 0.05 and R = g
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Reviewing the intervention usage displayed in Figure 7.46, it would appear that UC is
finding a different area of solutions when compared with SPC and 2PC when pm = 0.
UC is using around 68 interventions, with 2PC using around 80 and SPC requiring
approximately 84 interventions. This reduction in intervention usage appears highly
beneficial for schedule production, as shown with the associated fitness scores. As both
2PC and UC perform more recombination of genetic material, this would explain why
both of these crossover techniques outperform SPC when pm = 0.
Figure 7.47 shows the fitness scores and intervention usage when pm is increased to
0.005. Unlike intervention usage for pm of 0, each of the approaches use a similar
number of interventions for pm of 0.005. This may explain the large overlap between
fitness scores returned by each of the crossover approaches.
Figure 7.48 details the effect of further increasing pm to 0.05. As with the intervention
usage and fitness scores for a pm of 0.005, when pm is 0.05 each approach uses a similar
number of interventions, resulting in similar fitness scores across approaches. Unlike
the bio-control experiment, this increased mutation level does not represent an upper
bound, as the solutions produced when pm is 0.05 are fitter than those returned with
a mutation level of 0.005. This is in accordance with the findings of Petrovski et al
[84], as their statistical evaluation of the significant GA factors found a mutation rate
of 0.092 to be optimal.
From reviewing the traditional crossover approaches with intermediate parameter set-
tings and a generational replacement strategy, two conclusions can be drawn. Firstly,
in the absence of mutation, UC returns scores of considerably higher fitness than those
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found by both SPC and 2PC, with 2PC in turn producing fitter scores than SPC.
The second conclusion drawn from these experiments is that when pm is 0.005 or 0.05,
each of the crossover approaches perform in a similar manner and thus the choice of
traditional crossover approach is potentially arbitrary.
7.2.0.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the traditional crossover approaches, under a generational replacement strategy
for cancer chemotherapy scheduling. The average dosage strength and placement of
interventions will now be reviewed. If the average dosage was 15 for an intervention,
this would represent a maximum dosage by each of the 100 best solutions recorded at
that intervention point. Conversely, if the average dosage is 0, this shows that none of
the 100 best solutions apply drugs at that particular intervention.
In the case of no mutation (Figure 7.46), UC was shown to use less interventions than
both SPC and 2PC, with 2PC in turn using less interventions than SPC. The average
placement of these interventions at the end of the experiment, after 40,000 FFEs, are
shown in Figure 7.49.
Figure 7.46 detailed the fitness scores returned by each of the crossover approaches, in
the absence of mutation. The average placement and dosage strength detailed in Figure
7.49 show that UC applies less drugs than the other approaches and 2PC slightly less
than SPC.
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Figure 7.49: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0 and
R = g
Figure 7.47 showed that each of the crossover approaches returned fitter scores, using
fewer interventions, when pm was increased from 0 to 0.005. Figure 7.49 shows the
average placement and dosage strength of these applications. Each of the crossover
approaches returned similar fitness scores for this mutation rate, and Figure 7.47 shows
that each approach places interventions, in the same dosage range, on common days.
This intensive therapy late in the treatment period is in line with the mathematical
optimisation work of McCall et al [86].
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Figure 7.50: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.005
and R = g
Figure 7.48 detailed the fitness scores returned and interventions used when pm was
increased from 0.005 to 0.05. As detailed previously, the scores returned for this in-
creased mutation rate are fitter than those found when pm was 0.005, with each of the
crossover approaches returning scores of a similar fitness. Figure 7.51 shows that while
on average each of the crossover approaches have small doses throughout the schedule,
they also have a dose of approximately strength 3 on day 98, an increased dose of
strength 5 on day 99 and a final dose on day 100 with strength 13.
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Figure 7.51: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.05
and R = g
7.2.0.2 Steady state replacement
Figures 7.52 to 7.54 shows the steady state fitness scores for each approach with inter-
mediate parameter settings. The trends shown with generational replacement are still
apparent for steady state replacement. When pm is 0, as shown in Figure 7.52, UC
uses fewer interventions than both SPC and 2PC and returns fitter scores. As with the
generational equivalent, 2PC outperforms SPC for this mutation level.
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Figures 7.53 and 7.54 show pm levels of 0.005 and 0.05 respectively. As with gener-
ational replacement, for each of these mutation levels each crossover approach uses a
similar number of interventions for schedule optimisation. This similarity between in-
tervention usage in schedules would account for the similar fitness scores displayed by
each of the crossover approaches. Note that for these mutation levels, a steady state
replacement strategy produces scores with fitter scores than with the generational re-
placement strategy.
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Figure 7.52: Results for N = 100, pc = 0.9, pm = 0 and R = ss
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Figure 7.53: Results for N = 100, pc = 0.9, pm = 0.005 and R = ss
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Figure 7.54: Results for N = 100, pc = 0.9, pm = 0.05 and R = ss
171
CHAPTER 7. EVALUATION OF TRADITIONAL CROSSOVER
APPROACHES
7.2.1 Summary of experiment for chemotherapy treatment schedul-
ing
This section has reviewed the abilities of SPC, 2PC and UC for deriving schedules for
chemotherapy application, over a range of mutation rates and replacement strategies.
Each of the traditional crossover approaches are shown to perform poorly when there
is no mutation introduced into the population. When pm is 0, UC returns scores of a
higher fitness than both SPC and 2PC under generational replacement. Under a steady
state replacement strategy, UC returns scores of a higher fitness than both SPC and
2PC. The fitness scores returned by each of the crossover approaches are considerably
poorer under a steady state replacement strategy. This shows that with a steady state
replacement strategy and a pm level of 0, a lack of genetic variety is being introduced to
the population, resulting in scores of lesser fitness than a generational strategy which
replaces most of the population in each generation.
Irrespective of replacement strategy, for pm levels of 0.005 or 0.05, the choice of crossover
approach is arbitrary as similar fitness scores are returned by each of the crossover
approaches, using a similar number of FFEs to do so.
The intervention placement for each of the crossover approaches was shown to be similar
for each of the mutation rates. In the absence of mutation, each approach had small
dosages and when pm was 0.005, each approach applied late in the schedule. For a
further increase in pm to 0.05, each approach had a number of smaller interventions as
well as 3 successively larger applications on days 98, 99 and 100.
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Over the range of pm values, UC is always at least as good as the other traditional
crossover approaches. In the absence of mutation, regardless of replacement strategy,
UC returns scores of a higher fitness than both SPC and 2PC. For these reasons, when
evaluating the directed intervention techniques for chemotherapy scheduling in Section
8.2, UC will be used as the baseline crossover operator for comparison.
7.2.2 Further analysis
The previous section reviewed SPC, 2PC and UC using the intermediate parameter
settings. In order to further analyse the abilities of each of the crossover approaches, it
appears necessary to review them across a range of parameters outwith the intermediate
set discussed previously. Appendix A.2 details the abilities of SPC, 2PC and UC across
the range of population sizes, crossover rates and mutation rates. This describes how in
the absence of mutation, UC finds fitter scores than both SPC and 2PC and that when
the mutation rate is increased to 0.005, all approaches find comparable solutions. This
also describes how each of the crossover approaches return comparable scores when the
mutation rate is increased further to 0.05.
7.3 Summary of the evaluation of traditional crossover
approaches
This chapter has reviewed the abilities of SPC, 2PC and UC for deriving schedules of
both bio-control treatments and chemotherapy drug treatments. Section 7.1 reviewed
these traditional crossover techniques over a range of intervention penalties. Analysis
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of these experiments found that UC was consistently at least as good as the other
crossover approaches when measured over a range of mutation levels. As detailed in
Section 7.1.7, this trend also held when varying population sizes, mutation rates and
crossover rates were analysed.
Similar analysis was undertaken to compare the abilities of the traditional crossover
approaches for chemotherapy scheduling. Section 7.2 reviewed the approaches using
the intermediate parameter settings and a range of mutation levels. From this ex-
perimentation, UC was shown to be better than both SPC and 2PC at finding fitter
solutions in the absence of mutation. Each of the traditional crossover approaches were
shown to return similar scores when the mutation rate was increased to 0.005 or 0.05.
Further analysis, using a range of population sizes, mutation rates and crossover rates
was conducted in Section 7.2.2. As with the intermediate parameter settings, UC was
shown to be better at finding fitter scores than the other approaches in the absence
of mutation, and with a mutation rate of 0.005 or 0.05, each of the approaches were
comparable.
UC has been shown to be consistently at least as good as the other crossover approaches
for both problems under review. Due to this, it will therefore be used as the benchmark
crossover technique to compare the directed intervention techniques with.
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Evaluation of directed
intervention crossover approaches
Chapter 7 reviewed the abilities of SPC, 2PC and UC for both bio-control and chemother-
apy schedule optimisation. For both problems, UC was always at least as good as the
other approaches and therefore was determined to be the benchmark crossover tech-
nique with which to compare the directed intervention crossover approaches.
This chapter compares the directed intervention techniques of CalEB, TInSSel and
DUC, described in Chapter 4, against UC for both bio-control and chemotherapy
scheduling. One difference to the experiments undertaken in Chapter 7 is that sta-
tistical analysis will be carried out for each experiment, as described in Section 6.9.
This statistical test is for ascertaining whether there is a statistically significant ad-
vantage in using the directed intervention crossover techniques over the standard UC
approach. In accordance with the findings discussed in Section 6.9.1, these statistical
tests will be non-parametric, as normality cannot be assumed.
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The following sections review the abilities of CalEB, TInSSel and DUC, in comparison
with UC, for deriving bio-control schedules for mushroom farming. The subsequent
section will then review the performance of these same algorithms for the construction
of single drug treatment schedules for chemotherapy.
As described in Section 4.1, DUC is a test approach to confirm that a range of offspring
intervention levels provides a more efficient search than purely adhering to the number
of interventions in the fitter parent. The following experiments should therefore show
that both TInSSel and CalEB are more efficient than DUC at deriving schedules of
both bio-control and chemotherapy treatments.
8.1 Evaluation of directed intervention crossover techniques
for bio-control scheduling
For this evaluation, the same parameter configuration is used as for the traditional
crossover experiments detailed in Section 7.1. The bio-control problem is therefore
sampled over 5,000 fitness function evaluations (FFEs), at intervals of 100, resulting in
50 data points for review. For each sample point, 100 runs of each crossover approach
were recorded for each parameter combination, with the best scoring values for each
run for each FFE being recorded.
Each of the following sections review the effectiveness of CalEB, TInSSel and DUC,
with comparison to UC, for bio-control scheduling over a range of penalty values per
intervention. As with the traditional crossover experiments detailed in Chapter 7, the
crossover techniques are tested over a range of parameter settings. A complete set of
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results across the parameter combinations has therefore been collected and these can
be seen in Appendix C. This Appendix contains the complete set of results showing
the fitness scores against FFEs associated with these experiments across a range of
population sizes, intervention penalties and crossover and mutation rates.
As with the traditional crossover experiments, the intermediate parameter settings for
each approach will be reviewed in detail, rather than explicitly detailing each possible
parameter combination. The following sections will therefore review CalEB, TInSSel
and DUC in comparison to UC, for the varying levels of intervention penalty P , as
described in Section 5.3.2, with a population of N = 100, crossover rate, pc = 0.9, and
mutation rates, pm, of 0, 0.005 and 0.05. These results can then be compared against
the complete set of results in Appendix C to check for consistency.
Inline with the traditional crossover experiments, initial analysis for each intervention
point will review the intermediate parameter settings with a generational replacement
strategy. The average placement of interventions will then be analysed. Intermediate
parameter settings will then be reviewed under a steady state replacement strategy. As
with previous experiments, the replacement mechanism, R, for each experiment will be
defined as either generational, R = g, or steady state, R = ss.
The results for both the fitness scores and associated intervention usage for the in-
termediate parameter settings under both generational and steady state replacement
will now be reviewed. As before, graphs showing the fitness scores versus FFEs and
intervention usage versus FFEs are plotted over the range of FFE samples. Note that
as the bio-control optimisation problem is a minimisation problem, lower scores are
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fitter than higher valued scores. On the graphs, U, C, T and D represent UC, CalEB,
TInSSel and DUC respectively.
8.1.1 0 penalty points per intervention
This section reviews CalEB, TInSSel and DUC, in comparison with UC, for bio-control
scheduling with a penalty of 0 points per intervention. As described in Section 8.1, this
will focus on the intermediate parameter settings. Figures 8.1 to 8.3 shows the fitness
scores and associated intervention usage for pm levels of 0, 0.005 and 0.05 respectively.
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Figure 8.1: Results for N = 100, pc = 0.9, pm = 0,P = 0 and R = g
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Figure 8.2: Results for N = 100, pc = 0.9, pm = 0.005,P = 0 and R = g
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Figure 8.3: Results for N = 100, pc = 0.9, pm = 0.05,P = 0 and R = g
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Reviewing Figure 8.1, a correlation appears between CalEB and TInSSel’s rapid in-
crease in fitness with the accumulation of interventions. This shows that, in the absence
of mutation, while UC steadily gathers interventions, and DUC converges to using
around 33 interventions at around 1,000 FFEs, both CalEB and TInSSel rapidly gain
interventions, before settling to schedules utilising approximately 45 interventions. This
rapid accumulation of interventions match the rapid increase in fitness demonstrated
by CalEB and TInSSel.
Figure 8.2 details the fitness scores and intervention usage when pm is increased to
0.005. All crossover approaches end the optimisation process using approximately the
same number of interventions and returning scores in a similar fitness range. As with
a pm level of 0, CalEB and TInSSel rapidly accumulate interventions, whereas UC
intervention usage grows steadily, finally settling to the same level as both CalEB and
TInSSel. DUC is much slower than the other approaches at increasing intervention
usage, but after 5,000 FFEs has increased in intervention usage to similar levels to that
of UC, CalEB and TInSSel. As was demonstrated in the experiment with no mutation,
a correlation appears between rapid accumulation of interventions for schedules and
speedy increase in fitness for CalEB and TInSSel.
Figure 8.3 shows the effects of further increasing pm to 0.05. For this mutation level
two distinct intervention usage patterns appear. CalEB and TInSSel rapidly increase
to approximately 48 interventions, whereas both UC and DUC gradually increase the
number of interventions to around 39.
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It would appear that the rapid improvement in fitness scores shown by CalEB and
TInSSel is directly related to their rapid accumulation of interventions. In this exper-
iment, as each crossover approach settles on higher number of interventions, due to
there being no cost associated with intervening, fitness scores in a similar range are
produced for all crossover approaches under review.
8.1.1.1 Intervention placement
Section 8.1.1 outlined the fitness scores and associated intervention usage for the di-
rected intervention crossover approaches, in comparison to UC, under a generational
replacement strategy for a penalty of 0 points per intervention.
In the case of no mutation, as shown in Figure 8.1, CalEB and TInSSel are shown
to use more interventions than both UC and DUC, with UC using more interventions
than DUC. From the statistical analysis undertaken in Appendix E.1, after 5,000 FFEs
both CalEB and TInSSel were shown to outperform UC and UC, TInSSel and CalEB
were shown to outperform DUC. This section reviews the placement of interventions
by each of the crossover approaches at 5,000 FFEs. The average placement of these
interventions are shown in Figure 8.4. This shows that both CalEB and TInSSel are
focusing interventions on days 2 - 21, 24 - 39 and 42 - 50. As UC is not as focussed on
each of these days, this accounts for the lesser fitness scores returned by this approach.
When UC, CalEB and TInSSel are compared to DUC, DUC is shown to have less
focussed intervention placement than the other approaches, resulting in lesser fitness
scores.
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Figure 8.4: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 0
and R = g
When pm was increased to 0.005, as shown in Figure 8.2, CalEB, TInSSel and UC are
shown to use more interventions than DUC. From the statistical analysis undertaken
in Appendix E.2, after 5,000 FFEs, UC, CalEB and TInSSel were shown to outperform
DUC. The average placement of interventions are shown in Figure 8.5. This shows that
while UC, CalEB and TInSSel have three distinct application areas, DUC targets two
of these but is less focussed on the third (days 42 - 50).
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Figure 8.5: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 0 and R = g
When pm was further increased to 0.05, as shown in Figure 8.3, CalEB used the most
interventions, followed by TInSSel, then DUC then UC. From the statistical analysis
undertaken in Appendix E.3, after 5,000 FFEs, CalEB, TInSSel and DUC were all
shown to outperform UC, with both CalEB and TInSSel outperforming DUC. The
average placement of interventions for each of the crossover approaches are shown in
Figure 8.6. CalEB and TInSSel are shown to regularly intervene on more days than
both UC and DUC, with DUC on average, intervening on more days than UC.
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Figure 8.6: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 0 and R = g
8.1.1.2 Steady state replacement
Section 8.1.1 reviewed CalEB, TInSSel and DUC, in comparison with UC, for bio-
control scheduling, with an intervention penalty of 0 per intervention and generational
replacement. The experiments undertaken in Chapter 7.1, outlined the importance
of reviewing the crossover approaches under both generational and steady state re-
placement strategies. As with the generational equivalent described in Section 8.1.1,
186
CHAPTER 8. EVALUATION OF DIRECTED INTERVENTION
CROSSOVER APPROACHES
this experiment details the performance of approaches under steady state replacement
with intermediate parameter settings. Figures 8.7 to 8.9 show the fitness and inter-
vention usage associated with performing the previous set of tests with a steady state
replacement strategy.
Figure 8.7 shows that similar trends are displayed for steady state replacement as
those shown by generational replacement for similar parameter settings when pm is
0. CalEB and TInSSel are again quicker than UC or DUC at deriving fit solutions.
The intervention usage follows a similar pattern to that observed under generational
replacement. CalEB and TInSSel rapidly increase the number of interventions in the
schedules, with UC increasing intervention levels at a lesser rate. As with generational
replacement, DUC quickly converges to around 34 interventions and shows no further
increase in intervention levels throughout the rest of the experiment.
Although all the approaches perform in a similar manner with steady state replacement
compared to generational for a pm of 0, there is one exception. When pm is 0, using
a steady state replacement strategy, there is very little new material being added at
each generation, and although UC, CalEB and TInSSel are able to deal with this
condition, DUC returns scores that are less fit than those observed with the generational
equivalent.
Figure 8.8 shows the fitness scores and intervention usage for a steady state replacement
strategy when pm = 0.005. As with a pm of 0, each of the approaches behave in
a similar way under steady state replacement as for generational replacement. One
exception is that DUC is quicker at accumulating interventions under steady state
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replacement than under the generational version for these parameter settings. One
possible explanation for this is that under a steady state replacement strategy, offspring
can be used immediately as part of the breeding pool. This has been shown to make a
shift towards the optimal solution in an early part of the optimisation process [45] and
could account for the enhanced speed of intervention accumulation displayed by DUC.
It can be seen that whether under steady state replacement (Figure 8.9) or generational
replacement (Figure 8.3), all crossover approaches behave in a similar manner when
pm = 0.05.
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Figure 8.7: Results for N = 100, pc = 0.9, pm = 0,P = 0 and R = ss
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Figure 8.8: Results for N = 100, pc = 0.9, pm = 0.005,P = 0 and R = ss
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Figure 8.9: Results for N = 100, pc = 0.9, pm = 0.05,P = 0 and R = ss
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8.1.2 5 penalty points per intervention
The following section investigates how CalEB, TInSSel and DUC compare to UC at bio-
control scheduling with a penalty of 5 points per intervention. As with the experiment
detailed in Section 8.1.1, intermediate parameters of N = 100, and pc = 0.9 will be
used.
Figure 8.10 shows the fitness scores and associated intervention usage for a mutation
rate pm, of 0. Figures 8.11 and 8.12 details the fitness and intervention usage for pm lev-
els of 0.005 and 0.05 respectively. As with the earlier experiments described in Section
7.1, when the intervention penalty is increased from 0 to 5 points per intervention, the
strategy changes from that of rapidly accumulating interventions to a more controlled,
parsimonious approach of intervention selection.
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Figure 8.10: Results for N = 100, pc = 0.9, pm = 0,P = 5 and R = g
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Figure 8.11: Results for N = 100, pc = 0.9, pm = 0.005,P = 5 and R = g
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Figure 8.12: Results for N = 100, pc = 0.9, pm = 0.05,P = 5 and R = g
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Figure 8.10 shows the fitness scores and intervention usage for the intermediate para-
meter settings with a penalty of 5 points per intervention and pm of 0. In the absence
of mutation, all approaches reduce in intervention usage. CalEB and TInSSel rapidly
reduce, with CalEB settling on less interventions than TInSSel. UC gradually reduces
to a similar level of interventions as TInSSel, while DUC converges to a higher inter-
vention usage than the other approaches. The associated fitness score graph shows
that while UC, CalEB and TInSSel reduce to use fewer interventions than DUC, this
provides fitter scores. As described in Section 4.2, both CalEB and TInSSel use the
same intervention selection calculation. Thus for the first 1,000 FFEs, although both
CalEB and TInSSel use the same number of interventions, they return scores of a dif-
ferent fitness. This shows that stochastic selection is more advantageous to a uniform
distribution over time for this particular experiment.
Figure 8.11 shows the fitness scores and intervention usage when the mutation rate,
pm, is increased to 0.005. In this instance, DUC is slower at reducing the number of
interventions compared to the other approaches. After around 3,000 FFEs however, all
approaches have converged to approximately 17 interventions and return similar fitness
scores.
Figure 8.12 shows the effect of increasing pm to 0.05. In this situation, CalEB and
TInSSel reduce to around 15 interventions, whereas both UC and DUC settle on around
17 interventions. Even with this difference in intervention levels, all approaches return
similar fitness scores.
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8.1.2.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention us-
age for the directed intervention crossover approaches, in comparison to UC, under a
generational replacement strategy for a penalty of 5 points per intervention.
In the case of no mutation, as shown in Figure 8.10, DUC is shown to use the most
interventions, with UC and TInSSel using less, and CalEB using the least interven-
tions. From the statistical analysis undertaken in Appendix E.4, after 5,000 FFEs, UC
was shown to outperform DUC, TInSSel outperformed CalEB and DUC and CalEB
outperformed DUC for this FFE point. This section reviews the placement of inter-
ventions by each of the crossover approaches at 5,000 FFEs. The average placement
of these interventions are shown in Figure 8.13. This shows that CalEB, TInSSel and
UC all use more focussed interventions than DUC, and as there is a cost associated
with each intervention, this explains this fitness difference. Both TInSSel and UC are
shown to have on average more applications on days 11 and 12 than CalEB.
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Figure 8.13: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 5
and R = g
The interventions and fitness scores for a mutation rate, pm, of 0.005 are shown in Fig-
ure 8.11. Each of the approaches were shown to use the same number of interventions,
producing similar fitness scores. From the statistical analysis of these experiments, in
Appendix E.5, the only statistical difference between approaches for 5,000 FFEs was
that CalEB outperformed DUC. From reviewing the average intervention placement for
this mutation level, shown in Figure 8.14, each of the approaches use similar interven-
tion placement. The statistical difference between CalEB and DUC can be explained
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by CalEB using interventions 13 - 16 the least of all the crossover approaches and DUC
using these the most.
Figure 8.14: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 5 and R = g
The interventions and fitness scores when pm is increased to 0.05 are shown in Figure
8.12. DUC and UC use more interventions than the other approaches, with TInSSel
using more than CalEB. From the statistical analysis of these experiments, in Appendix
E.6, both TInSSel and DUC were shown to outperform both CalEB and UC. From
reviewing the average intervention placement for this mutation level, shown in Figure
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8.15, CalEB and UC are shown to use interventions on days 40 - 50 more often on
average than TInSSel and DUC.
Figure 8.15: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 5 and R = g
8.1.2.2 Steady state replacement
We now consider the alternative steady state replacement strategy. Figures 8.16 to
8.18 show the fitness score and intervention usage when R = ss with pm values of 0,
0.005 and 0.05. There is a penalty of 5 points associated with each intervention.
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Figure 8.16 shows that when pm = 0, DUC struggles to find scores of a comparable
fitness for steady state as for generational replacement. This was also the case for
0 penalty points per intervention. Through inspection of intervention usage, DUC
converges to schedules using 25 interventions under steady state replacement, while
reducing to approximately 23 interventions under generational replacement. In the
generational case, both UC and TInSSel settled to a similar number of interventions.
This is not the case under steady state replacement, with UC requiring more interven-
tions than TInSSel. Due to this, UC returns scores of a lower fitness under steady state
replacement than with the generational equivalent.
Figure 8.17 details the effect of increasing pm to 0.005. With a steady state replacement
strategy, each of the crossover approaches follow the same patterns as demonstrated
for a generational replacement strategy. This is in terms of both fitness scores and
intervention usage.
When pm is further increased to 0.05, as shown in Figure 8.18, similar trends are
displayed by the crossover approaches, regardless of which replacement strategy is
used.
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Figure 8.16: Results for N = 100, pc = 0.9, pm = 0,P = 5 and R = ss
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Figure 8.17: Results for N = 100, pc = 0.9, pm = 0.005,P = 5 and R = ss
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Figure 8.18: Results for N = 100, pc = 0.9, pm = 0.05,P = 5 and R = ss
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8.1.3 20 penalty points per intervention
The next experiment considers the effect of increasing the number of penalty points per
intervention from 5 to 20. Figures 8.19 to 8.21 show the fitness scores and associated
intervention usage for a penalty of 20 per intervention and pm values of 0, 0.005 and
0.05 respectively.
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Figure 8.19: Results for N = 100, pc = 0.9, pm = 0,P = 20 and R = g
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Figure 8.20: Results for N = 100, pc = 0.9, pm = 0.005,P = 20 and R = g
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Figure 8.21: Results for N = 100, pc = 0.9, pm = 0.05,P = 20 and R = g
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Although there have been correlations between intervention usage and fitness scores
for lower intervention penalties, for a penalty of 20 per intervention, the relationship
is more apparent.
Figure 8.19 shows that when pm is 0, DUC settles on approximately 17 interventions,
compared to the approximately 5 interventions used by UC, CalEB and TInSSel. A
trend is demonstrated in the number of interventions used by the schedule and the
associated fitness score. CalEB and TInSSel are quicker to produce schedules requiring
a small number of interventions, and this is reflected in the rapid reduction in fitness
scores. UC is slower than both CalEB and TInSSel to reduce intervention levels,
and this gradual reduction in intervention level are shown in a similar pattern for the
fitness score. DUC quickly stagnates to around 17 interventions, and this produces
poorer scores for the duration of this experiment.
Figure 8.20 details the experiment when the probability of mutation, pm, is increased
to 0.005. There is a clear trend between the reduction in intervention levels to approx-
imately 5 and the fitness scores returned from each of the approaches. The order in
which the crossover techniques undertake intervention reduction is the same as for a
pm of 0. CalEB and TInSSel quickly reduce intervention levels, UC does so at a more
gradual rate and DUC requires approximately double the FFEs to reduce to a similar
number of interventions.
When pm is increased to 0.05, as shown in Figure 8.21, UC and DUC settle to approx-
imately 7 interventions, while CalEB and TInSSel settle on 5. This difference in the
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number of interventions used is clearly reflected with the different converged fitness
scores returned by the approaches.
8.1.3.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention us-
age for the directed intervention crossover approaches, in comparison to UC, under a
generational replacement strategy for a penalty of 20 points per intervention.
In the case of no mutation, as shown in Figure 8.19, as with a penalty of 5 points per
intervention, DUC is shown to use the most interventions, with UC and TInSSel using
less, and CalEB using the least interventions. From the statistical analysis undertaken
in Appendix E.7, after 5,000 FFEs, UC, CalEB and TInSSel are all shown to outperform
DUC. TInSSel also outperforms CalEB at this mutation rate. This section reviews the
placement of interventions by each of the crossover approaches at 5,000 FFEs. The
average placement of these interventions are shown in Figure 8.22.
UC, CalEB and TInSSel all focus interventions predominantly on the first sciarid larvae
cycle, days 5 - 9. While DUC also places interventions at these points, it also places
interventions to target the second sciarid larvae cycle. The benefit achieved through
targeting this second cycle appears to be outweighed by the associated intervention
penalties. TInSSel outperforms CalEB for this FFE and this appears to be due to
TInSSel placing more emphasis on interventions on days 8 and 9 of the schedule.
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Figure 8.22: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 20 and R = g
The intervention usage and fitness scores when pm was increased to 0.005 are shown
in Figure 8.20. All approaches use a similar number of interventions at 5,000 FFEs,
resulting in no statistical differences between approaches, as described in Appendix
E.8. The average placement of these interventions are shown in Figure 8.23. This
shows that for this mutation level, each of the crossover approaches focus mainly on
intervening on days 6 - 9 of the schedule.
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Figure 8.23: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 20 and R = g
The intervention usage and fitness scores when pm was further increased to 0.05 are
shown in Figure 8.21. For this mutation level, UC and DUC use more interventions
than CalEB or TInSSel. From the statistical analysis undertaken in Appendix E.9
CalEB, TInSSel and DUC all outperform UC at 5,000 FFEs, with CalEB and TInSSel
also outperforming DUC at this point. The average placement of interventions are
shown in Figure 8.24. This shows that for this mutation level, while all approaches
focus on the first sciarid larvae cycle, both UC and DUC also place more interventions
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between days 20 and 50 than the other approaches. This explains why CalEB and
TInSSel outperform the other approaches. As DUC places less emphasis than UC at
the later cycle, this also accounts for DUC outperforming UC at this mutation level.
Figure 8.24: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 20 and R = g
8.1.3.2 Steady state replacement
We now repeat the previous evaluation for a steady state replacement strategy. Figures
8.25 to 8.27 show the fitness scores and associated intervention usage for a steady state
replacement strategy with a penalty of 20 per intervention.
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Figure 8.25 shows a steady state replacement strategy and a pm of 0. At this mutation
level, CalEB, TInSSel and DUC behave in a similar manner as they did under a gen-
erational replacement strategy. UC converges to around 6 interventions under steady
state, as opposed to 4 interventions under generational replacement. This higher num-
ber of interventions in schedules results in less optimal scores for UC under steady state
replacement.
When pm is increased to 0.005, as shown in Figure 8.26, UC, CalEB and TInSSel
perform in a similar manner as under generational replacement. DUC is quicker at
reducing intervention levels under steady state replacement. This results in DUC con-
verging to similar scores as the other crossover approaches after 3,000 FFEs under
steady state replacement as opposed to 4,000 FFEs for generational replacement.
Figure 8.27 shows a steady state replacement strategy when pm is further increased
to 0.05. This has a similar intervention usage pattern as for generational replacement,
resulting in similar fitness trends.
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Figure 8.25: Results for N = 100, pc = 0.9, pm = 0,P = 20 and R = ss
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Figure 8.26: Results for N = 100, pc = 0.9, pm = 0.005,P = 20 and R = ss
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Figure 8.27: Results for N = 100, pc = 0.9, pm = 0.05,P = 20 and R = ss
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8.1.4 35 penalty points per intervention
The previous sections have detailed the abilities of CalEB, TInSSel, DUC and UC
over a range of intervention penalty values. This section reviews the affects of further
increasing the penalty per intervention, from 20 to 35 points per intervention.
Figure 8.28 shows the fitness scores and associated intervention usage when pm = 0.
Figures 8.29 to 8.30 detail pm levels of 0.005 and 0.05 respectively.
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Figure 8.28: Results for N = 100, pc = 0.9, pm = 0,P = 35 and R = g
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Figure 8.29: Results for N = 100, pc = 0.9, pm = 0.005,P = 35 and R = g
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Figure 8.30: Results for N = 100, pc = 0.9, pm = 0.05,P = 35 and R = g
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As with lower intervention penalties, there is a clear correlation between the movement
in intervention usage and fitness scores returned.
Figure 8.28 shows that in the absence of mutation, with a penalty of 35 points per
intervention, DUC uses 17 interventions as opposed to the 3 interventions used by UC,
CalEB and TInSSel. This correlates with the gap in fitness scores returned by DUC
compared to the other approaches for this experiment. There is further correlation
between the steady intervention reduction of UC and the gradual progression of fitter
scores found. Both CalEB and TInSSel demonstrate a correlation between reduced
intervention usage and fitness of solution found, with a rapid decrease in intervention
usage for schedules matched by a rapid improvement in fitness scores found.
Figure 8.29 shows the effect of increasing pm to 0.005. For this mutation level, CalEB
and TInSSel are quicker to reduce to 3 interventions than the other approaches. For
this reason, they are quicker at deriving highly fit solutions. UC requires another 1,000
FFEs to settle on a similar number of interventions and return solutions of a comparable
fitness. DUC requires approximately another 2,000 FFEs than UC to reduce to the
same intervention level and fitness scores as the other approaches.
Figure 8.30 shows the effect of further increasing the mutation rate, pm, to 0.05. For
this mutation rate, a correlation appears between the lesser fitness scores returned
by UC and DUC compared to CalEB and TInSSel, and the fact that UC and DUC
converge to using around 5 interventions, whereas both CalEB and TInSSel settle on
3. It appears that with mutation at such a high level, CalEB and TInSSel can avoid
222
CHAPTER 8. EVALUATION OF DIRECTED INTERVENTION
CROSSOVER APPROACHES
the noise this introduces to reduce to smaller schedules, whereas UC and DUC struggle
to reduce the number of interventions in schedules.
8.1.4.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention us-
age for the directed intervention crossover approaches, in comparison to UC, under a
generational replacement strategy for a penalty of 35 points per intervention.
In the case of no mutation, as shown in Figure 8.28, DUC is shown to use more
interventions than the other approaches, with CalEB, TInSSel and UC settling to a
similar number of interventions. From the statistical analysis undertaken in Appendix
E.10, after 5,000 FFEs, UC, CalEB and TInSSel are all shown to outperform DUC
for this mutation rate. The average placement of the interventions relating to these
findings are shown in Figure 8.31. This shows that UC, CalEB and TInSSel are each
focussing interventions on days 6, 7 and 8, DUC focusses on this cycle as well as on the
second larvae cycle. The extra interventions used by DUC are accruing extra penalty
costs, producing less fit scores than the other approaches which focus solely on the first
larvae cycle.
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Figure 8.31: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 35 and R = g
When pm was increased to 0.005, as shown in Figure 8.29, each of the approaches use the
same number of interventions, producing similar fitness scores. The statistical analysis
undertaken in Appendix E.11, shows that after 5,000 FFEs, there is no statistical
difference between crossover approaches for this mutation rate. The average placement
of the interventions relating to these findings are shown in Figure 8.32. This shows
that each of the crossover approaches focus on days 6, 7 and 8 of the schedule, focusing
on the initial sciarid larvae cycle.
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Figure 8.32: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 35 and R = g
When pm was further increased to 0.05, as shown in Figure 8.30, UC and DUC were
shown to use more interventions than TInSSel and CalEB. The statistical analysis un-
dertaken in Appendix E.12, shows that after 5,000 FFEs, each of the directed interven-
tion crossover approaches outperform UC, with CalEB and TInSSel also outperforming
DUC for this mutation rate. The average placement of the interventions relating to
these findings are shown in Figure 8.33. This shows that while each of the crossover
approaches focus on days 6 - 9, UC and DUC both also have interventions in the range
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20 - 50. DUC does not use interventions after day 15 of the cycle as often as UC, hence
the difference between these approaches.
Figure 8.33: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 35 and R = g
8.1.4.2 Steady state replacement
We now repeat the previous evaluation for a steady state replacement strategy. Figures
8.34 to 8.36 shows the fitness scores and associated intervention usage for the inter-
mediate parameter settings, a penalty of 35 points per intervention and a steady state
replacement strategy.
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Figure 8.34 shows the intervention usage and fitness scores when pm is 0. As was the
case with steady state replacement and a penalty of 20 per intervention, UC settles
to schedules with more interventions under steady state replacement than generational
replacement when pm is 0. This results in UC producing less optimal scores under
steady state replacement. DUC uses 17 interventions under both replacement strate-
gies and produces similar scores. TInSSel also uses a similar number of interventions
under both replacement strategies. CalEB settles on 2 interventions for steady state
replacement as opposed to the 3 used in schedules under generational replacement but
returns scores of a similar fitness under both replacement approaches.
Figure 8.35 shows the fitness scores and associated intervention usage when pm is
increased to 0.005. UC, CalEB and TInSSel display similar trends under both gener-
ational and steady state replacement for these parameter settings. As with a penalty
of 20 per intervention, DUC is quicker to reduce intervention levels under steady state
replacement as opposed to generational replacement. Under steady state replacement,
DUC reduces to 3 interventions after 2,700 FFEs, whereas this takes approximately a
1,000 more FFEs under generational replacement.
Figure 8.36 show the fitness scores and intervention usage when pm is further increased
to 0.05. For this mutation level, similar trends are demonstrated by each of the crossover
approaches with steady state replacement as under generational replacement.
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Figure 8.34: Results for N = 100, pc = 0.9, pm = 0,P = 35 and R = ss
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Figure 8.35: Results for N = 100, pc = 0.9, pm = 0.005,P = 35 and R = ss
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Figure 8.36: Results for N = 100, pc = 0.9, pm = 0.05,P = 35 and R = ss
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8.1.5 50 penalty points per intervention
The final bio-control experiment describes how CalEB, TInSSel, DUC and UC compare
when the intervention penalty is further increased to 50 points per intervention. Figures
8.37 to 8.39 show the fitness scores and associated intervention usage for intermediate
parameter settings, a penalty of 50 points per intervention and pm levels of 0, 0.005
and 0.05 respectively.
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Figure 8.37: Results for N = 100, pc = 0.9, pm = 0,P = 50 and R = g
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Figure 8.38: Results for N = 100, pc = 0.9, pm = 0.005,P = 50 and R = g
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Figure 8.39: Results for N = 100, pc = 0.9, pm = 0.05,P = 50 and R = g
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Figure 8.37 shows the fitness scores and associated intervention usage for the intermedi-
ate parameter setting in the absence of mutation. As with lower intervention penalties,
a direct correlation appears between the number of interventions used in schedules and
the fitness scores returned. CalEB and TInSSel rapidly decrease in intervention usage
and this is mirrored by a rapid improvement in fitness scores. UC displays a steady
decrease in intervention usage in schedules, which is reflected by the gradual improve-
ment in fitness scores. DUC converges to 16 interventions as opposed to the 2 settled
on by the other approaches. This accounts for the difference in fitness scores between
DUC and the other approaches for this mutation level.
Figure 8.38 shows the effect of increasing pm from 0 to 0.005. UC, CalEB and TInSSel
reduce in interventions at approximately the same rate as with a pm of 0. This results
in these approaches returning similar fitness scores. DUC requires approximately 4,000
FFEs to reduce the intervention level to the same level as the other approaches, and it
is at this point that all four approaches return similar fitness scores.
Figure 8.39 shows the fitness scores and intervention usage when pm is further increased
to 0.05. As with lower penalties, UC and DUC produce comparable results and use a
similar number of interventions. CalEB and TInSSel use fewer interventions and return
fitter scores than both UC and DUC.
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8.1.5.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention us-
age for the directed intervention crossover approaches, in comparison to UC, under a
generational replacement strategy for a penalty of 50 points per intervention.
In the case of no mutation, as shown in Figure 8.37, DUC is shown to use more
interventions than the other crossover techniques, with UC, CalEB and TInSSel using
the same number. From the statistical analysis undertaken in Appendix E.13, after
5,000 FFEs, CalEB, TInSSel and UC all statistically outperform DUC for this mutation
level. The average placement of the interventions relating to these findings are shown
in Figure 8.40. This shows that while UC, CalEB and TInSSel mainly focus two
interventions, at days 6 and 7, DUC uses many more. These extra interventions appear
to be costing more in penalty values than they are gaining in sciarid larvae reduction,
hence the lesser fitness scores for DUC for this mutation rate.
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Figure 8.40: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 50 and R = g
When pm is increased to 0.005, as shown in Figure 8.38, each of the crossover approaches
settle to the same number of interventions and return similar scores after 5,000 FFEs.
From the statistical analysis undertaken in Appendix E.14, after 5,000 FFEs, there
is no statistical difference between approaches for this mutation level. The average
placement of the interventions relating to these findings are shown in Figure 8.41. This
shows that each of the approaches focus two interventions, one on day 6 and one on
day 7 of the schedule.
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Figure 8.41: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 50 and R = g
As pm is further increased to 0.05, as shown in Figure 8.39, UC and DUC settle to
schedules using more interventions than both CalEB and TInSSel. From the statistical
analysis undertaken in Appendix E.15, after 5,000 FFEs, each of the directed inter-
vention approaches are shown to statistically outperform UC for this mutation level,
with CalEB and TInSSel both also outperforming DUC.The average placement of the
interventions relating to these findings are shown in Figure 8.42. This shows that both
CalEB and TInSSel mainly focus on interventions on days 6 and 7, with UC and DUC
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also displaying other interventions throughout the schedule. As DUC has less extra
interventions distributed throughout the schedule than UC, this explains why DUC is
better than UC for this mutation level.
Figure 8.42: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 50 and R = g
8.1.5.2 Steady state replacement
The same experiment will now be reviewed for a steady state replacement strategy.
Figures 8.43 to 8.45 shows the fitness scores and associated intervention usage graphs
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for each approach using intermediate parameter settings, a penalty of 50 points per
intervention and a steady state replacement strategy.
Figure 8.43 shows the fitness scores and intervention usage for steady state replacement
when pm is 0. Both CalEB and TInSSel perform in a similar way under steady state as
with generational replacement both in terms of intervention usage and fitness scores.
DUC settles on approximately 17 interventions for steady state replacement, which is
one more intervention than used in schedules under generational replacement. Due to
this, there is a slight decline in the fitness scores found by DUC between replacement
strategies. UC also uses more interventions under steady state replacement. With a
steady state approach, UC settles to 3 interventions, rather than the 2 used under
generational replacement. As with DUC, this slight increase in intervention usage
results in less fit scores being produced by UC under steady state replacement, when
pm is 0.
Figure 8.44 details the fitness scores and associated intervention usage when pm is
increased to 0.005. As with lesser intervention penalties, DUC is quicker to reduce
in interventions under steady state replacement than with generational replacement.
UC, CalEB and TInSSel display similar trends for both generational and steady state
replacement.
Figure 8.45 shows the fitness scores and intervention usage when pm is further in-
creased to 0.05. As with the lesser intervention penalties, the behavior of the crossover
approaches under steady state replacement is similar to that under the generational
equivalent.
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Figure 8.43: Results for N = 100, pc = 0.9, pm = 0,P = 50 and R = ss
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Figure 8.44: Results for N = 100, pc = 0.9, pm = 0.005,P = 50 and R = ss
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Figure 8.45: Results for N = 100, pc = 0.9, pm = 0.05,P = 50 and R = ss
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8.1.6 Summary of bio-control scheduling experiment
The previous experiments have reviewed CalEB, TInSSel and DUC, in comparison
to UC, for a range of intervention penalties. This section draws together the salient
points from each of these experiments, to demonstrate the effectiveness of the directed
intervention crossover techniques.
In order to ascertain if there is any statistical significant differences between approaches
for this problem, the Kruskal-Wallis test results for the intermediate test cases were
calculated. These are shown in Tables E.1 to E.15. This shows the asymptotic signifi-
cance (AS) value for each FFE for the approaches and the mean rank scores for each of
the crossover techniques. The AS value represents the likelihood of a difference existing
between samples. If the AS value is less than 0.01 this means that there is a statistically
significant difference between at least 2 of the samples at the 99% confidence level. By
using Equation 6.1, it is possible to establish which groups are statistically significantly
different from which other groups.
As described in Section 6.9.1, if the absolute difference between mean ranks is greater
than 47.99, this indicates a statistically significant difference between samples. This
value is derived from a comparison of 4 samples, with 100 cases per sample and an α
value of 0.01. For clarity, Appendix J shows which crossover approaches are significantly
different over the range of FFEs.
Table 8.1 shows an excerpt from one of these tables (Table J.1). This shows the samples
with a statistically significant difference for the first 300 FFEs of the experiment with
U, C, T and D representing UC, CalEB, TInSSel and DUC respectively. This shows
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that there is no statistically significant difference between UC and DUC or CalEB and
DUC for these FFEs. CalEB outperforms UC after 300 FFEs and TInSSel is the best
performing approach for this FFE range, outperforming UC for 200 and 300 FFEs and
both CalEB and DUC after 300 FFEs.
Table 8.1: Sample data from Table J.1
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T
300 C T T T
Each of the intervention penalties will be reviewed in turn, with Section 8.1.7 describing
the trends demonstrated across the range of penalty values.
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8.1.6.1 Penalty of 0 points per intervention
Figure 8.46: FFEs to reach the best score found by UC (355) with a penalty of 0 points
per intervention
Section 8.1.1 described the scores found by the directed intervention crossover ap-
proaches, in comparison to UC, for a penalty of 0 points per intervention. This showed
that both CalEB and TInSSel were faster to increase intervention levels compared with
UC and DUC, resulting in fitter scores being returned for these directed intervention
approaches.
The statistical analysis detailed in Appendix E.1.1 shows that there is a statistical
difference between at least two of the crossover approaches from 300 to 5,000 FFEs for
each of the mutation levels. For clarity, the crossover approaches which are statistically
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different to each other are described in Appendix J.1.1. This shows that for each of
the mutation levels, CalEB and TInSSel statistically outperform both UC and DUC
for almost all FFEs under observation. DUC is shown to be outperformed by UC for
around two thirds of the FFEs when pm is 0 or 0.005, but is shown to outperform
UC from 1,700 to 5,000 FFEs when the mutation rate is increased to 0.05. TInSSel is
the only approach that is never outperformed by any other technique, outperforming
CalEB for a couple of FFEs early in the experiments.
Over the range of mutation levels, the best score found by UC for a penalty of 0 points
per intervention was 355. This was found when the mutation rate was 0.005. Figure
8.46 shows the FFEs required by each of the crossover approaches to find this best score
returned by UC, over the range of mutation levels. This shows that in the absence of
mutation, both UC and DUC do not find this score, even after 5,000 FFEs. CalEB
finds a score of 355 after 1,000 FFEs, with TInSSel requiring only 900 FFEs.
When the mutation rate was increased to 0.005, Figure 8.46 shows that all of the
crossover approaches find a score of 355. UC requires 2,500 FFEs, with DUC, CalEB
and TInSSel using 3,000, 1,000 and 900 FFEs respectively. When the mutation rate is
further increased to 0.05, as with the case of no mutation, both UC and DUC do not
find a score of 355, even after 5,000 FFEs. For this higher mutation rate, there is a
slight increase in FFEs required by both CalEB and TInSSel, due to the increase in
noise introduced via mutation, with CalEB and TInSSel using 1,600 and 1,500 FFEs
respectively.
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8.1.6.2 Penalty of 5 points per intervention
Figure 8.47: FFEs to reach the best score found by UC (476) with a penalty of 5 points
per intervention
Section 8.1.2 described the scores found by the directed intervention crossover ap-
proaches, in comparison to UC, for a penalty of 5 points per intervention. This showed
that while both CalEB and TInSSel were faster to decrease in intervention levels than
UC and DUC, TInSSel produced fitter scores than UC and DUC, whereas CalEB did
not. It was noted that as CalEB and TInSSel use the same offspring intervention cal-
culation, a stochastic approach for choosing offspring genes was better for this problem
than one which picks genes in a uniform distribution over time.
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The statistical analysis detailed in Appendix E.1.2 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. As 100 FFEs represents the initial scoring of the randomly
created population, one would not expect there to be statistical differences between
approaches at this point. The crossover approaches which are statistically different to
each other are described in Appendix J.1.2. This shows that unlike the case of 0 penalty
points per intervention, CalEB is outperformed by each of the other approaches for at
least some FFEs, regardless of the mutation rate. In line with the previous penalty,
UC outperforms DUC for a range of FFEs when pm is 0 or 0.005 but DUC outperforms
UC from 1,700 to 5,000 FFEs when the mutation rate is further increased to 0.05.
TInSSel is again shown to be the only crossover approach not outperformed by any
other technique, regardless of the mutation rate.
Over the range of mutation levels, the best score found by UC for a penalty of 5 points
per intervention was 476. This was found when the mutation rate was 0 or 0.005.
Figure 8.47 shows the FFEs required by each of the crossover approaches to find this
best score returned by UC, over the range of mutation levels. This shows that in the
absence of mutation, only UC returns this score, but as stated above, the score found
by TInSSel is still close enough to not be statistically different.
When the mutation rate was increased to 0.005, Figure 8.47 shows that all of the
crossover approaches find a score of 476. UC requires 2,100 FFEs, with DUC, CalEB
and TInSSel using 2,600, 3,100 and 2000 FFEs respectively. When the mutation rate
is further increased to 0.05, each of the approaches are shown to be disrupted by the
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noise introduced via mutation, with none of the crossover approaches finding scores of
476, even after 5,000 FFEs.
8.1.6.3 Penalty of 20 points per intervention
Figure 8.48: FFEs to reach the best score found by UC (603) with a penalty of 20
points per intervention
Section 8.1.3 described the scores found by the directed intervention crossover ap-
proaches, in comparison to UC, for a penalty of 20 points per intervention. This
showed that both CalEB and TInSSel were faster to decrease in intervention levels
than UC and DUC, resulting in fitter scores being returned in fewer FFEs.
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The statistical analysis detailed in Appendix E.1.3 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. The crossover approaches which are statistically different
to each other are described in Appendix J.1.3. This shows that as with a penalty of
0 points per intervention, both CalEB and TInSSel return significantly better scores
than UC and DUC for a range of FFEs, regardless of the mutation rate. In line with
the previous experiments, UC is shown to outperform DUC when pm is 0 or 0.005,
but when the mutation rate is further increased to 0.05, DUC outperforms UC for
approximately two-thirds of the FFEs. Once again, TInSSel is the only approach to
not be outperformed by any other technique, regardless of FFE observed or mutation
rate.
Over the range of mutation levels, the best score found by UC for a penalty of 20
points per intervention was 603. This was found when the mutation rate was 0 or
0.005. Figure 8.48 shows the FFEs required by each of the crossover approaches to find
this best score returned by UC, over the range of mutation levels. This shows that in
the absence of mutation, only UC and TInSSel find this score, with UC doing so after
2,100 FFEs and TInSSel 1,200 FFEs.
When the mutation rate was increased to 0.005, Figure 8.48 shows that all of the
crossover approaches find a score of 603. UC requires 2,200 FFEs, with DUC, CalEB
and TInSSel using 4,400, 1,600 and 1,300 FFEs respectively. When the mutation rate
is further increased to 0.05, each of the approaches are shown to be disrupted by the
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noise introduced via mutation, with none of the crossover approaches finding scores of
603, even after 5,000 FFEs.
8.1.6.4 Penalty of 35 points per intervention
Figure 8.49: FFEs to reach the best score found by UC (655) with a penalty of 35
points per intervention
Section 8.1.4 described the scores found by the directed intervention crossover ap-
proaches, in comparison to UC, for a penalty of 35 points per intervention. This
showed that as with a penalty of 20 points per intervention, both CalEB and TInSSel
were faster to decrease in intervention levels than UC and DUC, resulting in fitter
scores being returned in fewer FFEs.
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The statistical analysis detailed in Appendix E.1.4 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. The crossover approaches which are statistically different
to each other are described in Appendix J.1.4. This shows that as with a penalty of 20
points per intervention, both CalEB and TInSSel return significantly better scores than
UC and DUC for a range of FFEs, regardless of the mutation rate. As demonstrated
with lower intervention penalties, UC is shown to outperform DUC when pm is 0 or
0.005, but when the mutation rate is further increased to 0.05, DUC outperforms UC
for a range of FFEs. As with all previous intervention penalties, TInSSel is the only
approach to not be outperformed by any other technique, however for this intervention
penalty, there is no statistical difference between CalEB or TInSSel for any FFE.
Over the range of mutation levels, the best score found by UC for a penalty of 35
points per intervention was 655. This was found when the mutation rate was 0 or
0.005. Figure 8.49 shows the FFEs required by each of the crossover approaches to find
this best score returned by UC, over the range of mutation levels. This shows that in
the absence of mutation, DUC is the only approach not to find a score of this fitness,
with UC, CalEB and TInSSel finding such scores using 1,900, 1,300 and 1,100 FFEs
respectively.
When the mutation rate was increased to 0.005, Figure 8.49 shows that all of the
crossover approaches find a score of 655. UC requires 1,900 FFEs, with DUC, CalEB
and TInSSel using 3,900, 1,400 and 1,200 FFEs respectively. When the mutation rate
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is further increased to 0.05, none of the crossover approaches find scores of 655, even
after 5,000 FFEs.
8.1.6.5 Penalty of 50 points per intervention
Figure 8.50: FFEs to reach the best score found by UC (698) with a penalty of 50
points per intervention
Section 8.1.5 described the scores found by the directed intervention crossover ap-
proaches, in comparison to UC, for a penalty of 50 points per intervention. This
showed that as with a penalties of 20 and 35 points per intervention, both CalEB and
TInSSel were faster to decrease in intervention levels than UC and DUC, resulting in
fitter scores being returned in fewer FFEs.
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The statistical analysis detailed in Appendix E.1.5 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. The crossover approaches which are statistically different
to each other are described in Appendix J.1.5. This shows that as with a penalty of 20
or 35 points per intervention, CalEB and TInSSel return significantly better scores than
UC or DUC for a range of FFEs. As with the trend observed for lesser intervention
penalties, while UC outperforms DUC for mutation rates of 0 or 0.005, when pm is
further increased to 0.05, DUC is shown to return scores significantly better to those
found by UC. As with a penalty of 35 points per intervention, there is no statistical
difference between CalEB or TInSSel regardless of FFE observed or mutation rate.
Over the range of mutation levels, the best score found by UC for a penalty of 50
points per intervention was 698. This was found when the mutation rate was 0 or
0.005. Figure 8.50 shows the FFEs required by each of the crossover approaches to find
this best score returned by UC, over the range of mutation levels. This shows that in
the absence of mutation, DUC is the only approach not to find a score of this fitness,
with UC, CalEB and TInSSel finding such scores using 1,800, 1,100 and 1,000 FFEs
respectively.
When the mutation rate was increased to 0.005, Figure 8.50 shows that all of the
crossover approaches find a score of 698. UC requires 1,900 FFEs, with DUC, CalEB
and TInSSel using 4,000, 1,100 and 1,100 FFEs respectively. When the mutation rate
is further increased to 0.05, only CalEB and TInSSel find scores of 698, with CalEB
doing so after 2,600 FFEs and TInSSel 2,200 FFEs.
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8.1.7 Summary
The previous sections have reviewed the directed intervention crossover approaches,
in comparison to UC, over a range of intervention penalties. This has outlined the
statistical differences between approaches and the number of FFEs required to find the
best score found by UC.
Over the range of parameter settings and intervention penalties, TInSSel is the only
crossover approach that is not statistically outperformed by any other technique. CalEB
is the next most successful technique and is only outperformed by UC or DUC when
there is a penalty of 5 points per intervention. As stated previously, as CalEB and
TInSSel use the same calculation for offspring intervention levels, for this low penalty,
picking genes in a uniform distribution is not as effective as picking offspring genes in
a stochastic way.
DUC is outperformed by all 3 of the other approaches when pm is 0 or 0.005. When
pm is increased to 0.05, DUC finds solutions of a lesser fitness than both CalEB and
TInSSel, but tends to solutions significantly better than those returned by UC. This
shows that for a high mutation level, i.e. when there is a lot of noise, even a simple
offspring intervention target such as that used by DUC is more effective than UC.
From inspecting the crossover approaches over a range of intervention penalties and
parameter values, certain deductions can be made:
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• As TInSSel is always at least as good as the other approaches, it would appear
to be the crossover technique of choice for the bio-control scheduling problem,
regardless of intervention penalty and parameter values.
• Both CalEB and TInSSel use the same intervention sizing technique for children
and only differ in the intervention selection process. This means that for this
problem, as CalEB never outperforms TInSSel, but is outperformed by TInSSel
at times, enforcing a uniform distribution for selection of genetic material is less
efficient than a purely stochastic selection. This is most apparent with a penalty
of 5 per intervention.
• DUC uses the same intervention selection mechanism as TInSSel, but has a sim-
pler method for calculating the number of interventions to use in offspring. For
every intervention penalty and parameter setting, DUC never outperforms TInS-
Sel, but is often statistically outperformed by it. As mentioned in Section 8,
both TInSSel and CalEB were expected to outperform DUC for this problem.
This has been shown to be the case, demonstrating the benefit of using a window
of selection around the fitter parent, as opposed to strictly using the number of
interventions in the fitter parent as the target for this problem.
• When pm is 0.05, a lot of genetic material is being added to the system, and thus
there is a lot of noise present. In this situation, CalEB, TInSSel and DUC tend
to outperform UC. This shows that even a simplistic target for the number of
interventions, such as that used by DUC, is more efficient in the presence of large
quantities of noise, than having no intervention target to aim for.
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Both CalEB and TInSSel are robust to the replacement strategy used, returning simi-
lar scores under both generational and steady state replacement. UC tends to produce
poorer scores under steady state replacement, when pm is 0. As steady state replace-
ment introduces new population members in smaller numbers than the complete pop-
ulation replacement used by the generational approach, in the absence of mutation, it
would appear that there is not enough diversity being introduced for UC to exploit.
This would explain the poorer scores produced by UC for this setting. When pm is
0.005, UC, TInSSel and CalEB are generally unaffected by the replacement strategy
used. DUC is quicker to reduce the number of interventions under steady state replace-
ment as opposed to generational for this mutation level. As stated in Section 8.1.1.2,
this could be attributed to the child solutions being immediately available for selection
after insertion to the population earlier in the process with steady state replacement
than with generational replacement.
As described above, TInSSel is the most efficient crossover approach under review for
this problem. When compared to UC, TInSSel is shown to require far fewer FFEs
to find similar scores, and TInSSel also statistically outperforms UC for many FFEs
across the penalty range.
Figure 8.51 shows the percentage of improvement, in terms of both fewer FFEs re-
quired and statistically better scores found, through using TInSSel instead of UC. This
shows the results for a mutation rate of 0.005, which was where each of the crossover
approaches on average performed best. This shows that for a penalty of 0 points per
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intervention, TInSSel requires 64% fewer FFEs than UC to find the same score and
that for 86% of the FFEs under review, TInSSel returns significantly better scores.
When the penalty was increased to 5 penalty points per intervention, the increase in
performance demonstrated by TInSSel over UC is less than for a penalty of 0 points per
intervention, but is still sizeable. For this penalty value, there was an 4.7% reduction
in FFEs required for TInSSel to find the same score as UC and TInSSel statistically
outperformed UC for 24% of all FFEs.
A further increase in penalty value, from 5 to 20, demonstrates a larger performance
gain in using TInSSel when compared to UC. For this setting TInSSel finds the best
score found by UC using 40% less FFEs. TInSSel also statistically outperforms UC for
40% of the FFEs under review.
For a penalty of 35 points per intervention, TInSSel requires 36% fewer FFEs to find
the best score returned by UC. For this penalty setting the scores returned by TInSSel
are statistically better than those found by UC for 34% of the FFEs. A further increase
in penalty value, to 50 points per intervention, shows that TInSSel requires 42% less
FFEs to discover the final value returned by UC. As with a penalty of 35 points per
intervention, TInSSel finds statistically better scores for 34% of all FFEs.
The average gain in performance over all penalty values for a mutation rate of 0.005
is shown in Figure 8.51. This shows that over all 5 penalty levels, TInSSel requires
37% fewer FFEs to find the best score returned by UC. On average, TInSSel finds
statistically better scores for 43% of all FFEs under review.
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Figure 8.51: Performance improvement between UC and TInSSel when pm = 0.005
8.1.8 Further analysis
The previous sections reviewed CalEB, TInSSel and DUC in comparison to UC across
a range of intervention penalties using the intermediate parameter settings.
In order to further analyse the abilities of each of the crossover approaches, it is nec-
essary to review these techniques across a range of parameter settings, outwith the
intermediate set used in the previous sections.
Appendix C details the performance of CalEB, TInSSel, DUC and UC across a range of
population sizes, crossover rates, mutation rates and intervention penalties. A review
of the crossover approaches over this range of parameters are detailed in Appendix
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A.3. In this analysis over the range of parameter settings, each of the trends outlined
in Section 8.1.6 are shown to hold across the range of parameter settings.
8.2 Evaluation of directed intervention crossover techniques
for chemotherapy scheduling
The directed intervention crossover approaches, CalEB, TInSSel and DUC will now be
reviewed for the task of chemotherapy treatment scheduling. As with the bio-control
experiments detailed in Section 8.1, these techniques will be compared with UC.
The methodology used in this section is the same as that used for analysis of the
traditional crossover approaches for chemotherapy scheduling in Section 7.2. This leads
to the result being sampled over 40,000 FFE, at intervals of 1,000 FFEs, resulting in
40 data points for review. For each sample point, 100 runs of each crossover approach
were recorded for each of the parameter combinations. The best scoring values for each
run for each FFE are recorded.
As with the traditional crossover experiments detailed in Chapter 7, the crossover
techniques are tested over a range of parameter settings. A complete set of results
across the parameter combinations has therefore been collected and these can be seen
in Appendix G. This Appendix contains the complete set of results showing the fitness
scores against FFEs associated with these experiments across a range of population
sizes, crossover rates and mutation rates.
As with previous experiments, the intermediate parameter settings for each approach
will be reviewed in detail, rather than explicitly detailing each possible parameter com-
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bination. The following analysis will therefore review CalEB, TInSSel and DUC in
comparison to UC, with a population of N = 100, crossover rate of pc = 0.9 and mu-
tation rates, pm, of 0, 0.005 and 0.05. Inline with the previous crossover experiments,
initial analysis for each intervention point will review the intermediate parameter set-
tings with a generational replacement strategy. This will be followed by a statistical
evaluation of these results, to ascertain if there is any statistically significant differ-
ences between crossover approaches. The average placement and dosage levels will be
analysed. Intermediate parameter settings will then be reviewed under a steady state
replacement strategy.
As stated previously, as the cancer chemotherapy treatment optimisation problem is a
maximisation problem, higher scores are fitter than lower valued scores.
Figures 8.52 to 8.54 show the fitness score and intervention usage for the intermediate
parameter settings and a pm of 0, 0.005 and 0.05 respectively.
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Figure 8.52: Results for N = 100, pc = 0.9, pm = 0 and R = g
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Figure 8.53: Results for N = 100, pc = 0.9, pm = 0.005 and R = g
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Figure 8.54: Results for N = 100, pc = 0.9, pm = 0.05 and R = g
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Figure 8.52 shows the performance of each crossover approach for treatment scheduling
in the absence of mutation. When pm is 0, UC and DUC produce schedules using
considerably different numbers of interventions compared to those returned by CalEB
and TInSSel. UC and DUC utilise more interventions than both CalEB and TInSSel
but this results in lower scores than those produced under the more parsimonious
intervention allocation of CalEB and TInSSel.
Figure 8.53 shows the intervention usage and fitness scores when pm is increased to
0.005. As with a pm of 0, CalEB and TInSSel produce schedules using approximately
20 interventions. UC uses a similar number of interventions to CalEB and TInSSel
and this produces fitness scores closer to those produced by CalEB and TInSSel. DUC
settles on approximately 45 interventions and this results in poorer scoring schedules
than those produced by CalEB, TInSSel and UC.
Figure 8.54 details the effect of further increasing pm to 0.05. As with pm levels of 0
and 0.005, CalEB and TInSSel produce schedules using approximately 20 interventions.
Both DUC and UC return schedules using approximately 26 interventions. CalEB and
TInSSel return fitness scores of a similar value, with DUC producing scores that are
fitter than those returned by UC.
8.2.0.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention us-
age for the directed intervention crossover approaches, in comparison to UC, under a
generational replacement strategy for cancer chemotherapy treatment scheduling.
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In the absence of mutation, as shown in Figure 8.52, DUC uses the most interventions,
then UC, CalEB and finally TInSSel after 40,000 FFEs. From the statistical analysis
undertaken in Appendix I.1, after 40,000 FFEs, CalEB, TInSSel and UC all outperform
DUC, with CalEB and TInSSel also outperforming UC for this mutation level. The
average placement of the interventions relating to these findings are shown in Figure
8.55. This shows that DUC, on average, uses higher dosage strengths than each of the
other approaches. Both CalEB and TInSSel also focus more drug dosage on the later
interventions than the other approaches.
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Figure 8.55: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0 and
R = g
When pm is increased to 0.005, as shown in Figure 8.53, DUC uses the most inter-
ventions, followed by UC, then CalEB and TInSSel. From the statistical analysis
undertaken in Appendix I.2, after 40,000 FFEs, CalEB, TInSSel and UC outperform
DUC, and CalEB and TInSSel also outperform UC. The average placement of the in-
terventions relating to these findings are shown in Figure 8.56. This shows that DUC
has the least focussed interventions at the end of the schedule, resulting in weaker fit-
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ness scores. Both TInSSel and CalEB use larger dosages than UC, resulting in higher
fitness scores for this mutation rate.
Figure 8.56: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.005
and R = g
When pm is further increased to 0.05, as shown in Figure 8.54, DUC and UC use the
same number of interventions, which are more than those used by both CalEB and
TInSSel. From the statistical analysis undertaken in Appendix I.3, after 40,000 FFEs,
CalEB, TInSSel and DUC outperform UC, with CalEB and TInSSel both also outper-
forming DUC. The average placement of the interventions relating to these findings are
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shown in Figure 8.57. CalEB, TInSSel and DUC each have larger doses over the last 3
interventions than UC. DUC applies smaller dosages over the last 3 interventions than
CalEB and TInSSel, resulting in poorer fitness scores for this mutation rate.
This shows that UC has the least focussed interventions at the end of the schedule,
resulting in poorer fitness scores. Both TInSSel and CalEB use larger dosages than
DUC, resulting in better fitness scores for this mutation rate.
Figure 8.57: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.05
and R = g
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8.2.0.2 Steady state replacement
The same experiment will now be reviewed for a steady state replacement strategy.
Figures 8.58 to 8.60 show the fitness scores and associated intervention usage for inter-
mediate parameter settings and a steady state replacement strategy.
Figure 8.58 details the approaches in the absence of mutation. This shows that when
pm is 0, both CalEB and TInSSel utilise a similar number of interventions under steady
state replacement as for a generational replacement strategy. This results in similar
fitness scores being returned by these crossover approaches. DUC uses a similar num-
ber of interventions under steady state replacement as for generational replacement,
whereas UC produces schedules requiring approximately 10 more interventions than
schedules produced under a generational replacement strategy. Both UC and DUC
produce scores with a weaker fitness under steady state replacement as opposed to the
generational equivalent when pm is 0.
Figure 8.59 shows the fitness and intervention graphs for the crossover approaches un-
der steady state replacement when pm is increased to 0.005. As with the generational
equivalent, CalEB and TInSSel still produce schedules with approximately 20 inter-
ventions, with UC using slightly more. DUC again uses more interventions than UC,
CalEB and TInSSel. The fitness scores are similar to those produced under genera-
tional replacement, with CalEB and TInSSel again outperforming UC, which in turn
outperforms DUC.
Figure 8.60 details the fitness scores and intervention usage when pm is further increased
to 0.05. The intervention usage is similar to that used under generational replacement,
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and this results in similar fitness scores returned by each of the approaches under a
steady state replacement strategy.
Figure 8.58: Results for N = 100, pc = 0.9, pm = 0 and R = ss
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Figure 8.59: Results for N = 100, pc = 0.9, pm = 0.005 and R = ss
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Figure 8.60: Results for N = 100, pc = 0.9, pm = 0.05 and R = ss
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8.2.1 Summary of experiment for chemotherapy treatment schedul-
ing
The previous experiment reviewed CalEB, TInSSel and DUC, in comparison to UC,
for the task of cancer chemotherapy scheduling. This section draws together the salient
points from these experiments, to demonstrate the effectiveness of the directed inter-
vention crossover techniques.
In order to ascertain if there is any statistical significant differences between approaches
for this problem, the Kruskal-Wallis test results for the intermediate test cases were
calculated. These are shown in Tables I.1 to I.3. As with the bio-control experiments
discussed previously, for clarity, Appendix J.2 shows which crossover approaches are sig-
nificantly different over the range of FFEs. As detailed in Section 6.9, the chemotherapy
experiments are evaluated over 40,000 FFEs, in observable increments of 1,000 FFEs.
This means that for each pm level, there are 40 FFE points under observation for each
approach, ranging from 1,000 FFEs to 40,000 FFEs.
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Figure 8.61: FFEs to reach the best score found by UC (9)
This section has reviewed the directed intervention crossover approaches against UC,
for the production of cancer chemotherapy treatment schedules. This analysis has been
undertaken over a range of mutation rates and replacement strategies.
The statistical analysis detailed in Appendix I.1 shows that there is a statistical differ-
ence between at least two of the crossover approaches from 1,000 to 40,000 FFEs for
each of the mutation levels. For clarity, the crossover approaches which are statistically
different to each other are described in Appendix J.2. This shows that for each of the
mutation levels, CalEB and TInSSel statistically outperform both UC and DUC for
each FFE point under observation. DUC is shown to be outperformed by UC for 3,000
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to 40,000 FFEs for mutation rates of 0 and 0.005, but this is reversed for a mutation
rate of 0.05, with DUC outperforming UC in this FFE range.
Section 8.1.6 found that for bio-control scheduling, with large values of pm, DUC re-
turned fitter scores than those found by UC. This was also the case for chemotherapy
treatment optimisation with a large mutation value. As with the bio-control problem,
this shows that in the presence of large quantities of new genetic material being intro-
duced through mutation, having a target number of interventions, even a simple target
like DUC, is more efficient than UC for this problem since UC finds it hard to get rid
of interventions.
As stated previously, DUC uses the same intervention selection mechanism as TInSSel,
but has a different method for calculating the number of interventions to be present
in offspring. For every pm setting, regardless of replacement strategy, DUC never
outperforms TInSSel, but is often statistically outperformed by it. As stated in Section
8, DUC was expected to be poorer than both CalEB and TInSSel for this problem, due
to its simplistic intervention target calculation. This has been shown to be the case,
demonstrating the benefit of using a window of selection around the fitter parent, as
opposed to strictly using the number of interventions in the fitter parent as the target
for this chemotherapy scheduling problem.
As CalEB and TInSSel are always shown to return fitter scores than the other crossover
approaches, they would appear to be the crossover techniques of choice for the chemother-
apy scheduling problem, regardless of pm setting or replacement strategy used.
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The previous analysis has shown that both CalEB and TInSSel are faster to discover
fitter intervention levels, resulting in better scores being returned by these approaches
when compared with UC and DUC.
Over the range of mutation levels, the best score found by UC for the cancer chemother-
apy scheduling problem was 9. This was found when the mutation rate was 0.05. Figure
8.61 shows the FFEs required by each of the crossover approaches to find this best score
returned by UC, over the range of mutation levels. This shows that in the absence of
mutation, none of the crossover approaches return this score.
When the mutation rate was increased to 0.005, Figure 8.61 shows that both CalEB
and TInSSel find this score, after 4,000 FFEs. Even after 40,000 FFEs, neither DUC
or UC find a score of this fitness. For a further mutation increase to 0.05, each of
the crossover approaches find a score of at least 9. UC requires 39,000 FFEs to find
this value and DUC uses 14,000. As with a mutation rate of 0.005, both CalEB and
TInSSel still require only 4,000 FFEs to find the same solution.
From inspecting the crossover approaches over a range of intervention penalties and
parameter values, certain deductions can be made:
• Both CalEB and TInSSel outperform the other approaches, and are therefore the
crossover technique of choice for the chemotherapy scheduling problem.
• DUC uses the same intervention selection mechanism as TInSSel, but has a sim-
pler method for calculating the number of interventions to be present in offspring.
For every intervention penalty and parameter setting, DUC never outperforms
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TInSSel, but is always statistically outperformed by it. As previously mentioned
in Section 8, both TInSSel and CalEB were expected to outperform DUC for this
problem. This has been shown to be the case, demonstrating the benefit of using
a window of selection around the fitter parent, as opposed to strictly using the
number of interventions in the fitter parent as the target for this problem.
• When pm is 0.05, a lot of genetic material is being added to the system, and
thus there is a lot of noise present. It is only for this mutation level that DUC
or UC find fit solutions. As CalEB, TInSSel and DUC outperform UC for this
mutation rate, this again shows the benefit of using a target for the interventions
for offspring. Even a simple directed approach like DUC is more beneficial for
this problem than no target.
As described above, CalEB and TInSSel are the most efficient crossover approach under
review for this problem, displaying identical performance over the range of mutation
rates. When compared to UC, CalEB and TInSSel are shown to require fewer FFEs to
find scores which statistically outperforms UC for all FFEs.
Figure 8.62 shows the percentage of improvement, in terms of both fewer FFEs required
and statistically better scores found, through using TInSSel instead of UC. This shows
the results for a mutation rate of 0.05, which was where each of the crossover approaches
on average performed best. This shows that TInSSel requires 89% fewer FFEs than
UC to find the same score and that for all of the FFEs under review, TInSSel returns
significantly better scores.
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Figure 8.62: Performance improvement between UC and TInSSel when pm = 0.05
8.2.2 Further analysis
The previous section reviewed CalEB, TInSSel and DUC in comparison to UC for
chemotherapy treatment scheduling, using the intermediate parameter settings.
In order to further analyse the abilities of each of the crossover approaches, it was
necessary to review them across a range of parameter settings, outwith the intermediate
set used in the previous sections.
Appendix G details the performance of CalEB, TInSSel, DUC and UC across the range
of population sizes, crossover rates, and mutation rates. A review of the crossover
approaches over this range of parameters are detailed in Appendix A.4. This review
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describes how the trends demonstrated in Section 8.2.1 hold with changing mutation
rates, crossover rates and population sizes.
8.3 Summary of the evaluation of directed intervention
crossover approaches
This chapter has reviewed the abilities of CalEB, TInSSel and DUC, in comparison
with UC, for deriving schedules of both bio-control treatments and chemotherapy drug
treatments. Section 8.1 reviewed these techniques for bio-control scheduling over a
range of intervention penalties. Analysis of these experiments found that TInSSel was
statistically better than all of the other crossover approaches, regardless of the penalty
per intervention, both in terms of number of FFEs required and fitness score of solutions
found. On average, TInSSel requires 37% fewer FFEs to find the best score returned
by UC.
Similar analysis was undertaken to compare the abilities of CalEB, TInSSel and DUC,
in comparison with UC, for chemotherapy scheduling. This found that both CalEB
and TInSSel statistically outperform both UC and DUC for every FFE point. Both
CalEB and TInSSel demonstrated a 89% reduction in the number of fitness functions
evaluations required to find the best score returned by UC.
From the experiments described in Sections 8.1 and 8.2, certain trends have appeared
which hold for both bio-control scheduling and cancer chemotherapy scheduling. As
described in Section 8, DUC is a test crossover approach which was not expected to
perform as well as the other directed intervention crossover approaches. DUC has a
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simplistic offspring target intervention calculation which simply uses the number of
interventions in the fitter parent as the target for offspring intervention levels. From
both of the test problems described previously, DUC is shown to perform poorer than
CalEB or TInSSel. This highlights that a window of offspring intervention levels is
critical to the successful search of directed intervention crossover approaches.
DUC is outperformed by UC for mutation levels of 0 or 0.005. It is interesting to note
that for both problems, when the mutation rate is further increased to 0.05, DUC is a
more effective crossover approach than UC. This shows that when large quantities of
genetic noise are being added to the population through a high mutation rate, having
a target number of interventions for offspring, even a simple target like DUC, is more
efficient than UC which has no offspring intervention target.
Although both CalEB and TInSSel perform in a similar manner for cancer chemother-
apy scheduling, for bio-control scheduling TInSSel is shown to outperform CalEB for
many of the FFEs under review. This shows that from the problems under review,
there is never utility in enforcing a uniform distribution of gene selection as stochas-
tic selection of genetic material is always at least as good as a uniformly distributed
approach.
From reviewing the bio-control problem, as fitness scores are generally poorer when
pm is increased from 0.005 to 0.05, this shows a limit for mutation. This is not the
case however for cancer chemotherapy scheduling, as the best results are found under
a mutation rate, pm, of 0.05.
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The abilities of directed intervention crossover has been demonstrated. They have
been shown to be effective on both problems with an explicit penalty value per in-
tervention, that of bio-control scheduling, and on chemotherapy scheduling, whereby
the intervention penalty is less pronounced. This has shown that stochastic selection
and a window of target intervention levels for offspring can dramatically improve the
GA crossover process for problems of this type. The next chapter introduces another
novel crossover approach, Fitness Directed Crossover (FDC). This further extends the
windowed approach of TInSSel, while adhering to the stochastic selection of genetic
material.
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Fitness Directed Crossover
Chapter 8 reviewed the directed intervention crossover techniques of CalEB, TInSSel
and DUC compared with UC for both bio-control and cancer chemotherapy scheduling.
This has shown the benefits, in terms of both fitness scores and the reduction of FFEs
required, of using directed intervention crossover techniques compared with UC, for
the problems under investigation.
From the analysis undertaken in Chapter 8, TInSSel was shown to be the best per-
forming crossover approach for the problems under investigation. This uses stochastic
selection of genetic material once the target number of interventions has been calcu-
lated. Although this target calculation uses the difference in intervention levels between
parents, it does not take into account the relative difference in fitness between parents
selected for crossover.
This chapter introduces a further extension to the directed intervention crossover tech-
niques termed Fitness Directed Crossover (FDC). This new approach reviews the bene-
fit of incorporating the relative fitness difference of parents into the intervention target
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calculations. Section 9.1 will describe the FDC technique. Section 9.2 compares FDC
with UC, CalEB and TInSSel for bio-control scheduling. This is followed by Section 9.3
which compares FDC, UC, CalEB and TInSSel for the scheduling of cancer chemother-
apy treatments.
9.1 Fitness Directed Crossover
Both the TInSSel and CalEB techniques use the difference in the number of interven-
tions between parents to scale the window of possible intervention sizes around the
fitter parent. These approaches use the fitness of the parents purely to decide which
parent’s intervention level should be used for IF . The previous studies raise the ques-
tion of whether additional information is contained in the fitness of parents, especially
on their comparative relative fitness levels when compared with the rest of the popula-
tion that can be used to further guide the search process? If so, there may be a better
way of determining IT which would utilise both the difference in intervention levels be-
tween parents as well as the relative difference in fitness scores? The Fitness Directed
Crossover technique is an approach designed to utilise these features and determine if
such benefits can be gained.
FDC uses both the difference in the number of interventions between parents as well
as the relative fitness difference to calculate the size of potential offspring. The FDC
approach places an emphasis on selecting offspring intervention sizes that are close
to the size of the fitter parent, while shifting in the direction that appears to offer
the best improvement, based on the intervention and fitness gradients between the
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two parents. For example, if the fitter parent has more interventions than the less fit
parent, then an intervention size will be returned that is greater than the fittest parent
with a margin that is proportional to this fitness difference. In essence, this technique
looks for information on which direction potentially offers the highest utility and moves
in this direction based on potential return, where this return is scaled based on the
relative fitness difference between parents.
The concept of extending in a direction to attempt higher gain is not new in GAs.
Work by Deb et al has created the self-adaptive simulated binary crossover operator
[111; 112]. This technique reviews if the created child solution is better than the
participating parent solutions, if so, the child is extended further in the hope of creating
an even better solution. Simulated binary crossover uses a distribution index parameter
nc. Large values of nc produce offspring close to the parents and conversely, for small
values of nc, solutions away from the parent are likely to be created. Unlike the directed
intervention work, this extension is not in terms of intervention usage, but of binary
representation of real parameter values, however the underlying principle of extending
in promising directions is similar.
As with the other crossover approaches discussed earlier, the FDC algorithm is pre-
sented with two parents for selection. F1 is the normalised fitness associated with
parent one and I1 is the number of interventions used by parent one, with F2 and I2
being the respective values for parent two.
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The normalised fitness score, Fnorm is calculated by finding the maximum (Fmax)
and minimum (Fmin) fitness scores contained in the current population and applying
Equation 9.1, where F is the score being normalised.
Fnorm =
F − Fmin
Fmax − Fmin (9.1)
The number of interventions used by the fitter of the two parents is recorded as IF and
the target fitness score is recorded as T , where T=0 for a minimisation problem and
T=1 for a maximisation problem.
The number of interventions to select in the offspring IT , is then calculated as shown
in Equation 9.2.
IT = IF + (2T − 1)(I1 − I2)(F1 − F2) (9.2)
As with the other directed intervention techniques, IT is a natural number constrained
by the minimum number of interventions Imin, which must be applied (usually 1) and
a maximum number of interventions Imax. As with the previous directed intervention
crossover approaches, Imax is limited to the size of the set of interventions present in
both parents.
The FDC calculation for IT incorporates both the fitness and size difference between
parents and therefore provides an intervention estimate that captures the dynamics of
the relationship between the parents fitness and intervention values. Note that if there
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is no difference between the number of interventions in the parents or if the fitness score
for parents are the same, the calculation of IT is equivalent to the DUC approach.
To demonstrate the operation of FDC, consider a GA with a population of 10 chromo-
somes as shown below:
0 0 0 0 0 0 0 1 1 0
0 0 1 1 1 0 0 1 0 0
0 0 1 1 1 0 0 1 1 0
0 0 1 1 1 0 0 1 1 1
1 1 1 1 1 0 0 1 0 1
1 1 0 1 1 1 1 1 1 1
0 0 1 1 1 1 1 1 0 0
0 0 1 1 1 0 1 1 0 1
0 0 1 1 1 1 1 1 1 1
1 0 1 1 1 1 1 1 1 1
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In this example, a minimisation problem is assumed, thus the closer a fitness score is
to zero, the better. If the 10 chromosomes described above had fitness scores of 10,
25, 30, 45, 59, 69, 72, 88, 91 and 101 respectively, and if chromosomes 2 and 6 were
randomly selected for breeding (with fitness scores of 25 and 69 respectively), FDC
would proceed in the following manner:
• The normalised fitness score would be calculated for each parent based on equa-
tion 9.1. The minimum score in the population is 10 and the maximum score is
101. Thus Parent 1 would have a normalised score of 0.165, calculated as 25−10101−10 .
Parent 2 would have a normalised score of 0.648 calculated as 69−10101−10 .
• Equation 9.2 is then used to calculate the number of interventions for offspring
IT . The offspring intervention size is then calculated as shown in equation 9.3,
where T = 0 as it is a minimisation problem, IF = 4, I1 = 4, I2 = 9 and
F1 = 0.165, F2 = 0.648.
• In the above equation, IT = 1.585. As all IT values are rounded down, this results
in IT = 1. The required number of interventions IT are then selected in the same
manner as for the TInSSel or DUC approaches.
IT = 4 + (−1)(4− 9)(0.165− 0.648) (9.3)
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Example T I1 I2 F1 F2 IF FF IT
1 1 6 4 0.9 0.4 6 0.9 7
2 0 6 4 0.9 0.4 4 0.4 3
3 1 6 4 0.4 0.9 4 0.9 3
4 0 6 4 0.4 0.9 6 0.4 7
5 1 4 6 0.9 0.4 4 0.9 3
6 0 4 6 0.9 0.4 6 0.4 7
7 1 4 6 0.4 0.9 6 0.9 7
8 0 4 6 0.4 0.9 4 0.4 3
Table 9.1: Example of FDC operation
9.1.1 FDC examples
This section further demonstrates the operation of the FDC approach. Table 9.1 shows
the FDC operation for both minimisation and maximisation problems, with the “Ex-
ample” column allowing identification of each row. For clarity, an extra parameter FF
is introduced which shows the fitter normalised fitness score for each example.
• Example 1 shows that for a maximisation problem (T = 1), as F1 is fitter, IF = 6.
With the FDC calculation, the intervention size is further increased to 7.
• Example 2 shows that for a minimisation problem, as the fitter parent contains
less interventions than the lesser fit parent, IT is decreased to 3.
• Example 3 shows a maximisation problem where IF = 4. As fewer interventions
produce a fitter score, FDC uses this information to further decrease IT to 3.
• Example 4 shows that for a minimisation problem, if more interventions appears
fitter, IT will contain more interventions than IF .
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• Example 5 shows that for a maximisation problem, if less interventions appears
to offer more utility, IT will be even less than IF .
• Example 6 shows that for a minimisation problem, if larger schedules offer more
utility, IT will be increased beyond IF .
• Example 7 shows that for a maximisation problem, if the larger schedule is fitter,
IT will be extended beyond this. Finally, Example 8 shows that for a minimisation
problem, if a smaller schedule is fitter, IT will contain less interventions than IF .
This section has introduced the concept of fitness directed crossover. The following
sections will compare FDC to TInSSel, CalEB and UC at the task of deriving bio-
control schedules for mushroom farming. The subsequent section then reviews the
performance of these same algorithms for the construction of cancer chemotherapy
treatment schedules.
9.2 Evaluation of FDC for bio-control scheduling
For this evaluation, the same parameter configuration is used as for the traditional
crossover experiments detailed in Chapter 7 and the directed intervention experiments
described in Chapter 8. The bio-control problem is therefore sampled over 5,000 fitness
function evaluations (FFEs), at intervals of 100, resulting in 50 data points for review.
For each sample point, 100 runs of each crossover approach were recorded for each
parameter combination, with the best scoring values for each run for each FFE being
recorded.
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Each of the following sections review the effectiveness of FDC, in comparison to CalEB,
TInSSel and UC, for the task of bio-control scheduling. This is undertaken over a range
of penalty values per intervention. As with the previous experiments, the crossover
techniques are tested over a range of parameter settings. A complete set of results
across the parameter combinations has also been collected and these can be seen in
Appendix D. This Appendix contains the complete set of results showing the fitness
scores against FFEs associated with these experiments across a range of population
sizes, intervention penalties and crossover and mutation rates.
As with the previous experiments, the intermediate parameter settings for each ap-
proach will be reviewed in detail, rather than explicitly detailing each possible para-
meter combination. The following sections will therefore review FDC, compared to
CalEB, TInSSel and UC, for the varying levels of intervention penalty P , as described
in Section 5.3.2, with a population of N = 100, crossover rate of pc = 0.9 and mutation
rates, pm, of 0, 0.005 and 0.05.
As with the directed intervention experiments in Chapter 8 the intermediate parameter
settings will use a generational replacement strategy and will be followed by analysis of
the average placement of interventions. Intermediate parameter settings will then be
reviewed under a steady state replacement strategy. As with previous experiments, the
replacement mechanism, R, for each experiment will be defined as either generational,
R = g, or steady state, R = ss.
Graphs displaying the results for both the fitness scores and associated intervention
usage for the intermediate parameter settings under both generational and steady state
292
CHAPTER 9. FITNESS DIRECTED CROSSOVER
replacement will now be reviewed. Both fitness scores versus FFEs and intervention
usage versus FFEs are plotted over the range of FFE samples. As stated previously,
as the bio-control optimisation problem is a minimisation problem, lower scores are
fitter than higher valued scores. On the graphs, U, C, T and F represent UC, CalEB,
TInSSel and FDC respectively.
9.2.1 0 penalty points per intervention
This section reviews FDC, in comparison to CalEB, TInSSel and UC, for bio-control
scheduling with a penalty of 0 points per intervention. As described in Section 9.2, this
will focus on the intermediate parameter settings. Figures 9.1 to 9.3 show the fitness
scores and associated intervention usage for pm levels of 0, 0.005 and 0.05 respectively.
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Figure 9.1: Results for N = 100, pc = 0.9, pm = 0,P = 0 and R = g
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Figure 9.2: Results for N = 100, pc = 0.9, pm = 0.005,P = 0 and R = g
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Figure 9.3: Results for N = 100, pc = 0.9, pm = 0.05,P = 0 and R = g
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Reviewing Figure 9.1 shows that for this parameter setting, FDC follows a similar trend
to both CalEB and TInSSel. This is in terms of both the accumulation of interventions
into schedules and fitness scores returned. Each of the directed intervention techniques
settle to a similar number of interventions after approximately 1,700 FFEs.
Figure 9.2 details the fitness scores and intervention usage when pm is increased to
0.005. As was the case when pm was 0, each of the directed intervention techniques
follow similar trends in terms of fitness scores and intervention usage. Each of the
directed approaches also settle to a similar number of interventions.
Figure 9.3 shows the effect of increasing pm to 0.05. As with the lower mutation
values, each of the directed techniques follow similar trends in terms of both fitness
scores returned and intervention usage.
From these experiments, each of the directed intervention approaches are shown to
follow similar trends, regardless of pm, when the penalty is 0 points per intervention.
Although a penalty of 0 points per intervention is unrealistic, it provides a test scenario
where each approach should rapidly accumulate interventions, as there is no cost asso-
ciated per intervention. Each of the crossover approaches rapidly increase the number
of interventions in schedules, with the directed intervention techniques quicker to adapt
to this trend.
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9.2.1.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approach, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for a penalty of 0 points per intervention.
In the case of no mutation, as shown in Figure 9.1, FDC, CalEB and TInSSel are shown
to use more interventions than UC. From the statistical analysis undertaken in Appen-
dix E.16, after 5,000 FFEs, FDC is shown to outperform UC but is also outperformed
by both TInSSel and CalEB. This section reviews the placement of interventions by
each of the crossover approaches at 5,000 FFEs. The average placement of these inter-
ventions, in the case of no mutation, are shown in Figure 9.4. From this FDC can be
seen to focus interventions on days 1 - 21 and 24 - 39 more often than UC, but less
than both CalEB and TInSSel. This would explain the fitness difference between these
approaches for this parameter setting.
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Figure 9.4: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 0
and R = g
When the mutation rate, pm, is increased to 0.005, as shown in Figure 9.2, each of
the crossover approaches use a similar number of interventions. From the statistical
analysis undertaken in Appendix E.17, after 5,000 FFEs, while there is no significant
difference between FDC and CalEB or TInSSel, FDC is shown to outperform UC. The
average placement of interventions by these approaches is shown in Figure 9.5. This
shows that each of the directed approaches target days 40 and 41 less often than UC,
while placing more emphasis on days 42 and 43.
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Figure 9.5: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 0 and R = g
When pm is further increased to 0.05, as shown in Figure 9.3, CalEB uses the most
interventions, followed by FDC and TInSSel, with UC using the least interventions.
From the statistical analysis undertaken in Appendix E.18, after 5,000 FFEs, as with a
mutation rate of 0.005, there is no statistical difference between the directed approaches,
and FDC again outperforms UC. The average placement of interventions is shown in
Figure 9.6. This shows that while the directed approaches follow a similar placement
of interventions, UC does not target as many days as these approaches on average.
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Figure 9.6: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 0 and R = g
9.2.1.2 Steady state replacement
Section 9.2.1 reviewed FDC, compared to CalEB, TInSSel and UC for bio-control
scheduling, with an intervention penalty of 0 points per intervention and generational
replacement. This experiment details the performance of approaches under a steady
state replacement strategy with intermediate parameter settings. Figures 9.7 to 9.9
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show the fitness and intervention usage associated with these experiments for pm levels
of 0, 0.005 and 0.05 respectively.
Figure 9.7 shows that similar trends are shown by FDC in terms of both fitness scores
and intervention usage regardless of replacement strategy when pm is 0. These trends
are similar to those of TInSSel. This pattern of FDC performing in a similar manner to
TInSSel, both in terms of fitness scores and intervention usage is shown to hold when
pm is increased to 0.005 (Figure 9.8) and further increased to 0.05 (Figure 9.9). As
with TInSSel, FDC is largely unaffected by the choice of replacement strategy applied
for these experiment settings.
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Figure 9.7: Results for N = 100, pc = 0.9, pm = 0,P = 0 and R = ss
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Figure 9.8: Results for N = 100, pc = 0.9, pm = 0.005,P = 0 and R = ss
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Figure 9.9: Results for N = 100, pc = 0.9, pm = 0.05,P = 0 and R = ss
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9.2.2 5 penalty points per intervention
This section describes how FDC compares to CalEB, TInSSel and UC at bio-control
scheduling with a penalty of 5 points per intervention. As with the experiment detailed
in Section 9.2.1, intermediate parameters of N = 100, and pc = 0.9 will be used.
Figure 9.10 shows the fitness scores and associated intervention usage for a mutation
rate, pm, of 0. Figures 9.11 and 9.12 detail the fitness and intervention usage for
approaches with pm levels of 0.005 and 0.05 respectively.
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Figure 9.10: Results for N = 100, pc = 0.9, pm = 0,P = 5 and R = g
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Figure 9.11: Results for N = 100, pc = 0.9, pm = 0.005,P = 5 and R = g
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Figure 9.12: Results for N = 100, pc = 0.9, pm = 0.05,P = 5 and R = g
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Figure 9.10 shows the fitness scores and intervention usage for the intermediate para-
meter settings with a penalty of 5 points per intervention and a pm of 0. This shows
that as with CalEB and TInSSel, FDC rapidly reduces intervention levels. The fitness
scores returned by FDC follow a similar trend to TInSSel, with the exception that
FDC appears to settle on scores of slightly less fitness than those found by the other
approaches when there is no mutation.
Figure 9.11 shows the fitness scores and intervention usage when the mutation rate, pm,
is increased to 0.005. For this mutation level, FDC is quicker to reduce intervention
levels than TInSSel. The fitness of returned solutions are very similar between FDC
and TInSSel for this mutation level.
The effect of further increasing pm to 0.05 is shown in Figure 9.12. FDC is quicker
than the other approaches at reducing intervention levels for this mutation level. FDC
also appears to return fitter scores than each of the other approaches for this level of
mutation.
9.2.2.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approaches, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for a penalty of 5 points per intervention.
In the case of no mutation, as shown in Figure 9.10, UC and TInSSel are shown to use
the most interventions, followed by FDC and then CalEB. From the statistical analysis
undertaken in Appendix E.19, after 5,000 FFEs, FDC is shown to be outperformed by
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both UC and TInSSel. Through reviewing the average placement of these interventions,
shown in Figure 9.13, FDC is shown to target days 5 - 12 and 28 - 36 less than both
UC and TInSSel.
Figure 9.13: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0, P = 5
and R = g
When the mutation rate is increased to 0.005, as shown in Figure 9.11, each of the
crossover approaches are shown to converge to solutions using a similar number of
interventions. From the statistical analysis undertaken in Appendix E.20, after 5,000
FFEs, there is no statistical difference between FDC and any of the other crossover
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approaches. Through reviewing the average placement of these interventions, shown in
Figure 9.14, each of the approaches are shown to focus interventions on similar days,
hence the similarity in fitness scores returned.
Figure 9.14: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 5 and R = g
When the mutation rate is further increased to 0.05, as shown in Figure 9.12, UC uses
more interventions than each of the directed approaches. From the statistical analysis
undertaken in Appendix E.21, after 5,000 FFEs, FDC is shown to outperform both UC
and CalEB. The average placement of these interventions are shown in Figure 9.15.
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This shows that FDC focuses interventions mainly on days 4 - 12 and 28 - 38 and has
less interventions on other days than both UC and CalEB.
Figure 9.15: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 5 and R = g
9.2.2.2 Steady state replacement
We now consider the steady state replacement strategy. Figures 9.16 to 9.18 show the
fitness scores and intervention usage when R = ss with pm values of 0, 0.005 and 0.05
respectively.
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Figure 9.16 shows that when pm is 0 the FDC approach uses the same number of inter-
ventions as CalEB, which is less than those used by TInSSel. As with the generational
equivalent, FDC does not find scores of the same fitness as those returned by TInSSel
for this pm level.
Figure 9.18 details the effect of increasing pm to 0.005. Although TInSSel, CalEB
and FDC all reduce intervention levels, FDC does so in a more direct way. FDC is
quicker than both TInSSel and CalEB to reduce in intervention levels, and also reduces
further in intervention levels than both TInSSel and CalEB. After 1,000 FFEs, FDC
has reduced to approximately 14 interventions and then increases in intervention usage
to approximately 17 interventions. This is the same number of interventions that UC,
TInSSel and CalEB settle to for this problem.
When pm is further increased to 0.05, as shown in Figure 9.18, similar trends are
displayed by FDC in terms of both intervention usage and fitness scores regardless of
the choice of replacement strategy.
314
CHAPTER 9. FITNESS DIRECTED CROSSOVER
Figure 9.16: Results for N = 100, pc = 0.9, pm = 0,P = 5 and R = ss
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Figure 9.17: Results for N = 100, pc = 0.9, pm = 0.005,P = 5 and R = ss
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Figure 9.18: Results for N = 100, pc = 0.9, pm = 0.05,P = 5 and R = ss
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9.2.3 20 penalty points per intervention
The next experiment considers the effect of increasing the number of penalty points per
intervention from 5 to 20. Figures 9.19 to 9.21 show the fitness scores and associated
intervention usage for a penalty of 20 points per intervention and pm values of 0, 0.005
and 0.05 respectively.
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Figure 9.19: Results for N = 100, pc = 0.9, pm = 0,P = 20 and R = g
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Figure 9.20: Results for N = 100, pc = 0.9, pm = 0.005,P = 20 and R = g
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Figure 9.21: Results for N = 100, pc = 0.9, pm = 0.05,P = 20 and R = g
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Figure 9.19 shows that when pm is 0, FDC is quicker than CalEB and TInSSel at
reducing intervention levels. Although this rapid reduction in intervention levels returns
fitter scores for approximately the first 1,000 FFEs, from this point FDC returns less
fit scores than the other approaches.
Figure 9.20 details the experiment when the probability of mutation, pm is increased
to 0.005. As with the case when pm was 0, FDC is quicker to reduce intervention levels
than the other approaches. This accounts for the fitter scores returned by FDC over
the first 1,000 FFEs.
When pm is increased further to 0.05, as shown in Figure 9.21, FDC is again quicker
at reducing intervention levels. This rapid reduction in intervention levels correlates
to FDC producing fitter scores than the other approaches, most evidently in the first
1,500 FFEs.
9.2.3.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approaches, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for a penalty of 20 points per intervention.
In the case of no mutation, as shown in Figure 9.19, TInSSel and UC are shown to use
more interventions than both CalEB and FDC. From the statistical analysis undertaken
in Appendix E.22, after 5,000 FFEs, FDC is shown to be outperformed by both TInSSel
and UC. The average placement of interventions are shown in Figure 9.22. This shows
that FDC does not target days 5 - 9 as strongly as both UC and TInSSel.
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Figure 9.22: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 20 and R = g
When the mutation rate is increased to 0.005, as shown in Figure 9.20, each of the
crossover approaches are shown to use a similar number of interventions. From the sta-
tistical analysis undertaken in Appendix E.23, after 5,000 FFEs, there was no statistical
difference between crossover approaches. The average placement of interventions are
shown in Figure 9.23 and this shows that each of the approaches target days 6 - 9,
hence the similar fitness scores returned.
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Figure 9.23: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 20 and R = g
When the mutation rate is further increased to 0.05, as shown in Figure 9.21, UC is
shown to use the most interventions, followed by FDC and then TInSSel and CalEB.
From the statistical analysis undertaken in Appendix E.24, after 5,000 FFEs, FDC is
shown to outperform both UC and CalEB. The average placement of interventions are
shown in Figure 9.24. This shows that FDC targets days 6 - 9 more strongly than both
CalEB and UC and also has less interventions on other days of the schedule.
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Figure 9.24: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 20 and R = g
9.2.3.2 Steady state replacement
We now repeat the previous evaluation for a steady state replacement strategy. Figures
9.25 to 9.27 show the fitness scores and associated intervention usage for a steady state
replacement strategy with a penalty of 20 points per intervention.
For a pm of 0, as shown in Figure 9.25, FDC uses a similar number of interventions
as CalEB. This was also the case for a generational replacement strategy. The fitness
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scores returned by FDC are less fit than those found under the generational equivalent
for this mutation level.
Figure 9.26 shows the fitness scores and intervention usage when pm is increased to
0.005. For this mutation level FDC displays trends, in terms of both fitness and inter-
vention usage, very similar to those shown with a generational replacement strategy.
When pm is further increased to 0.05, as shown in Figure 9.27, FDC again displays sim-
ilar fitness and intervention patterns as demonstrated under a generational replacement
strategy for this mutation level.
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Figure 9.25: Results for N = 100, pc = 0.9, pm = 0,P = 20 and R = ss
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Figure 9.26: Results for N = 100, pc = 0.9, pm = 0.005,P = 20 and R = ss
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Figure 9.27: Results for N = 100, pc = 0.9, pm = 0.05,P = 20 and R = ss
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9.2.4 35 penalty points per intervention
The previous sections have detailed the abilities of FDC, in comparison with CalEB,
TInSSel and UC, over a range of intervention penalty values. This section reviews the
effect on FDC of further increasing the intervention penalty, from 20 to 35 penalty
points per intervention.
Figures 9.28 to 9.30 show the fitness scores and associated intervention usage for pm
levels of 0, 0.005 and 0.05 respectively.
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Figure 9.28: Results for N = 100, pc = 0.9, pm = 0,P = 35 and R = g
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Figure 9.29: Results for N = 100, pc = 0.9, pm = 0.005,P = 35 and R = g
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Figure 9.30: Results for N = 100, pc = 0.9, pm = 0.05,P = 35 and R = g
333
CHAPTER 9. FITNESS DIRECTED CROSSOVER
Figure 9.28 shows that in the absence of mutation, FDC is quicker than the other ap-
proaches at reducing intervention levels. Due to this, FDC is also quicker at producing
fit scores, but, as with lesser intervention penalties, FDC appears to return less fit
scores than the other approaches later in the run.
Figure 9.29 shows the effect of increasing pm to 0.005. For this mutation level, FDC
is again quicker at reducing intervention levels than the other approaches and returns
fitter scores for approximately the first 1,000 FFEs. Unlike the case with no mutation,
FDC appears to produce scores of a similar fitness for the rest of the experiment.
The effect of further increasing pm to 0.05 is shown in Figure 9.30. For this mutation
level, as with the lesser mutation rates, FDC is quicker at reducing intervention levels
than the other approaches. FDC settles on approximately the same number of inter-
ventions as TInSSel and returns scores at least as good as the other approaches for this
mutation level.
9.2.4.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approaches, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for a penalty of 35 points per intervention.
In the case of no mutation, as shown in Figure 9.28, each of the crossover approaches are
shown to converge to a similar number of interventions. From the statistical analysis
undertaken in Appendix E.25, after 5,000 FFEs, FDC is shown to be outperformed by
TInSSel, CalEB and UC. The average placement of interventions are shown in Figure
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9.31. This shows that FDC does not target days 6 - 8 as often as the other crossover
approaches.
Figure 9.31: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 35 and R = g
When the mutation rate is increased to 0.005, as shown in Figure 9.29, each of the
crossover approaches are shown to converge to a similar number of interventions. From
the statistical analysis undertaken in Appendix E.26, after 5,000 FFEs, no statistical
difference was shown between any of the crossover approaches. The average place-
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ment of interventions are shown in Figure 9.32. This shows that each of the crossover
approaches target the same interventions, days 6 - 8.
Figure 9.32: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 35 and R = g
When the mutation rate is further increased to 0.05, as shown in Figure 9.30, UC
is shown to use more interventions than each of the directed crossover approaches.
From the statistical analysis undertaken in Appendix E.27, after 5,000 FFEs, FDC was
shown to statistically outperform UC, CalEB and TInSSel. The average placement of
interventions are shown in Figure 9.33. This shows that UC is less focussed on days
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6 and 7 than FDC, and also places interventions on other days of the schedule where
FDC does not. Both CalEB and TInSSel target days 6 and 7 in a similar way to FDC
but place less emphasis on interventions on day 8.
Figure 9.33: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 35 and R = g
9.2.4.2 Steady state replacement
The previous experiment is now repeated for a steady state replacement strategy. Fig-
ures 9.34 to 9.36 show the fitness scores and intervention usage for intermediate para-
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meter settings, a penalty of 35 points per intervention and a steady state replacement
strategy.
Figure 9.34 shows that for steady state replacement, with no mutation, FDC settles to 2
interventions as does CalEB. In line with the steady state experiment with 20 penalty
points per intervention, for a penalty of 35 points per intervention FDC produces
slightly poorer scores than with the generational equivalent.
For a steady state replacement strategy and mutation levels of 0.005 (Figure 9.35) and
0.05 (Figure 9.36), FDC displays similar trends to those demonstrated with generational
replacement, both in terms of fitness scores returned and intervention usage. This was
also the case for a penalty of 20 points per intervention.
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Figure 9.34: Results for N = 100, pc = 0.9, pm = 0,P = 35 and R = ss
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Figure 9.35: Results for N = 100, pc = 0.9, pm = 0.005,P = 35 and R = ss
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Figure 9.36: Results for N = 100, pc = 0.9, pm = 0.05,P = 35 and R = ss
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9.2.5 50 penalty points per intervention
The final bio-control experiment describes how FDC compares to CalEB, TInSSel and
UC with a penalty of 50 points per intervention. Figures 9.37 to 9.39 show the fitness
scores and associated intervention usage for intermediate parameter settings, a penalty
of 50 points per intervention and pm levels of 0, 0.005 and 0.05 respectively.
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Figure 9.37: Results for N = 100, pc = 0.9, pm = 0,P = 50 and R = g
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Figure 9.38: Results for N = 100, pc = 0.9, pm = 0.005,P = 50 and R = g
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Figure 9.39: Results for N = 100, pc = 0.9, pm = 0.05,P = 50 and R = g
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Figure 9.37 shows the approaches when pm is set to 0. For this mutation level, as
with lesser intervention penalties, FDC is once again quicker to return fit scores than
the other approaches. Also in accordance with the lesser intervention penalties, FDC
appears to prematurely converge and settle to less fit scores than those returned by the
other techniques.
The effect of increasing the pm value to 0.005 is shown in Figure 9.38. FDC is again
quicker than the other approaches at returning fit solutions, and unlike the case with
no mutation, FDC settles to scores of a similar fitness than those found by the other
techniques.
Figure 9.39 shows the effect of further increasing pm from 0.005 to 0.05. For this
increased mutation level, FDC returns fitter scores than the other directed approaches
until approximately 2,500 FFEs, and returns fitter scores than UC for the duration of
the experiment.
9.2.5.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approaches, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for a penalty of 50 points per intervention.
In the case of no mutation, as shown in Figure 9.37, each of the crossover approaches are
shown to converge to a similar number of interventions. From the statistical analysis
undertaken in Appendix E.28, after 5,000 FFEs, FDC is shown to be outperformed by
TInSSel, CalEB and UC. The average placement of interventions are shown in Figure
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9.40. This shows that FDC does not target day 7 as often as the other crossover
approaches.
Figure 9.40: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0,
P = 50 and R = g
When the mutation rate, pm, is increased to 0.005, as shown in Figure 9.38, each of
the crossover approaches are shown to converge to a similar number of interventions.
From the statistical analysis undertaken in Appendix E.29, after 5,000 FFEs, there is
shown to be no statistical difference between approaches. The average placement of in-
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terventions are shown in Figure 9.41. This shows that each of the crossover approaches
target interventions exclusively on days 6 and 7 of the schedule.
Figure 9.41: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.005,
P = 50 and R = g
When the mutation rate is further increased to 0.05, as shown in Figure 9.39, UC
is shown to use more interventions than the directed intervention approaches. From
the statistical analysis undertaken in Appendix E.30, after 5,000 FFEs, there is shown
to be no statistical difference between FDC, CalEB and TInSSel, with FDC shown to
outperform UC. The average placement of interventions are shown in Figure 9.42. This
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shows that UC is less focussed on days 6 and 7 than FDC and that UC also targets
many other days of the schedule, whereas FDC focusses solely on days 6 and 7.
Figure 9.42: Intervention placement for 5,000 FFEs, N = 100, pc = 0.9, pm = 0.05,
P = 50 and R = g
9.2.5.2 Steady state replacement
The same experiment will now be reviewed for a steady state replacement strategy.
Figures 9.43 to 9.45 show the fitness scores and associated intervention usage graphs
for each approach using the intermediate parameter settings, a penalty of 50 points per
intervention and a steady state replacement strategy.
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Figure 9.43 shows that in the absence of mutation, FDC settles on fewer interventions
than under generational replacement. This leads to less fit scores being returned by
FDC for steady state replacement for this mutation level. This was also the case for
intervention penalties of 20 and 35 points per intervention.
When the mutation rate is increased to 0.005, as shown in Figure 9.44, FDC behaves
in a similar way under steady state as for generational replacement. This is both in
terms of fitness scores and intervention usage.
A further mutation increase to 0.05 is shown in Figure 9.45. As with a pm of 0.005,
FDC behaves in a similar way, in terms of both fitness scores and intervention usage,
regardless of the replacement strategy used.
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Figure 9.43: Results for N = 100, pc = 0.9, pm = 0,P = 50 and R = ss
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Figure 9.44: Results for N = 100, pc = 0.9, pm = 0.005,P = 50 and R = ss
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Figure 9.45: Results for N = 100, pc = 0.9, pm = 0.05,P = 50 and R = ss
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9.2.6 Summary of bio-control scheduling experiment
The previous experiments have reviewed FDC in comparison to UC, CalEB and TInSSel
for a range of intervention penalties. This section draws together the salient points from
each of these experiments.
In order to ascertain if there is any statistical significant differences between approaches
for this problem, the Kruskal-Wallis test results for the intermediate test cases were
calculated and are shown in Tables E.16 to E.30. For clarity, Appendix J.3 shows which
crossover approaches are significantly different over the range of FFEs.
Each of the intervention penalties will be reviewed in turn, with Section 9.2.7 describing
the trends demonstrated across the range of penalty values.
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9.2.6.1 Penalty of 0 points per intervention
Figure 9.46: FFEs to reach the best score found by UC (355) with a penalty of 0 points
per intervention
Section 9.2.1 described the scores found by FDC, in comparison to UC, CalEB and
TInSSel for a penalty of 0 points per intervention. This showed that FDC, as with
CalEB and TInSSel, is faster to increase intervention levels than UC, resulting in fitter
scores being returned by these directed intervention approaches.
The statistical analysis detailed in Appendix E.2.1 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. For clarity, the crossover approaches which are statistically
different to each other are described in Appendix J.3.1.
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This shows that regardless of mutation level, FDC outperforms UC for almost all
FFEs under review. FDC does appear to prematurely converge in the absence of
mutation though as FDC outperforms CalEB at 200 and 400 FFEs but is statistically
outperformed by CalEB from 1,800 FFEs onwards. Although FDC is comparable to
TInSSel for the first 1,500 FFEs, due to the premature convergence of FDC, TInSSel
outperforms FDC for the remaining FFEs, 1,600 to 5,000.
When the mutation rate is increased to 0.005, FDC outperforms CalEB from 300 to
500 FFEs and is only outperformed by TInSSel at 2,400 FFEs. A further increase in
mutation rate to 0.05 shows that while TInSSel and FDC return similar scores, FDC
outperforms CalEB from 300 to 500 FFEs.
As described in Section 8.1.6.1, over the range of mutation levels, the best score found
by UC for a penalty of 0 points per intervention was 355. This was found when the
mutation rate was 0.005. Figure 9.46 shows the FFEs required by each of the crossover
approaches to find this best score returned by UC, over the range of mutation levels.
This shows that FDC uses the same number of FFEs for CalEB in the absence of
mutation, which is 100 more FFEs than TInSSel. When the mutation rate is increased
to 0.005, FDC uses the same number of FFEs as TInSSel, and for a further mutation
increase to 0.05, FDC uses 100 less FFEs than TInSSel.
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9.2.6.2 Penalty of 5 points per intervention
Figure 9.47: FFEs to reach the best score found by UC (476) with a penalty of 5 points
per intervention
Section 9.2.2 described the scores found by FDC, in comparison to UC, CalEB and
TInSSel for a penalty of 5 points per intervention. This showed that FDC, as with
CalEB and TInSSel, were faster to reduce in intervention levels than UC, resulting in
fitter scores being returned by these directed intervention approaches.
The statistical analysis detailed in Appendix E.2.2 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. The crossover approaches which are statistically different
to each other are described in Appendix J.3.2.
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FDC was shown to prematurely converge in the absence of mutation for a penalty of 0
points per intervention. This is also the case with an intervention penalty of 5 points
per intervention. Although initially better than UC, from 700 to 1,700 FFEs, from
2,100 FFEs onward UC outperforms FDC. TInSSel and FDC are similar for the first
2,000 FFEs but from this point onwards, TInSSel statistically outperforms FDC. When
the mutation rate is increased to 0.005, FDC outperforms UC from 600 to 1,800 FFEs,
and is only outperformed by TInSSel from 2,200 to 2,500 FFEs. A further mutation
increase to 0.05 shows a benefit in using FDC. FDC outperforms UC for most of the
FFEs and also outperforms TInSSel from 1,000 to 2,400 FFEs. CalEB was previously
shown to be poor for this experiment and due to this FDC outperforms CalEB for at
least half of all FFEs regardless of mutation rate
As described in Section 8.1.6.2, over the range of mutation levels, the best score found
by UC for a penalty of 5 points per intervention was 476. This was found when the
mutation rate was 0.005. Figure 9.47 shows the FFEs required by each of the crossover
approaches to find this best score returned by UC, over the range of mutation levels.
This shows that FDC, as with the other directed approaches, do not find this result in
the absence of mutation. When pm is increased to 0.005, FDC requires slightly more
FFEs than both UC and TInSSel to find this value, but requires fewer than CalEB.
None of the approaches find a score of 476 when the mutation rate is increased to 0.05.
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9.2.6.3 Penalty of 20 points per intervention
Figure 9.48: FFEs to reach the best score found by UC (603) with a penalty of 20
points per intervention
Section 9.2.3 described the scores found by FDC, in comparison to UC, CalEB and
TInSSel for a penalty of 20 points per intervention. This showed that FDC, as with
CalEB and TInSSel, is faster to reduce in intervention levels than UC, resulting in
fitter scores being returned by these directed intervention approaches.
The statistical analysis detailed in Appendix E.2.3 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
each of the mutation levels. The crossover approaches which are statistically different
to each other are described in Appendix J.3.3.
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FDC was shown to prematurely converge in the absence of mutation for previous in-
tervention penalties. This is also the case with an intervention penalty of 20 points
per intervention. Although FDC outperforms UC from 700 to 1,700 FFEs, it is sub-
sequently outperformed from 2,100 to 5,000 FFEs. TInSSel also outperforms FDC for
the latter half of the FFEs in the absence of mutation. FDC outperforms CalEB for
the first quarter of FFEs.
When the mutation rate is increased to 0.005, the ability of FDC improves. For this
mutation level FDC outperforms each of the other crossover approaches for at least
some of the initial FFEs. FDC outperforms UC from 200 to 2,400 FFEs, CalEB from
200 to 1,400 FFEs and TInSSel from 300 to 900 FFEs. A further increase in mutation
rate sees FDC outperform all of the other crossover approaches for almost every FFE
point.
As described in Section 8.1.6.3, over the range of mutation levels, the best score found
by UC for a penalty of 20 points per intervention was 603. This was found when the
mutation rate was 0.005. Figure 9.48 shows the FFEs required by each of the crossover
approaches to find this best score returned by UC, over the range of mutation levels.
This shows that in the absence of mutation, FDC does not find this target. When the
mutation rate is increased to 0.005, FDC takes 100 more FFEs to reach the target than
TInSSel. No crossover approach finds a score of 603 when the mutation rate is further
increased to 0.05.
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9.2.6.4 Penalty of 35 points per intervention
Figure 9.49: FFEs to reach the best score found by UC (655) with a penalty of 35
points per intervention
Section 9.2.4 described the scores found by FDC, in comparison to UC, CalEB and
TInSSel for a penalty of 35 points per intervention. This showed that FDC was faster
than the other directed intervention approaches to reduce the number of interventions
in schedules resulting in fitter scores being returned by FDC for the initial FFEs.
The statistical analysis detailed in Appendix E.2.4 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs for
mutation levels of 0 and 0.05. For a mutation rate of 0.005 there exists a difference
between approaches from 200 to 2,200 FFEs.
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As with previous experiments, in the absence of mutation FDC is shown to prematurely
converge. FDC outperforms the other approaches for the first fifth of the FFEs but is
later outperformed by each of the other crossover approaches.
When the mutation rate is increased to 0.005, the ability of FDC improves. For this
mutation level FDC outperforms each of the other crossover approaches for at least
some of the initial FFEs. FDC outperforms UC, CalEB and TInSSel from 200 to
2,000, 1,300 and 1,000 FFEs respectively. A further increase in mutation rate sees
FDC outperform both UC and CalEB for almost every FFE and TInSSel for three
quarters of the FFE range.
As described in Section 8.1.6.4, over the range of mutation levels, the best score found
by UC for a penalty of 35 points per intervention was 655. This was found when the
mutation rate was 0.005. Figure 9.49 shows the FFEs required by each of the crossover
approaches to find this best score returned by UC, over the range of mutation levels.
This shows that in the absence of mutation, FDC does not find this target. When the
mutation rate is increased to 0.005, FDC is faster than both TInSSel and CalEB to
find this value. For a further increase in the mutation rate, FDC is the only approach
to discover a score of at least 655.
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9.2.6.5 Penalty of 50 points per intervention
Figure 9.50: FFEs to reach the best score found by UC (698) with a penalty of 50
points per intervention
Section 9.2.5 described the scores found by FDC, in comparison to UC, CalEB and
TInSSel for a penalty of 50 points per intervention. This showed that as with a penalty
of 35 points per intervention, FDC was faster than the other directed intervention
approaches to reduce the number of interventions in schedules resulting in fitter scores
being returned by FDC for the initial FFEs.
The statistical analysis detailed in Appendix E.2.5 shows that there is a statistical
difference between at least two of the crossover approaches from 200 to 5,000 FFEs
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for mutation levels of 0 and 0.05. For a mutation rate of 0.005 there is no statistical
difference between approaches from 2,700 to 3,200 FFEs.
As with previous experiments, in the absence of mutation FDC is shown to prematurely
converge. FDC again outperforms the other approaches for the initial FFEs but is later
outperformed by each of the other crossover approaches.
When the mutation rate is increased to 0.005, the ability of FDC improves. For this
mutation level FDC outperforms each of the other crossover approaches for at least
some of the initial FFEs. FDC outperforms UC, CalEB and TInSSel from 200 to
2,000, 1,000 and 1,000 FFEs respectively. A further increase in mutation rate sees
FDC outperform both UC for almost every FFE point and outperform CalEB and
TInSSel for approximately half of the FFE range.
As described in Section 8.1.6.5, over the range of mutation levels, the best score found
by UC for a penalty of 50 points per intervention was 698. This was found when the
mutation rate was 0.005. Figure 9.50 shows the FFEs required by each of the crossover
approaches to find this best score returned by UC, over the range of mutation levels.
This shows that in the absence of mutation, FDC does not find this target. When the
mutation rate is increased to 0.005, FDC is faster than both TInSSel and CalEB to
find this value. For a further increase in the mutation rate, FDC is again faster than
the other approaches to find a score of 698.
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9.2.7 Summary
This section has reviewed FDC, in comparison to CalEB, TInSSel and UC for de-
riving optimal control schedules of bio-control applications. These experiments have
been conducted over a range of intervention penalties, mutation rates and replacement
strategies. The intervention penalties have ranged from 0, as described in Section 9.2.1,
through to a penalty of 50 points per intervention, as detailed in Section 9.2.5.
When there is no mutation, FDC is shown to converge to less fit scores than those found
by the other approaches. As detailed in Section 2.2.7, mutation diversifies the search
directions and avoids convergence to a local optima [41]. GAs typically use mutation,
thus FDC not performing in the absence of mutation is of no major detriment to the
technique.
For a mutation level of 0.005, FDC is shown to outperform the other approaches for
the initial FFEs, when the intervention penalty is increased beyond 5 points per in-
tervention. This can be ascribed to FDC using the intervention penalty to drive the
intervention sizing process. If there is not a strong intervention penalty, FDC is unable
to determine the direction to move intervention levels, thus returning poorer scores.
When there is a penalty per intervention of 20, 35 or 50, this gives FDC a clearer direc-
tion to move in, thus explaining the rapid production of good scores for these penalty
levels.
For a mutation rate of 0.05, FDC is clearly the best performing crossover operator.
Regardless of intervention penalty, for this mutation level FDC is quicker to identify
promising intervention levels and thus returns fitter scores than the other approaches
365
CHAPTER 9. FITNESS DIRECTED CROSSOVER
for a range of FFEs. Note that the only difference between TInSSel and FDC is the
calculation of the target number of interventions. This points to using the relative
differences in parent numbers as a more robust approach to directing offspring in the
presence of large quantities of noise, as introduced via mutation.
When FDC is shown to outperform the other approaches, this is generally for FFEs
in the early stages of the experiment. This implies that FDC is better at identifying
trends in terms of intervention usage and moves in these directions in a more prompt
way than the other directed intervention techniques.
FDC is shown to be poorer under a steady state replacement strategy as opposed to
a generational approach for certain intervention penalties. As FDC is better with a
generational approach, which replaces a large proportion of the population per gener-
ation, this points to FDC performing better with large amounts of genetic variation
in the population. This would explain why FDC is less efficient under generational
replacement with a pm of 0, as opposed to mutation levels of 0.005 and 0.05.
Figure 9.51 shows the percentage of improvement, in terms of both FFEs required and
statistically better scores found, through using FDC instead of UC. This shows the
results for a mutation rate of 0.005, which was where UC on average performed best.
This shows that for a penalty of 0 points per intervention, FDC requires 64% fewer
FFEs than UC to find the same score and that for 84% of the FFEs under review, FDC
returns significantly better scores.
When the penalty was increased to 5 penalty points per intervention, FDC is shown
to be poorer than UC. As stated previously, FDC uses the intervention penalties to
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drive the intervention level selection. Therefore with a low penalty there is a low drive.
Although FDC is not as quick at finding the target score as UC, this difference in
performance is only 8%. For this penalty value, FDC statistically outperforms UC for
24% of the FFE range.
A further increase in penalty value, from 5 to 20, provides enough direction for FDC to
accurately calculate offspring intervention levels. For this setting, FDC finds the best
score found by UC using 36% less FFEs. FDC also statistically outperforms UC for
44% of the FFEs under review.
For a penalty of 35 points per intervention, FDC requires 42% fewer FFEs to find the
best score returned by UC. For this penalty setting the scores returned by FDC are
statistically better than those found by UC for 36% of the FFEs. A further increase in
penalty value, to 50 points per intervention, shows that FDC requires 57% less FFEs to
discover the final value returned by UC. As with a penalty of 35 points per intervention,
FDC finds statistically better scores for 36% of all FFEs.
The average gain in performance over all penalty values for a mutation rate of 0.005 is
shown in Figure 9.51. This shows that over all 5 penalty levels, FDC requires 38.2%
fewer FFEs to find the best score returned by UC. On average, FDC finds statistically
better scores for 44.8% of all FFEs under review. These mean values are slightly better
than the values returned by TInSSel in comparison to UC. This shows that even with
the poor score shown for a penalty of 5 points per intervention, on average FDC is as
effective for bio-control scheduling as TInSSel.
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Figure 9.51: Performance improvement between UC and FDC when pm = 0.005
9.2.8 Further analysis
The previous sections reviewed FDC in comparison to CalEB, TInSSel and UC for the
task of bio-control scheduling. This analysis was conducted over a range of intervention
penalties using intermediate parameter settings.
In order to further analyse the abilities of FDC, compared to the other crossover ap-
proaches, it is necessary to review them across a range of parameter settings, outwith
the intermediate set used in the previous sections.
Appendix D details the abilities of FDC, CalEB, TInSSel and UC across a range of
population sizes, crossover rates, mutation rates and intervention penalties. A review of
the crossover approaches over the range of parameters are detailed in Appendix A.5. In
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that review, FDC was shown to follow similar trends to TInSSel for most experiments,
with the exception of experiments with small population sizes or low mutation rates.
These findings are in line with the points described in Section 9.2.6, as FDC appears to
work best in populations with greater genetic diversity, hence the problems with small
population sizes and no mutation.
9.3 Evaluation of FDC for chemotherapy treatment schedul-
ing
FDC will now be compared to CalEB, TInSSel and UC for the task of chemotherapy
treatment scheduling. The methodology used is the same as for previous chemotherapy
treatment scheduling experiments. The problem is again sampled over 40,000 FFEs,
at intervals of 1,000 FFEs, resulting in 40 data points for review. For each sample
point, 100 runs of each crossover approach were recorded for each of the parameter
combinations. The best scoring values for each run for each FFE were recorded.
A complete set of results across the parameter combinations has therefore been collected
and these can be seen in Appendix H. This Appendix contains the complete set of
results showing the fitness scores against FFEs associated with these experiments across
a range of population sizes and crossover and mutation rates.
As with the previous experiments, the intermediate parameter settings for each ap-
proach will be reviewed in detail, rather than explicitly detailing each possible parame-
ter combination. As with Section 9.2, the following sections will review FDC, compared
369
CHAPTER 9. FITNESS DIRECTED CROSSOVER
to CalEB, TInSSel and UC, with a population of N = 100, crossover rate of pc = 0.9
and mutation rates, pm of 0, 0.005 and 0.05.
As with the bio-control experiments, described in Section 9.2 the intermediate parame-
ter settings will use a generational replacement strategy. The placement of interventions
will then be analysed. Intermediate parameter settings will then be reviewed under a
steady state replacement strategy. As with previous experiments, the replacement
mechanism, R, for each experiment will be defined as either generational, R = g, or
steady state, R = ss.
Graphs displaying the results for both the fitness scores and associated intervention
usage for the intermediate parameter settings under both generational and steady state
replacement will now be reviewed. Both fitness scores versus FFEs and intervention
usage versus FFEs are plotted over the range of FFE samples. As stated previously, as
the cancer chemotherapy treatment optimisation problem is a maximisation problem,
higher scores are fitter than lower valued scores.
Figures 9.52 to 9.54 show the fitness score and associated intervention usage for the
intermediate parameter settings and a pm of 0, 0.005 and 0.05 respectively.
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Figure 9.52: Results for N = 100, pc = 0.9, pm = 0 and R = g
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Figure 9.53: Results for N = 100, pc = 0.9, pm = 0.005 and R = g
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Figure 9.54: Results for N = 100, pc = 0.9, pm = 0.05 and R = g
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Figure 9.52 shows that in the absence of mutation, FDC uses fewer intervention than
each of the other approaches. This returns fitness scores in a similar range as those
produced by TInSSel and CalEB.
Figure 9.53 shows the fitness scores and intervention usage when pm is increased to
0.005. For this mutation level, as with the case of no mutation, FDC uses fewer
interventions than each of the other crossover approaches. This results in FDC, as
with CalEB and TInSSel, outperforming UC for each FFE point.
Figure 9.54 details the effect of further increasing pm to 0.05. For this increased muta-
tion level, FDC uses approximately the same number of interventions as TInSSel and
CalEB, and returns fitter scores than each of the other approaches.
9.3.0.1 Intervention placement
The previous section has outlined the fitness scores and associated intervention usage
for the FDC crossover approaches, in comparison to CalEB, TInSSel and UC, under a
generational replacement strategy for cancer chemotherapy treatment scheduling.
In the case of no mutation, as shown in Figure 9.52, UC is shown to use the most
interventions, followed by CalEB, then TInSSel and finally FDC. From the statistical
analysis undertaken in Appendix I.4, after 40,000 FFEs, FDC is shown to outperform
UC. The average placement of interventions and dosage strengths are shown in Figure
9.55. This shows that FDC, as well as CalEB and TInSSel, place larger doses at the
end of the intervention schedule, whereas UC does not.
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Figure 9.55: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0 and
R = g
When the mutation rate is increased to 0.005, as shown in Figure 9.53, UC uses the
most interventions. CalEB and TInSSel use the same number of interventions and
FDC uses less. From the statistical analysis undertaken in Appendix I.5, after 40,000
FFEs, FDC is shown to outperform UC. The average placement of interventions and
dosage strengths are shown in Figure 9.56. This shows that while all approaches target
interventions late in the treatment schedule, UC does not apply as large a dosage as
the other approaches.
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Figure 9.56: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.005
and R = g
When the mutation rate is further increased to 0.05, as shown in Figure 9.54, as with
previous mutation levels, UC uses the most interventions. CalEB, TInSSel and FDC
converge to a similar number of interventions. From the statistical analysis undertaken
in Appendix I.6, after 40,000 FFEs, FDC is shown to outperform UC, CalEB and
TInSSel. The average placement of interventions and dosage strengths are shown in
Figure 9.57. This shows that while all approaches target interventions late in the
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treatment schedule, FDC uses larger dosages on days 97 - 100 than each of the other
crossover approaches.
Figure 9.57: Intervention placement for 40,000 FFEs, N = 100, pc = 0.9, pm = 0.05
and R = g
9.3.0.2 Steady state replacement
The same experiment will now be reviewed for a steady state replacement strategy.
Figures 9.58 to 9.60 show the fitness scores and associated intervention usage for inter-
mediate parameter settings and a steady state replacement strategy.
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Figure 9.58 shows that, in the absence of mutation, as with generational replacement
FDC, CalEB and TInSSel return similar fitness scores. Each of these crossover ap-
proaches are quicker to reduce intervention levels for a steady state approach, resulting
in the use of fewer FFEs to find positive scores. It can also be noted that FDC uses fewer
interventions under steady state replacement as opposed to the generational equivalent.
Figure 9.59 details the fitness scores and intervention usage when pm is increased to
0.005. For this mutation level, as with the case of no mutation, FDC, CalEB and
TInSSel are quicker at reducing in intervention levels under a steady state approach.
For most FFEs, FDC returns similar scores under both a generational and a steady
state replacement strategy.
Figure 9.60 shows that for a mutation rate, pm, of 0.05, similar trends are displayed as
for the lower mutation rates. FDC, CalEB and TInSSel are quicker to reduce interven-
tion levels under a steady state replacement strategy, as opposed to the generational
equivalent. Similar scores are returned by FDC for most FFEs, regardless of the re-
placement strategy used.
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Figure 9.58: Results for N = 100, pc = 0.9, pm = 0 and R = ss
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Figure 9.59: Results for N = 100, pc = 0.9, pm = 0.005 and R = ss
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Figure 9.60: Results for N = 100, pc = 0.9, pm = 0.05 and R = ss
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9.3.1 Summary of chemotherapy treatment scheduling experiment
The previous experiment reviewed FDC in comparison to CalEB, TInSSel and UC, for
the task of cancer chemotherapy scheduling. This section draws together the salient
points from this experimentation.
In order to ascertain if there is any statistical significant differences between approaches
for this problem, the Kruskal-Wallis test results for the intermediate test cases were
calculated. These are shown in Tables I.4 to I.6. As with the bio-control experiments
discussed previously, for clarity, Appendix J.4 shows which crossover approaches are sig-
nificantly different over the range of FFEs. As detailed in Section 6.9, the chemotherapy
experiments are evaluated over 40,000 FFEs, in observable increments of 1,000 FFEs.
This means that for each pm level, there are 40 FFE points under observation for each
approach, ranging from 1,000 FFEs to 40,000 FFEs.
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Figure 9.61: FFEs to reach the best score found by UC (9)
This section has reviewed the directed intervention crossover approaches against UC,
for the production of cancer chemotherapy treatment schedules. This analysis has been
undertaken over a range of mutation rates and replacement strategies.
The statistical analysis detailed in Appendix I.2 shows that there is a statistical differ-
ence between at least two of the crossover approaches from 1,000 to 40,000 FFEs for
each of the mutation levels. For clarity, the crossover approaches which are statisti-
cally different to each other are described in Appendix J.4. This shows that for each of
the mutation levels, FDC outperforms UC for each FFE. In the absence of mutation,
FDC outperforms both CalEB and TInSSel for 1,000 FFEs. As the mutation rate is
increased, so is the number of FFEs with which FDC outperforms both CalEB and
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TInSSel. For a mutation rate of 0.005, FDC outperforms CalEB and TInSSel from
1,000 to 4,000 and 3,000 FFEs respectively. For a further mutation increase to 0.05,
FDC outperforms CalEB for every FFE and TInSSel for a fifth of all FFEs.
As FDC is always at least as good as CalEB and TInSSel for this problem, it would ap-
pear to be the crossover techniques of choice for the chemotherapy scheduling problem,
regardless of pm setting.
Over the range of mutation levels, the best score found by UC for the cancer chemother-
apy scheduling problem was 9. This was found when the mutation rate was 0.05. Figure
9.61 shows the FFEs required by each of the crossover approaches to find this best score
returned by UC, over the range of mutation levels. This shows that in the absence of
mutation, none of the crossover approaches return this score.
When the mutation rate was increased to 0.005, Figure 9.61 shows that FDC is quicker
than both CalEB and TInSSel to reach a score of 9, requiring 3,000 FFEs, with CalEB
and TInSSel both using 4,000 FFEs. For a further mutation increase to 0.05, each of
the crossover approaches find a score of at least 9, the FFEs required by FDC, CalEB
and TInSSel are the same as for a mutation rate of 0.005.
From inspecting the crossover approaches over a range of intervention penalties and
parameter values, certain deductions can be made:
• FDC is always at least as good as the other directed intervention approaches for
this problem and is therefore the crossover approach of choice for this problem.
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• As this problem has more genetic variety than the bio-control scheduling problem,
this shows that FDC is better for problems with more variety in the population
• FDC works for problems where the penalty per intervention is not as pronounced
as the penalty in the bio-control problem.
Figure 9.62 shows the percentage of improvement, in terms of both fewer FFEs required
and statistically better scores found, through using FDC instead of UC. This shows the
results for a mutation rate of 0.05, which was where each of the crossover approaches
on average performed best. This shows that FDC requires 92% fewer FFEs than UC
to find the same score and that for 100% of the FFEs under review, FDC returns
significantly better scores. As TInSSel and CalEB used 89% fewer FFEs than UC,
this shows a further 3% improvement in FFEs required by using FDC. When FDC is
compared to TInSSel, FDC is shown to statistically outperform TInSSel for a quarter
of the FFE range and outperform CalEB for 100% of FFEs.
The previous experiments in Section 8.2.1 concluded that CalEB or TInSSel are the
best performing crossover operators for this problem. This section has shown that FDC
often statistically outperforms both of these techniques for chemotherapy scheduling,
regardless of the mutation rate chosen. It has also shown that FDC requires fewer
FFEs than either UC, CalEB or TInSSel to find these scores. Due to this, FDC is
demonstrated to be a more efficient crossover approach for this problem.
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Figure 9.62: Performance improvement between UC and FDC when pm = 0.05
9.3.2 Further analysis
The previous experiment reviewed FDC in comparison to CalEB, TInSSel and UC for
the task of cancer chemotherapy treatment scheduling. This analysis was conducted
over a range of intervention penalties using the intermediate parameter settings.
In order to further analyse the abilities of FDC, compared to the other crossover ap-
proaches, it is necessary to review them across a range of parameter settings, outwith
the intermediate set used in the previous sections.
Appendix H details the abilities of CalEB, TInSSel, FDC and UC across a range
of population sizes, crossover rates and mutation rates. A review of the crossover
approaches over this range of parameters are detailed in Appendix A.6.
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In that review, although FDC was shown to follow similar trends to TInSSel for most
experiments, FDC often found fit scores at earlier stages of the experiment. As with
the findings detailed in Section 9.3, FDC is often at least as good as TInSSel, and this
is shown to hold regardless of population size, mutation rate or crossover rate.
9.4 Summary of the evaluation of Fitness Directed Crossover
This chapter has introduced the FDC approach as an extension to the directed in-
tervention crossover approaches detailed earlier. The performance of FDC has been
reviewed in comparison to CalEB, TInSSel and UC, for both bio-control scheduling
(Section 9.2) and cancer chemotherapy treatment scheduling (Section 9.3).
FDC was shown to initially outperform the other crossover techniques in the absence
of mutation for bio-control scheduling, but converged to less fit solutions than other
approaches. As the mutation rate was increased, so did the performance of FDC for this
problem, with FDC outperforming all of the other approaches for intervention penalties
of 20, 35 and 50, when pm was 0.005. When the mutation was further increased to 0.05,
FDC was shown to outperform the other techniques, across the range of intervention
penalty values. Further analysis found that FDC was at least as good as the other
approaches when the mutation rate was greater than 0 and the population was greater
than 50. For this problem, FDC required 38.2% fewer FFEs on average to find the best
score returned by UC and outperformed UC for 44.8% of FFEs. This mean performance
is a slight increase on TInSSel.
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For the cancer chemotherapy scheduling problem, FDC is never outperformed by any
of the other techniques and is shown to have a statistical advantage over the other
approaches, regardless of mutation levels. In the further analysis of FDC for this
problem, FDC was shown to perform at least as well as TInSSel, regardless of the
population size or mutation rate. For this problem, FDC was shown to find the best
score returned by UC in 92% fewer FFEs and returns significantly better scores than
those found by UC for every FFE point.
This raises the question as to why FDC is capable of outperforming the other ap-
proaches, when pm is 0 and N = 50 for the cancer chemotherapy problem but is poorer
than the other approaches for equivalent parameters for bio-control scheduling? The
most logical reason behind this trend would appear to be that of genetic variation in
the population. FDC is shown to improve as the mutation rate and population size
increases for bio-control scheduling, and in that problem, each population member is
represented by a 50 bit schedule. For the cancer chemotherapy problem, each chromo-
some is represented by a 100 integers, where each integer has a value in the range of 0
- 15. The representation space for these two problems are therefore very different. A
randomly initialised population of 50 for the chemotherapy problem could be expected
to contain more variety, due to the number of genes / allowable range per gene. As
FDC is shown to perform better with more variability in the population, this would
explain the ability of FDC to cope with small populations and low mutation rates as
long as the population has enough variety.
388
CHAPTER 9. FITNESS DIRECTED CROSSOVER
The ability of FDC to cope well with a large degree of genetic variation is a very
useful trait. By adhering to a target number of interventions FDC can avoid much of
the genetic noise introduced via large mutation rates and as many real world problems
contain a lot of genetic noise, this could provide an area where the FDC approach could
prove extremely useful. Further analysis would assist in further exploring the potential
of FDC and indeed the other directed intervention crossover approaches. This as well
as other recommendations for the future of this work are contained in the next chapter.
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Conclusions
This work has introduced the concept of directed intervention crossover techniques for
application to optimal control problems. The previous chapters have described the
motivation for these techniques, their methodology and their effectiveness compared to
traditional crossover techniques for deriving schedules for both bio-control application
and cancer chemotherapy treatments. This chapter discusses the findings relating to
this work, showing how the hypothesis described in Chapter 1 has been proven, and
outlines possible areas for further investigation.
Over the course of this work, a number of observations have been made. The core of
these relate to directed intervention crossover techniques while other observations are
more general in nature. Section 10.1 discusses these observations and is then followed by
Section 10.2, which details the contributions to research of this work, as well as reflection
on its key strengths and limitations. This chapter is concluded with Section 10.3,
which details areas for further investigation relating to directed intervention crossover
techniques.
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10.1 Summary of findings
As stated above, both findings relating specifically to directed intervention crossover
and other, more general findings, have been made. It appears prudent to consider
these findings separately, therefore Section 10.1.1 details the general findings from this
work and Section 10.1.2 describes those findings relating specifically to the directed
intervention crossover techniques.
10.1.1 Summary of general findings
This work has reviewed both traditional crossover approaches and directed interven-
tion crossover approaches for creating schedules for bio-control application and cancer
chemotherapy treatments. Through this analysis, findings have been made, which, al-
though not directly relating to the directed intervention techniques described in this
work, are informative for problems of this type.
Chapter 7 detailed analysis of SPC, 2PC and UC for both bio-control scheduling and
cancer chemotherapy treatment scheduling. This experimentation across a range of
parameter values offers insight into the comparative abilities of SPC, 2PC and UC for
these problems. This has shown that, regardless of mutation rates, crossover rates,
population sizes or penalty values, UC is empirically demonstrated to be more robust
and effective for these optimal control problems than either SPC or 2PC.
Chapters 7, 8 and 9 detail experimentation on both the bio-control scheduling problem
and the cancer chemotherapy treatment problem. This work has produced a wide
range of data pertaining to the fitness of solutions and the number and placement of
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interventions required to produce these scores. These findings should inform further
research into these problems.
10.1.2 Summary of directed intervention crossover findings
Chapter 3 described the issues relating to the application of GAs to optimal control
problems. One of the main drawbacks was that they were slower to converge to good
solutions than other heuristic techniques.
The hypothesis put forward in Chapter 1 was that GAs can be improved for intervention
based optimal control problems through using the number of interventions present in
parent schedules to direct the offspring to promising areas of the search space. In
order to prove this position, the novel crossover approaches described in this work were
developed and tested.
Through comparison with traditional GA crossover approaches for optimisation of bio-
control and cancer chemotherapy schedules, the validity of the novel crossover tech-
niques have been demonstrated.
The experiments detailed in Chapters 8 and 9 demonstrate the benefits of using directed
intervention techniques. These benefits are both in terms of better solution fitness and
fewer fitness function evaluations required to find good solutions.
For the bio-control scheduling problem, TInSSel was shown to require, on average,
37% fewer FFEs than UC to find the best score returned by UC. FDC improves on this
further, requiring on average, 38.2% fewer FFEs than UC to find the best score found
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by UC. Both TInSSel and FDC are shown to outperform UC, on average, for 44% of
all FFEs.
When applied to the task of cancer chemotherapy scheduling, the gains in using TInSSel
or FDC are even more apparent. TInSSel requires 89% fewer FFEs than UC to return
the best score found by UC. FDC is even better, requiring 92% fewer FFEs than UC
to return the best score found by UC. Both TInSSel and FDC are shown to return
statistically better scores than UC for 100% of the FFEs under review.
From this work, various finding have been made with regard to the directed interven-
tion crossover processes. Through using DUC as a test approach, this has shown that
directed intervention crossover approaches are always better with a window of inter-
ventions for offspring as opposed to strictly adhering to the intervention levels of the
fitter parent. Although this was the expected outcome, by creating DUC as a test
method, this hypothesis has been proven. This has shown that without a window of
interventions, the directed intervention process stagnates and poor scores are returned.
It can be noted however, that in the presence of large quantities of noise introduced by
mutation, even the simple intervention calculation of DUC is more effective than UC
for each of the problems.
Initially CalEB was created to ascertain if there was any benefit to selecting genetic
material in a uniform distribution over time. Through experimentation over a range of
problems and parameter settings, CalEB was never once better than TInSSel, but was
often outperformed by it. As both CalEB and TInSSel use the same intervention sizing
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calculation, this shows that for selection of genetic material, a stochastic approach to
selection is more efficient than one which is uniformly distributed over time.
FDC was developed to utilise these findings, both in terms of the importance of a
window for offspring intervention levels and for stochastic selection of genetic material.
This has shown that the FDC approach is driven by a penalty and that when the penalty
is weak, FDC is not the most effective approach. However, as shown for bio-control
scheduling with larger intervention penalties and also for the chemotherapy scheduling
problem, for certain problems, FDC can discover and exploit intervention trends in
a much faster way than the other approaches. In the presence of large quantities of
mutation, FDC is always shown to be the best performing technique. This means that
for problems with large quantities of noise, FDC is the crossover approach of choice.
This work has shown that by using a target for the intervention levels for offspring,
many benefits can be achieved. This can better direct offspring to promising areas
of the search space, thus requiring fewer FFEs. Directing offspring intervention levels
can also direct search into areas whereby the traditional approaches such as UC are
not exploiting. This is most clearly shown with both TInSSel and FDC returning
statistically better scores than UC for 100% of the FFE range.
The use of directed intervention approaches has also improved the robustness of ap-
proaches to mutation rate. When the mutation rate was increased to 0.05, the directed
intervention approaches were less affected by this parameter change than UC. This can
be explained by UC only being able to shed intervention via crossover and mutation.
With all the extra interventions being added by a high mutation rate, UC takes longer
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to reduce intervention levels. The directed intervention approaches do not have this
problem as they work to a target level of intervention. This means that regardless of
the number of interventions being added via mutation, they can still produce inter-
vention schedules with a few or a lot of interventions, depending on the pattern which
offers most utility.
One of the main difficulties in applying any EA to real-world applications is the large
number of fitness function evaluations typically required [113]. The reduced evalua-
tions required by the directed intervention techniques described in this work would
allow for application of GAs to computationally expensive problems. As shown in
the experiments detailed in Chapters 8 and 9, significant reductions in the number of
FFEs required can be achieved through using directed intervention techniques. This
reduction in fitness function evaluations required would become more significant as the
computational time of each fitness function increased.
The directed intervention techniques have been shown as effective at identifying fitness
trends, such as rapidly increasing or decreasing intervention levels to return fitter scores.
This may prove beneficial for their application to problems whose landscape changes
over time and thus require prompt analysis of trends. This does raise an implication for
the directed intervention techniques, that of misleading or deceptive fitness landscapes.
Section 10.3 describes this as well as other areas which form the suggested future work
for directed intervention crossover approaches.
The contributions to research of the current work into analysis of directed intervention
crossover techniques will now be reviewed.
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10.2 Contributions of research
This research has tested the hypothesis, described in Chapter 1, that GAs can be
improved for intervention based optimal control problems through using the number
of interventions present in parent schedules to direct the offspring to promising areas
of the search space.
As described in Section 10.1.2, this hypothesis has been confirmed and the validity
of the novel crossover approaches demonstrated. This work has therefore provided
insight into the effects of directing offspring through using the intervention information
contained in parent solutions. Other contributions to research include:
• An introduction to the directed intervention crossover approaches, allowing future
researchers to apply these techniques to a wider range of problems.
• As the directed intervention techniques have been shown to significantly reduce
the number of FFEs required for GAs to find fit solutions to optimal control prob-
lems, this allows for GAs to be applied to computationally intensive problems,
which may previously have been infeasible.
• This work has provided empirical information about the abilities of SPC, 2PC
and UC for optimal control problems, over a range of mutation rates, crossover
rates and population sizes.
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10.2.1 Key strengths
As stated above, this research has contributed to the field in a number of ways. The
following are some other key strengths of this work:
• In order to process the volume of experiments described in this work in a feasible
time period, multiple computers were required. For this reason, the Condor
tool [114] was deployed and this provided for distribution of experiments over
approximately 75 of the department workstations. This allowed for the range of
experimentation described in this work in a reasonable amount of time. Now that
this setup is in place, further researchers in the department are able to harness
this environment to run computationally intensive experiments in considerably
less time.
• This work has used both bio-control and cancer chemotherapy treatment schedul-
ing test problems for analysis. The novel research conducted in this work has pro-
vided insight into these problems as well as independently confirming the findings
of previous researchers as described in Sections 7.1.3.1 and 7.2.0.1.
• This work provides a statistically robust review of the abilities of both traditional
GA crossover approaches and directed intervention crossover approaches for bio-
control and cancer chemotherapy scheduling.
• This research has produced 9 conference publications. Work on turning the find-
ings discussed herewith into a journal publication is already underway.
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• This work has both further developed existing collaborative involvement and
opened new areas for collaboration with a range of researchers in the field.
10.2.2 Limitations
Due to the empirical nature of this work to review the contributions of directed inter-
vention crossover techniques, a range of experiments were required. The experimental
method, as described in Chapter 6, outlined the values chosen for this experimentation.
This detailed the rationale behind each of the experiment parameters which include
population size, crossover rate and mutation rate. Although the values for these para-
meters were chosen to facilitate a fair comparison of the directed crossover techniques
with existing crossover approaches, these are only a small subset of the infinite number
of experiments that could be undertaken.
It was in order to facilitate a fair comparison of crossover approaches that two separate
optimal control test problems were chosen for review. Although other problems could
also provide valuable insight into the directed intervention crossover approaches, due
to the time required in setting up, testing and reviewing experiments, further test
problems were not viable.
Although there exist many other potential optimal control test problems and parameter
settings for experimentation, as this work has provided key insights into the directed
intervention crossover techniques, it would appear that correct experimental choices
have been made. Further analysis using more test problems and parameter combina-
tions could provide even more information about the operation and usefulness of the
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directed intervention crossover techniques. These as well as other potential areas for
future work are now described.
10.3 Future work
This work has introduced the concept of directed intervention crossover techniques to
enhance GA performance for optimal control problems. These techniques have been
demonstrated as effective on the two test problems used in this work, compared to
conventional SPC, 2PC and UC crossover approaches.
The main objective of this work was to determine if GAs could be made more efficient
for deriving schedules of interventions for optimal control problems by reviewing the
number of interventions in parents to direct offspring intervention levels. As stated in
Section 10.1, this objective has been achieved for both bio-control and chemotherapy
scheduling through the use of directed intervention crossover approaches.
Due to the novel nature of the directed intervention crossover approaches, a range of
directions for further work exist. For clarity these areas for further work are grouped
into two sections, one reviewing further analysis requiring no change to the current
directed intervention approaches and the other involving change to the novel crossover
techniques. Sections 10.3.1 and 10.3.2 detail each of these areas respectively.
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10.3.1 Future work requiring no change to the directed intervention
techniques
This work has introduced directed intervention crossover approaches as a novel way to
enhance the performance of GAs for application to optimal control problems. Further
use of these techniques can be achieved that do not require any modification to the
approaches described in this work.
10.3.1.1 Application to other domains
In this work the novel approaches have been applied to the optimisation of interven-
tion schedules. This task required the techniques to select from a range of potential
interventions in order to optimise fitness criterion.
Although this work has focussed on selecting from a range of interventions, this could
be abstracted to other application areas requiring selection of optimal members from a
set of options. One such application area where the novel techniques described in this
work could be applied is that of feature selection.
Work by Jourdan et al into discovering genetic features and environmental factors that
are involved in multifactorial diseases used GAs to assist in feature selection [115].
This used a two stage process. The first stage involved selection of significant features
from a very large dataset using the GA. The next step used a k-means clustering
algorithm to pick out individuals according to the features identified by the GA. In that
work, Jourdan et al found this approach to be robust and able to identify interesting
associations, which were later validated by biologists.
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Many of the datasets used for feature selection involve tens or hundreds of thousands
of variables [116]. Although there are a large number of variables, for some problems,
typically fewer than 5% of features are significant [117]. This therefore appears con-
ducive to the directed intervention approaches. The directed intervention techniques
have been empirically shown as beneficial in terms of both number of FFEs required
and solutions produced for selecting from a large range of potentials, and thus could
aid GA performance for the task of feature selection.
10.3.1.2 Comparison with other search heuristics
As stated in Section 3.2, GAs have proven slower at deriving good solutions to optimal
control problems than other techniques, including evolution strategies, evolutionary
programming, simulated annealing and particle swarm optimisation. As demonstrated
in the previous chapters, the performance of GAs for deriving intervention schedules for
optimal control problems has been significantly enhanced through the use of directed
intervention crossover techniques. Future work could therefore include an empirical
analysis of the directed intervention techniques compared to these other search heuris-
tics. This would show how the increase in solution fitness and reduction in evaluations
required to find good solutions gained through GA directed intervention techniques
compares with these other search heuristics.
As described in Section 3.2, EDAs use a probabilistic sampling of the population rather
than mutation or crossover and use the information gained from this sampling to pro-
duce the next set of population members. When viewed in an abstract way, the directed
intervention techniques also perform a probabilistic sampling, not on large quantities
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of the population as per EDAs, but on the two parents selected for crossover. This
relationship between EDAs and the directed intervention techniques could be further
analysed to determine further similarities and differences. This could offer more un-
derstanding of the theoretical underpinnings of both of these techniques.
10.3.1.3 Multi-drug chemotherapy scheduling
The cancer chemotherapy model used in this work only reviews schedules for application
of one drug over the treatment time period. As detailed in Section 5.4, GAs have
previously been successfully used for multi-drug scheduling.
It would seem prudent for further analysis to consider the abilities of the directed inter-
vention techniques at multi-drug scheduling, as this may provide key insights into their
strengths and weaknesses for a more complex problem representation. As mentioned in
Section 10.1.2, this would provide a more expensive fitness function, in terms of com-
putational time per FFE, with which to apply the directed intervention techniques.
10.3.1.4 Extension of directed intervention crossover to multi-objective
problems
As detailed in Section 5.4, previous work by Petrovski and McCall have reviewed repre-
senting the chemotherapy scheduling problem in a multi-objective (MO) manner [100].
As many real world problems are multi-objective in nature, it would be informative
to evaluate the directed intervention techniques on problems of this type. Future
work could therefore consider how best to adapt the directed intervention crossover
techniques for a MO environment. These MO directed intervention crossover tech-
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niques could then be applied to the multi-objective cancer chemotherapy model. The
bio-control problem described in Section 5.1 could also be extended to a MO represen-
tation. For example, a two objective extension is to minimise the number of Sciarid
larvae present, and to minimise the number of nematodes or applications required.
Application of the directed intervention crossover approaches to multi-objective prob-
lems would require no changes to the crossover approaches, however the GA method
used in this work would have to be modified. Common multi-objective GA approaches
include Non-dominated Sorting Genetic Algorithm (NSGA2) [118] and Multi-Objective
Genetic Algorithm (MOGA) [119]. Both of these approaches return a set of trade-off
solutions across the multiple objectives, termed the Pareto set. This set of solutions
is then evaluated by the decision maker. This would determine if the benefits demon-
strated by the directed intervention techniques apply to a broader range of approaches.
10.3.1.5 Dynamic and deceptive problems
Although GAs are commonly applied to static fitness functions, or non-static problems
represented in a static way, dynamic fitness landscapes are receiving increased attention
[120]. In dynamic problems the fitness landscape changes over time. Solutions of such
problems therefore seem to require an approach which is quicker to react to the changing
landscape. As demonstrated in this work, the directed intervention techniques are
quicker to identify and subsequently exploit fitness trends. Dynamic problems would
therefore appear as a logical application area for techniques described in this work.
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As outlined in Section 10.1, one of the key characteristics of directed intervention
techniques is their effectiveness at identifying fitness trends, such as rapidly increasing
or decreasing intervention levels to return fitter scores. This raises the question as to
how the directed techniques would perform on problems which have a function which
leads to a local optimum instead of the global optimum? Test functions of this type,
termed deceptive problems, have been studied widely for GAs [121].
To ascertain the abilities of the directed intervention approach on such problems would
require creation of appropriate optimal control deceptive fitness functions. This would
provide useful information relating to the robustness of the directed intervention tech-
niques to problems of this type.
10.3.1.6 Parameter settings
This work has evaluated the crossover approaches across a range of parameter settings,
described in detail in Chapter 6. The range of parameter settings could be further
extended to provide more detailed analysis of the novel crossover techniques.
As described in Section 6.6, binary tournament selection was used for the experiments
undertaken in this work. This approach has a low selection pressure and offered no
advantage to any particular crossover approach under review and thus allowed for
a fair and unbiased analysis of each of the crossover approaches. Further analysis
could try a range of selection operators, in order to ascertain the effect of selection
type and pressure on the directed intervention crossover approaches. By increasing
the tournament size, the number of competing individuals for selection, the selection
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pressure of tournament selection is increased. This provides for increased breeding
rights to fitter solutions. Further analysis could review the effect of the tournament
size or could use one of the range of other selection operators available. This would
show how the convergence properties of the directed intervention approaches are linked
with the choice of selection method and associated selection pressure applied.
The crossover rates used in this work are in the range 0.8, 0.9 and 1.0 as described in
Section 6.4 and the mutation rates used, as described in Section 6.5, were 0, 0.005 and
0.05. This allowed for experimentation across a range of parameter settings. Further
work into the abilities of the directed crossover approaches could consider reviewing
other mutation and crossover rates. One such approach would be to use a low crossover
rate, in the range 0.2, with a high mutation rate, in the range of 0.5. This would allow
inspection of how the directed techniques progress when presented with a plethora of
new material for schedules to incorporate.
As described in Section 5.3.2, a range of intervention penalty values have been exper-
imented with for the bio-control scheduling problems. These values were 0, 5, 20, 35
and 50 points per intervention and were constant throughout the experiment. One
area for further review would be to modify the intervention penalty value as the ex-
periment is running. Starting with a low penalty would encourage a broad search of
the solution space, and as the penalty increased throughout the experiment, optimal
placement of interventions would become more important, thus inspecting a smaller
area of the search space. This approach would provide interesting insights into the
directed crossover approaches and also to the underlying bio-control model.
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10.3.1.7 Framework inclusion
A framework has been proposed by Vieira and Fonseca for a conceptual model of
optimisation problems [122; 123]. This aims to separate the problem specific and solver
specific aspects of optimisation, to facilitate a fairer assessment and comparison of
different optimisation methods [122]. Although this framework is still in development,
Fonseca has proposed including the directed intervention techniques detailed in this
work into this framework. This would allow for analysis of the novel techniques by a
range of GA practitioners, on a wide range of problems. This could provide further
insight and understanding of the directed intervention crossover techniques introduced
in this work.
10.3.2 Future work requiring change to the directed intervention tech-
niques
Section 10.3.1 details potential future work associated with the directed intervention
crossover approaches that do not require any modification to the techniques described
in this work. This section details other interesting areas for future work which require
changes to the underlying directed intervention crossover approaches.
10.3.2.1 Retaining memory of interventions
The directed intervention techniques use the parent solutions to calculate the number
of interventions to be present in offspring. Each calculation for offspring intervention
levels is based on the number of interventions contained in parents and a stochastic
element. Over the entire GA run, information relating to many parents and their
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associated intervention levels and fitness are processed. One area for further analysis
could be to build a memory of this parent information over the course of the GA run
and use this to assist in optimally sizing and placing offspring interventions. This
would use information gathered from many parents, being refined over the duration of
the GA run, and could potentially better direct offspring than the current approach
which simply uses the information contained in the parents selected for breeding.
10.3.2.2 Changing intervention application calculation
As described previously, the directed intervention crossover approaches select material
in a similar manner to UC. When an integer representation of genes is being used, as
in the chemotherapy scheduling problem, this means that if an intervention is selected
for offspring which is present in both parents, one of the parent intervention values will
be copied to the offspring. Consider an instance where an intervention was chosen for
addition to offspring and this was present in both parents with a dosage strength of 5
for the first parent and a dosage strength of 9 for the other. The current UC style of
selection gives an offspring intervention a 50% chance of being strength 5 and a 50%
chance of being strength 9. A further extension to this approach could be to review the
utility of performing some form of arithmetic crossover between the dosage strengths,
such as the mean value, which would create an intervention with a dosage strength of
7 from the previous example. Another approach could be to scale towards the value of
the fitter parents dosage while also considering the other dosage level. This approach
would allow for information relating to dosage strength to be used from both parents,
407
CHAPTER 10. CONCLUSIONS
as opposed to purely selecting the dosage strength from one parent and may allow for
a more extensive search of the solution space.
10.3.2.3 Changing parent numbers
GAs commonly use two parents to produce children, as this is the most prevalent
approach displayed in nature. Multi-parent GAs have been reviewed [124] and have
been found to improve performance, with the largest performance increase being when
the number of parents were changed from 2 to 3. This offered more utility than any
successive increase in parent numbers.
Further work could review the effects of using more than two parents to produce off-
spring. This would require modification of the intervention sizing calculation, described
in Section 4.1, but could allow information from a range of parents to provide a more
detailed calculation of the number of interventions required to optimally direct off-
spring.
10.3.2.4 Increasing disruption with homogeneity
De Jong stated the usefulness in an adaptive crossover operator which would increase
in disruptive potential as homogeneity of solutions increased [40]. As the population
converges, many copies of similar solutions are present in the population. This may
limit the usefulness of the directed intervention crossover approaches, as they use the
difference in parents to calculate the offspring.
An obvious way to adapt directed intervention crossover approaches would be to in-
crease the intervention window size as the population converges. This adapted approach
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could therefore be evaluated to determine if fitter solutions were found quicker than
with standard directed intervention crossover approaches. Such improvement would
have to be balanced against the additional cost of measuring population convergence.
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Appendix A
Further analysis of crossover
approaches over a range of
parameter settings
Chapters 7, 8 and 9 give analysis of the results of crossover approach experiments
using only intermediate parameter settings. The complete set of experiments, across
the range of parameter settings are recorded in Appendixes B, C, D, F, G and H.
It is prudent to identify whether the trends described for crossover approaches with
the intermediate parameter settings are displayed across the entire range of parameter
values. This would ensure one, or a collection of crossover approaches, which are
identified as better than others, are better throughout the range of experiments and
not simply on the intermediate parameter settings.
The rest of this section is organised as follows. Section A.1 reviews the traditional
crossover approaches of SPC, 2PC and UC for bio-control scheduling. Section A.2
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reviews the same crossover approaches for the task of cancer chemotherapy scheduling.
As described in Chapter 7, as UC is shown to consistently perform at least as well as the
other approaches, it is therefore used as the benchmark for further experiments. Section
A.3 reviews UC, CalEB, TInSSel and DUC for bio-control scheduling, and Section A.4
reviews the crossover approaches for cancer chemotherapy scheduling. Sections A.5
and A.6 review UC, CalEB, TInSSel and FDC for the task of bio-control and cancer
chemotherapy scheduling respectively.
The range of parameter settings are probability of crossover, pc, of 0.8, 0.9 and 1.0,
probability of mutation, pm, of 0, 0.005 and 0.05, and population size, N , of 50, 100
and 150. The bio-control experiments are also reviewed over a range of intervention
penalty values, P , of 0, 5, 20, 35 and 50. Each of the results discussed in this section
are for a generational replacement strategy, R = g.
As the bio-control scheduling problem is a minimisation problem, lower scores are fitter.
The cancer chemotherapy scheduling problem is a maximisation problem, with higher
scores reflecting higher fitness.
A.1 Further analysis of SPC, 2PC and UC for bio-control
scheduling
This section reviews the traditional crossover approaches for the task of bio-control
scheduling over the range of parameter settings. Appendix B contains graphs detailing
the results of these experiments across the range of penalties per intervention.
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The results for experiments over this range of parameter settings for a penalty of 0
points per intervention are shown in Figures B.1 to B.5. For a population size of 50,
when there is no mutation, UC returns fitter scores than both SPC and 2PC. UC is
more flexible than both SPC and 2PC, in that it can produce more combinations of
parent genes. Even with a small population with no new material introduced through
mutation, UC can exploit the available genetic material to perform a more thorough
search than both SPC and 2PC. As 2PC performs more gene exchange than SPC it
should return better scores than SPC for small populations. As shown in populations
of 50 in Figures B.1 to B.5, this is the case.
Another result of having a population size of 50 is that regardless of the crossover rate,
when the mutation rate is 0.005, UC appears to derive fit solutions quicker than both
SPC and 2PC. When the mutation rate is increased to 0.05, this represents a large
increase in genetic material introduced through mutation. All crossover approaches
under review perform in a similar way, returning scores which are less fit that those
found when pm is 0.005.
When population size is increased to 100 or 150, the patterns described for the smaller
population of 50 are still displayed. With increased population size there is more
variation in the population for both SPC and 2PC to exploit. Due to this, both SPC
and 2PC return fitter scores in the absence of mutation when the population is 100,
compared to when the population size was 50. Since the larger population size increases
the material in the population, each of the approaches take longer to find good solutions.
If the pm level of 0.005 is compared between populations of 50 and 100, similar fitness
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trends are displayed, but it takes longer for these highly fit solutions to be found with
a larger population.
This experiment has shown that probability of crossover, pc, has little effect on each of
the crossover approaches, regardless of pm, population size or penalty level.
Figures B.6 - B.10, B.11 - B.15, B.16 - B.20 and B.21 - B.25 shows the results for
each of the crossover approaches over the range of parameter settings for intervention
penalties of 5, 20, 35 and 50 respectively. When the intervention penalty is increased to
any of these points per intervention, the patterns described for intervention penalties
of 0 are still shown.
A.2 Further analysis of SPC, 2PC and UC for cancer
chemotherapy scheduling
This section reviews the traditional crossover approaches for the task of cancer chemother-
apy scheduling over the range of parameter settings. The relevant graphs are contained
in Appendix F.
The results for a population of 50 are shown in Figures F.1 to F.3 and these detail each
of the crossover approaches with pc of 0.8, 0.9 and 1.0 respectively. For each of these
experiments, UC outperforms both SPC and 2PC when pm is 0. This is inline with the
findings discussed in Section 7.2.1. It should be noted that in the absence of mutation,
although the scores returned by UC are of a much higher fitness than those returned
by SPC or 2PC, these scores are still poor.
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When pm is increased to 0.005, regardless of the pc level, each of the approaches return
scores of a similar fitness. This is also seen when pm is further increased to 0.05, but
note that this increased mutation rate produces better scores for each of the crossover
approaches compared with a pm of 0.005.
The effects of increasing the population size from 50 to 100 are shown in Figures F.4
to F.6. The trends displayed with the population of 50 hold. UC outperforms both
SPC and 2PC when pm is 0, with each of the approaches returning fitter scores with
this increased population setting. Each of the crossover approaches appear similar for
pm levels of 0.005 and 0.05 for most FFE levels. Once again, fitter scores are returned
by each of the crossover approaches when pm is 0.05 compared to a mutation rate of
0.005. These trends hold regardless of pc being 0.8, 0.9 or 1.0.
The effect of further increasing the population size to 150 is shown in Figures F.7 to F.9.
As with populations of 50 and 100, when pm is 0, UC outperforms both SPC and 2PC.
The increased population size produces fitter scores by each of the crossover approaches
in the absence of mutation. When pm is increased to 0.005 or 0.05, approaches return
similar scores over the range of FFEs, however, UC appears to be outperforming both
of the other approaches for the first 6,000 FFEs when pm is 0.005.
As with the bio-control experiments described in Appendix A.1 it is interesting to note
that pc has little effect on each of the crossover approaches for this experimentation,
regardless of mutation probability or population size.
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A.3 Further analysis of UC, CalEB TInSSel and DUC for
bio-control scheduling
This section reviews UC, CalEB, TInSSel and DUC for the task of bio-control schedul-
ing over the range of parameter settings. Appendix C contains graphs detailing the
results of these experiments across the range of penalties per intervention.
Fitness graphs for comparison of UC, CalEB, TInSSel and DUC for the bio-control
scheduling problem with 0 penalty per intervention are shown in Figures C.1 to C.5.
When the population size is 50, as shown in Figures C.1 and C.2, when pm is 0,
regardless of pc level, CalEB and TInSSel are quicker to derive fit solutions. UC does
find solutions with similar fitness scores, but requires more FFEs to do so. DUC
converges to solutions of a lesser fitness than those found by the other approaches.
When pm is increased to 0.005 or 0.05, CalEB and TInSSel find similar solutions to
UC and DUC, but require fewer FFEs to do so. For a mutation probability of 0.05,
DUC is quicker to find good solutions than UC and each of the crossover approaches
are slower to find comparable solutions to those found when pm = 0.005.
When the population size is increased to 100, as shown in Figures C.2 to C.3, similar
trends are demonstrated as for a population of 50. CalEB and TInSSel are consistently
faster at deriving solutions of at least the same fitness as the other approaches. When
pm is 0.05, DUC is faster than UC at converging to good solutions.
If the population size is further increased to 150, the trend demonstrated for popu-
lations of 50 and 100 still hold. Figures C.4 and C.5 show the fitness scores for this
population size. Although all of the crossover approaches converge to similar solutions
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when pm is 0.005 or 0.05, there is a marked difference in the number of FFEs required
for convergence. CalEB and TInSSel are faster than UC or DUC at discovering the
solutions to which each of the approaches later converge.
A penalty of 5 penalty points per intervention is now considered. The fitness scores for
these tests are shown in Figures C.6 to C.10.
For a population of 50, and pm of 0, regardless of pc, DUC converges to less fit solutions
than CalEB, TInSSel and UC. CalEB appears slower than UC, TInSSel and DUC when
the population is 50, regardless of pm, although it does converge to solutions in the
same fitness range after approximately 1000 FFEs. This is most clearly displayed when
pm is 0.05.
When the population size is increased to 100, as shown in Figures C.7 and C.8, re-
gardless of pc, CalEB appears slower to find good solutions than the other approaches.
As with a population of 50, DUC struggles when pm is 0 and converges to less op-
timal solutions than those returned by UC, CalEB and TInSSel. When pm = 0.005,
TInSSel is faster to converge to good solutions. When pm is 0.05, all approaches re-
turn scores in a similar fitness range, especially after 1000 FFEs. Note that all of the
crossover approaches are slower to converge to solutions of a similar fitness score when
the population is 100 as opposed to a population of 50.
Figures C.9 and C.10 show the fitness scores for approaches when the population size
is increased to 150. As with populations of 50 and 100, DUC again converges to
sub-optimal solutions when pm is 0, although the scores are fitter than with lesser
population sizes. When pm is increased to 0.005 or 0.05, all crossover approaches
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eventually produce similar solutions. CalEB however, is slower to converge to good
solutions than the other approaches. With the increased population size, each of the
approaches take longer to find solutions of a similar fitness to those found with a smaller
population.
An intervention penalty of 20 penalty points per intervention is now considered. Figures
C.11 to C.15 show the fitness scores associated with these experiments.
When the population is 50, in the absence of mutation, DUC converges to less optimal
solutions than UC, CalEB or TInSSel. Both CalEB and TInSSel are quicker to reduce
to good solutions than UC, with CalEB and TInSSel converging to good solutions by
600 FFEs, while UC takes around 1000 FFEs to find solutions in a similar fitness range.
When pm is increased to 0.005, regardless of pc, the ordering of approaches for con-
vergence to fit solutions is consistent with that already seen. CalEB and TInSSel are
quicker to reduce in fitness scores, requiring around 700 FFEs, with UC requiring 1200
FFEs to derive solutions of a similar fitness. DUC finds solutions of a similar fitness
as the other approaches but requires around 2000 FFEs to achieve this.
When pm is further increased to 0.05, a distinct separation occurs between the scores
returned by UC and DUC compared to the scores produced by CalEB and TInSSel.
For pc of 0.8 or 0.9, even after 5000 FFEs, there is a difference in fitness of solutions
produced by these groups. When pc is 1.0, UC still converges to sub-optimal solutions,
whereas after 5000 FFEs, DUC, CalEB and TInSSel are returning fitter scores.
Figures C.12 and C.13 show the fitness scores when the population is increased to 100.
When pm is 0, as with populations of 50, DUC converges to less fit solutions than
436
APPENDIX A. FURTHER ANALYSIS OF CROSSOVER
APPROACHES OVER A RANGE OF PARAMETER SETTINGS
UC, CalEB and TInSSel. When pm is increased to 0.005, CalEB and TInSSel quickly
converge to good solutions after approximately 1000 FFEs. UC is slightly slower than
both CalEB and TInSSel, finding solutions of a similar fitness, but requiring around
1700 FFEs to do so. DUC does find similar solutions as the other approaches but is
much slower to do so, requiring between 2000 FFEs to 3000 FFEs to achieve this.
When pm is increased to 0.05, CalEB and TInSSel converge to better scores than both
UC and DUC. The converged scores for DUC lie between the worse scores of UC and
the better scores of both CalEB and TInSSel.
Figures C.14 and C.15 show the fitness scores when the population is increased to 150.
Similar trends are displayed as those shown for populations of 50 and 100. When pm
is 0, CalEB and TInSSel rapidly find fit solutions, requiring about 1500 FFEs to do
so. UC finds scores of a similar fitness as CalEB and TInSSel, but requires around
2300 FFEs to do so. DUC converges to solutions of less fitness than all of the other
approaches for this level of pm.
When pm is increased to 0.005, all approaches converge to similar solutions. CalEB
and TInSSel find these scores after approximately 1500 FFEs, UC requires around 2500
FFEs and DUC is only starting to converge to solutions of similar fitness at around
5000 FFEs. Each of the approaches take longer to find solutions of a similar fitness for
the increased population size.
When pm is further increased to 0.05, as with a population of 100, CalEB and TInSSel
converge to fitter solutions than both UC and DUC, with DUC again producing solu-
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tions with a fitness in between that found by UC and those returned by CalEB and
TInSSel.
Several trends have been identified in this experiment. In the absence of mutation,
CalEB and TInSSel are quicker to converge to fitter solutions than both UC and DUC.
UC returns less fit scores than CalEB and TInSSel, with DUC returning scores of less
fitness than all other approaches. When pm is increased to 0.005, CalEB and TInSSel
are quicker to find fit solutions. When pm is further increased to 0.05, CalEB and
TInSSel are again quicker to converge to fit solutions. For this mutation level, DUC
returns solutions of a lesser fitness than both CalEB and TInSSel, but of a higher
fitness than those returned by UC. Each of these trends hold with an increase in the
population. One result of increasing the population size is the ability of DUC to
return fitter scores in the absence of mutation, due to the increased genetic variation
in the population. Another result of increasing the population size is that with each
population increase, the time taken to find solutions of a similar fitness in terms of
FFEs, by each of the crossover approaches, increases.
Each of the trends identified for an intervention penalty of 20 penalty points per in-
tervention hold as the intervention penalty is increased to 35 or 50. Figures C.16 to
C.20 and Figures C.21 to C.25 show the fitness scores for these experiments under
varying levels of population sizes, pc and pm with a penalty of 35 penalty points per
intervention and 50 penalty points per intervention respectively.
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A.4 Further analysis of UC, CalEB TInSSel and DUC for
cancer chemotherapy scheduling
This section reviews UC, CalEB, TInSSel and DUC for cancer chemotherapy scheduling
over the range of parameter settings. Appendix G contains graphs detailing the results
of these experiments across the range of parameter settings.
Graphs detailing the fitness results for each crossover approach for the chemotherapy
scheduling problem are shown in Figures G.1 to G.9. When the population size is 50,
as shown in Figures G.1 and G.3, when pm is 0, CalEB and TInSSel return scores of
a higher fitness than both UC and DUC. For this mutation level, UC returns less fit
scores in comparison to CalEB and TInSSel, with DUC producing scores of a lesser
fitness than UC.
When pm is increased to 0.005, for this population size, CalEB and TInSSel are quicker
to find fitter scores than both UC and DUC over the first 2000 FFEs. By reviewing
the zoomed graphs of this setting, CalEB and TInSSel always produce higher scores
than UC or DUC. As was the case for a pm level of 0, UC returns scores that are less
fit than those produced by CalEB and TInSSel, with DUC producing scores of a lesser
fitness than UC.
When pm is further increased to 0.05, as with a pm of 0.005, CalEB and TInSSel are
quicker than UC and DUC at producing high fitness scores over the initial 2000 FFEs.
Unlike the previous mutation levels, DUC outperforms UC in terms of fitness scores.
Each of the approaches return scores of a higher fitness with this increased mutation
level, when compared to lesser pm levels.
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The fitness graphs when the population is increased to 100 are shown in Figures G.4
to G.6. The trends identified for smaller population settings hold for this increased
population size. Similarly for a population of 150, as shown in Figures G.7 to G.9.
As with the experiments reviewing the traditional crossover approaches for cancer
chemotherapy scheduling as described in Appendix A.2 note that pc has little effect
on each of the crossover approaches for this experimentation, regardless of mutation
probability or population size.
A.5 Further analysis of UC, CalEB TInSSel and FDC for
bio-control scheduling
This section reviews UC, CalEB, TInSSel and FDC for the task of bio-control scheduling
over the range of parameter settings. As TInSSel has consistently produced at least
as fit scores as UC and CalEB, as described in Section A.3, this section will focus on
evaluation of FDC with respect to TInSSel. Appendix D contains graphs detailing the
results of these experiments across the range of penalties per intervention.
The results for experiments over this range of parameter settings for a penalty of
0 points per intervention are shown in Figures D.1 to D.5. For each of the mutation
levels, FDC follows similar trends to TInSSel for each of the population sizes / crossover
levels.
When a penalty of 5 points per intervention is introduced, the dynamics of the problem
are changed. Figures D.6 to D.10 show graphs representing the results of these runs. In
these experiments, FDC is seen to return scores in similar fitness to TInSSel, requiring
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fewer FFEs to do so. One exception is that for a population size of 50, in the absence of
mutation, FDC returns scores with lesser fitness compared to those found by TInSSel
or CalEB.
The results for increasing the penalty per intervention further to 20 points per inter-
vention are shown in Figures D.11 to D.15. As was the case for a penalty of 5 points
per intervention, in the absence of mutation, for a small population size, FDC returns
less fit scores than TInSSel. Apart from this exception, for all other parameter set-
tings, FDC returns similar fitness scores to TInSSel, requiring fewer FFEs to do so.
Both of these trends are demonstrated for further penalty increases, as shown by an
intervention penalty of 35 penalty points per intervention (Figures D.16 to D.20) or 50
penalty points per intervention (Figures D.21 to D.25).
A.6 Further analysis of UC, CalEB TInSSel and FDC for
cancer chemotherapy scheduling
This section reviews UC, CalEB, TInSSel and FDC for the task of cancer chemotherapy
scheduling over the range of parameter settings. Appendix H contains graphs detailing
the results of these experiments. As with the bio-control experiments described in
Section A.5, FDC will be compared with TInSSel as this has been shown to always be
at least as good as the other crossover approaches.
Figures H.1 to H.3 show the crossover rates and mutation rate combinations for a
population size of 50. In the absence of mutation, FDC requires fewer FFEs to find
similar fitness scores to those found by TInSSel. When the mutation rate is increased
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to 0.005, FDC is again quicker at finding fit scores than TInSSel, with the fitness of
scores found being higher than those found by TInSSel. With a further mutation rate
increase to 0.05, FDC is quicker at finding fit scores than TInSSel, with both of the
approaches returning scores of a similar fitness. As with all of the other crossover
approaches, FDC produces fitter scores with the increased mutation rate.
The effects of increasing the population size to 100 are shown in Figures H.4 to H.6.
Regardless of the mutation rate, FDC requires fewer FFEs to produce scores of a
similar fitness to those returned by TInSSel. This is also the case when the population
is further increased to 150, as shown in Figures H.6 to H.9.
A.7 Summary of further analysis of crossover approaches
over the range of parameter settings
The previous sections have reviewed the crossover approaches over a range of parameter
settings for both bio-control and cancer chemotherapy scheduling.
Various trends have been identified across approaches. Regardless of the optimisation
problem or crossover approach used, pc has little effect on the results produced. This
has previously been identified for the cancer chemotherapy problem by Petrovski et al
[84].
For the bio-control experiments, a mutation rate of 0.005 was found to be more optimal
than a higher setting of 0.05. This was not the case with the chemotherapy scheduling
problem, with fitter results being returned by the larger mutation rate. This result is
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in line with the findings of Petrovski et al [84], who found a mutation rate of 0.092 as
optimal for the cancer chemotherapy scheduling problem.
The range of population sizes chosen has proved sufficient for the bio-control prob-
lem. This is demonstrated by crossover approaches finding similar scores with larger
population sizes, but requiring more FFEs to do so compared to a smaller population
setting.
SPC, 2PC, UC and DUC all produce better results with a pm of 0 with a larger
population. This is logical in that larger populations allow more variety in the genetic
representations for the crossover approaches to exploit.
Through reviewing DUC, it is interesting to note that although poor when pm is 0 or
0.005, it is better than UC when pm is 0.05. This leads to the conclusion that a target
intervention, even a basic approach as used by DUC, is more beneficial than no target
when large quantities of material are being added through mutation.
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2PC AND UC
Figure B.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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2PC AND UC
Figure B.2: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure B.3: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure B.4: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.5: N = 150, pc 1.0, with pm 0, 0.005
B.0.2 5 penalty points per intervention
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Figure B.6: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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Figure B.7: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure B.8: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure B.9: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.10: N = 150, pc 1.0, with pm 0, 0.005
B.0.3 20 penalty points per intervention
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Figure B.11: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
455
APPENDIX B. BIO-CONTROL SCHEDULING GRAPHS FOR SPC,
2PC AND UC
Figure B.12: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure B.13: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure B.14: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.15: N = 150, pc 1.0, with pm 0, 0.005
B.0.4 35 penalty points per intervention
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Figure B.16: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
460
APPENDIX B. BIO-CONTROL SCHEDULING GRAPHS FOR SPC,
2PC AND UC
Figure B.17: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure B.18: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure B.19: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.20: N = 150, pc 1.0, with pm 0, 0.005
B.0.5 50 penalty points per intervention
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Figure B.21: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.22: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure B.23: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure B.24: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure B.25: N = 150, pc 1.0, with pm 0, 0.005
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Bio-control scheduling graphs for
UC, CalEB, TInSSel and DUC
C.0.6 0 penalty points per intervention
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APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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Figure C.2: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure C.3: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure C.4: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure C.5: N = 150, pc 1.0, with pm 0, 0.005
C.0.7 5 penalty points per intervention
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Figure C.6: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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Figure C.7: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure C.8: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure C.9: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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CALEB, TINSSEL AND DUC
Figure C.10: N = 150, pc 1.0, with pm 0, 0.005
C.0.8 20 penalty points per intervention
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CALEB, TINSSEL AND DUC
Figure C.11: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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CALEB, TINSSEL AND DUC
Figure C.12: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure C.13: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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Figure C.14: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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Figure C.15: N = 150, pc 1.0, with pm 0, 0.005
C.0.9 35 penalty points per intervention
485
APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.16: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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Figure C.17: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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Figure C.18: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.19: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
489
APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.20: N = 150, pc 1.0, with pm 0, 0.005
C.0.10 50 penalty points per intervention
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APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.21: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.22: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
492
APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.23: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
493
APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.24: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX C. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND DUC
Figure C.25: N = 150, pc 1.0, with pm 0, 0.005
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Appendix D
Bio-control scheduling graphs for
UC, CalEB, TInSSel and FDC
D.0.11 0 penalty points per intervention
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.2: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.3: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.4: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.5: N = 150, pc 1.0, with pm 0, 0.005
D.0.12 5 penalty points per intervention
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.6: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9, with
pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.7: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.8: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.9: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.10: N = 150, pc 1.0, with pm 0, 0.005
D.0.13 20 penalty points per intervention
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.11: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.12: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.13: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.14: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.15: N = 150, pc 1.0, with pm 0, 0.005
D.0.14 35 penalty points per intervention
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.16: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.17: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.18: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
514
APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.19: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.20: N = 150, pc 1.0, with pm 0, 0.005
D.0.15 50 penalty points per intervention
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.21: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 50, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.22: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by N = 100, pc 0.8,
with pm 0, 0.005, 0.05
518
APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.23: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by N = 100, pc 1.0,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.24: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by N = 150, pc 0.9,
with pm 0, 0.005, 0.05
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APPENDIX D. BIO-CONTROL SCHEDULING GRAPHS FOR UC,
CALEB, TINSSEL AND FDC
Figure D.25: N = 150, pc 1.0, with pm 0, 0.005
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Appendix E
KW
E.1 KW values for comparisons between UC, CalEB, TInS-
Sel and DUC for the bio-control problem
E.1.1 0 penalty points per intervention
Table E.1: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
100 205.22 203.34 202.65 190.79 0.809
200 227.01 211.15 173.45 190.39 0.006
300 247.06 195.41 144.63 214.9 0
400 266.27 179.13 113.72 242.88 0
500 278.32 153.49 104.59 265.61 0
600 283.94 137.5 101.65 278.91 0
700 287.95 128.61 97.59 287.85 0
800 285.43 123.71 94.4 298.47 0
900 283.09 116.41 95.69 306.82 0
1,000 285.05 108.77 98.6 309.59 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.1 – Continued
FFE(s) UC CalEB TInSSel DUC AS
1,100 277.7 109.5 95.29 319.52 0
1,200 276.03 109.17 94.57 322.24 0
1,300 275.62 107.55 94.79 324.05 0
1,400 273.12 109.29 92.97 326.63 0
1,500 269.04 109.03 94.03 329.91 0
1,600 266.52 110.29 92.16 333.04 0
1,700 265.21 107.61 96.01 333.18 0
1,800 262.91 104.4 100.11 334.58 0
1,900 262.24 102.16 102.35 335.26 0
2,000 261.53 101.6 103.57 335.3 0
2,100 261.86 100.62 104.21 335.31 0
2,200 260.9 99.46 106.29 335.36 0
2,300 261.51 99.41 105.91 335.17 0
2,400 261.87 100.03 105.33 334.77 0
2,500 262.09 98.31 107.1 334.51 0
2,600 261.29 98.45 107.68 334.59 0
2,700 261.16 98.17 108.38 334.31 0
2,800 261.19 98.5 108.12 334.21 0
2,900 261.27 97.96 108.57 334.21 0
3,000 259.77 98.95 109.07 334.21 0
3,100 259.65 99 109.14 334.22 0
3,200 259.69 99.48 108.62 334.22 0
3,300 259.68 99.48 108.63 334.22 0
3,400 259.73 98.9 109.16 334.22 0
3,500 259.74 98.89 109.16 334.22 0
3,600 259.74 98.89 109.16 334.22 0
3,700 259.74 98.89 109.16 334.22 0
3,800 259.74 98.89 109.16 334.22 0
3,900 259.74 98.89 109.16 334.22 0
4,000 259.78 99.38 108.63 334.22 0
4,100 259.78 99.38 108.63 334.22 0
4,200 259.78 99.38 108.63 334.22 0
4,300 259.78 99.38 108.63 334.22 0
4,400 259.78 99.38 108.63 334.22 0
4,500 259.78 99.38 108.63 334.22 0
4,600 259.78 99.38 108.63 334.22 0
4,700 259.78 99.38 108.63 334.22 0
4,800 259.78 99.38 108.63 334.22 0
4,900 259.78 99.38 108.63 334.22 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.1 – Continued
FFE(s) UC CalEB TInSSel DUC AS
5,000 259.78 99.38 108.63 334.22 0
Table E.2: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
100 210.18 198.54 198.8 194.48 0.796
200 217.66 214.64 162.23 207.47 0.002
300 247.57 213.98 138.89 201.56 0
400 266.68 188.58 114.51 232.23 0
500 283.23 153.58 100.4 264.8 0
600 296.63 130.88 103.52 270.97 0
700 295.64 118.12 104.47 283.78 0
800 299.66 110.68 98.68 292.99 0
900 301.71 107.46 96.83 296 0
1,000 297.57 105.23 97.02 302.18 0
1,100 293.43 105.31 97.42 305.84 0
1,200 286.29 106.64 95.95 313.12 0
1,300 284 105.8 96.26 315.95 0
1,400 279.78 105.49 96.83 319.9 0
1,500 281.33 105.62 96.32 318.73 0
1,600 278.26 103.66 97.89 322.2 0
1,700 277.36 106.78 95.17 322.7 0
1,800 277.09 107.27 94.62 323.02 0
1,900 275.89 105.48 96.03 324.62 0
2,000 273.93 106.69 95.27 326.12 0
2,100 273.49 107.91 94.08 326.52 0
2,200 272.22 105.5 96.14 328.15 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.2 – Continued
FFE(s) UC CalEB TInSSel DUC AS
2,300 270.21 106.13 95.54 330.12 0
2,400 270.96 107.11 93.89 330.05 0
2,500 270.67 104.71 97.48 329.15 0
2,600 268.16 101.79 100.51 331.55 0
2,700 266.36 101.62 100.6 333.43 0
2,800 264.86 102.73 101.7 332.72 0
2,900 264.26 103.2 101.15 333.39 0
3,000 262.51 103.82 101.73 333.95 0
3,100 260.43 103.86 102.8 334.91 0
3,200 257.84 103.24 105.4 335.52 0
3,300 252.29 105.75 108 335.97 0
3,400 250.46 106.27 108.54 336.73 0
3,500 243.4 109.37 110.56 338.68 0
3,600 238.64 112.96 112.96 337.44 0
3,700 228.56 117.02 117.02 339.41 0
3,800 225.9 118.08 118.08 339.95 0
3,900 220.31 119.33 120.65 341.72 0
4,000 215.71 121.35 122.7 342.24 0
4,100 208.42 125.39 126.78 341.41 0
4,200 204.2 128.92 130.33 338.56 0
4,300 195.32 133.44 134.88 338.36 0
4,400 189.82 135.97 137.44 338.78 0
4,500 188.54 139.01 140.52 333.93 0
4,600 188.68 142.04 142.04 329.25 0
4,700 187.68 146.06 146.06 322.21 0
4,800 183.64 150.09 150.09 318.19 0
4,900 183.7 150.1 150.1 318.11 0
5,000 182.54 150.6 150.6 318.26 0
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.3: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
100 218.75 191.62 203.6 188.03 0.229
200 223.7 199.23 180.13 198.94 0.067
300 225.17 202.31 157.8 216.72 0
400 251.68 182.85 130.25 237.22 0
500 273.06 167.81 121.23 239.9 0
600 300.47 140.98 111.53 249.03 0
700 306.82 133.02 105.83 256.33 0
800 312.29 127.83 105 256.89 0
900 317.57 118.66 99.67 266.1 0
1,000 318.99 112.87 102.84 267.31 0
1,100 319.65 107.37 101.34 273.64 0
1,200 320.88 107.22 99.47 274.44 0
1,300 319.6 110.59 94.33 277.48 0
1,400 323.34 111.97 92.36 274.34 0
1,500 322.48 110.02 94 275.5 0
1,600 323.33 111.99 91.29 275.39 0
1,700 324.31 111.31 91.75 274.63 0
1,800 326.36 110.21 91.53 273.91 0
1,900 324.86 111.29 90.49 275.37 0
2,000 324.74 112.13 91.15 273.99 0
2,100 325.27 111.16 91.83 273.74 0
2,200 325.89 111.33 91.49 273.3 0
2,300 324.24 110.76 92.02 274.99 0
2,400 325.3 108.58 95.59 272.54 0
2,500 325.95 109.62 94.5 271.94 0
2,600 327.35 110.01 94.38 270.26 0
2,700 329.15 108.52 95.8 268.54 0
2,800 328.22 108.5 95.74 269.55 0
2,900 327.29 107.5 96.6 270.61 0
3,000 327.48 107.13 98.6 268.79 0
3,100 326.09 107.14 98.7 270.07 0
3,200 324.88 107.95 97.71 271.47 0
3,300 323.19 107.1 98.37 273.35 0
3,400 324.07 107.28 98.16 272.49 0
3,500 324.24 107.04 98.28 272.44 0
3,600 323.52 106.07 99.22 273.19 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.3 – Continued
FFE(s) UC CalEB TInSSel DUC AS
3,700 325.73 106.6 98.62 271.06 0
3,800 327.05 106.21 98.95 269.8 0
3,900 328.01 105.38 99.66 268.95 0
4,000 327.97 105.91 100.22 267.9 0
4,100 327.75 105.6 100.53 268.12 0
4,200 327.6 104.7 101.27 268.44 0
4,300 327.72 103.31 102.61 268.37 0
4,400 327.49 102.42 103.27 268.82 0
4,500 326.66 101.37 104.24 269.73 0
4,600 327.96 102.46 103.26 268.33 0
4,700 328.08 101.28 104.21 268.43 0
4,800 328.65 100.97 104.51 267.88 0
4,900 328.91 102.29 103.07 267.74 0
5,000 329.07 103.95 101.29 267.7 0
E.1.2 5 penalty points per intervention
Table E.4: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
100 189.07 197.33 207.08 208.52 0.602
200 182.51 246.89 188.12 184.48 0
300 179.11 296.16 154.97 171.76 0
400 173.95 314.36 153.62 160.07 0
500 168.95 322.45 144.42 166.18 0
600 168.65 319.98 145.69 167.68 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.4 – Continued
FFE(s) UC CalEB TInSSel DUC AS
700 163.91 320.85 133.79 183.45 0
800 183.33 314.31 117.28 187.08 0
900 187.68 314.88 113 186.45 0
1,000 199.99 302.13 103.73 196.15 0
1,100 195.7 303.68 95.83 206.79 0
1,200 188.17 305.75 87.09 220.99 0
1,300 181.32 307.96 81.88 230.84 0
1,400 180.96 296.68 82.17 242.2 0
1,500 168.09 295.25 82.2 256.47 0
1,600 160.21 288.34 83.92 269.54 0
1,700 148.96 282.35 90.13 280.57 0
1,800 132.18 277.94 100.77 291.12 0
1,900 126.37 270.51 106.2 298.94 0
2,000 118.75 264.26 112.68 306.32 0
2,100 119.44 255.61 115.19 311.77 0
2,200 119.18 245.93 119.79 317.11 0
2,300 120.27 238.12 123.5 320.13 0
2,400 120.39 232.72 126.22 322.68 0
2,500 121.8 226.96 128.88 324.37 0
2,600 124.01 219.66 132.48 325.86 0
2,700 125.02 215.8 134.46 326.73 0
2,800 126.44 211.86 136.22 327.49 0
2,900 127.22 209.43 137.41 327.95 0
3,000 127.96 207.44 138.39 328.22 0
3,100 128.41 206.45 138.73 328.42 0
3,200 128.49 206.17 138.88 328.48 0
3,300 128.74 205.68 139.11 328.48 0
3,400 128.74 205.68 139.11 328.48 0
3,500 128.74 205.68 139.11 328.48 0
3,600 128.74 205.6 139.18 328.48 0
3,700 128.74 205.6 139.18 328.48 0
3,800 129.17 204.77 139.56 328.52 0
3,900 129.17 204.77 139.56 328.52 0
4,000 129.17 204.77 139.56 328.52 0
4,100 129.17 204.77 139.56 328.52 0
4,200 129.17 204.77 139.56 328.52 0
4,300 129.17 204.77 139.56 328.52 0
4,400 129.17 204.77 139.56 328.52 0
4,500 129.17 204.77 139.56 328.52 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.4 – Continued
FFE(s) UC CalEB TInSSel DUC AS
4,600 129.17 204.77 139.56 328.52 0
4,700 129.17 204.77 139.56 328.52 0
4,800 129.17 204.77 139.56 328.52 0
4,900 129.17 204.77 139.56 328.52 0
5,000 129.17 204.77 139.56 328.52 0
Table E.5: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
100 204.44 200.17 206.51 190.88 0.782
200 189.26 252.34 178.01 182.39 0
300 165.25 287.97 185.33 163.45 0
400 161.43 311.82 170.46 158.29 0
500 166.4 320.51 154.41 160.68 0
600 177.15 313.77 146.34 164.74 0
700 180.01 308.83 140.29 172.87 0
800 186.62 300.23 133.97 181.18 0
900 197.26 289.68 127.84 187.22 0
1,000 206.59 287.11 124.91 183.39 0
1,100 203.73 289.84 116.67 191.76 0
1,200 200.56 296.47 110.12 194.85 0
1,300 198.26 290.31 109.4 204.03 0
1,400 196.78 295.48 97.05 212.69 0
1,500 187.98 298.83 95.77 219.43 0
1,600 186.11 297.22 93.73 224.95 0
1,700 180.85 295.05 97.8 228.31 0
1,800 176.93 298.95 95.87 230.25 0
Continued on Next Page. . .
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APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.5 – Continued
FFE(s) UC CalEB TInSSel DUC AS
1,900 165.04 303.49 104.89 228.59 0
2,000 163.01 298.51 110.38 230.1 0
2,100 157.42 301.84 113.04 229.71 0
2,200 156.2 306.24 118.43 221.14 0
2,300 155.08 299.47 121.87 225.59 0
2,400 150.48 295.77 125.22 230.55 0
2,500 156.89 282.78 130.36 231.98 0
2,600 159.44 274.6 132.16 235.82 0
2,700 166.44 264.83 136.05 234.69 0
2,800 168.41 255.97 143.64 233.99 0
2,900 171.13 253.97 146.46 230.45 0
3,000 174.87 247.64 151.07 228.43 0
3,100 181.63 235.23 158.6 226.55 0
3,200 185.27 227.12 161.14 228.49 0
3,300 189.05 222.02 163.56 227.38 0
3,400 191.89 216.86 169.03 224.23 0
3,500 195.04 209.14 172.68 225.15 0.001
3,600 200.58 202.9 174.79 223.74 0.002
3,700 202.13 198.61 176.34 224.93 0.002
3,800 202.77 196.07 178.76 224.41 0.003
3,900 204.3 192.97 179 225.74 0.001
4,000 205.84 190.2 179.39 226.58 0
4,100 206.96 187.24 180.44 227.36 0
4,200 207.72 184.93 181.33 228.02 0
4,300 208.48 182.62 182.22 228.68 0
4,400 208.86 181.47 182.67 229.01 0
4,500 208.86 181.47 182.67 229.01 0
4,600 208.86 181.47 182.67 229.01 0
4,700 208.86 181.47 182.67 229.01 0
4,800 209.62 179.16 183.56 229.67 0
4,900 209.62 179.16 183.56 229.67 0
5,000 209.62 179.16 183.56 229.67 0
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VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
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Table E.6: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
100 209.78 200.89 195.72 195.61 0.802
200 198.37 247.68 177.63 178.32 0
300 197.85 276.72 160.95 166.48 0
400 195.61 283.89 158.19 164.31 0
500 184.42 293.53 156.47 167.58 0
600 175.81 303.02 142.46 180.71 0
700 172.74 298.15 153.64 177.48 0
800 172.97 293.72 158.44 176.87 0
900 179.21 285.59 156.52 180.68 0
1,000 192.23 270.06 164.96 174.75 0
1,100 198.24 264.12 163.83 175.81 0
1,200 203.94 261.42 157 179.64 0
1,300 211.53 260.66 154.48 175.33 0
1,400 214.6 255.64 155.46 176.31 0
1,500 220.3 254.58 146.4 180.72 0
1,600 219.27 259.84 142.27 180.62 0
1,700 226.43 267.6 135.38 172.59 0
1,800 231.74 268.55 137.13 164.58 0
1,900 229.04 266.46 135.93 170.57 0
2,000 229.51 264.65 137.56 170.28 0
2,100 233.37 265.63 134.91 168.09 0
2,200 233.94 265.11 135.59 167.36 0
2,300 238.57 263.08 135.04 165.31 0
2,400 238.59 266.89 133.28 163.24 0
2,500 237.42 269.67 130.73 164.18 0
2,600 237.66 268.54 129.6 166.2 0
2,700 238.11 266.12 127.81 169.96 0
2,800 233.13 270.18 126.18 172.51 0
2,900 235.15 268.04 125.06 173.75 0
3,000 237.02 269.04 125.52 170.42 0
3,100 238.65 268.48 128 166.87 0
3,200 236.11 273.72 131.36 160.81 0
3,300 235.98 275.55 132.25 158.22 0
3,400 239.24 276.41 128.17 158.18 0
3,500 240.28 276.68 127.32 157.72 0
3,600 240.12 276.47 126.61 158.81 0
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Table E.6 – Continued
FFE(s) UC CalEB TInSSel DUC AS
3,700 240.07 276.84 126.34 158.76 0
3,800 241.72 279.14 125.11 156.04 0
3,900 241.55 279.4 124.21 156.84 0
4,000 243.47 280.93 124.01 153.59 0
4,100 244.67 280.17 123.95 153.21 0
4,200 244.74 283.21 124.92 149.13 0
4,300 242.12 285.04 124.13 150.71 0
4,400 242.43 286.43 123.16 149.99 0
4,500 242.35 284.63 123.35 151.68 0
4,600 242.36 286.28 122.06 151.31 0
4,700 242.58 288.08 121.16 150.19 0
4,800 244.02 287.24 121.13 149.62 0
4,900 245.49 287.14 122.33 147.05 0
5,000 243.12 287.37 120.61 150.91 0
E.1.3 20 penalty points per intervention
Table E.7: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
100 189.12 198.56 188.86 225.46 0.083
200 204.09 191.21 165.13 241.57 0
300 248.48 155.61 145.07 252.84 0
400 265.68 135.67 117.97 282.68 0
500 263.33 131.41 103.45 303.82 0
600 258.56 124.45 94.84 324.15 0
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Table E.7 – Continued
FFE(s) UC CalEB TInSSel DUC AS
700 252.72 125.75 88.67 334.87 0
800 250.14 125.44 83.18 343.24 0
900 249.68 127.03 77.71 347.59 0
1,000 248.27 130.6 73.84 349.3 0
1,100 247.97 128.65 75.4 349.99 0
1,200 246.4 130.27 75.03 350.31 0
1,300 244.68 129.66 77.21 350.46 0
1,400 243.93 127.45 80.13 350.5 0
1,500 236.01 129.67 85.82 350.5 0
1,600 224.6 135.45 91.46 350.5 0
1,700 207.21 144.31 99.99 350.5 0
1,800 189.53 155.67 106.31 350.5 0
1,900 175.69 163.93 111.88 350.5 0
2,000 166.35 167.88 117.27 350.5 0
2,100 155.6 173.24 122.66 350.5 0
2,200 150.67 175.73 125.1 350.5 0
2,300 148.53 176.86 126.12 350.5 0
2,400 145.09 178.46 127.95 350.5 0
2,500 144.44 178.7 128.36 350.5 0
2,600 144.44 178.7 128.36 350.5 0
2,700 144.44 178.7 128.36 350.5 0
2,800 143.79 178.94 128.77 350.5 0
2,900 143.79 178.94 128.77 350.5 0
3,000 143.79 178.94 128.77 350.5 0
3,100 143.79 178.94 128.77 350.5 0
3,200 143.79 178.94 128.77 350.5 0
3,300 143.79 178.94 128.77 350.5 0
3,400 143.79 178.94 128.77 350.5 0
3,500 143.79 178.94 128.77 350.5 0
3,600 143.79 178.94 128.77 350.5 0
3,700 143.79 178.94 128.77 350.5 0
3,800 143.79 178.94 128.77 350.5 0
3,900 143.79 178.94 128.77 350.5 0
4,000 143.79 178.94 128.77 350.5 0
4,100 143.79 178.94 128.77 350.5 0
4,200 143.79 178.94 128.77 350.5 0
4,300 143.79 178.94 128.77 350.5 0
4,400 143.79 178.94 128.77 350.5 0
4,500 143.79 178.94 128.77 350.5 0
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Table E.7 – Continued
FFE(s) UC CalEB TInSSel DUC AS
4,600 143.79 178.94 128.77 350.5 0
4,700 143.79 178.94 128.77 350.5 0
4,800 143.79 178.94 128.77 350.5 0
4,900 143.79 178.94 128.77 350.5 0
5,000 143.79 178.94 128.77 350.5 0
Table E.8: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
100 211.63 200.89 178.88 210.6 0.159
200 223.01 196.34 167.59 215.06 0.003
300 250.59 165.78 149.75 235.88 0
400 269.76 145.5 121.21 265.53 0
500 274.88 134.02 104.19 288.92 0
600 271.78 125.47 97.26 307.49 0
700 268.94 123.87 89.12 320.07 0
800 266.52 120.72 87.13 327.64 0
900 259.04 120.65 84.1 338.21 0
1,000 257.68 122.56 80.17 341.6 0
1,100 254.66 128.55 73.64 345.16 0
1,200 254.44 127.11 74.89 345.56 0
1,300 252.39 126 75.7 347.91 0
1,400 250.2 127.55 75.98 348.28 0
1,500 248.74 123.86 80.6 348.8 0
1,600 242.86 121.96 87.54 349.65 0
1,700 237.56 124.27 90.38 349.8 0
1,800 228.49 124.89 98.52 350.11 0
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Table E.8 – Continued
FFE(s) UC CalEB TInSSel DUC AS
1,900 220.21 128.21 103.49 350.1 0
2,000 207.67 131.55 112.5 350.29 0
2,100 198.01 133.68 120 350.32 0
2,200 187.41 139.31 125 350.29 0
2,300 178.93 140.27 132.5 350.31 0
2,400 176.6 140.77 134.5 350.14 0
2,500 171.94 141.54 138.5 350.02 0
2,600 168.36 142.6 141 350.04 0
2,700 163.15 144.5 144.5 349.86 0
2,800 160.16 146 146 349.85 0
2,900 160.3 146 146 349.7 0
3,000 159.18 146.5 146.5 349.82 0
3,100 159.38 146.5 146.5 349.63 0
3,200 159.59 146.5 146.5 349.41 0
3,300 160.2 147 147 347.81 0
3,400 158.73 150 150 343.27 0
3,500 158.26 153 153 337.74 0
3,600 158.27 154.5 154.5 334.74 0
3,700 160.32 156.5 156.5 328.68 0
3,800 161.95 158 158 324.05 0
3,900 164.52 160.5 160.5 316.49 0
4,000 165.75 163.5 163.5 309.26 0
4,100 167.36 165.5 165.5 303.65 0
4,200 171.89 170 170 290.12 0
4,300 174.5 174.5 174.5 278.5 0
4,400 177.5 177.5 177.5 269.5 0
4,500 182 182 182 256 0
4,600 185 185 185 247 0
4,700 187 187 187 241 0
4,800 189 189 189 235 0
4,900 192 192 192 226 0
5,000 193 193 193 223 0
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Table E.9: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
100 199.17 189.02 192.21 221.6 0.184
200 215.09 174.63 177.93 234.35 0
300 235.74 169.78 168 228.48 0
400 265.58 152.14 134.52 249.76 0
500 274.63 136.66 122.04 268.67 0
600 286.46 127.52 115.77 272.26 0
700 290.63 121.87 112.24 277.27 0
800 294.29 117.7 106.72 283.29 0
900 298.36 113.44 104.47 285.73 0
1,000 302.18 107.66 101.32 290.85 0
1,100 308.49 106.95 99.38 287.19 0
1,200 311.81 107.62 96.63 285.94 0
1,300 318.19 109.62 93.35 280.85 0
1,400 315.11 113.11 90.36 283.42 0
1,500 318.38 117.34 84.55 281.73 0
1,600 320.8 117.99 84.24 278.97 0
1,700 322.51 117.12 86.18 276.19 0
1,800 325.3 116.34 87.37 272.99 0
1,900 324.1 114.88 88.01 275.01 0
2,000 322.28 116.15 87.36 276.22 0
2,100 321 114.85 89.1 277.06 0
2,200 320.2 110.83 94.75 276.23 0
2,300 321.68 110.94 95.18 274.21 0
2,400 323.69 109.11 95.53 273.68 0
2,500 323.89 111.63 94.09 272.39 0
2,600 324.94 111.39 94.04 271.64 0
2,700 325.74 109.8 96.37 270.1 0
2,800 326.58 111.18 96.58 267.67 0
2,900 326.33 111.91 96.31 267.45 0
3,000 326.31 112.55 97.2 265.94 0
3,100 326.52 112.62 97.49 265.38 0
3,200 326.06 111.02 99.32 265.61 0
3,300 326.55 112.27 98.33 264.86 0
3,400 327.26 113.72 96.97 264.06 0
3,500 328.1 113.32 96.97 263.62 0
3,600 328.39 114.12 96.77 262.73 0
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Table E.9 – Continued
FFE(s) UC CalEB TInSSel DUC AS
3,700 329.03 112.34 98.39 262.25 0
3,800 329.15 111.45 98.58 262.83 0
3,900 329.5 112.88 97.79 261.83 0
4,000 330.65 112.71 97.9 260.75 0
4,100 331.14 114.29 95.41 261.17 0
4,200 332.2 114.51 95.74 259.56 0
4,300 331.57 114.95 95.75 259.74 0
4,400 330.97 114.96 95.59 260.48 0
4,500 331.99 115.19 95.51 259.32 0
4,600 332.42 114.78 96.6 258.21 0
4,700 332.68 115.85 96.21 257.27 0
4,800 333.64 116.14 95.72 256.51 0
4,900 333.92 115.46 96.55 256.09 0
5,000 333.51 117.27 94.53 256.7 0
E.1.4 35 penalty points per intervention
Table E.10: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
100 217.56 191.11 195.85 197.48 0.381
200 237.01 164.4 156.68 243.91 0
300 248.6 154.39 122.81 276.2 0
400 259.06 125.1 108.79 309.05 0
500 257.03 117.69 98.84 328.45 0
600 251.66 114.59 95.52 340.24 0
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Table E.10 – Continued
FFE(s) UC CalEB TInSSel DUC AS
700 247.47 109.33 98.15 347.05 0
800 247.62 112.62 92.65 349.12 0
900 249.17 111.92 91.33 349.58 0
1,000 250.25 117.44 84.35 349.97 0
1,100 249.66 118.22 83.85 350.27 0
1,200 249.93 118.58 83.04 350.45 0
1,300 249.07 115.94 86.51 350.49 0
1,400 246.58 119 85.93 350.49 0
1,500 233.94 123.86 93.71 350.5 0
1,600 218.71 130.01 102.79 350.5 0
1,700 199.84 139.11 112.56 350.5 0
1,800 184.51 147.28 119.72 350.5 0
1,900 168.77 155.77 126.97 350.5 0
2,000 154.79 163.18 133.53 350.5 0
2,100 150.29 165.31 135.91 350.5 0
2,200 146.97 167.03 137.5 350.5 0
2,300 146.78 167.17 137.55 350.5 0
2,400 145.69 167.74 138.08 350.5 0
2,500 145.69 167.74 138.08 350.5 0
2,600 145.69 167.74 138.08 350.5 0
2,700 145.69 167.74 138.08 350.5 0
2,800 145.69 167.74 138.08 350.5 0
2,900 145.69 167.74 138.08 350.5 0
3,000 145.69 167.74 138.08 350.5 0
3,100 145.69 167.74 138.08 350.5 0
3,200 145.69 167.74 138.08 350.5 0
3,300 145.69 167.74 138.08 350.5 0
3,400 145.69 167.74 138.08 350.5 0
3,500 145.69 167.74 138.08 350.5 0
3,600 145.69 167.74 138.08 350.5 0
3,700 145.69 167.74 138.08 350.5 0
3,800 145.69 167.74 138.08 350.5 0
3,900 145.69 167.74 138.08 350.5 0
4,000 145.69 167.74 138.08 350.5 0
4,100 145.69 167.74 138.08 350.5 0
4,200 145.69 167.74 138.08 350.5 0
4,300 145.69 167.74 138.08 350.5 0
4,400 145.69 167.74 138.08 350.5 0
4,500 145.69 167.74 138.08 350.5 0
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Table E.10 – Continued
FFE(s) UC CalEB TInSSel DUC AS
4,600 145.69 167.74 138.08 350.5 0
4,700 145.69 167.74 138.08 350.5 0
4,800 145.69 167.74 138.08 350.5 0
4,900 145.69 167.74 138.08 350.5 0
5,000 145.69 167.74 138.08 350.5 0
Table E.11: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
100 228.19 181.46 196.85 195.5 0.033
200 239.91 161.25 171.48 229.36 0
300 254.2 134.79 150.36 262.65 0
400 266.5 118.95 122.8 293.75 0
500 261.27 114.2 113.33 313.2 0
600 258.33 109.68 107.44 326.56 0
700 253.4 113.89 96.69 338.02 0
800 254.54 111.7 93.65 342.11 0
900 250.75 116.95 88.24 346.07 0
1,000 250.34 117.24 86.29 348.13 0
1,100 250.92 121.09 81.44 348.56 0
1,200 249.96 123.06 79.59 349.4 0
1,300 249.85 115.72 86.45 349.99 0
1,400 249.81 111.09 90.91 350.2 0
1,500 247.49 110.28 93.9 350.34 0
1,600 237.26 114.03 100.35 350.37 0
1,700 223.01 120.99 107.64 350.37 0
1,800 204.83 128.72 118.09 350.36 0
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Table E.11 – Continued
FFE(s) UC CalEB TInSSel DUC AS
1,900 188.94 135.41 127.18 350.48 0
2,000 177.43 141.31 132.88 350.39 0
2,100 174.37 140.7 136.5 350.43 0
2,200 163.78 144.64 143.2 350.38 0
2,300 157.87 148.32 145.38 350.43 0
2,400 156.22 148.4 146.92 350.46 0
2,500 156.69 148.95 147.46 348.91 0
2,600 157.12 146.49 149.48 348.91 0
2,700 155.14 147.49 150.48 348.89 0
2,800 154.1 148 151 348.9 0
2,900 152.52 148.01 152.52 348.96 0
3,000 154.08 149.52 152.56 345.84 0
3,100 154.59 151.53 154.59 341.29 0
3,200 155.15 152.05 155.15 339.65 0
3,300 157.21 154.07 157.21 333.51 0
3,400 159.83 155 159.83 327.34 0
3,500 163.44 158.5 163.44 316.63 0
3,600 166.01 161 166.01 308.98 0
3,700 169.63 164.5 169.63 298.24 0
3,800 174.78 169.5 173.02 284.7 0
3,900 179.92 174.5 178.11 269.48 0
4,000 184.6 179 182.73 255.68 0
4,100 189.69 184 185.9 242.42 0
4,200 191.76 186 187.92 236.32 0
4,300 195.34 189.5 191.45 225.72 0
4,400 196.37 190.5 192.46 222.68 0
4,500 198.43 192.5 194.48 216.6 0
4,600 199.94 194 195.98 212.08 0.001
4,700 201.99 196 198 206.02 0.082
4,800 203 197 199 203 0.271
4,900 203 197 199 203 0.271
5,000 203 197 199 203 0.271
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Table E.12: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
100 203.5 195.09 187.69 215.72 0.355
200 238.59 169.23 156.28 237.9 0
300 256.87 155.37 132.32 257.44 0
400 267.03 140.54 122.56 271.87 0
500 279.7 124.45 120.32 277.53 0
600 295.75 118.24 106.49 281.52 0
700 303.77 113.05 103.1 282.09 0
800 301 113.88 97.97 289.16 0
900 299.71 112.26 96.12 293.91 0
1,000 301.95 112.26 94.59 293.21 0
1,100 304.37 109.29 94.28 294.06 0
1,200 307.11 110.6 92.32 291.97 0
1,300 313.08 112.68 89.83 286.41 0
1,400 318.02 110.57 91.97 281.45 0
1,500 318.87 107.6 94.79 280.75 0
1,600 321.68 104.5 98.12 277.7 0
1,700 319.93 104.86 98.9 278.31 0
1,800 319.35 107.31 97.23 278.12 0
1,900 320.67 106.42 97.55 277.37 0
2,000 321.63 106.84 97.04 276.49 0
2,100 321.23 109.04 95.04 276.7 0
2,200 322.91 109.99 93.95 275.15 0
2,300 323.45 108.33 95.32 274.9 0
2,400 323.44 107.62 95.95 274.99 0
2,500 325.67 108.64 95.93 271.76 0
2,600 325.64 108.85 95.52 271.99 0
2,700 326.38 108.7 95.62 271.3 0
2,800 325.83 106.23 97.97 271.98 0
2,900 327.35 103.49 100.92 270.25 0
3,000 328.95 105.48 98.64 268.94 0
3,100 328.22 106.67 99.02 268.1 0
3,200 329.29 108.85 98.36 265.51 0
3,300 329.79 108.96 98.46 264.8 0
3,400 331.1 111.21 96.19 263.51 0
3,500 330.61 110.77 95.96 264.67 0
3,600 334.49 112.08 94.4 261.04 0
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Table E.12 – Continued
FFE(s) UC CalEB TInSSel DUC AS
3,700 335.31 113.36 93.03 260.31 0
3,800 335.79 114.01 92.56 259.65 0
3,900 336.68 113.42 92.65 259.26 0
4,000 336.75 115.03 94.21 256.02 0
4,100 335.06 116.76 94 256.19 0
4,200 335.46 118.74 93.52 254.29 0
4,300 335.37 118.06 94.05 254.53 0
4,400 336.51 116.91 94.83 253.76 0
4,500 333.84 117.87 96.44 253.86 0
4,600 335.25 118.36 95.72 252.67 0
4,700 334.77 117.63 96.93 252.68 0
4,800 334.92 116.72 97.43 252.94 0
4,900 334.22 117.15 97.72 252.92 0
5,000 334.06 118.45 97.61 251.89 0
E.1.5 50 penalty points per intervention
Table E.13: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
100 197.51 204.63 209.45 190.41 0.67
200 220.04 178.5 156.47 246.99 0
300 244.09 142.25 126.67 288.99 0
400 250.93 126.95 108.5 315.62 0
500 244.05 118.61 101.64 337.71 0
600 244.02 111.77 100.3 345.92 0
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Table E.13 – Continued
FFE(s) UC CalEB TInSSel DUC AS
700 246.86 108.22 98.23 348.69 0
800 247.72 110.55 94.13 349.61 0
900 249.91 115.95 86.29 349.86 0
1,000 249.15 114.63 88.03 350.2 0
1,100 249.72 112.93 88.95 350.41 0
1,200 248.82 107.25 95.43 350.5 0
1,300 247.51 107.25 96.74 350.5 0
1,400 244.29 107.59 99.63 350.5 0
1,500 232.47 114.53 104.5 350.5 0
1,600 216.15 122.33 113.02 350.5 0
1,700 193.52 133.8 124.18 350.5 0
1,800 178.96 141.12 131.42 350.5 0
1,900 169.8 145.66 136.04 350.5 0
2,000 164.12 148.42 138.96 350.5 0
2,100 162.14 149.4 139.96 350.5 0
2,200 162.14 149.4 139.96 350.5 0
2,300 162.09 149.43 139.98 350.5 0
2,400 161.16 149.88 140.46 350.5 0
2,500 161.16 149.88 140.46 350.5 0
2,600 161.16 149.88 140.46 350.5 0
2,700 161.16 149.88 140.46 350.5 0
2,800 161.16 149.88 140.46 350.5 0
2,900 161.16 149.88 140.46 350.5 0
3,000 161.16 149.88 140.46 350.5 0
3,100 161.16 149.88 140.46 350.5 0
3,200 161.16 149.88 140.46 350.5 0
3,300 161.16 149.88 140.46 350.5 0
3,400 161.16 149.88 140.46 350.5 0
3,500 161.16 149.88 140.46 350.5 0
3,600 161.16 149.88 140.46 350.5 0
3,700 161.16 149.88 140.46 350.5 0
3,800 161.16 149.88 140.46 350.5 0
3,900 161.16 149.88 140.46 350.5 0
4,000 161.16 149.88 140.46 350.5 0
4,100 161.16 149.88 140.46 350.5 0
4,200 161.16 149.88 140.46 350.5 0
4,300 161.16 149.88 140.46 350.5 0
4,400 161.16 149.88 140.46 350.5 0
4,500 161.16 149.88 140.46 350.5 0
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Table E.13 – Continued
FFE(s) UC CalEB TInSSel DUC AS
4,600 161.16 149.88 140.46 350.5 0
4,700 161.16 149.88 140.46 350.5 0
4,800 161.16 149.88 140.46 350.5 0
4,900 161.16 149.88 140.46 350.5 0
5,000 161.16 149.88 140.46 350.5 0
Table E.14: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
100 202.35 199.22 193.61 206.82 0.875
200 229.92 160.1 149.17 262.81 0
300 247.96 134.35 121.24 298.45 0
400 251.06 122.19 109.61 319.14 0
500 247.64 113.54 106.04 334.79 0
600 247.84 108.98 102.2 342.98 0
700 248.17 108.83 98.03 346.98 0
800 247.68 110.71 94.54 349.07 0
900 247.86 107.41 96.54 350.2 0
1,000 248.58 108.14 94.87 350.41 0
1,100 248.62 108.28 94.7 350.41 0
1,200 249.15 108.07 94.31 350.48 0
1,300 248.56 104.07 98.89 350.49 0
1,400 246.74 106.81 97.98 350.48 0
1,500 241.7 107.31 102.5 350.5 0
1,600 234.16 109.35 108 350.5 0
1,700 222.01 115.5 114 350.5 0
1,800 204.5 123.5 123.5 350.5 0
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Table E.14 – Continued
FFE(s) UC CalEB TInSSel DUC AS
1,900 188.5 131.5 131.5 350.5 0
2,000 177.5 137 137 350.5 0
2,100 168.5 141.5 141.5 350.5 0
2,200 165.51 143 143 350.49 0
2,300 160.51 145.5 145.5 350.49 0
2,400 156.51 147.5 147.5 350.49 0
2,500 154.52 148.5 148.5 350.48 0
2,600 154.59 148.5 148.5 350.41 0
2,700 153.52 149 149 350.48 0
2,800 154.05 149.5 149.5 348.96 0
2,900 155.14 150.5 150.5 345.87 0
3,000 153.06 151.5 151.5 345.95 0
3,100 153.58 152 152 344.43 0
3,200 154.59 153 153 341.41 0
3,300 156.5 156.5 156.5 332.5 0
3,400 159 159 159 325 0
3,500 160.5 160.5 160.5 320.5 0
3,600 163.5 163.5 163.5 311.5 0
3,700 165.5 165.5 165.5 305.5 0
3,800 170 170 170 292 0
3,900 173.5 173.5 173.5 281.5 0
4,000 177.5 177.5 177.5 269.5 0
4,100 180 180 180 262 0
4,200 185.5 185.5 185.5 245.5 0
4,300 186.5 186.5 186.5 242.5 0
4,400 187.5 187.5 187.5 239.5 0
4,500 188.5 188.5 188.5 236.5 0
4,600 190.5 190.5 190.5 230.5 0
4,700 191.5 191.5 191.5 227.5 0
4,800 193.5 193.5 193.5 221.5 0
4,900 196 196 196 214 0
5,000 197 197 197 211 0
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Table E.15: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
100 196.57 200.62 200.14 204.67 0.97
200 218.5 172.12 168.56 242.82 0
300 248.04 153.71 143.27 256.98 0
400 269.63 138.68 124.38 269.31 0
500 274.43 128.96 116.81 281.8 0
600 282.22 123.73 108.2 287.85 0
700 291.4 114.71 101.86 294.03 0
800 295.57 112.13 99.12 295.18 0
900 292.16 114.07 92.42 303.35 0
1,000 297.89 115.76 89.31 299.04 0
1,100 297.64 114.89 89.68 299.79 0
1,200 304.5 114.36 88.55 294.59 0
1,300 306.32 114.72 87.11 293.85 0
1,400 305.56 112.23 90.02 294.2 0
1,500 306.95 112.33 90.16 292.57 0
1,600 307.78 111.49 90.77 291.96 0
1,700 306.34 112.59 89.33 293.75 0
1,800 308.94 110.8 90.87 291.4 0
1,900 309.88 109.7 92.45 289.98 0
2,000 312.9 109.44 92.34 287.32 0
2,100 314.2 111.81 90.29 285.71 0
2,200 316.14 111.44 90.46 283.97 0
2,300 317.22 111.11 90.4 283.28 0
2,400 316.41 113.12 88.8 283.68 0
2,500 317.83 112.88 88.72 282.58 0
2,600 318.87 109.98 91.47 281.69 0
2,700 319.9 108.88 92.47 280.76 0
2,800 321.77 108.6 92.88 278.75 0
2,900 321.89 109.09 92.5 278.52 0
3,000 321.23 107.59 93.97 279.22 0
3,100 323.16 108.41 93.1 277.33 0
3,200 325.1 108.71 93.17 275.02 0
3,300 326.63 108.49 93.37 273.52 0
3,400 326.71 107.98 93.89 273.43 0
3,500 326.86 107.5 94.41 273.24 0
3,600 325.61 108.37 95.31 272.73 0
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Table E.15 – Continued
FFE(s) UC CalEB TInSSel DUC AS
3,700 325.37 108.27 95.53 272.84 0
3,800 327.65 107.95 95.63 270.78 0
3,900 329.31 107.93 95.59 269.18 0
4,000 329.46 107.78 96.62 268.15 0
4,100 330.23 108.28 96.31 267.19 0
4,200 330.51 108.4 96.27 266.83 0
4,300 330.87 108.15 96.87 266.13 0
4,400 331.03 107.58 97.41 266 0
4,500 332.18 107.47 97.55 264.8 0
4,600 332.89 107.85 98.18 263.09 0
4,700 334.71 108.16 98.71 260.43 0
4,800 335.47 108.21 98.74 259.59 0
4,900 336.39 107.39 99.35 258.88 0
5,000 336.81 107.59 99.41 258.19 0
E.2 KW values for comparisons between UC, CalEB, TInS-
Sel and FDC for the bio-control problem
E.2.1 0 penalty points per intervention
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Table E.16: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
100 203.63 201.83 201.44 195.1 0.958
200 234.99 217.97 180.63 168.41 0
300 259.87 209.3 159.56 173.27 0
400 293.38 207.42 142.09 159.11 0
500 313.09 190.89 142.93 155.09 0
600 324.17 177.04 143.58 157.22 0
700 332.92 171.63 139.51 157.95 0
800 337.21 167.16 133.84 163.8 0
900 341.69 161.79 139.84 158.69 0
1,000 345.3 159.04 147.31 150.36 0
1,100 346.76 161.15 140.87 153.22 0
1,200 347.77 159.42 137.62 157.2 0
1,300 348.89 153.78 136.12 163.21 0
1,400 348.69 155.06 133.08 165.17 0
1,500 347.24 151.45 130.47 172.85 0
1,600 347.61 149.21 124.64 180.55 0
1,700 344.65 143.32 126.51 187.53 0
1,800 342.32 136.56 129.41 193.72 0
1,900 340.87 130.55 130.34 200.25 0
2,000 337.87 127.61 129 207.53 0
2,100 337.02 125.24 128.7 211.05 0
2,200 333.99 122.76 130.11 215.16 0
2,300 332.96 120.82 128.22 220 0
2,400 331.67 121.65 127.79 220.9 0
2,500 330.72 119.29 130.13 221.87 0
2,600 329.27 119.21 130.83 222.7 0
2,700 328.32 117.94 130.67 225.08 0
2,800 327.93 118.09 130.18 225.81 0
2,900 327.77 116.86 130.17 227.21 0
3,000 326.01 117.71 130.77 227.52 0
3,100 325.61 117.75 130.84 227.81 0
3,200 325.58 118.26 130.13 228.03 0
3,300 325.5 118.26 130.14 228.1 0
3,400 325.49 117.36 130.67 228.49 0
3,500 325.45 117.6 130.91 228.05 0
3,600 325.45 117.6 130.91 228.05 0
Continued on Next Page. . .
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Table E.16 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,700 325.45 117.6 130.91 228.05 0
3,800 325.47 117.6 130.91 228.03 0
3,900 325.47 117.6 130.91 228.03 0
4,000 325.51 118.09 130.14 228.27 0
4,100 325.51 118.09 130.14 228.27 0
4,200 325.51 118.09 130.14 228.27 0
4,300 325.51 118.09 130.14 228.27 0
4,400 325.51 118.09 130.14 228.27 0
4,500 325.51 118.09 130.14 228.27 0
4,600 325.51 118.09 130.14 228.27 0
4,700 325.51 118.09 130.14 228.27 0
4,800 325.51 118.09 130.14 228.27 0
4,900 325.51 118.09 130.14 228.27 0
5,000 325.51 118.09 130.14 228.27 0
Table E.17: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
100 210.28 198.63 199.3 193.79 0.78
200 230.24 227.27 176.78 167.71 0
300 262.83 230.24 162.16 146.77 0
400 290.02 217.33 148.67 145.99 0
500 315.47 191.89 139.65 155 0
600 327.85 172.32 141.56 160.28 0
700 334.46 162.04 145.88 159.63 0
800 341.25 157.56 142.11 161.08 0
900 344.43 157.48 143.63 156.47 0
Continued on Next Page. . .
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Table E.17 – Continued
FFE(s) UC CalEB TInSSel FDC AS
1,000 346.1 154.85 143.69 157.37 0
1,100 345.75 156.1 146.17 153.99 0
1,200 346.51 158.06 143.87 153.57 0
1,300 347.56 155.85 142.06 156.54 0
1,400 346.43 156.2 143.34 156.04 0
1,500 347.43 154.23 140.9 159.45 0
1,600 347.96 148.39 140.15 165.51 0
1,700 347.87 152.21 135.52 166.4 0
1,800 347.81 148.67 131.12 174.4 0
1,900 348.95 145.16 131.68 176.23 0
2,000 347.87 146.55 130.2 177.4 0
2,100 347.57 150.77 131.37 172.3 0
2,200 347.77 144.4 131.43 178.4 0
2,300 347.61 146.17 131.2 177.03 0
2,400 348.37 147.1 128.13 178.41 0
2,500 346.89 143.07 132.6 179.45 0
2,600 346.12 138.82 136.81 180.26 0
2,700 346.22 140.66 139.17 175.96 0
2,800 342.39 142.23 140.76 176.62 0
2,900 342.25 142.34 139.38 178.04 0
3,000 340.1 144 141 176.91 0
3,100 338.23 144.59 143.08 176.11 0
3,200 335.4 144.62 147.7 174.28 0
3,300 327.23 147.17 150.34 177.26 0
3,400 325.18 148.19 151.38 177.25 0
3,500 316.8 151.29 152.94 180.98 0
3,600 309.6 155.87 155.87 180.67 0
3,700 297.21 159.93 159.93 184.93 0
3,800 293.86 160.98 160.98 186.19 0
3,900 288.48 162.28 164.06 187.18 0
4,000 283.05 165.32 167.13 186.51 0
4,100 272.55 169.36 171.21 188.89 0
4,200 265.29 172.37 174.24 190.1 0
4,300 253.54 176.89 178.78 192.8 0
4,400 246.32 179.92 181.83 193.94 0
4,500 241.95 181.45 183.39 195.22 0
4,600 239.81 183.45 183.45 195.3 0
4,700 235.27 184.96 184.96 196.82 0
4,800 228.24 187.97 187.97 197.82 0
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Table E.17 – Continued
FFE(s) UC CalEB TInSSel FDC AS
4,900 228.68 188.48 188.48 196.38 0
5,000 227.65 189.48 189.48 195.4 0
Table E.18: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
100 212.09 185.34 197.35 207.22 0.371
200 233.3 208.43 189.59 170.68 0.001
300 243.93 220.68 176.96 160.43 0
400 274.39 210.34 158.09 159.18 0
500 296.98 199.58 155.27 150.17 0
600 325.39 183.63 152.78 140.21 0
700 333.23 181.88 151.49 135.41 0
800 337.71 177.86 153.15 133.29 0
900 343.81 170.96 148.55 138.68 0
1,000 344.68 163.48 150.92 142.92 0
1,100 346.78 160.08 151.4 143.75 0
1,200 348.7 160.24 147.21 145.86 0
1,300 349.32 168.61 143.59 140.49 0
1,400 349.41 174.73 144.42 133.45 0
1,500 349.58 169.24 145.69 137.5 0
1,600 349.79 170.62 140.3 141.3 0
1,700 349.84 172.01 142.9 137.25 0
1,800 350.33 169.12 140.6 141.96 0
1,900 350.31 169.99 138.48 143.23 0
2,000 350.49 168.74 137.05 145.73 0
2,100 350.5 167.54 138.77 145.19 0
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Table E.18 – Continued
FFE(s) UC CalEB TInSSel FDC AS
2,200 350.5 169.57 139.41 142.53 0
2,300 350.47 170.08 141.5 139.95 0
2,400 350.48 162.67 142.95 145.91 0
2,500 350.49 165.54 142.52 143.45 0
2,600 350.49 166.23 142.89 142.39 0
2,700 350.49 164.83 145.59 141.09 0
2,800 350.49 166.26 146.95 138.31 0
2,900 350.49 164.75 147.87 138.9 0
3,000 350.49 162.77 149.28 139.46 0
3,100 350.36 164.1 150.63 136.92 0
3,200 350.4 166.64 150.41 134.56 0
3,300 350.44 166.19 151.8 133.58 0
3,400 350.44 166.24 151.35 133.98 0
3,500 350.45 165.57 151.22 134.77 0
3,600 350.45 164.4 152.77 134.39 0
3,700 350.45 163.74 150.89 136.92 0
3,800 350.45 162.97 151.61 136.97 0
3,900 350.45 161.34 152.42 137.8 0
4,000 350.45 161.87 153.27 136.42 0
4,100 350.42 161.78 154.35 135.45 0
4,200 350.43 160.31 155.03 136.24 0
4,300 350.42 158.13 156.86 136.6 0
4,400 350.46 158.62 159.21 133.72 0
4,500 350.46 157.16 160.85 133.53 0
4,600 350.48 159.17 159.69 132.67 0
4,700 350.48 157.07 160.48 133.97 0
4,800 350.48 157.62 161.76 132.15 0
4,900 350.48 160.13 160.43 130.97 0
5,000 350.48 163.24 158.95 129.34 0
E.2.2 5 penalty points per intervention
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Table E.19: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
100 192.09 200.13 209.63 200.15 0.764
200 183.41 248.15 189.28 181.16 0
300 180.55 297.66 156.05 167.74 0
400 175.66 315.68 155.28 155.38 0
500 174.25 324.37 151.15 152.23 0
600 180.31 322.72 156.89 142.08 0
700 188.81 327.82 156.41 128.96 0
800 208.63 323.02 142.37 127.98 0
900 216.87 324.82 142.14 118.17 0
1,000 231.97 317.27 138.36 114.4 0
1,100 233.45 321.94 137.13 109.49 0
1,200 230.24 326.77 126.96 118.04 0
1,300 227.26 331.07 122.47 121.21 0
1,400 228.61 325.69 124.41 123.29 0
1,500 220.71 329.76 124.42 127.12 0
1,600 212.16 328.75 124.26 136.84 0
1,700 197.88 327.95 126.94 149.24 0
1,800 174.5 327.96 135.68 163.87 0
1,900 164.12 323.32 138.97 175.6 0
2,000 151.85 318.35 144.65 187.16 0
2,100 148.72 308.84 143.84 200.61 0
2,200 147.34 298.85 148.88 206.93 0
2,300 147.64 289.72 152.38 212.27 0
2,400 147.16 283.25 154.86 216.74 0
2,500 148.29 276 157.51 220.21 0
2,600 150.15 266.25 160.93 224.68 0
2,700 150.99 261.12 162.91 227 0
2,800 152.41 255.81 164.67 229.13 0
2,900 153.19 252.39 165.86 230.57 0
3,000 153.92 249.6 166.84 231.65 0
3,100 154.37 248.41 167.18 232.05 0
3,200 154.45 248.05 167.33 232.18 0
3,300 154.71 247.44 167.56 232.31 0
3,400 154.71 247.44 167.56 232.31 0
3,500 154.71 247.44 167.56 232.31 0
3,600 154.71 247.27 167.63 232.4 0
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Table E.19 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,700 154.71 247.27 167.63 232.4 0
3,800 155.13 246.21 168.01 232.66 0
3,900 155.13 246.21 168.01 232.66 0
4,000 155.13 246.21 168.01 232.66 0
4,100 155.13 246.21 168.01 232.66 0
4,200 155.13 246.21 168.01 232.66 0
4,300 155.13 246.21 168.01 232.66 0
4,400 155.13 246.21 168.01 232.66 0
4,500 155.13 246.21 168.01 232.66 0
4,600 155.13 246.21 168.01 232.66 0
4,700 155.13 246.21 168.01 232.66 0
4,800 155.13 246.21 168.01 232.66 0
4,900 155.13 246.21 168.01 232.66 0
5,000 155.13 246.21 168.01 232.66 0
Table E.20: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
100 202.17 197.6 203.53 198.7 0.981
200 188.97 251.19 177.91 183.93 0
300 167.4 288.8 187.4 158.4 0
400 163.93 313.15 172.65 152.27 0
500 170.89 321.34 158.94 150.83 0
600 188.02 317.43 157.34 139.21 0
700 199.62 315.25 160.62 126.51 0
800 208.46 308.66 156.45 128.43 0
900 220.93 302.66 152.98 125.43 0
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Table E.20 – Continued
FFE(s) UC CalEB TInSSel FDC AS
1,000 234.12 302.26 155.96 109.67 0
1,100 232.56 306.68 151.27 111.49 0
1,200 233.54 312.61 149.1 106.75 0
1,300 233.06 311.06 146.61 111.28 0
1,400 234.86 317.43 140.29 109.43 0
1,500 228.16 321.14 135.51 117.2 0
1,600 226.37 321.36 128.73 125.55 0
1,700 218.63 320.04 129.94 133.39 0
1,800 211.64 323.3 124.71 142.36 0
1,900 194.94 325.37 129.68 152.02 0
2,000 187.66 319.11 130.49 164.76 0
2,100 177.99 322.43 129.32 172.27 0
2,200 170.12 321.97 129.47 180.46 0
2,300 168.43 316.09 132.3 185.19 0
2,400 162.52 310.92 135.09 193.49 0
2,500 169.04 297.05 141.06 194.85 0
2,600 173.45 289.51 145.64 193.41 0
2,700 179.63 279.95 148.87 193.56 0
2,800 180.94 271.57 155.24 194.27 0
2,900 181.66 267.85 156.43 196.07 0
3,000 185.07 262.84 160.46 193.64 0
3,100 192.27 249.67 168.67 191.4 0
3,200 196.63 241.78 171.98 191.62 0
3,300 201.5 236.93 175.63 187.95 0
3,400 202.9 230.54 179.35 189.22 0
3,500 207.09 223.23 184.25 187.43 0.005
3,600 211.41 215.08 184.87 190.65 0.023
3,700 213.58 211.36 187.26 189.81 0.035
3,800 213.74 208.3 189.51 190.46 0.068
3,900 215.27 204.78 189.64 192.33 0.078
4,000 216.94 201.93 190.16 192.98 0.049
4,100 217.94 198.94 191.16 193.97 0.045
4,200 220.22 198.18 193.83 189.77 0.011
4,300 220.98 195.62 194.72 190.68 0.008
4,400 221.36 194.34 195.17 191.14 0.006
4,500 221.36 194.34 195.17 191.14 0.006
4,600 221.36 194.34 195.17 191.14 0.006
4,700 221.36 194.34 195.17 191.14 0.006
4,800 222.12 191.78 196.06 192.05 0.003
Continued on Next Page. . .
555
APPENDIX E. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
BIO-CONTROL OPTIMISATION
Table E.20 – Continued
FFE(s) UC CalEB TInSSel FDC AS
4,900 222.12 191.78 196.06 192.05 0.003
5,000 222.12 191.78 196.06 192.05 0.003
Table E.21: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
100 205.18 195.32 190.29 211.21 0.572
200 194.25 243.49 173.49 190.77 0
300 193.5 272.98 156.9 178.62 0
400 193.87 283.48 154.82 169.83 0
500 186.22 294.02 158.45 163.31 0
600 184.28 307.99 151.6 158.13 0
700 183.08 302.15 164.36 152.41 0
800 190.31 300.92 174.68 136.09 0
900 198.1 295.48 175.32 133.1 0
1,000 211.38 282.35 184.98 123.29 0
1,100 218.97 277.17 185.59 120.27 0
1,200 226.66 276.62 180.69 118.03 0
1,300 232.97 276.31 178.76 113.96 0
1,400 237.41 272.86 179.68 112.05 0
1,500 245.67 274.66 174.86 106.81 0
1,600 244.43 279.2 169.99 108.39 0
1,700 249.57 284.7 162.02 105.72 0
1,800 252.1 284.26 162.57 103.07 0
1,900 250.58 284.57 161.5 105.35 0
2,000 250.83 281.54 162.61 107.02 0
2,100 253.42 281.5 159.01 108.07 0
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Table E.21 – Continued
FFE(s) UC CalEB TInSSel FDC AS
2,200 254.09 281.02 161.1 105.79 0
2,300 258.34 279.64 160.09 103.93 0
2,400 256.75 282.31 158.03 104.91 0
2,500 255.32 284.32 154.39 107.97 0
2,600 257.1 284.93 153.27 106.7 0
2,700 257.56 282.84 150.93 110.67 0
2,800 252.31 286.3 150.35 113.04 0
2,900 254.89 285.28 150.53 111.3 0
3,000 255.52 284.78 149.09 112.62 0
3,100 256.2 283.57 150.71 111.53 0
3,200 251.31 286.52 151.82 112.36 0
3,300 249.94 287.02 152.04 113.01 0
3,400 252.86 287.67 147.87 113.61 0
3,500 253.8 287.79 146.68 113.74 0
3,600 254.34 288.05 146.57 113.06 0
3,700 253.85 287.85 145.77 114.54 0
3,800 255.41 289.81 143.97 112.83 0
3,900 255.12 289.89 142.6 114.4 0
4,000 255.77 290.49 140.56 115.19 0
4,100 257.59 290.36 141.74 112.32 0
4,200 256.56 292.33 141.08 112.04 0
4,300 254.29 293.94 140.83 112.95 0
4,400 254.8 295.93 139.1 112.18 0
4,500 254.76 294.31 139.15 113.79 0
4,600 254.77 295.54 138.98 112.71 0
4,700 254.28 296.64 137.27 113.81 0
4,800 255.09 295.3 137.33 114.29 0
4,900 256.31 294.92 138.21 112.57 0
5,000 254.76 295.79 136.58 114.88 0
E.2.3 20 penalty points per intervention
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Table E.22: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
100 198.3 207.38 197.95 198.37 0.925
200 240.32 225.78 202.5 133.4 0
300 293.05 208.77 199.05 101.13 0
400 320.81 206.86 191.65 82.68 0
500 328.21 211.03 184.3 78.47 0
600 337.15 206.95 174.13 83.78 0
700 339.29 212.44 165.24 85.04 0
800 343.78 214.41 158.08 85.74 0
900 346.78 212.41 143.53 99.28 0
1,000 346.59 211.46 129.75 114.21 0
1,100 346.33 203.81 124.92 126.95 0
1,200 343.53 196.51 115.03 146.95 0
1,300 339.33 190.07 113.04 159.57 0
1,400 336.31 181.04 112.71 171.95 0
1,500 321.87 178.25 116.48 185.41 0
1,600 301.88 181.64 120.95 197.54 0
1,700 273.57 189.02 129.25 210.16 0
1,800 245.08 199.97 135.16 221.8 0
1,900 223.26 208.23 140.5 230.02 0
2,000 209.41 211.77 145.89 234.94 0
2,100 193.68 217.13 151.28 239.92 0
2,200 186.52 219.62 153.72 242.15 0
2,300 183.38 220.74 154.74 243.15 0
2,400 178.48 222.35 156.57 244.61 0
2,500 177.62 222.59 156.98 244.82 0
2,600 177.62 222.59 156.98 244.82 0
2,700 177.62 222.59 156.98 244.82 0
2,800 176.75 222.83 157.39 245.04 0
2,900 176.75 222.83 157.39 245.04 0
3,000 176.75 222.83 157.39 245.04 0
3,100 176.75 222.83 157.39 245.04 0
3,200 176.75 222.83 157.39 245.04 0
3,300 176.75 222.83 157.39 245.04 0
3,400 176.75 222.83 157.39 245.04 0
3,500 176.75 222.83 157.39 245.04 0
3,600 176.75 222.83 157.39 245.04 0
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Table E.22 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,700 176.75 222.83 157.39 245.04 0
3,800 176.75 222.83 157.39 245.04 0
3,900 176.75 222.83 157.39 245.04 0
4,000 176.75 222.83 157.39 245.04 0
4,100 176.75 222.83 157.39 245.04 0
4,200 176.75 222.83 157.39 245.04 0
4,300 176.75 222.83 157.39 245.04 0
4,400 176.75 222.83 157.39 245.04 0
4,500 176.75 222.83 157.39 245.04 0
4,600 176.75 222.83 157.39 245.04 0
4,700 176.75 222.83 157.39 245.04 0
4,800 176.75 222.83 157.39 245.04 0
4,900 176.75 222.83 157.39 245.04 0
5,000 176.75 222.83 157.39 245.04 0
Table E.23: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
100 211.18 199.34 177.55 213.93 0.104
200 242.69 216.79 188.68 153.84 0
300 288.17 208.88 193.49 111.46 0
400 315.98 205.88 182.34 97.8 0
500 330.27 204.96 174.59 92.19 0
600 336.56 205.26 170.87 89.32 0
700 342.09 208.85 162.19 88.87 0
800 345.17 205.01 158.18 93.64 0
900 347.02 205.34 153.39 96.26 0
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Table E.23 – Continued
FFE(s) UC CalEB TInSSel FDC AS
1,000 348.81 205.71 145.77 101.71 0
1,100 349.32 212.62 132.93 107.14 0
1,200 349.48 204.58 127.71 120.24 0
1,300 349.8 198.77 121.8 131.64 0
1,400 347.54 197.62 118.7 138.15 0
1,500 345.84 187.69 122.19 146.3 0
1,600 337.85 180.22 129.65 154.28 0
1,700 329.71 180.68 131.87 159.75 0
1,800 315.48 177.79 141.33 167.41 0
1,900 304.95 182.9 149.45 164.71 0
2,000 285.1 183.68 158 175.23 0
2,100 271.19 185.69 167.5 177.62 0
2,200 255.82 191.83 173 181.36 0
2,300 242.06 190.77 180.5 188.68 0
2,400 238.63 191.24 183 189.14 0
2,500 231.35 191.51 187.5 191.64 0
2,600 225.76 192.08 190 194.16 0
2,700 217.4 193.5 193.5 197.6 0
2,800 212.93 195 195 199.07 0
2,900 213.47 195.5 195.5 197.54 0
3,000 211.97 196 196 198.03 0
3,100 211.97 196 196 198.03 0
3,200 211.97 196 196 198.03 0
3,300 211.97 196 196 198.03 0
3,400 207.49 197.5 197.5 199.52 0.01
3,500 205 199 199 199 0.029
3,600 203.5 199.5 199.5 199.5 0.111
3,700 203.5 199.5 199.5 199.5 0.111
3,800 203.5 199.5 199.5 199.5 0.111
3,900 203.5 199.5 199.5 199.5 0.111
4,000 202 200 200 200 0.392
4,100 202 200 200 200 0.392
4,200 202 200 200 200 0.392
4,300 200.5 200.5 200.5 200.5 1
4,400 200.5 200.5 200.5 200.5 1
4,500 200.5 200.5 200.5 200.5 1
4,600 200.5 200.5 200.5 200.5 1
4,700 200.5 200.5 200.5 200.5 1
4,800 200.5 200.5 200.5 200.5 1
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Table E.23 – Continued
FFE(s) UC CalEB TInSSel FDC AS
4,900 200.5 200.5 200.5 200.5 1
5,000 200.5 200.5 200.5 200.5 1
Table E.24: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
100 205.46 194.96 199.54 202.04 0.932
200 239.65 201.75 204.3 156.3 0
300 274.53 212.86 213.8 100.81 0
400 308.5 209.35 199.07 85.08 0
500 322.55 200.01 193.36 86.08 0
600 330.9 197.07 192.77 81.27 0
700 335.22 196.32 193 77.47 0
800 340.13 193.66 189.39 78.83 0
900 342.5 189.84 187.07 82.6 0
1,000 346.81 187.07 182.12 86.01 0
1,100 348.42 185.76 179.19 88.64 0
1,200 349.36 185.92 173.76 92.97 0
1,300 350.06 190.48 169.51 91.96 0
1,400 349.66 193.05 164.44 94.85 0
1,500 350.32 199.83 154.63 97.23 0
1,600 350.29 199.53 153.57 98.62 0
1,700 350.41 198.65 156.99 95.95 0
1,800 349.87 197.38 158.99 95.77 0
1,900 350.06 193.76 155.98 102.21 0
2,000 349.74 198.91 160.24 93.12 0
2,100 349.32 197.55 163.84 91.3 0
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Table E.24 – Continued
FFE(s) UC CalEB TInSSel FDC AS
2,200 348.22 188.58 168.49 96.72 0
2,300 348.05 188.46 170.38 95.12 0
2,400 348.45 186.32 168.78 98.46 0
2,500 348.68 188.51 164.48 100.34 0
2,600 348.97 187.11 164.41 101.52 0
2,700 349.04 184.22 166.86 101.89 0
2,800 349.04 184.42 166.89 101.66 0
2,900 349.06 185.92 166.59 100.44 0
3,000 348.98 185.44 166.92 100.66 0
3,100 349.09 186.15 167.03 99.74 0
3,200 349.18 183.11 167.73 101.99 0
3,300 349.16 184.14 165.63 103.08 0
3,400 349.21 184.87 162.24 105.69 0
3,500 349.38 184.6 162.06 105.97 0
3,600 349.48 184.82 161.49 106.22 0
3,700 349.62 182.59 163.06 106.75 0
3,800 349.67 181.67 162.82 107.85 0
3,900 349.75 181.4 159.77 111.1 0
4,000 349.8 180.54 159.34 112.33 0
4,100 350.02 182.68 158.36 110.95 0
4,200 350.02 182.63 158.7 110.66 0
4,300 349.55 182.93 158.73 110.8 0
4,400 349.65 181.61 156.97 113.78 0
4,500 349.65 181.99 156.9 113.46 0
4,600 349.67 181.38 158.95 112.01 0
4,700 349.77 181.92 159.26 111.06 0
4,800 349.79 183.44 160.47 108.31 0
4,900 349.85 181.63 160.79 109.74 0
5,000 349.53 183.6 157.51 111.37 0
E.2.4 35 penalty points per intervention
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Table E.25: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
100 214.2 188.99 193.37 205.44 0.398
200 273.7 205.95 200.04 122.31 0
300 303.41 222.38 194.4 81.81 0
400 327.54 206.94 191.93 75.6 0
500 338.18 207.8 186.22 69.8 0
600 342.57 205.24 178.96 75.24 0
700 344.57 196.03 178 83.41 0
800 346.32 195.25 162.99 97.45 0
900 348.16 189 156.01 108.84 0
1,000 349.57 186.42 135.47 130.55 0
1,100 348.53 176.87 124.72 151.88 0
1,200 348.29 169.71 116.48 167.53 0
1,300 344.81 156.8 113.84 186.56 0
1,400 337.45 156.78 109.84 197.94 0
1,500 314.13 158.56 117.36 211.96 0
1,600 287.42 162.58 126.43 225.58 0
1,700 255.82 170.71 136.2 239.28 0
1,800 231.52 178.87 143.36 248.26 0
1,900 206.99 187.36 150.61 257.05 0
2,000 185.64 194.78 157.18 264.41 0
2,100 179.82 196.9 159.55 265.74 0
2,200 174.84 198.63 161.15 267.39 0
2,300 174.43 198.77 161.2 267.62 0
2,400 172.85 199.33 161.72 268.11 0
2,500 172.85 199.33 161.72 268.11 0
2,600 172.85 199.33 161.72 268.11 0
2,700 172.85 199.33 161.72 268.11 0
2,800 172.85 199.33 161.72 268.11 0
2,900 172.85 199.33 161.72 268.11 0
3,000 172.85 199.33 161.72 268.11 0
3,100 172.85 199.33 161.72 268.11 0
3,200 172.85 199.33 161.72 268.11 0
3,300 172.85 199.33 161.72 268.11 0
3,400 172.85 199.33 161.72 268.11 0
3,500 172.85 199.33 161.72 268.11 0
3,600 172.85 199.33 161.72 268.11 0
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Table E.25 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,700 172.85 199.33 161.72 268.11 0
3,800 172.85 199.33 161.72 268.11 0
3,900 172.85 199.33 161.72 268.11 0
4,000 172.85 199.33 161.72 268.11 0
4,100 172.85 199.33 161.72 268.11 0
4,200 172.85 199.33 161.72 268.11 0
4,300 172.85 199.33 161.72 268.11 0
4,400 172.85 199.33 161.72 268.11 0
4,500 172.85 199.33 161.72 268.11 0
4,600 172.85 199.33 161.72 268.11 0
4,700 172.85 199.33 161.72 268.11 0
4,800 172.85 199.33 161.72 268.11 0
4,900 172.85 199.33 161.72 268.11 0
5,000 172.85 199.33 161.72 268.11 0
Table E.26: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
100 224.31 177.61 193.25 206.83 0.031
200 275.12 201.89 210.52 114.47 0
300 303.59 200.6 212.38 85.43 0
400 327.74 199.35 202.67 72.25 0
500 332.23 200.81 198.19 70.78 0
600 337.94 196.69 195.35 72.03 0
700 342.2 202.17 185.85 71.79 0
800 346.52 200.32 178.09 77.08 0
900 346.57 204.17 163.75 87.51 0
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Table E.26 – Continued
FFE(s) UC CalEB TInSSel FDC AS
1,000 348.12 201 155.2 97.69 0
1,100 349.12 205.37 145.67 101.85 0
1,200 348.89 202.05 138.52 112.55 0
1,300 349.33 185 142.04 125.64 0
1,400 349.41 172.37 142.8 137.43 0
1,500 346.33 168.83 144.98 141.87 0
1,600 330.92 168.36 148.8 153.93 0
1,700 308.77 172.69 153.66 166.89 0
1,800 280.59 178.77 164.06 178.59 0
1,900 257.65 186.4 175.15 182.81 0
2,000 240.24 192.3 180.85 188.62 0
2,100 235.05 190.16 184.48 192.32 0
2,200 218.65 193.11 191.18 199.07 0.003
2,300 209.54 196.79 192.86 202.82 0.136
2,400 207.82 197.4 195.42 201.36 0.298
2,500 208.23 197.93 195.94 199.91 0.293
2,600 208.12 193.98 197.96 201.94 0.141
2,700 205.12 194.98 198.96 202.94 0.346
2,800 203.56 195.49 199.48 203.47 0.462
2,900 201 195 201 205 0.318
3,000 201.5 195.5 199.5 205.5 0.279
3,100 200 196 200 206 0.257
3,200 200 196 200 206 0.257
3,300 200 196 200 206 0.257
3,400 201 195 201 205 0.191
3,500 201 195 201 205 0.191
3,600 201 195 201 205 0.191
3,700 201 195 201 205 0.191
3,800 201.5 195.5 199.5 205.5 0.15
3,900 201.5 195.5 199.5 205.5 0.15
4,000 201.5 195.5 199.5 205.5 0.15
4,100 202 196 198 206 0.082
4,200 202 196 198 206 0.082
4,300 202 196 198 206 0.082
4,400 202 196 198 206 0.082
4,500 202 196 198 206 0.082
4,600 202 196 198 206 0.082
4,700 202 196 198 206 0.082
4,800 202 196 198 206 0.082
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Table E.26 – Continued
FFE(s) UC CalEB TInSSel FDC AS
4,900 202.5 196.5 198.5 204.5 0.165
5,000 202.5 196.5 198.5 204.5 0.165
Table E.27: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
100 202.61 194.51 187.36 217.52 0.288
200 275.58 209.95 196.33 120.14 0
300 300.97 215.1 190.37 95.56 0
400 316.44 213.92 191.91 79.73 0
500 328.92 207.82 201.17 64.09 0
600 338.87 207.75 193.37 62.01 0
700 343.63 205.34 192.35 60.69 0
800 344.55 207.6 188.16 61.7 0
900 346.54 205.28 185.52 64.66 0
1,000 347.4 204.95 182.14 67.51 0
1,100 349.26 200.86 181.49 70.4 0
1,200 349.84 199.79 177.02 75.36 0
1,300 350.17 200.22 172.21 79.41 0
1,400 350.4 197.96 177.72 75.92 0
1,500 350.47 194.26 180.86 76.42 0
1,600 350.31 189.18 184.09 78.42 0
1,700 350.17 187.88 183.36 80.59 0
1,800 350.28 188.92 177.24 85.57 0
1,900 350.4 187.96 174.95 88.7 0
2,000 350.35 188.87 174.65 88.13 0
2,100 350.37 189.76 170.13 91.75 0
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Table E.27 – Continued
FFE(s) UC CalEB TInSSel FDC AS
2,200 350.47 190.72 168.94 91.88 0
2,300 350.48 187.66 169.84 94.02 0
2,400 350.48 187.18 170.36 93.99 0
2,500 350.48 187.74 169.65 94.14 0
2,600 350.5 186.36 167.58 97.57 0
2,700 350.5 185.87 167.23 98.41 0
2,800 350.5 181.52 169.07 100.91 0
2,900 350.5 178.2 173.19 100.11 0
3,000 350.5 181.43 171.04 99.04 0
3,100 350.5 179.56 168.39 103.56 0
3,200 350.5 181.14 166.38 103.98 0
3,300 350.5 181.65 166.89 102.96 0
3,400 350.5 183.21 162.38 105.92 0
3,500 350.5 183.68 161.96 105.87 0
3,600 350.5 184.53 159.48 107.5 0
3,700 350.49 185.47 156.88 109.16 0
3,800 350.49 186.7 156.65 108.17 0
3,900 350.49 186.46 156.31 108.75 0
4,000 350.46 186.73 157.28 107.54 0
4,100 350.37 188.37 156.1 107.17 0
4,200 350.37 189.54 154.03 108.07 0
4,300 350.4 189.27 155.13 107.2 0
4,400 350.43 189.96 158.45 103.16 0
4,500 348.11 189.93 159.87 104.1 0
4,600 348.12 189.89 158.09 105.91 0
4,700 348.16 187.79 159.3 106.75 0
4,800 348.18 186.35 159.78 107.71 0
4,900 348.2 187.09 160.7 106.02 0
5,000 348.22 186.97 158.4 108.42 0
E.2.5 50 penalty points per intervention
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Table E.28: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
100 190.01 197.35 201.46 213.18 0.55
200 262.26 219.46 198.96 121.32 0
300 306.74 212.73 200.98 81.55 0
400 324.99 212.4 194.73 69.89 0
500 333.08 211.62 190.67 66.63 0
600 340.05 201.72 187.46 72.78 0
700 345.21 193.91 181.32 81.57 0
800 346.89 191.06 167.71 96.35 0
900 349.28 184.31 139.56 128.85 0
1,000 348.85 168.06 126.95 158.15 0
1,100 349.63 152.98 116.61 182.79 0
1,200 345.99 138.01 120.25 197.77 0
1,300 337.74 133.82 119.08 211.37 0
1,400 325.06 132.51 121.52 222.92 0
1,500 297.02 139.06 125.84 240.09 0
1,600 264.2 146.06 134.14 257.61 0
1,700 231.41 157.53 145.3 267.76 0
1,800 210.01 164.85 152.54 274.6 0
1,900 197.83 169.39 157.16 277.63 0
2,000 190.73 172.15 160.08 279.05 0
2,100 188.12 173.13 161.08 279.67 0
2,200 188.12 173.13 161.08 279.67 0
2,300 187.99 173.16 161.1 279.75 0
2,400 186.85 173.61 161.58 279.97 0
2,500 186.85 173.61 161.58 279.97 0
2,600 186.85 173.61 161.58 279.97 0
2,700 186.85 173.61 161.58 279.97 0
2,800 186.85 173.61 161.58 279.97 0
2,900 186.85 173.61 161.58 279.97 0
3,000 186.85 173.61 161.58 279.97 0
3,100 186.85 173.61 161.58 279.97 0
3,200 186.85 173.61 161.58 279.97 0
3,300 186.85 173.61 161.58 279.97 0
3,400 186.85 173.61 161.58 279.97 0
3,500 186.85 173.61 161.58 279.97 0
3,600 186.85 173.61 161.58 279.97 0
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Table E.28 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,700 186.85 173.61 161.58 279.97 0
3,800 186.85 173.61 161.58 279.97 0
3,900 186.85 173.61 161.58 279.97 0
4,000 186.85 173.61 161.58 279.97 0
4,100 186.85 173.61 161.58 279.97 0
4,200 186.85 173.61 161.58 279.97 0
4,300 186.85 173.61 161.58 279.97 0
4,400 186.85 173.61 161.58 279.97 0
4,500 186.85 173.61 161.58 279.97 0
4,600 186.85 173.61 161.58 279.97 0
4,700 186.85 173.61 161.58 279.97 0
4,800 186.85 173.61 161.58 279.97 0
4,900 186.85 173.61 161.58 279.97 0
5,000 186.85 173.61 161.58 279.97 0
Table E.29: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
100 202.2 199.32 193.8 206.68 0.884
200 272.74 203.55 194.09 131.62 0
300 312.13 205.13 190.68 94.06 0
400 327.37 207.55 193.36 73.72 0
500 334.42 202.84 193.71 71.03 0
600 340.99 199.93 191.3 69.79 0
700 344.77 198.76 185.46 73.02 0
800 346.48 202.83 176.89 75.8 0
900 347.57 191.82 175.17 87.45 0
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Table E.29 – Continued
FFE(s) UC CalEB TInSSel FDC AS
1,000 348.48 183.95 166.04 103.54 0
1,100 348.54 173.55 154.12 125.8 0
1,200 349.13 165.56 145.06 142.26 0
1,300 347.97 155.52 147.94 150.58 0
1,400 345.1 158.01 144.97 153.92 0
1,500 337.4 157.38 150.5 156.73 0
1,600 325.69 158.36 156.5 161.46 0
1,700 307.8 165.5 163.5 165.21 0
1,800 281.18 173 173 174.82 0
1,900 257.5 181.5 181.5 181.5 0
2,000 241 187 187 187 0
2,100 227.5 191.5 191.5 191.5 0
2,200 223 193 193 193 0
2,300 215.5 195.5 195.5 195.5 0
2,400 209.5 197.5 197.5 197.5 0
2,500 206.5 198.5 198.5 198.5 0.007
2,600 206.5 198.5 198.5 198.5 0.007
2,700 205 199 199 199 0.029
2,800 205 199 199 199 0.029
2,900 205 199 199 199 0.029
3,000 202 200 200 200 0.392
3,100 202 200 200 200 0.392
3,200 202 200 200 200 0.392
3,300 200.5 200.5 200.5 200.5 1
3,400 200.5 200.5 200.5 200.5 1
3,500 200.5 200.5 200.5 200.5 1
3,600 200.5 200.5 200.5 200.5 1
3,700 200.5 200.5 200.5 200.5 1
3,800 200.5 200.5 200.5 200.5 1
3,900 200.5 200.5 200.5 200.5 1
4,000 200.5 200.5 200.5 200.5 1
4,100 200.5 200.5 200.5 200.5 1
4,200 200.5 200.5 200.5 200.5 1
4,300 200.5 200.5 200.5 200.5 1
4,400 200.5 200.5 200.5 200.5 1
4,500 200.5 200.5 200.5 200.5 1
4,600 200.5 200.5 200.5 200.5 1
4,700 200.5 200.5 200.5 200.5 1
4,800 200.5 200.5 200.5 200.5 1
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Table E.29 – Continued
FFE(s) UC CalEB TInSSel FDC AS
4,900 200.5 200.5 200.5 200.5 1
5,000 200.5 200.5 200.5 200.5 1
Table E.30: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
100 197.81 201.75 200.92 201.52 0.995
200 260.86 215.81 213.72 111.61 0
300 298.89 217.17 210.21 75.73 0
400 320.23 213.54 200.7 67.53 0
500 327.04 211.46 197.88 65.62 0
600 334.42 209.87 191.44 66.27 0
700 343.34 204.84 188.26 65.57 0
800 345.43 204.59 185.58 66.41 0
900 347.28 207.16 178.58 68.99 0
1,000 347.65 209.49 175.76 69.11 0
1,100 348.43 206.8 176.24 70.54 0
1,200 349.54 205.56 171.87 75.03 0
1,300 350.14 206.47 169.03 76.37 0
1,400 349.66 201.33 170.83 80.18 0
1,500 349.56 202.18 172.92 77.35 0
1,600 349.42 198.77 174.55 79.27 0
1,700 349.79 199.78 172.75 79.69 0
1,800 349.97 197.19 172.41 82.44 0
1,900 350.02 193.01 170.1 88.88 0
2,000 350.21 191.66 168.97 91.17 0
2,100 350.34 193.28 164.56 93.83 0
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Table E.30 – Continued
FFE(s) UC CalEB TInSSel FDC AS
2,200 350.37 190.19 162.1 99.35 0
2,300 350.45 187.95 159.6 104.01 0
2,400 350.28 189.98 156.58 105.17 0
2,500 350.36 188.9 154.7 108.05 0
2,600 350.42 182.67 157.54 111.38 0
2,700 350.44 179.51 157.51 114.55 0
2,800 350.47 177.49 156.38 117.67 0
2,900 350.49 177.91 155.43 118.18 0
3,000 350.49 174.37 155.9 121.25 0
3,100 350.49 174.12 152.56 124.84 0
3,200 350.49 173.58 152.1 125.84 0
3,300 350.49 172.38 151.3 127.83 0
3,400 350.49 171.29 151.8 128.42 0
3,500 350.49 170.71 152.8 128 0
3,600 350.49 169.6 151.91 130 0
3,700 350.49 168.91 151.6 131 0
3,800 350.49 167.77 150.74 133 0
3,900 350.49 167.79 150.73 133 0
4,000 350.5 166.26 150.74 134.5 0
4,100 350.5 166.54 150.47 134.5 0
4,200 350.5 166.05 149.96 135.5 0
4,300 350.5 165.03 150.47 136 0
4,400 350.5 163.99 151.01 136.5 0
4,500 350.5 163.37 150.63 137.5 0
4,600 350.5 162.76 150.24 138.5 0
4,700 350.5 162.21 149.8 139.5 0
4,800 350.5 162.19 149.81 139.5 0
4,900 350.5 160.59 149.91 141 0
5,000 350.5 160.59 149.91 141 0
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
574
APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.2: N = 50, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.3: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.4: N = 100, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.5: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.6: N = 100, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.7: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.8: N = 150, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX F. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR SPC, 2PC AND UC
Figure F.9: N = 150, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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Appendix G
Single drug cancer chemotherapy
scheduling graphs for UC,
CalEB, TInSSel and DUC
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.2: N = 50, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.3: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.4: N = 100, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.5: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.6: N = 100, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.7: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.8: N = 150, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX G. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND DUC
Figure G.9: N = 150, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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Appendix H
Single drug cancer chemotherapy
scheduling graphs for UC,
CalEB, TInSSel and FDC
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.1: N = 50, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.2: N = 50, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.3: N = 50, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.4: N = 100, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.5: N = 100, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.6: N = 100, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.7: N = 150, pc 0.8, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.8: N = 150, pc 0.9, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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APPENDIX H. SINGLE DRUG CANCER CHEMOTHERAPY
SCHEDULING GRAPHS FOR UC, CALEB, TINSSEL AND FDC
Figure H.9: N = 150, pc 1.0, with pm 0, 0.005 and 0.05 followed by magnified versions
of pm 0.005 and 0.05
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Appendix I
KW
I.1 KW values for comparisons between UC, CalEB, TInS-
Sel and DUC for the chemotherapy problem
Table I.1: Mutation rate of 0
FFE(s) UC CalEB TInSSel DUC AS
1,000 104.58 293.69 300.61 103.13 0
2,000 124.09 300.01 300.99 76.92 0
3,000 141.48 299.05 301.95 59.53 0
4,000 145.77 299.14 301.86 55.23 0
5,000 146.7 299.14 301.86 54.3 0
6,000 147.21 298.99 301.77 54.03 0
7,000 147.21 298.99 301.77 54.03 0
8,000 147.21 298.99 301.77 54.03 0
9,000 147.21 298.99 301.77 54.03 0
10,000 147.21 298.99 301.77 54.03 0
11,000 147.21 298.99 301.77 54.03 0
12,000 147.21 298.99 301.77 54.03 0
13,000 147.21 298.99 301.77 54.03 0
Continued on Next Page. . .
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APPENDIX I. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
CHEMOTHERAPY OPTIMISATION
Table I.1 – Continued
FFE(s) UC CalEB TInSSel DUC AS
14,000 147.21 298.99 301.77 54.03 0
15,000 147.21 298.99 301.77 54.03 0
16,000 147.21 298.99 301.77 54.03 0
17,000 147.21 298.99 301.77 54.03 0
18,000 147.21 298.99 301.77 54.03 0
19,000 147.21 298.99 301.77 54.03 0
20,000 147.21 298.99 301.77 54.03 0
21,000 147.21 298.99 301.77 54.03 0
22,000 147.21 298.99 301.77 54.03 0
23,000 147.21 298.99 301.77 54.03 0
24,000 147.21 298.99 301.77 54.03 0
25,000 147.21 298.99 301.77 54.03 0
26,000 147.21 298.99 301.77 54.03 0
27,000 147.21 298.99 301.77 54.03 0
28,000 147.21 298.99 301.77 54.03 0
29,000 147.21 298.99 301.77 54.03 0
30,000 147.21 298.99 301.77 54.03 0
31,000 147.21 298.99 301.77 54.03 0
32,000 147.21 298.99 301.77 54.03 0
33,000 147.21 298.99 301.77 54.03 0
34,000 147.21 298.99 301.77 54.03 0
35,000 147.21 298.99 301.77 54.03 0
36,000 147.21 298.99 301.77 54.03 0
37,000 147.21 298.99 301.77 54.03 0
38,000 147.21 298.99 301.77 54.03 0
39,000 147.21 298.99 301.77 54.03 0
40,000 147.21 298.99 301.77 54.03 0
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VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
CHEMOTHERAPY OPTIMISATION
Table I.2: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel DUC AS
1,000 102.53 304.82 284.2 110.46 0
2,000 114.16 307.33 292.89 87.62 0
3,000 132.84 300.53 300.47 68.16 0
4,000 141.28 301.5 296.96 62.26 0
5,000 142.28 298.71 289.75 71.26 0
6,000 147.09 294.32 284.57 76.02 0
7,000 150.92 291.2 281.91 77.97 0
8,000 151.14 291.22 280.06 79.58 0
9,000 151.12 290.88 280.12 79.88 0
10,000 150.96 290.42 281 79.62 0
11,000 151.69 290.65 280.37 79.29 0
12,000 151.44 290.85 280.67 79.04 0
13,000 151.26 291.09 280.75 78.9 0
14,000 152.44 290.93 280.41 78.22 0
15,000 154.24 290.61 279.5 77.65 0
16,000 155.35 289.74 279.47 77.44 0
17,000 155.44 289.7 278.77 78.09 0
18,000 155.35 290.13 278.47 78.05 0
19,000 155.67 289.83 278.69 77.81 0
20,000 155.56 289.5 279.22 77.72 0
21,000 155.7 290.15 278.76 77.39 0
22,000 156.06 289.8 279.11 77.03 0
23,000 155.75 289.64 279.77 76.84 0
24,000 155.39 288.63 281.07 76.91 0
25,000 155.58 288.62 281 76.8 0
26,000 155.13 288.13 282.16 76.58 0
27,000 155.88 287.69 281.94 76.49 0
28,000 156.58 287.92 281.19 76.31 0
29,000 156.44 287.6 281.69 76.27 0
30,000 155.99 287.32 282.23 76.46 0
31,000 155.76 287.95 282.11 76.18 0
32,000 155.18 287.91 282.9 76.01 0
33,000 156.29 287.54 282.27 75.9 0
34,000 156.33 287.69 282.26 75.72 0
35,000 156.27 287.44 283.48 74.81 0
36,000 156.83 287.38 283.11 74.68 0
Continued on Next Page. . .
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APPENDIX I. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
CHEMOTHERAPY OPTIMISATION
Table I.2 – Continued
FFE(s) UC CalEB TInSSel DUC AS
37,000 157.5 286.38 283.62 74.5 0
38,000 156.83 288.69 282.48 74 0
39,000 156.88 288.6 282.64 73.88 0
40,000 156.91 289.24 282.22 73.63 0
Table I.3: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel DUC AS
1,000 91.73 280.2 299.94 130.14 0
2,000 80.22 293.93 303.34 124.52 0
3,000 79.12 289.53 302.37 130.98 0
4,000 79.86 282.56 306.78 132.8 0
5,000 83.75 279.18 304.88 134.19 0
6,000 80.18 279.84 306.12 135.86 0
7,000 77.78 276.93 305.52 141.77 0
8,000 75.54 270.16 307.39 148.91 0
9,000 78.61 269.77 307.45 146.17 0
10,000 75.03 275.06 305.67 146.24 0
11,000 73.49 276.92 303.86 147.74 0
12,000 77.16 275.74 302.03 147.08 0
13,000 74.8 275.69 301.34 150.18 0
14,000 73.93 274.05 302.01 152.02 0
15,000 74.22 271.79 303.26 152.74 0
16,000 73.5 269.32 305.3 153.89 0
17,000 71.44 267.59 307.12 155.86 0
18,000 70.77 272.23 305.12 153.89 0
19,000 69.54 272.7 306.41 153.35 0
Continued on Next Page. . .
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APPENDIX I. KRUSKAL-WALLIS ONE-WAY ANALYSIS OF
VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
CHEMOTHERAPY OPTIMISATION
Table I.3 – Continued
FFE(s) UC CalEB TInSSel DUC AS
20,000 71.07 271.68 308.22 151.03 0
21,000 70.9 273.05 307.69 150.36 0
22,000 70.24 273.52 308.07 150.17 0
23,000 69.59 275.49 307.49 149.43 0
24,000 70.49 275.11 307.53 148.87 0
25,000 70.38 274.22 308.33 149.07 0
26,000 69.34 273.58 310.71 148.37 0
27,000 70.82 272.72 311.76 146.7 0
28,000 71.07 274.54 309.97 146.42 0
29,000 70.4 273 311.04 147.56 0
30,000 69.91 272.53 311.17 148.39 0
31,000 70.32 274.01 310.47 147.2 0
32,000 70.46 277.15 308.45 145.94 0
33,000 69.64 278.08 308.73 145.55 0
34,000 70.12 277.82 309.61 144.45 0
35,000 71.43 277.58 308.71 144.28 0
36,000 71.33 278.79 307.87 144.01 0
37,000 70.58 277.13 309.37 144.92 0
38,000 70.21 276.23 310.75 144.81 0
39,000 69.15 278.7 308.3 145.85 0
40,000 68.84 277.34 307.91 147.91 0
I.2 KW values for comparisons between UC, CalEB, TInS-
Sel and FDC for the chemotherapy problem
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VARIANCE FOR UC, CALEB, TINSSEL AND DUC FOR
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Table I.4: Mutation rate of 0
FFE(s) UC CalEB TInSSel FDC AS
1,000 53.92 212.04 219.21 316.84 0
2,000 50.5 239.33 240.19 271.98 0
3,000 50.5 247.55 251.77 252.18 0
4,000 50.5 247.82 251.72 251.96 0
5,000 50.5 247.82 251.72 251.96 0
6,000 50.91 247.67 251.63 251.79 0
7,000 50.91 247.67 251.63 251.79 0
8,000 50.91 247.67 251.63 251.79 0
9,000 50.91 247.67 251.63 251.79 0
10,000 50.91 247.67 251.63 251.79 0
11,000 50.91 247.67 251.63 251.79 0
12,000 50.91 247.67 251.63 251.79 0
13,000 50.91 247.67 251.63 251.79 0
14,000 50.91 247.67 251.63 251.79 0
15,000 50.91 247.67 251.63 251.79 0
16,000 50.91 247.67 251.63 251.79 0
17,000 50.91 247.67 251.63 251.79 0
18,000 50.91 247.67 251.63 251.79 0
19,000 50.91 247.67 251.63 251.79 0
20,000 50.91 247.67 251.63 251.79 0
21,000 50.91 247.67 251.63 251.79 0
22,000 50.91 247.67 251.63 251.79 0
23,000 50.91 247.67 251.63 251.79 0
24,000 50.91 247.67 251.63 251.79 0
25,000 50.91 247.67 251.63 251.79 0
26,000 50.91 247.67 251.63 251.79 0
27,000 50.91 247.67 251.63 251.79 0
28,000 50.91 247.67 251.63 251.79 0
29,000 50.91 247.67 251.63 251.79 0
30,000 50.91 247.67 251.63 251.79 0
31,000 50.91 247.67 251.63 251.79 0
32,000 50.91 247.67 251.63 251.79 0
33,000 50.91 247.67 251.63 251.79 0
34,000 50.91 247.67 251.63 251.79 0
35,000 50.91 247.67 251.63 251.79 0
36,000 50.91 247.67 251.63 251.79 0
Continued on Next Page. . .
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Table I.4 – Continued
FFE(s) UC CalEB TInSSel FDC AS
37,000 50.91 247.67 251.63 251.79 0
38,000 50.91 247.67 251.63 251.79 0
39,000 50.91 247.67 251.63 251.79 0
40,000 50.91 247.67 251.63 251.79 0
Table I.5: Mutation rate of 0.005
FFE(s) UC CalEB TInSSel FDC AS
1,000 56.01 227.15 204.81 314.04 0
2,000 50.93 227.63 211.71 311.73 0
3,000 50.5 223.91 226.8 300.79 0
4,000 53.14 236.14 231.63 281.09 0
5,000 64.23 238.83 227.05 271.89 0
6,000 73.37 237.5 223.96 267.17 0
7,000 79.95 235.96 222.52 263.57 0
8,000 80.97 237.24 221.17 262.62 0
9,000 81.08 236.91 221.49 262.52 0
10,000 81.06 236.6 222.82 261.52 0
11,000 81.63 237.36 222.3 260.71 0
12,000 80.92 237.37 222.22 261.49 0
13,000 80.62 236.8 221.56 263.02 0
14,000 81.2 236.42 220.97 263.41 0
15,000 83.37 236.71 220.2 261.72 0
16,000 84.64 235.77 220.54 261.05 0
17,000 85.08 236.46 220.22 260.24 0
18,000 85.32 237.12 220.08 259.48 0
19,000 85.33 236.82 220.52 259.33 0
Continued on Next Page. . .
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Table I.5 – Continued
FFE(s) UC CalEB TInSSel FDC AS
20,000 85.05 236.68 221.13 259.14 0
21,000 84.83 237.67 220.47 259.03 0
22,000 84.78 237.37 221.07 258.78 0
23,000 84.21 236.5 221.09 260.2 0
24,000 83.8 235.34 223.24 259.62 0
25,000 83.84 235.17 223.16 259.83 0
26,000 83.22 234.51 224.32 259.95 0
27,000 84.2 233.82 223.81 260.17 0
28,000 84.69 233.61 222.35 261.35 0
29,000 84.71 233.71 223.52 260.06 0
30,000 84.16 232.73 223.82 261.29 0
31,000 83.59 233.19 223.72 261.5 0
32,000 82.87 233.63 224.92 260.58 0
33,000 84.39 233.04 224.45 260.12 0
34,000 83.92 232.4 223.91 261.77 0
35,000 83.62 231.51 225.36 261.51 0
36,000 84 231.42 224.68 261.9 0
37,000 85.22 230.67 225.79 260.32 0
38,000 84.39 232.88 224.2 260.53 0
39,000 84.26 232.33 224.47 260.94 0
40,000 84.12 233.2 224.03 260.65 0
Table I.6: Mutation rate of 0.05
FFE(s) UC CalEB TInSSel FDC AS
1,000 58.15 194.62 215.26 333.98 0
2,000 51.47 208.34 221.17 321.02 0
Continued on Next Page. . .
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Table I.6 – Continued
FFE(s) UC CalEB TInSSel FDC AS
3,000 53.81 216.66 234.92 296.61 0
4,000 51.86 217.78 248.18 284.18 0
5,000 54.64 216.53 249.09 281.74 0
6,000 54.04 216.46 250.59 280.91 0
7,000 53.47 216.49 252.65 279.39 0
8,000 54.15 211.38 257.73 278.74 0
9,000 55.96 211.61 258.52 275.91 0
10,000 54.33 217.58 255.68 274.41 0
11,000 53.6 219.49 253.19 275.73 0
12,000 55.19 218.16 250.83 277.83 0
13,000 54.74 217.16 248.88 281.23 0
14,000 54.9 215.38 249.67 282.06 0
15,000 55.81 213.13 251.41 281.66 0
16,000 55.46 210.53 253.6 282.42 0
17,000 55.15 208.04 254.77 284.05 0
18,000 54.4 213.4 252.87 281.34 0
19,000 53.77 212.76 254.3 281.17 0
20,000 53.71 211.33 256.72 280.24 0
21,000 53.45 212.33 254.6 281.62 0
22,000 53.24 212.62 254.7 281.44 0
23,000 52.99 213.83 253.24 281.94 0
24,000 53.24 212.7 252.11 283.95 0
25,000 53.17 211.35 252.59 284.89 0
26,000 52.66 207.73 253.03 288.58 0
27,000 52.62 205.45 252.38 291.55 0
28,000 52.35 207.83 250.81 291.01 0
29,000 52.31 206.02 252.35 291.32 0
30,000 52.29 205.29 252.67 291.75 0
31,000 51.95 204.54 249.76 295.75 0
32,000 51.76 207.65 247.27 295.32 0
33,000 51.56 208.19 247.7 294.55 0
34,000 51.52 208.03 248.05 294.4 0
35,000 52.9 207.84 246.26 295 0
36,000 52.83 209.02 244.52 295.63 0
37,000 52.77 207.57 246.89 294.77 0
38,000 52.61 205.43 247.44 296.52 0
39,000 52.48 208.25 244.19 297.08 0
40,000 52.44 207.39 244.29 297.88 0
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Appendix J
Statistical differences between
approaches
J.1 Statistical differences between UC, CalEB, TInSSel
and DUC for bio-control scheduling
J.1.1 0 penalty points per intervention
Section E.1.1 shows the Kruskal-Wallis test values for each of the approaches with
an intervention penalty of 0 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.1 to J.3 detail which crossover ap-
proaches are statistically significantly different for mutation levels of 0, 0.005 and 0.05
respectively.
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APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
Table J.1: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T
300 C T T T
400 C T T C T
500 C T T C T
600 C T C T
700 C T C T
800 C T C T
900 C T C T
1000 C T C T
1100 C T C T
1200 C T C T
1300 C T U C T
1400 C T U C T
1500 C T U C T
1600 C T U C T
1700 C T U C T
Continued on Next Page. . .
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Table J.1 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1800 C T U C T
1900 C T U C T
2000 C T U C T
2100 C T U C T
2200 C T U C T
2300 C T U C T
2400 C T U C T
2500 C T U C T
2600 C T U C T
2700 C T U C T
2800 C T U C T
2900 C T U C T
3000 C T U C T
3100 C T U C T
3200 C T U C T
3300 C T U C T
3400 C T U C T
3500 C T U C T
Continued on Next Page. . .
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Table J.1 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3600 C T U C T
3700 C T U C T
3800 C T U C T
3900 C T U C T
4000 C T U C T
4100 C T U C T
4200 C T U C T
4300 C T U C T
4400 C T U C T
4500 C T U C T
4600 C T U C T
4700 C T U C T
4800 C T U C T
4900 C T U C T
5000 C T U C T
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Table J.2: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T T
300 T T T
400 C T T T
500 C T T C T
600 C T C T
700 C T C T
800 C T C T
900 C T C T
1000 C T C T
1100 C T C T
1200 C T C T
1300 C T C T
1400 C T C T
1500 C T C T
1600 C T C T
1700 C T C T
Continued on Next Page. . .
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Table J.2 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1800 C T C T
1900 C T U C T
2000 C T U C T
2100 C T U C T
2200 C T U C T
2300 C T U C T
2400 C T U C T
2500 C T U C T
2600 C T U C T
2700 C T U C T
2800 C T U C T
2900 C T U C T
3000 C T U C T
3100 C T U C T
3200 C T U C T
3300 C T U C T
3400 C T U C T
3500 C T U C T
Continued on Next Page. . .
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Table J.2 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3600 C T U C T
3700 C T U C T
3800 C T U C T
3900 C T U C T
4000 C T U C T
4100 C T U C T
4200 C T U C T
4300 C T U C T
4400 C T U C T
4500 C T U C T
4600 U C T
4700 U C T
4800 U C T
4900 U C T
5000 U C T
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Table J.3: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
100
200
300 T T
400 C T T C T
500 C T C T
600 C T D C T
700 C T D C T
800 C T D C T
900 C T D C T
1000 C T D C T
1100 C T C T
1200 C T C T
1300 C T C T
1400 C T D C T
1500 C T C T
1600 C T C T
1700 C T D C T
Continued on Next Page. . .
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Table J.3 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1800 C T D C T
1900 C T D C T
2000 C T D C T
2100 C T D C T
2200 C T D C T
2300 C T D C T
2400 C T D C T
2500 C T D C T
2600 C T D C T
2700 C T D C T
2800 C T D C T
2900 C T D C T
3000 C T D C T
3100 C T D C T
3200 C T D C T
3300 C T D C T
3400 C T D C T
3500 C T D C T
Continued on Next Page. . .
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Table J.3 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3600 C T D C T
3700 C T D C T
3800 C T D C T
3900 C T D C T
4000 C T D C T
4100 C T D C T
4200 C T D C T
4300 C T D C T
4400 C T D C T
4500 C T D C T
4600 C T D C T
4700 C T D C T
4800 C T D C T
4900 C T D C T
5000 C T D C T
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J.1.2 5 penalty points per intervention
Section E.1.2 shows the Kruskal-Wallis test values for each of the approaches with
an intervention penalty of 5 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.4 to J.6 detail which crossover ap-
proaches are statistically significantly different for mutation levels of 0, 0.005 and 0.05
respectively.
Table J.4: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 U T D
300 U T D
400 U T D
500 U T D
600 U T D
700 U T D T
800 U T T D T
900 U T T D T
1000 U T T D T
Continued on Next Page. . .
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Table J.4 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1100 U T T D T
1200 U T T D T
1300 U T U T D T
1400 U T U T D T
1500 U T U T T
1600 U T U T T
1700 U T U T T
1800 U U T T
1900 U U T T
2000 U U T T
2100 U U T C T
2200 U U T C T
2300 U U T C T
2400 U U T C T
2500 U U T C T
2600 U U T C T
2700 U U T C T
2800 U U T C T
Continued on Next Page. . .
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Table J.4 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2900 U U T C T
3000 U U T C T
3100 U U T C T
3200 U U T C T
3300 U U T C T
3400 U U T C T
3500 U U T C T
3600 U U T C T
3700 U U T C T
3800 U U T C T
3900 U U T C T
4000 U U T C T
4100 U U T C T
4200 U U T C T
4300 U U T C T
4400 U U T C T
4500 U U T C T
4600 U U T C T
Continued on Next Page. . .
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Table J.4 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4700 U U T C T
4800 U U T C T
4900 U U T C T
5000 U U T C T
Table J.5: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 U T D
300 U T D
400 U T D
500 U T D
600 U T D
700 U T D
Continued on Next Page. . .
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Table J.5 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
800 U T T D
900 U T T D T
1000 U T T D T
1100 U T T D T
1200 U T T D T
1300 U T T D T
1400 U T T D T
1500 U T T D T
1600 U T T D T
1700 U T T D T
1800 U T U T D T
1900 U T U T D T
2000 U T U T D T
2100 U U T D T
2200 U U T D T
2300 U U T D T
2400 U U T D T
2500 U U T D T
Continued on Next Page. . .
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Table J.5 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2600 U U T T
2700 U U T T
2800 U U T T
2900 U U T T
3000 U U T T
3100 U T T
3200 T T
3300 T T
3400 T
3500 T
3600 T
3700 T
3800
3900
4000
4100
4200
4300
Continued on Next Page. . .
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Table J.5 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4400
4500
4600
4700
4800 C
4900 C
5000 C
Table J.6: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 U T D
300 U T D
400 U T D
Continued on Next Page. . .
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Table J.6 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
500 U T D
600 U T D
700 U T D
800 U T D
900 U T D
1000 U T D
1100 U T D
1200 U T D
1300 U T T D
1400 T T D
1500 T T D
1600 T T D
1700 T D T D
1800 T D T D
1900 T D T D
2000 T D T D
2100 T D T D
2200 T D T D
Continued on Next Page. . .
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Table J.6 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2300 T D T D
2400 T D T D
2500 T D T D
2600 T D T D
2700 T D T D
2800 T D T D
2900 T D T D T
3000 T D T D
3100 T D T D
3200 T D T D
3300 T D T D
3400 T D T D
3500 T D T D
3600 T D T D
3700 T D T D
3800 T D T D
3900 T D T D
4000 T D T D
Continued on Next Page. . .
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Table J.6 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4100 T D T D
4200 T D T D
4300 T D T D
4400 T D T D
4500 T D T D
4600 T D T D
4700 T D T D
4800 T D T D
4900 T D T D
5000 T D T D
J.1.3 20 penalty points per intervention
Section E.1.3 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 20 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.7 to J.9 detail which crossover ap-
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proaches are statistically significantly different for mutation levels of 0, 0.005 and 0.05
respectively.
Table J.7: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T
300 C T C T
400 C T C T
500 C T C T
600 C T U C T
700 C T U C T
800 C T U C T
900 C T U T C T
1000 C T U T C T
1100 C T U T C T
1200 C T U T C T
1300 C T U T C T
1400 C T U C T
1500 C T U C T
Continued on Next Page. . .
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Table J.7 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1600 C T U C T
1700 C T U C T
1800 T U T C T
1900 T U T C T
2000 T U T C T
2100 U T C T
2200 U T C T
2300 U T C T
2400 U T C T
2500 U T C T
2600 U T C T
2700 U T C T
2800 U T C T
2900 U T C T
3000 U T C T
3100 U T C T
3200 U T C T
3300 U T C T
Continued on Next Page. . .
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Table J.7 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3400 U T C T
3500 U T C T
3600 U T C T
3700 U T C T
3800 U T C T
3900 U T C T
4000 U T C T
4100 U T C T
4200 U T C T
4300 U T C T
4400 U T C T
4500 U T C T
4600 U T C T
4700 U T C T
4800 U T C T
4900 U T C T
5000 U T C T
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Table J.8: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T
300 C T C T
400 C T C T
500 C T C T
600 C T C T
700 C T U C T
800 C T U C T
900 C T U C T
1000 C T U C T
1100 C T U T C T
1200 C T U T C T
1300 C T U T C T
1400 C T U T C T
1500 C T U C T
1600 C T U C T
Continued on Next Page. . .
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Table J.8 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1700 C T U C T
1800 C T U C T
1900 C T U C T
2000 C T U C T
2100 C T U C T
2200 C T U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
3400 U C T
Continued on Next Page. . .
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Table J.8 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600 U C T
4700 U C T
4800
4900
5000
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Table J.9: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T
300 C T C T
400 C T C T
500 C T C T
600 C T C T
700 C T C T
800 C T C T
900 C T C T
1000 C T C T
1100 C T C T
1200 C T C T
1300 C T C T
1400 C T C T
1500 C T C T
1600 C T C T
1700 C T C T
Continued on Next Page. . .
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Table J.9 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1800 C T D C T
1900 C T D C T
2000 C T C T
2100 C T C T
2200 C T C T
2300 C T C T
2400 C T D C T
2500 C T D C T
2600 C T D C T
2700 C T D C T
2800 C T D C T
2900 C T D C T
3000 C T D C T
3100 C T D C T
3200 C T D C T
3300 C T D C T
3400 C T D C T
3500 C T D C T
Continued on Next Page. . .
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Table J.9 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3600 C T D C T
3700 C T D C T
3800 C T D C T
3900 C T D C T
4000 C T D C T
4100 C T D C T
4200 C T D C T
4300 C T D C T
4400 C T D C T
4500 C T D C T
4600 C T D C T
4700 C T D C T
4800 C T D C T
4900 C T D C T
5000 C T D C T
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J.1.4 35 penalty points per intervention
Section E.1.4 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 35 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.10 to J.12 detail which crossover
approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.10: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T C T
300 C T C T
400 C T U C T
500 C T U C T
600 C T U C T
700 C T U C T
800 C T U C T
900 C T U C T
1000 C T U C T
Continued on Next Page. . .
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Table J.10 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1100 C T U C T
1200 C T U C T
1300 C T U C T
1400 C T U C T
1500 C T U C T
1600 C T U C T
1700 C T U C T
1800 T U C T
1900 U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
Continued on Next Page. . .
643
APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
Table J.10 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
3400 U C T
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600 U C T
Continued on Next Page. . .
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Table J.10 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4700 U C T
4800 U C T
4900 U C T
5000 U C T
Table J.11: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T C T
300 C T C T
400 C T C T
500 C T U C T
600 C T U C T
700 C T U C T
Continued on Next Page. . .
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Table J.11 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
800 C T U C T
900 C T U C T
1000 C T U C T
1100 C T U C T
1200 C T U C T
1300 C T U C T
1400 C T U C T
1500 C T U C T
1600 C T U C T
1700 C T U C T
1800 C T U C T
1900 C T U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
Continued on Next Page. . .
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Table J.11 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2600 U C T
2700 U C T
2800 U C T
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
3400 U C T
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 C T
4300
Continued on Next Page. . .
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Table J.11 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4400
4500
4600
4700
4800
4900
5000
Table J.12: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T C T
300 C T C T
400 C T C T
Continued on Next Page. . .
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Table J.12 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
500 C T C T
600 C T C T
700 C T C T
800 C T C T
900 C T C T
1000 C T C T
1100 C T C T
1200 C T C T
1300 C T C T
1400 C T C T
1500 C T C T
1600 C T C T
1700 C T C T
1800 C T C T
1900 C T C T
2000 C T C T
2100 C T C T
2200 C T C T
Continued on Next Page. . .
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Table J.12 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
2300 C T D C T
2400 C T D C T
2500 C T D C T
2600 C T D C T
2700 C T D C T
2800 C T D C T
2900 C T D C T
3000 C T D C T
3100 C T D C T
3200 C T D C T
3300 C T D C T
3400 C T D C T
3500 C T D C T
3600 C T D C T
3700 C T D C T
3800 C T D C T
3900 C T D C T
4000 C T D C T
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Table J.12 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
4100 C T D C T
4200 C T D C T
4300 C T D C T
4400 C T D C T
4500 C T D C T
4600 C T D C T
4700 C T D C T
4800 C T D C T
4900 C T D C T
5000 C T D C T
J.1.5 50 penalty points per intervention
Section E.1.5 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 50 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.13 to J.15 detail which crossover
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approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.13: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T C T
300 C T C T
400 C T U C T
500 C T U C T
600 C T U C T
700 C T U C T
800 C T U C T
900 C T U C T
1000 C T U C T
1100 C T U C T
1200 C T U C T
1300 C T U C T
1400 C T U C T
1500 C T U C T
Continued on Next Page. . .
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Table J.13 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1600 C T U C T
1700 C T U C T
1800 U C T
1900 U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
Continued on Next Page. . .
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Table J.13 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3400 U C T
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600 U C T
4700 U C T
4800 U C T
4900 U C T
5000 U C T
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Table J.14: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 C T C T
300 C T U C T
400 C T U C T
500 C T U C T
600 C T U C T
700 C T U C T
800 C T U C T
900 C T U C T
1000 C T U C T
1100 C T U C T
1200 C T U C T
1300 C T U C T
1400 C T U C T
1500 C T U C T
1600 C T U C T
Continued on Next Page. . .
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Table J.14 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1700 C T U C T
1800 C T U C T
1900 C T U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
3400 U C T
Continued on Next Page. . .
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Table J.14 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600
4700
4800
4900
5000
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Table J.15: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
100
200 T C T
300 C T C T
400 C T C T
500 C T C T
600 C T C T
700 C T C T
800 C T C T
900 C T C T
1000 C T C T
1100 C T C T
1200 C T C T
1300 C T C T
1400 C T C T
1500 C T C T
1600 C T C T
1700 C T C T
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Table J.15 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
1800 C T C T
1900 C T C T
2000 C T C T
2100 C T C T
2200 C T C T
2300 C T C T
2400 C T C T
2500 C T C T
2600 C T C T
2700 C T C T
2800 C T C T
2900 C T C T
3000 C T C T
3100 C T C T
3200 C T D C T
3300 C T D C T
3400 C T D C T
3500 C T D C T
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Table J.15 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
3600 C T D C T
3700 C T D C T
3800 C T D C T
3900 C T D C T
4000 C T D C T
4100 C T D C T
4200 C T D C T
4300 C T D C T
4400 C T D C T
4500 C T D C T
4600 C T D C T
4700 C T D C T
4800 C T D C T
4900 C T D C T
5000 C T D C T
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J.2 Statistical differences between UC, CalEB, TInSSel
and DUC for chemotherapy scheduling
Section I.1 shows the Kruskal-Wallis test values for each of the crossover approaches.
When the AS value is less than 0.01, this shows that a statistical difference exists
between at least two of the crossover approaches at the 99% confidence level. Tables
J.16 to J.18 detail which crossover approaches are statistically significantly different
for mutation levels of 0, 0.005 and 0.05 respectively.
Table J.16: Mutation rate of 0
FFE(s) U/C U/T U/D C/T C/D T/D
1000 C T C T
2000 C T C T
3000 C T U C T
4000 C T U C T
5000 C T U C T
6000 C T U C T
7000 C T U C T
8000 C T U C T
9000 C T U C T
10000 C T U C T
Continued on Next Page. . .
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Table J.16 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
11000 C T U C T
12000 C T U C T
13000 C T U C T
14000 C T U C T
15000 C T U C T
16000 C T U C T
17000 C T U C T
18000 C T U C T
19000 C T U C T
20000 C T U C T
21000 C T U C T
22000 C T U C T
23000 C T U C T
24000 C T U C T
25000 C T U C T
26000 C T U C T
27000 C T U C T
28000 C T U C T
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Table J.16 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
29000 C T U C T
30000 C T U C T
31000 C T U C T
32000 C T U C T
33000 C T U C T
34000 C T U C T
35000 C T U C T
36000 C T U C T
37000 C T U C T
38000 C T U C T
39000 C T U C T
40000 C T U C T
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Table J.17: Mutation rate of 0.005
FFE(s) U/C U/T U/D C/T C/D T/D
1000 C T C T
2000 C T C T
3000 C T U C T
4000 C T U C T
5000 C T U C T
6000 C T U C T
7000 C T U C T
8000 C T U C T
9000 C T U C T
10000 C T U C T
11000 C T U C T
12000 C T U C T
13000 C T U C T
14000 C T U C T
15000 C T U C T
16000 C T U C T
17000 C T U C T
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Table J.17 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
18000 C T U C T
19000 C T U C T
20000 C T U C T
21000 C T U C T
22000 C T U C T
23000 C T U C T
24000 C T U C T
25000 C T U C T
26000 C T U C T
27000 C T U C T
28000 C T U C T
29000 C T U C T
30000 C T U C T
31000 C T U C T
32000 C T U C T
33000 C T U C T
34000 C T U C T
35000 C T U C T
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Table J.17 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
36000 C T U C T
37000 C T U C T
38000 C T U C T
39000 C T U C T
40000 C T U C T
Table J.18: Mutation rate of 0.05
FFE(s) U/C U/T U/D C/T C/D T/D
1000 C T C T
2000 C T C T
3000 C T D C T
4000 C T D C T
5000 C T D C T
6000 C T D C T
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Table J.18 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
7000 C T D C T
8000 C T D C T
9000 C T D C T
10000 C T D C T
11000 C T D C T
12000 C T D C T
13000 C T D C T
14000 C T D C T
15000 C T D C T
16000 C T D C T
17000 C T D C T
18000 C T D C T
19000 C T D C T
20000 C T D C T
21000 C T D C T
22000 C T D C T
23000 C T D C T
24000 C T D C T
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Table J.18 – Continued
FFE(s) U/C U/T U/D C/T C/D T/D
25000 C T D C T
26000 C T D C T
27000 C T D C T
28000 C T D C T
29000 C T D C T
30000 C T D C T
31000 C T D C T
32000 C T D C T
33000 C T D C T
34000 C T D C T
35000 C T D C T
36000 C T D C T
37000 C T D C T
38000 C T D C T
39000 C T D C T
40000 C T D C T
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J.3 Statistical differences between UC, CalEB, TInSSel
and FDC for bio-control scheduling
J.3.1 0 penalty points per intervention
Section E.2.1 shows the Kruskal-Wallis test values for each of the approaches with
an intervention penalty of 0 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.19 to J.21 detail which crossover
approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.19: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 T F F
300 C T F T
400 C T F T F
500 C T F
600 C T F
700 C T F
800 C T F
Continued on Next Page. . .
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Table J.19 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
900 C T F
1000 C T F
1100 C T F
1200 C T F
1300 C T F
1400 C T F
1500 C T F
1600 C T F T
1700 C T F T
1800 C T F C T
1900 C T F C T
2000 C T F C T
2100 C T F C T
2200 C T F C T
2300 C T F C T
2400 C T F C T
2500 C T F C T
2600 C T F C T
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Table J.19 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2700 C T F C T
2800 C T F C T
2900 C T F C T
3000 C T F C T
3100 C T F C T
3200 C T F C T
3300 C T F C T
3400 C T F C T
3500 C T F C T
3600 C T F C T
3700 C T F C T
3800 C T F C T
3900 C T F C T
4000 C T F C T
4100 C T F C T
4200 C T F C T
4300 C T F C T
4400 C T F C T
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Table J.19 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4500 C T F C T
4600 C T F C T
4700 C T F C T
4800 C T F C T
4900 C T F C T
5000 C T F C T
Table J.20: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 T F T F
300 T F T F
400 C T F T F
500 C T F T
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Table J.20 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
600 C T F
700 C T F
800 C T F
900 C T F
1000 C T F
1100 C T F
1200 C T F
1300 C T F
1400 C T F
1500 C T F
1600 C T F
1700 C T F
1800 C T F
1900 C T F
2000 C T F
2100 C T F
2200 C T F
2300 C T F
Continued on Next Page. . .
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Table J.20 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2400 C T F T
2500 C T F
2600 C T F
2700 C T F
2800 C T F
2900 C T F
3000 C T F
3100 C T F
3200 C T F
3300 C T F
3400 C T F
3500 C T F
3600 C T F
3700 C T F
3800 C T F
3900 C T F
4000 C T F
4100 C T F
Continued on Next Page. . .
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Table J.20 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4200 C T F
4300 C T F
4400 C T F
4500 C T
4600 C T
4700 C T
4800
4900
5000
Table J.21: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 F
Continued on Next Page. . .
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Table J.21 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
300 T F F
400 C T F T F
500 C T F F
600 C T F
700 C T F
800 C T F
900 C T F
1000 C T F
1100 C T F
1200 C T F
1300 C T F
1400 C T F
1500 C T F
1600 C T F
1700 C T F
1800 C T F
1900 C T F
2000 C T F
Continued on Next Page. . .
676
APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
Table J.21 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2100 C T F
2200 C T F
2300 C T F
2400 C T F
2500 C T F
2600 C T F
2700 C T F
2800 C T F
2900 C T F
3000 C T F
3100 C T F
3200 C T F
3300 C T F
3400 C T F
3500 C T F
3600 C T F
3700 C T F
3800 C T F
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Table J.21 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3900 C T F
4000 C T F
4100 C T F
4200 C T F
4300 C T F
4400 C T F
4500 C T F
4600 C T F
4700 C T F
4800 C T F
4900 C T F
5000 C T F
J.3.2 5 penalty points per intervention
Section E.2.2 shows the Kruskal-Wallis test values for each of the approaches with
an intervention penalty of 5 points per intervention. When the AS value is less than
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0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.22 to J.24 detail which crossover
approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.22: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 U T F
300 U T F
400 U T F
500 U T F
600 U T F
700 U F T F
800 U T F T F
900 U T F T F
1000 U T F T F
1100 U T F T F
1200 U T F T F
1300 U T F T F
Continued on Next Page. . .
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Table J.22 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1400 U T F T F
1500 U T F T F
1600 U T F T F
1700 U T F T F
1800 U T F
1900 U T F
2000 U T F
2100 U U T F T
2200 U U T F T
2300 U U T F T
2400 U U T F T
2500 U U T F T
2600 U U T T
2700 U U T T
2800 U U T T
2900 U U T T
3000 U U T T
3100 U U T T
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Table J.22 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3200 U U T T
3300 U U T T
3400 U U T T
3500 U U T T
3600 U U T T
3700 U U T T
3800 U U T T
3900 U U T T
4000 U U T T
4100 U U T T
4200 U U T T
4300 U U T T
4400 U U T T
4500 U U T T
4600 U U T T
4700 U U T T
4800 U U T T
4900 U U T T
Continued on Next Page. . .
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Table J.22 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
5000 U U T T
Table J.23: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 U T F
300 U T F
400 U T F
500 U T F
600 U F T F
700 U F T F
800 U T F T F
900 U T F T F
1000 U T F T F
Continued on Next Page. . .
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Table J.23 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1100 U T F T F
1200 U T F T F
1300 U T F T F
1400 U T F T F
1500 U T F T F
1600 U T F T F
1700 U T F T F
1800 U T F T F
1900 U T T F
2000 U T T F
2100 U T T F
2200 U T F T
2300 U T F T
2400 U T F T
2500 U T F T
2600 U T F
2700 U T F
2800 U T F
Continued on Next Page. . .
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Table J.23 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2900 U T F
3000 U T F
3100 U T F
3200 T F
3300 T F
3400 T
3500
3600
3700
3800
3900
4000
4100
4200
4300
4400
4500
4600
Continued on Next Page. . .
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Table J.23 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4700
4800
4900
5000
Table J.24: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 U T F
300 U T F
400 U T F
500 U T F
600 U T F
700 U T F
Continued on Next Page. . .
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Table J.24 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
800 U F T F
900 U F T F
1000 U F T F F
1100 U F T F F
1200 U F T F F
1300 T F T F F
1400 T F T F F
1500 T F T F F
1600 T F T F F
1700 T F T F F
1800 T F T F F
1900 T F T F F
2000 T F T F F
2100 T F T F F
2200 T F T F F
2300 T F T F F
2400 T F T F F
2500 T F T F
Continued on Next Page. . .
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Table J.24 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2600 T F T F
2700 T F T F
2800 T F T F
2900 T F T F
3000 T F T F
3100 T F T F
3200 T F T F
3300 T F T F
3400 T F T F
3500 T F T F
3600 T F T F
3700 T F T F
3800 T F T F
3900 T F T F
4000 T F T F
4100 T F T F
4200 T F T F
4300 T F T F
Continued on Next Page. . .
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Table J.24 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4400 T F T F
4500 T F T F
4600 T F T F
4700 T F T F
4800 T F T F
4900 T F T F
5000 T F T F
J.3.3 20 penalty points per intervention
Section E.2.3 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 20 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.25 to J.27 detail which crossover
approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
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Table J.25: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F T F F
900 C T F T F
1000 C T F T F
1100 C T F T F
1200 C T F T F
1300 C T F T
1400 C T F T T
1500 C T F T T
1600 C T F T T
1700 C T F T T
Continued on Next Page. . .
689
APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
Table J.25 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1800 T T T
1900 T T T
2000 T T T
2100 T T
2200 U T T
2300 U T T
2400 U T T
2500 U T T
2600 U T T
2700 U T T
2800 U T T
2900 U T T
3000 U T T
3100 U T T
3200 U T T
3300 U T T
3400 U T T
3500 U T T
Continued on Next Page. . .
690
APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
Table J.25 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3600 U T T
3700 U T T
3800 U T T
3900 U T T
4000 U T T
4100 U T T
4200 U T T
4300 U T T
4400 U T T
4500 U T T
4600 U T T
4700 U T T
4800 U T T
4900 U T T
5000 U T T
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Table J.26: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 T F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F T F F
1000 C T F T F
1100 C T F T F
1200 C T F T F
1300 C T F T F
1400 C T F T F
1500 C T F T
1600 C T F T
1700 C T F T
Continued on Next Page. . .
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Table J.26 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1800 C T F
1900 C T F
2000 C T F
2100 C T F
2200 C T F
2300 C T F
2400 T F
2500
2600
2700
2800
2900
3000
3100
3200
3300
3400
3500
Continued on Next Page. . .
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Table J.26 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3600
3700
3800
3900
4000
4100
4200
4300
4400
4500
4600
4700
4800
4900
5000
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Table J.27: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F F
1000 C T F F F
1100 C T F F F
1200 C T F F F
1300 C T F F F
1400 C T F F F
1500 C T F F F
1600 C T F F F
1700 C T F F F
Continued on Next Page. . .
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Table J.27 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1800 C T F F F
1900 C T F F F
2000 C T F F F
2100 C T F F F
2200 C T F F F
2300 C T F F F
2400 C T F F F
2500 C T F F F
2600 C T F F F
2700 C T F F F
2800 C T F F F
2900 C T F F F
3000 C T F F F
3100 C T F F F
3200 C T F F F
3300 C T F F F
3400 C T F F F
3500 C T F F F
Continued on Next Page. . .
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Table J.27 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3600 C T F F F
3700 C T F F F
3800 C T F F F
3900 C T F F F
4000 C T F F
4100 C T F F
4200 C T F F F
4300 C T F F
4400 C T F F
4500 C T F F
4600 C T F F
4700 C T F F F
4800 C T F F F
4900 C T F F F
5000 C T F F
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J.3.4 35 penalty points per intervention
Section E.2.4 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 35 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.28 to J.30 detail which crossover
approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.28: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 C T F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F
1000 C T F T F
Continued on Next Page. . .
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Table J.28 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1100 C T F T
1200 C T F T T
1300 C T F T
1400 C T F T
1500 C T F C T
1600 C T F C T
1700 C T C T
1800 C T C T
1900 T U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
Continued on Next Page. . .
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Table J.28 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
3400 U C T
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600 U C T
Continued on Next Page. . .
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Table J.28 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4700 U C T
4800 U C T
4900 U C T
5000 U C T
Table J.29: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 C T F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
Continued on Next Page. . .
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Table J.29 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
800 C T F F F
900 C T F F F
1000 C T F F F
1100 C T F T F
1200 C T F T F
1300 C T F F
1400 C T F
1500 C T F
1600 C T F
1700 C T F
1800 C T F
1900 C T F
2000 T F
2100 T
2200
2300
2400
2500
Continued on Next Page. . .
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Table J.29 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2600
2700
2800
2900
3000
3100
3200
3300
3400
3500
3600
3700
3800
3900
4000
4100
4200
4300
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Table J.29 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4400
4500
4600
4700
4800
4900
5000
Table J.30: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 C T F F F
300 C T F F F
400 C T F F F
Continued on Next Page. . .
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Table J.30 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F F
1000 C T F F F
1100 C T F F F
1200 C T F F F
1300 C T F F F
1400 C T F F F
1500 C T F F F
1600 C T F F F
1700 C T F F F
1800 C T F F F
1900 C T F F F
2000 C T F F F
2100 C T F F F
2200 C T F F F
Continued on Next Page. . .
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Table J.30 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
2300 C T F F F
2400 C T F F F
2500 C T F F F
2600 C T F F F
2700 C T F F F
2800 C T F F F
2900 C T F F F
3000 C T F F F
3100 C T F F F
3200 C T F F F
3300 C T F F F
3400 C T F F F
3500 C T F F F
3600 C T F F F
3700 C T F F
3800 C T F F F
3900 C T F F
4000 C T F F F
Continued on Next Page. . .
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Table J.30 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
4100 C T F F F
4200 C T F F
4300 C T F F
4400 C T F F F
4500 C T F F F
4600 C T F F F
4700 C T F F F
4800 C T F F F
4900 C T F F F
5000 C T F F F
J.3.5 50 penalty points per intervention
Section E.2.5 shows the Kruskal-Wallis test values for each of the approaches with an
intervention penalty of 50 points per intervention. When the AS value is less than
0.01, this shows that a statistical difference exists between at least two of the crossover
approaches at the 99% confidence level. Tables J.31 to J.33 detail which crossover
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approaches are statistically significantly different for mutation levels of 0, 0.005 and
0.05 respectively.
Table J.31: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 T F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F
1000 C T F
1100 C T F T
1200 C T F C T
1300 C T F C T
1400 C T F C T
1500 C T F C T
Continued on Next Page. . .
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Table J.31 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1600 C T C T
1700 C T C T
1800 T U C T
1900 U C T
2000 U C T
2100 U C T
2200 U C T
2300 U C T
2400 U C T
2500 U C T
2600 U C T
2700 U C T
2800 U C T
2900 U C T
3000 U C T
3100 U C T
3200 U C T
3300 U C T
Continued on Next Page. . .
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Table J.31 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3400 U C T
3500 U C T
3600 U C T
3700 U C T
3800 U C T
3900 U C T
4000 U C T
4100 U C T
4200 U C T
4300 U C T
4400 U C T
4500 U C T
4600 U C T
4700 U C T
4800 U C T
4900 U C T
5000 U C T
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Table J.32: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 C T F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F F
1000 C T F F F
1100 C T F
1200 C T F
1300 C T F
1400 C T F
1500 C T F
1600 C T F
Continued on Next Page. . .
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Table J.32 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1700 C T F
1800 C T F
1900 C T F
2000 C T F
2100
2200
2300
2400
2500
2600
2700
2800
2900
3000
3100
3200
3300
3400
Continued on Next Page. . .
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Table J.32 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3500
3600
3700
3800
3900
4000
4100
4200
4300
4400
4500
4600
4700
4800
4900
5000
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Table J.33: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
100
200 F F F
300 C T F F F
400 C T F F F
500 C T F F F
600 C T F F F
700 C T F F F
800 C T F F F
900 C T F F F
1000 C T F F F
1100 C T F F F
1200 C T F F F
1300 C T F F F
1400 C T F F F
1500 C T F F F
1600 C T F F F
1700 C T F F F
Continued on Next Page. . .
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Table J.33 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
1800 C T F F F
1900 C T F F F
2000 C T F F F
2100 C T F F F
2200 C T F F F
2300 C T F F F
2400 C T F F F
2500 C T F F
2600 C T F F
2700 C T F F
2800 C T F F
2900 C T F F
3000 C T F F
3100 C T F F
3200 C T F
3300 C T F
3400 C T F
3500 C T F
Continued on Next Page. . .
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Table J.33 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
3600 C T F
3700 C T F
3800 C T F
3900 C T F
4000 C T F
4100 C T F
4200 C T F
4300 C T F
4400 C T F
4500 C T F
4600 C T F
4700 C T F
4800 C T F
4900 C T F
5000 C T F
716
APPENDIX J. STATISTICAL DIFFERENCES BETWEEN
APPROACHES
J.4 Statistical differences between UC, CalEB, TInSSel
and FDC for chemotherapy scheduling
Section I.2 shows the Kruskal-Wallis test values for each of the crossover approaches.
When the AS value is less than 0.01, this shows that a statistical difference exists
between at least two of the crossover approaches at the 99% confidence level. Tables
J.34 to J.36 detail which crossover approaches are statistically significantly different
for mutation levels of 0, 0.005 and 0.05 respectively.
Table J.34: Mutation rate of 0
FFE(s) U/C U/T U/F C/T C/F T/F
1000 C T F F F
2000 C T F
3000 C T F
4000 C T F
5000 C T F
6000 C T F
7000 C T F
8000 C T F
9000 C T F
10000 C T F
Continued on Next Page. . .
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Table J.34 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
11000 C T F
12000 C T F
13000 C T F
14000 C T F
15000 C T F
16000 C T F
17000 C T F
18000 C T F
19000 C T F
20000 C T F
21000 C T F
22000 C T F
23000 C T F
24000 C T F
25000 C T F
26000 C T F
27000 C T F
28000 C T F
Continued on Next Page. . .
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Table J.34 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
29000 C T F
30000 C T F
31000 C T F
32000 C T F
33000 C T F
34000 C T F
35000 C T F
36000 C T F
37000 C T F
38000 C T F
39000 C T F
40000 C T F
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Table J.35: Mutation rate of 0.005
FFE(s) U/C U/T U/F C/T C/F T/F
1000 C T F F F
2000 C T F F F
3000 C T F F F
4000 C T F F
5000 C T F
6000 C T F
7000 C T F
8000 C T F
9000 C T F
10000 C T F
11000 C T F
12000 C T F
13000 C T F
14000 C T F
15000 C T F
16000 C T F
17000 C T F
Continued on Next Page. . .
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Table J.35 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
18000 C T F
19000 C T F
20000 C T F
21000 C T F
22000 C T F
23000 C T F
24000 C T F
25000 C T F
26000 C T F
27000 C T F
28000 C T F
29000 C T F
30000 C T F
31000 C T F
32000 C T F
33000 C T F
34000 C T F
35000 C T F
Continued on Next Page. . .
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Table J.35 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
36000 C T F
37000 C T F
38000 C T F
39000 C T F
40000 C T F
Table J.36: Mutation rate of 0.05
FFE(s) U/C U/T U/F C/T C/F T/F
1000 C T F F F
2000 C T F F F
3000 C T F F F
4000 C T F F
5000 C T F F
6000 C T F F
Continued on Next Page. . .
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Table J.36 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
7000 C T F F
8000 C T F F
9000 C T F F
10000 C T F F
11000 C T F F
12000 C T F F
13000 C T F F
14000 C T F F
15000 C T F F
16000 C T F F
17000 C T F F
18000 C T F F
19000 C T F F
20000 C T F F
21000 C T F F
22000 C T F F
23000 C T F F
24000 C T F F
Continued on Next Page. . .
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Table J.36 – Continued
FFE(s) U/C U/T U/F C/T C/F T/F
25000 C T F F
26000 C T F F
27000 C T F F
28000 C T F F
29000 C T F F
30000 C T F F
31000 C T F F
32000 C T F F F
33000 C T F F
34000 C T F F
35000 C T F F F
36000 C T F F F
37000 C T F F
38000 C T F F F
39000 C T F F F
40000 C T F F F
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